Irinotecan Clinical Trials (2026): 1,344 Studies for Colorectal Cancer & Metastatic Colorectal Cancer

Hipa.ai Research · Source: ClinicalTrials.gov / AACT

Synced daily from ClinicalTrials.gov via AACT. Last sync: .

1,344 Irinotecan clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 436 indications (including Colorectal Cancer & Metastatic Colorectal Cancer) and 177,253 total planned enrollment. 172 Phase 3 Irinotecan trials and 684 Phase 2, 15 Phase 4 are listed. 257 Irinotecan clinical trials are actively recruiting at 2,591 U.S. sites across 51 states. Most recent activity: NCT06450041 (Dec 2038).

Where to Participate: All Irinotecan Trial Sites in the U.S. (2,591 sites across 51 states)

Every actively recruiting Irinotecantrial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.

StateFacilityCityTrialMap
ALChildren's Hospital of AlabamaBirmingham35233NCT04322318Map
ALChildren's Hospital of AlabamaBirmingham35233NCT06172296Map
ALChildren's Hospital of AlabamaBirmingham35233NCT06401330Map
ALChildren's Hospital of AlabamaBirmingham35233NCT06620302Map
ALUniversity of Alabama at BirminghamBirmingham35294-3300NCT04657068Map
ALUniversity of Alabama at BirminghamBirmingham35294NCT01042379Map
ALUniversity of Alabama at Birmingham (Children's of Alabama)Birmingham35233NCT07194044Map
ALUniversity of Alabama/Children's of AlabamaBirmingham35233NCT06541262Map
ALUSA Health Strada Patient Care CenterMobile36604NCT04322318Map
ALUSA Health Strada Patient Care CenterMobile36604NCT06172296Map
ALUSA Health Strada Patient Care CenterMobile36604NCT06401330Map
AKAlaska Breast Care and Surgery LLCAnchorage99508NCT04205968Map
AKAlaska Breast Care and Surgery LLCAnchorage99508NCT05677490Map
AKAlaska Breast Care and Surgery LLCAnchorage99508NCT06998940Map
AKAlaska Oncology and Hematology LLCAnchorage99508NCT04205968Map
AKAlaska Oncology and Hematology LLCAnchorage99508NCT05677490Map
AKAlaska Oncology and Hematology LLCAnchorage99508NCT06998940Map
AKAlaska Women's Cancer CareAnchorage99508NCT04205968Map
AKAlaska Women's Cancer CareAnchorage99508NCT05677490Map
AKAlaska Women's Cancer CareAnchorage99508NCT06998940Map
AKAnchorage Associates in Radiation MedicineAnchorage98508NCT04205968Map
AKAnchorage Associates in Radiation MedicineAnchorage98508NCT05677490Map
AKAnchorage Associates in Radiation MedicineAnchorage98508NCT06998940Map
AKKatmai Oncology GroupAnchorage99508NCT04205968Map
AKKatmai Oncology GroupAnchorage99508NCT05677490Map
AKKatmai Oncology GroupAnchorage99508NCT06998940Map
AKProvidence Alaska Medical CenterAnchorage99508NCT04205968Map
AKProvidence Alaska Medical CenterAnchorage99508NCT04322318Map
AKProvidence Alaska Medical CenterAnchorage99508NCT05677490Map
AKProvidence Alaska Medical CenterAnchorage99508NCT06401330Map
AKProvidence Alaska Medical CenterAnchorage99508NCT06998940Map
AZIronwood Cancer and Research CenterChandler85224NCT06750094Map
AZArizona Center for Cancer Care - GilbertGilbert85297NCT06958328Map
AZBanner MD Anderson Cancer CenterGilbert85234NCT05863195Map
AZBanner MD Anderson Cancer CenterGilbert85234NCT06662786Map
AZBanner MD Anderson Cancer CenterGilbert85234NCT06750094Map
AZBanner MD Anderson Cancer CenterGilbert85234NCT06958328Map
AZKingman Regional Medical CenterKingman86401NCT04205968Map
AZKingman Regional Medical CenterKingman86401NCT05677490Map
AZBanner Children's at DesertMesa85202NCT04322318Map
AZBanner Children's at DesertMesa85202NCT06172296Map
AZBanner Children's at DesertMesa85202NCT06401330Map
AZArizona Center for Cancer Care-PeoriaPeoria85381NCT06958328Map
AZArizona Center for Cancer Care - PhoenixPhoenix85027NCT06958328Map
AZBanner-University Medical Center PhoenixPhoenix85006NCT05863195Map
AZCancer Center at Saint Joseph'sPhoenix85004NCT06998940Map
AZPhoenix Children's HospitalPhoenix85016NCT05999994Map
AZPhoenix Children's HospitalPhoenix85016NCT05999994Map
AZPhoenix Children's HospitalPhoenix85016NCT06541262Map
AZPhoenix Childrens HospitalPhoenix85016NCT04322318Map
AZPhoenix Childrens HospitalPhoenix85016NCT06172296Map
AZPhoenix Childrens HospitalPhoenix85016NCT06401330Map
AZArizona Center for Cancer Care - ScottsdaleScottsdale85258NCT06958328Map
AZMayo Clinic (Arizona)Scottsdale85259NCT04657068Map
AZResearch SiteScottsdale85259NCT06792695Map
AZBanner Boswell Medical CenterSun City85351NCT05863195Map
AZArizona Center for Cancer Care-SurpriseSurprise85374NCT06958328Map
AZArizona Center for Cancer CareTempe85284NCT06958328Map
AZBanner University Medical Center - TucsonTucson85719NCT04322318Map
AZBanner University Medical Center - TucsonTucson85719NCT06172296Map
AZUniversity of Arizona Cancer Center-University of Arizona Cancer Center ( Site 4927)Tucson85719NCT05319730Map
ARHighlands Oncology Group - FayettevilleFayetteville72703NCT06998940Map
ARMercy Hospital Fort SmithFort Smith72903NCT04205968Map
ARMercy Hospital Fort SmithFort Smith72903NCT05677490Map
ARNEA Baptist Memorial Hospital and Fowler Family Cancer Center - JonesboroJonesboro72401NCT04205968Map
ARNEA Baptist Memorial Hospital and Fowler Family Cancer Center - JonesboroJonesboro72401NCT06958328Map
ARNEA Baptist Memorial Hospital and Fowler Family Cancer Center - JonesboroJonesboro72401NCT06998940Map
ARSt. Bernard's Medical CenterJonesboro72401NCT06662786Map
ARSt. Bernard's Medical CenterJonesboro72401NCT06750094Map
ARArkansas Children's HospitalLittle Rock72202-3591NCT04322318Map
ARArkansas Children's HospitalLittle Rock72202-3591NCT06172296Map
ARArkansas Children's HospitalLittle Rock72202-3591NCT06401330Map
ARCARTI Cancer CenterLittle Rock72205NCT04205968Map
ARCARTI Cancer CenterLittle Rock72205NCT05677490Map
ARUniversity of Arkansas - Winthrop P. Rockefeller Cancer InstituteLittle Rock72205NCT04657068Map
ARHighlands Oncology Group - RogersRogers72758NCT06998940Map
ARHighlands Oncology GroupSpringdale72762NCT06662786Map
ARHighlands Oncology GroupSpringdale72762NCT06750094Map
ARHighlands Oncology GroupSpringdale72762NCT06998940Map
CAKaiser Permanente-AnaheimAnaheim92806NCT04205968Map
CAKaiser Permanente-Deer Valley Medical CenterAntioch94531NCT05677490Map
CAMission Hope Medical Oncology - Arroyo GrandeArroyo Grande93420NCT06998940Map
CAPCR OncologyArroyo Grande93420NCT04205968Map
CAPCR OncologyArroyo Grande93420NCT05677490Map
CASutter Auburn Faith HospitalAuburn95602NCT05677490Map
CASutter Auburn Faith HospitalAuburn95602NCT06998940Map
CASutter Cancer Centers Radiation Oncology Services-AuburnAuburn95603NCT05677490Map
CASutter Cancer Centers Radiation Oncology Services-AuburnAuburn95603NCT06998940Map
CAAIS Cancer Center at San Joaquin Community HospitalBakersfield93301NCT06958328Map
CACBCC Global ResearchBakersfield93309NCT06662786Map
CACBCC Global ResearchBakersfield93309NCT06750094Map
CAKaiser Permanente-Baldwin ParkBaldwin Park91706NCT04205968Map
CAKaiser Permanente-BellflowerBellflower90706NCT04205968Map
CAAlta Bates Summit Medical Center-Herrick CampusBerkeley94704NCT05677490Map
CAAlta Bates Summit Medical Center-Herrick CampusBerkeley94704NCT06958328Map
CAAlta Bates Summit Medical Center-Herrick CampusBerkeley94704NCT06998940Map
CAPrecision NextGen Oncology and ResearchBeverly Hills90212NCT03715933Map
CAProvidence Saint Joseph Medical Center/Disney Family Cancer CenterBurbank91505NCT04205968Map
CAProvidence Saint Joseph Medical Center/Disney Family Cancer CenterBurbank91505NCT05677490Map
CAProvidence Saint Joseph Medical Center/Disney Family Cancer CenterBurbank91505NCT06998940Map
CAMills-Peninsula Medical CenterBurlingame94010NCT05677490Map
CAMills-Peninsula Medical CenterBurlingame94010NCT06958328Map
CAMills-Peninsula Medical CenterBurlingame94010NCT06998940Map
CASutter Cancer Centers Radiation Oncology Services-Cameron ParkCameron Park95682NCT05677490Map
CASutter Cancer Centers Radiation Oncology Services-Cameron ParkCameron Park95682NCT06958328Map
CASutter Cancer Centers Radiation Oncology Services-Cameron ParkCameron Park95682NCT06998940Map
CAMercy Cancer Center - CarmichaelCarmichael95608NCT06998940Map
CAMercy San Juan Medical CenterCarmichael95608NCT06998940Map
CAEden Hospital Medical CenterCastro Valley94546NCT05677490Map
CAEden Hospital Medical CenterCastro Valley94546NCT06998940Map
CAUC Irvine Health Cancer Center-NewportCosta Mesa92627NCT05677490Map
CASutter Davis HospitalDavis95616NCT05677490Map
CASutter Davis HospitalDavis95616NCT06998940Map
CAUniversity of California - Davis, Comprehensive Cancer CenterDavis95817NCT01042379Map
CAKaiser Permanente Downey Medical CenterDowney90242NCT04322318Map
CAKaiser Permanente Downey Medical CenterDowney90242NCT06172296Map
CAKaiser Permanente Downey Medical CenterDowney90242NCT06401330Map
CACity of HopeDuarte91010NCT03715933Map
CACity of HopeDuarte91010NCT01042379Map
CACity of HopeDuarte91010NCT06586515Map
CACity of Hope Comprehensive Cancer CenterDuarte91010NCT06172296Map
CACity of Hope Medical CenterDuarte91010NCT04329494Map
CACity of Hope National Medical CenterDuarte91010NCT05382559Map
CAKaiser Permanente DublinDublin94568NCT05677490Map
CAMercy Cancer Center - Elk GroveElk Grove95758NCT06998940Map
CAKaiser Permanente-FontanaFontana92335NCT04205968Map
CAKaiser Permanente-FremontFremont94538NCT05677490Map
CAPalo Alto Medical Foundation-FremontFremont94538NCT05677490Map
CAPalo Alto Medical Foundation-FremontFremont94538NCT06958328Map
CAPalo Alto Medical Foundation-FremontFremont94538NCT06998940Map
CAFresno Cancer CenterFresno93720NCT05677490Map
CAKaiser Permanente Fresno Orchard PlazaFresno93720NCT05677490Map
CAKaiser Permanente-FresnoFresno93720NCT05677490Map
CACrosson Cancer Institute at Providence St. Jude Medical Center in FullertonFullerton92835NCT07409272Map
CAProvidence Medical FoundationFullerton92835NCT06644781Map
CALos Angeles Cancer NetworkGlendale91204NCT06662786Map
CALos Angeles Cancer NetworkGlendale91204NCT06750094Map
CAKaiser Permanente South BayHarbor City90710NCT04205968Map
CAKaiser Permanente-IrvineIrvine92618NCT04205968Map
CAUCI Health - Chao Family Comprehensive Cancer Center and Ambulatory CareIrvine92612NCT05677490Map
CAUCI Health - Chao Family Comprehensive Cancer Center and Ambulatory CareIrvine92612NCT06958328Map
CAUC San Diego Moores Cancer CenterLa Jolla92093NCT06958328Map
CAUniversity of California San DiegoLa Jolla92093-0698NCT01042379Map
CALoma Linda University Medical CenterLoma Linda92354NCT04322318Map
CALoma Linda University Medical CenterLoma Linda92354NCT06172296Map
CALoma Linda University Medical CenterLoma Linda92354NCT06401330Map
CAMiller Children's and Women's Hospital Long BeachLong Beach90806NCT04322318Map
CAMiller Children's and Women's Hospital Long BeachLong Beach90806NCT06172296Map
CAMiller Children's and Women's Hospital Long BeachLong Beach90806NCT06401330Map
CACancer and Blood Specialty ClinicLos Alamitos90720NCT06662786Map
CACancer and Blood Specialty ClinicLos Alamitos90720NCT06750094Map
CACedars-Sinai Medical CenterLos Angeles90048NCT04322318Map
CACedars-Sinai Medical CenterLos Angeles90048NCT06172296Map
CACedars-Sinai Medical CenterLos Angeles90048NCT06401330Map
CAChildren's Hospital Los AngelesLos Angeles90027NCT04322318Map
CAChildren's Hospital Los AngelesLos Angeles90027NCT06172296Map
CAChildren's Hospital Los AngelesLos Angeles90027-0700NCT06450041Map
CAChildren's Hospital Los AngelesLos Angeles90027NCT06620302Map
CAKaiser Permanente Los Angeles Medical CenterLos Angeles90027NCT04205968Map
CAKaiser Permanente West Los AngelesLos Angeles90034NCT04205968Map
CAKeck Medicine of USC KoreatownLos Angeles90020NCT05677490Map
CALos Angeles General Medical CenterLos Angeles90033NCT05677490Map
CAMattel Children's Hospital UCLALos Angeles90095NCT04322318Map
CAMattel Children's Hospital UCLALos Angeles90095NCT06172296Map
CAResearch SiteLos Angeles90089NCT06792695Map
CAUCLA Hematology/Oncology - Santa Monica ( Site 4905)Los Angeles90404NCT05319730Map
CAUniversity of California, Los Angeles UCLALos Angeles90404NCT05379595Map
CAUniversity of Southern CaliforniaLos Angeles90033NCT01042379Map
CAUSC / Norris Comprehensive Cancer CenterLos Angeles90033NCT05677490Map
CAUSC Norris Comprehensive Cancer CenterLos Angeles90033NCT04657068Map
CAUSC Norris Comprehensive Cancer CenterLos Angeles90033NCT06662786Map
CAUSC Norris Comprehensive Cancer CenterLos Angeles90033NCT06750094Map
CAValkyrie Clinical TrialsLos Angeles90067NCT03715933Map
CAYonemoto,LisaLos Angeles90095NCT05688215Map
CAValley Children's HospitalMadera93636NCT04322318Map
CAValley Children's HospitalMadera93636NCT06172296Map
CAValley Children's HospitalMadera93636NCT06401330Map
CAMercy Cancer CenterMerced95340NCT06998940Map
CAKaiser Permanente- Modesto MOB IIModesto95356NCT05677490Map
CAKaiser Permanente-ModestoModesto95356NCT05677490Map
CAMemorial Medical CenterModesto95355NCT05677490Map
CAMemorial Medical CenterModesto95355NCT06958328Map
CAMemorial Medical CenterModesto95355NCT06998940Map
CAPalo Alto Medical Foundation-Camino DivisionMountain View94040NCT05677490Map
CAPalo Alto Medical Foundation-Camino DivisionMountain View94040NCT06958328Map
CAPalo Alto Medical Foundation-Camino DivisionMountain View94040NCT06998940Map
CAPalo Alto Medical Foundation-Gynecologic OncologyMountain View94040NCT05677490Map
CAPalo Alto Medical Foundation-Gynecologic OncologyMountain View94040NCT06998940Map
CAProvidence Queen of The ValleyNapa94558NCT04205968Map
CAProvidence Queen of The ValleyNapa94558NCT05677490Map
CAProvidence Queen of The ValleyNapa94558NCT06998940Map
CAHoag Mem Hosp PresbyterianNewport Beach92663NCT07409272Map
CAHOAG Memorial Hospital PresbyterianNewport Beach92663NCT01042379Map
CAUSC Norris Oncology/Hematology-Newport BeachNewport Beach92663NCT05677490Map
CASutter Cancer Research ConsortiumNovato94945NCT05677490Map
CASutter Cancer Research ConsortiumNovato94945NCT06998940Map
CAKaiser Permanente Oakland-BroadwayOakland94611NCT05677490Map
CAKaiser Permanente-OaklandOakland94611NCT04322318Map
CAKaiser Permanente-OaklandOakland94611NCT05677490Map
CAKaiser Permanente-OaklandOakland94611NCT06172296Map
CAKaiser Permanente-OaklandOakland94611NCT06401330Map
CAUCSF Benioff Children's Hospital OaklandOakland94609NCT04322318Map
CAUCSF Benioff Children's Hospital OaklandOakland94609NCT06172296Map
CAUCSF Benioff Children's Hospital OaklandOakland94609NCT06401330Map
CAUCSF Benioff Children's Hospital OaklandOakland94609NCT06541262Map
CAKaiser Permanente-OntarioOntario91761NCT04205968Map
CAChao Family Comprehensive Cancer Center, UniversityOrange92868NCT05733689Map
CAChao Family Comprehensive Cancer Center, University of California, IrvineOrange92868NCT04920032Map
CAChildren's Hospital of Orange CountyOrange92868NCT04322318Map
CAChildren's Hospital of Orange CountyOrange92868NCT05999994Map
CAChildren's Hospital of Orange CountyOrange92868NCT06172296Map
CAChildren's Hospital of Orange CountyOrange92868NCT06401330Map
CAChildren's Hospital of Orange CountyOrange92868NCT06620302Map
CAResearch SiteOrange92868NCT06219941Map
CAUC Irvine Health/Chao Family Comprehensive Cancer CenterOrange92868NCT05677490Map
CAUC Irvine Health/Chao Family Comprehensive Cancer CenterOrange92868NCT06958328Map
CAUniversity of California Irvine Medical CenterOrange92868NCT05365581Map
CALucile Packard Children's Hospital Stanford UniversityPalo Alto94304NCT04322318Map
CALucile Packard Children's Hospital Stanford UniversityPalo Alto94304NCT06172296Map
CALucile Packard Children's Hospital Stanford UniversityPalo Alto94304NCT06401330Map
CAPalo Alto Medical Foundation Health CarePalo Alto94301NCT05677490Map
CAPalo Alto Medical Foundation Health CarePalo Alto94301NCT06958328Map
CAPalo Alto Medical Foundation Health CarePalo Alto94301NCT06998940Map
CAResearch SitePalo Alto94304NCT06219941Map
CAStanford Cancer Institute Palo AltoPalo Alto94304NCT06958328Map
CAStanford UniversityPalo Alto94304NCT06023641Map
CAKaiser Permanente - Panorama CityPanorama City91402NCT04205968Map
CAKaiser Permanente-Rancho Cordova Cancer CenterRancho Cordova95670NCT05677490Map
CAEisenhower Medical CenterRancho Mirage92270NCT05677490Map
CAKaiser Permanente- Marshall Medical OfficesRedwood City94063NCT05677490Map
CAKaiser Permanente-RichmondRichmond94801NCT05677490Map
CAKaiser Permanente-RiversideRiverside92505NCT04205968Map
CAMercy Cancer Center - RocklinRocklin95765NCT06998940Map
CARohnert Park Cancer CenterRohnert Park94928NCT05677490Map
CAKaiser Permanente-RosevilleRoseville95661NCT05677490Map
CASutter Cancer Centers Radiation Oncology Services-RosevilleRoseville95661NCT05677490Map
CASutter Cancer Centers Radiation Oncology Services-RosevilleRoseville95661NCT06958328Map
CASutter Cancer Centers Radiation Oncology Services-RosevilleRoseville95661NCT06998940Map
CASutter Roseville Medical CenterRoseville95661NCT05677490Map
CASutter Roseville Medical CenterRoseville95661NCT06958328Map
CASutter Roseville Medical CenterRoseville95661NCT06998940Map
CAThe Permanente Medical Group-Roseville Radiation OncologyRoseville95678NCT05677490Map
CAKaiser Permanente Downtown CommonsSacramento95814NCT05677490Map
CAKaiser Permanente-South SacramentoSacramento95823NCT05677490Map
CAMercy Cancer Center - SacramentoSacramento95816NCT06998940Map
CASouth Sacramento Cancer CenterSacramento95823NCT05677490Map
CASutter Medical Center SacramentoSacramento95816NCT05677490Map
CASutter Medical Center SacramentoSacramento95816NCT06172296Map
CASutter Medical Center SacramentoSacramento95816NCT06958328Map
CASutter Medical Center SacramentoSacramento95816NCT06998940Map
CAUniversity of California Davis Comprehensive Cancer CenterSacramento95817NCT04322318Map
CAUniversity of California Davis Comprehensive Cancer CenterSacramento95817NCT06172296Map
CAUniversity of California Davis Comprehensive Cancer CenterSacramento95817NCT06401330Map
CAInvestigative Site #101San Diego92037NCT06974110Map
CAKaiser Permanente-San Diego MissionSan Diego92108NCT04205968Map
CAKaiser Permanente-San Diego ZionSan Diego92120NCT04205968Map
CARady Children's HospitalSan Diego92123NCT06541262Map
CARady Children's Hospital - San DiegoSan Diego92123NCT04322318Map
CARady Children's Hospital - San DiegoSan Diego92123NCT06172296Map
CARady Children's Hospital - San DiegoSan Diego92123NCT06401330Map
CACalifornia Pacific Medical Center-Pacific CampusSan Francisco94115NCT05677490Map
CACalifornia Pacific Medical Center-Pacific CampusSan Francisco94115NCT06958328Map
CACalifornia Pacific Medical Center-Pacific CampusSan Francisco94115NCT06998940Map
CAKaiser Permanente-San FranciscoSan Francisco94115NCT05677490Map
CAUCSF Medical Center-Mission BaySan Francisco94158NCT04322318Map
CAUCSF Medical Center-Mission BaySan Francisco94158NCT06172296Map
CAUCSF Medical Center-Mission BaySan Francisco94158NCT06401330Map
CAUCSF Medical Center-Mission BaySan Francisco94158NCT06620302Map
CAUniversity of California San Francisco (UCSF)San Francisco94115NCT01042379Map
CAUniversity of California, San FranciscoSan Francisco94143NCT05694715Map
CAUniversity of California, San Francisco (UCSF)San Francisco94110NCT03715933Map
CAKaiser Permanente-Santa Teresa-San JoseSan Jose95119NCT05677490Map
CAKaiser Permanente San LeandroSan Leandro94577NCT05677490Map
CAPacific Central Coast Health Center-San Luis ObispoSan Luis Obispo93401NCT06998940Map
CAKaiser Permanente-San MarcosSan Marcos92078NCT04205968Map
CAMills Health CenterSan Mateo94401NCT05677490Map
CAMills Health CenterSan Mateo94401NCT06958328Map
CAMills Health CenterSan Mateo94401NCT06998940Map
CAKaiser San Rafael-GallinasSan Rafael94903NCT05677490Map
CARidley-Tree Cancer CenterSanta Barbara93105NCT05677490Map
CARidley-Tree Cancer CenterSanta Barbara93105NCT06958328Map
CARidley-Tree Cancer CenterSanta Barbara93105NCT06998940Map
CASansum ClinicSanta Barbara93105NCT04657068Map
CAKaiser Permanente Medical Center - Santa ClaraSanta Clara95051NCT05677490Map
CAPalo Alto Medical Foundation-Santa CruzSanta Cruz95065NCT05677490Map
CAPalo Alto Medical Foundation-Santa CruzSanta Cruz95065NCT06998940Map
CASanta Cruz Radiation Oncology Medical GroupSanta Cruz95065NCT05677490Map
CASanta Cruz Radiation Oncology Medical GroupSanta Cruz95065NCT06998940Map
CAMission Hope Medical Oncology - Santa MariaSanta Maria93444NCT06998940Map
CASarcoma Oncology CenterSanta Monica90403NCT03715933Map
CAUCLASanta Monica90404NCT06662786Map
CAUCLASanta Monica90404NCT06750094Map
CAUCLA Santa Monica Hematology OncologySanta Monica90404NCT05382559Map
CAUniversity of California, Los Angeles (UCLA)Santa Monica90404NCT06586515Map
CAKaiser Permanente-Santa RosaSanta Rosa95403NCT05677490Map
CAProvidence Medical FoundationSanta Rosa95403NCT04657068Map
CAProvidence Medical FoundationSanta Rosa95403NCT06662786Map
CAProvidence Medical FoundationSanta Rosa95403NCT06750094Map
CAProvidence Medical Foundation - Santa RosaSanta Rosa95403NCT04205968Map
CAProvidence Medical Foundation - Santa RosaSanta Rosa95403NCT05677490Map
CAProvidence Medical Foundation - Santa RosaSanta Rosa95403NCT06998940Map
CAProvidence Santa Rosa Memorial HospitalSanta Rosa95405NCT04205968Map
CAProvidence Santa Rosa Memorial HospitalSanta Rosa95405NCT05677490Map
CAProvidence Santa Rosa Memorial HospitalSanta Rosa95405NCT06998940Map
CAResearch SiteSanta Rosa95403NCT06219941Map
CASutter Pacific Medical FoundationSanta Rosa95403NCT05677490Map
CASutter Pacific Medical FoundationSanta Rosa95403NCT06958328Map
CASutter Pacific Medical FoundationSanta Rosa95403NCT06998940Map
CAKaiser Permanente Cancer Treatment CenterSouth San Francisco94080NCT05677490Map
CAKaiser Permanente-South San FranciscoSouth San Francisco94080NCT05677490Map
CAKaiser Permanente-StocktonStockton95210NCT05677490Map
CASaint Joseph's Medical CenterStockton95204NCT06998940Map
CAPalo Alto Medical Foundation-SunnyvaleSunnyvale94086NCT05677490Map
CAPalo Alto Medical Foundation-SunnyvaleSunnyvale94086NCT06958328Map
CAPalo Alto Medical Foundation-SunnyvaleSunnyvale94086NCT06998940Map
CATorrance Memorial Physicians NetworkTorrance90505NCT06662786Map
CATorrance Memorial Physicians NetworkTorrance90505NCT06750094Map
CAKaiser Permanente Medical Center-VacavilleVacaville95688NCT05677490Map
CAKaiser Permanente-VallejoVallejo94589NCT05677490Map
CASutter Solano Medical Center/Cancer CenterVallejo94589NCT05677490Map
CASutter Solano Medical Center/Cancer CenterVallejo94589NCT06958328Map
CASutter Solano Medical Center/Cancer CenterVallejo94589NCT06998940Map
CAKaiser Permanente-Walnut CreekWalnut Creek94596NCT05677490Map
CAWoodland Memorial HospitalWoodland95695NCT06998940Map
CAKaiser Permanente-Woodland HillsWoodland Hills91367NCT04205968Map
COChildren's Hospital ColoradoAurora80045NCT04322318Map
COChildren's Hospital ColoradoAurora80045NCT06172296Map
COChildren's Hospital ColoradoAurora80045NCT06401330Map
COChildren's Hospital ColoradoAurora80045NCT06620302Map
COChildren's Hospital Colorado Anschutz MedicalAurora80045NCT07549321Map
COUCHealth University of Colorado HospitalAurora80045NCT05863195Map
COUniversity of Colorado Cancer CenterAurora80045NCT01042379Map
COUniversity of Colorado Denver Anschultz Medical CampusAurora80045NCT06750094Map
COUniversity of Colorado HospitalAurora80045NCT03715933Map
COIntermountain Health Platte Valley HospitalBrighton80601NCT05677490Map
COMemorial Hospital NorthColorado Springs80920NCT06958328Map
COPenrose-Saint Francis HealthcareColorado Springs80907NCT06998940Map
CORocky Mountain Cancer Centers-PenroseColorado Springs80907NCT06958328Map
CORocky Mountain Cancer Centers-PenroseColorado Springs80907NCT06998940Map
COSaint Francis Cancer CenterColorado Springs80923NCT06998940Map
COUCHealth Memorial Hospital CentralColorado Springs80909NCT06958328Map
COAdventHealth PorterDenver80210NCT06958328Map
COCancer Center of Colorado at Sloan's LakeDenver80204NCT04205968Map
COCancer Center of Colorado at Sloan's LakeDenver80204NCT05677490Map
COChildren's Hospital of ColoradoDenver80218NCT05999994Map
CODenver HealthONE Drug Development UnitDenver80218NCT05382559Map
CONational Jewish Health-Main CampusDenver80206NCT04205968Map
CONational Jewish Health-Main CampusDenver80206NCT05677490Map
CORocky Mountain Cancer CenterDenver80218NCT04657068Map
CORocky Mountain Cancer Center - PrimaryDenver80218NCT07011576Map
CORocky Mountain Cancer CentersDenver80218NCT06662786Map
CORocky Mountain Cancer CentersDenver80218NCT06750094Map
CORocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical CenterDenver80218NCT04322318Map
CORocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical CenterDenver80218NCT06401330Map
COSaint Joseph Hospital - Cancer Centers of ColoradoDenver80218NCT04205968Map
COSaint Joseph Hospital - Cancer Centers of ColoradoDenver80218NCT05677490Map
COSarah Cannon Research Institute at HealthOneDenver80218NCT06586515Map
COSarah Cannon Research Institute at HealthONEDenver80218NCT04657068Map
COCommonSpirit Cancer Center MercyDurango81301NCT06998940Map
COMercy Medical CenterDurango81301NCT06998940Map
COCancer Care and Hematology-Fort CollinsFort Collins80528NCT05677490Map
COPoudre Valley HospitalFort Collins80524NCT05677490Map
COLutheran Hospital - Cancer Centers of ColoradoGolden80401NCT05677490Map
CONational Jewish Health-Western Hematology OncologyGolden80401NCT04205968Map
CONational Jewish Health-Western Hematology OncologyGolden80401NCT05677490Map
COSaint Mary's Hospital and Regional Medical CenterGrand Junction81501NCT04205968Map
COSaint Mary's Hospital and Regional Medical CenterGrand Junction81501NCT05677490Map
COUCHealth Greeley HospitalGreeley80631NCT05677490Map
COGood Samaritan Hospital - Cancer Centers of ColoradoLafayette80026NCT04205968Map
COGood Samaritan Hospital - Cancer Centers of ColoradoLafayette80026NCT05677490Map
COSaint Anthony HospitalLakewood80228NCT06998940Map
COAdventHealth LittletonLittleton80122NCT06958328Map
COLongmont United HospitalLongmont80501NCT06998940Map
COMedical Center of the RockiesLoveland80538NCT05677490Map
COAdventHealth ParkerParker80138NCT06958328Map
COSaint Mary Corwin Medical CenterPueblo81004NCT06998940Map
CONational Jewish Health-Northern Hematology OncologyThornton80260NCT04205968Map
CONational Jewish Health-Northern Hematology OncologyThornton80260NCT05677490Map
COSaint Anthony North HospitalWestminster80023NCT06998940Map
COIntermountain Health Lutheran HospitalWheat Ridge80401NCT04205968Map
COIntermountain Health Lutheran HospitalWheat Ridge80401NCT05677490Map
CTHartford HealthCare - AvonAvon06001NCT05677490Map
CTDanbury HospitalDanbury06810NCT06958328Map
CTSmilow Cancer Hospital-Derby Care CenterDerby06418NCT04205968Map
CTSmilow Cancer Hospital Care Center-FairfieldFairfield06824NCT04205968Map
CTSmilow Cancer Hospital Care Center at GreenwichGreenwich06830NCT04205968Map
CTSmilow Cancer Hospital Care Center - GuilfordGuilford06437NCT04205968Map
CTSmilow Cancer Hospital-Hamden Care CenterHamden06518NCT06958328Map
CTConnecticut Children's Medical CenterHartford06106NCT04322318Map
CTConnecticut Children's Medical CenterHartford06106NCT06172296Map
CTConnecticut Children's Medical CenterHartford06106NCT06401330Map
CTHartford HospitalHartford06102NCT05677490Map
CTSmilow Cancer Hospital Care Center at Saint FrancisHartford06105NCT04205968Map
CTHartford HealthCare - ManchesterManchester06042NCT05677490Map
CTMidstate Medical CenterMeriden06451NCT05677490Map
CTThe Hospital of Central ConnecticutNew Britain06050NCT05677490Map
CTSmilow Cancer Center at Yale New Haven HospitalNew Haven06520-8028NCT05382559Map
CTSmilow Cancer Center/Yale-New Haven HospitalNew Haven06510NCT04205968Map
CTYale Cancer CenterNew Haven06510NCT01042379Map
CTYale UniversityNew Haven06520NCT04322318Map
CTYale UniversityNew Haven06520NCT06172296Map
CTYale UniversityNew Haven06520NCT06401330Map
CTYale University School Of MedicineNew Haven06519NCT06662786Map
CTYale-New Haven Hospital North Haven Medical CenterNorth Haven06473NCT04205968Map
CTNorwalk HospitalNorwalk06856NCT06958328Map
CTEastern Connecticut Hematology & Oncology Assoc.Norwich06360NCT06750094Map
CTSmilow Cancer Hospital-Orange Care CenterOrange06477NCT04205968Map
CTStamford Hospital/Bennett Cancer CenterStamford06904NCT06998940Map
CTSmilow Cancer Hospital-Torrington Care CenterTorrington06790NCT04205968Map
CTSmilow Cancer Hospital Care Center-TrumbullTrumbull06611NCT04205968Map
CTSmilow Cancer Hospital-Waterbury Care CenterWaterbury06708NCT04205968Map
CTSmilow Cancer Hospital Care Center - WaterfordWaterford06385NCT04205968Map
DEBeebe Medical CenterLewes19958NCT05677490Map
DEBeebe Medical CenterLewes19958NCT06998940Map
DEBeebe South Coastal Health CampusMillville19967NCT05677490Map
DEBeebe South Coastal Health CampusMillville19967NCT06998940Map
DEChristiana Care Health System-Christiana HospitalNewark19718NCT05677490Map
DEChristiana Care Health System-Christiana HospitalNewark19718NCT06958328Map
DEChristiana Care Health System-Christiana HospitalNewark19718NCT06998940Map
DEHelen F Graham Cancer CenterNewark19713NCT05677490Map
DEHelen F Graham Cancer CenterNewark19713NCT06958328Map
DEHelen F Graham Cancer CenterNewark19713NCT06998940Map
DEMedical Oncology Hematology Consultants PANewark19713NCT05677490Map
DEMedical Oncology Hematology Consultants PANewark19713NCT06958328Map
DEMedical Oncology Hematology Consultants PANewark19713NCT06998940Map
DEBeebe Health CampusRehoboth Beach19971NCT05677490Map
DEBeebe Health CampusRehoboth Beach19971NCT06998940Map
DEAlfred I duPont Hospital for ChildrenWilmington19803NCT04322318Map
DEAlfred I duPont Hospital for ChildrenWilmington19803NCT06172296Map
DEAlfred I duPont Hospital for ChildrenWilmington19803NCT06401330Map
DEChristiana Care Health System-Wilmington HospitalWilmington19801NCT05677490Map
DEChristiana Care Health System-Wilmington HospitalWilmington19801NCT06958328Map
DEChristiana Care Health System-Wilmington HospitalWilmington19801NCT06998940Map
DCChildren's National Medical CenterWashington D.C.20010NCT04322318Map
DCChildren's National Medical CenterWashington D.C.20010NCT05999994Map
DCChildren's National Medical CenterWashington D.C.20010NCT06172296Map
DCChildren's National Medical CenterWashington D.C.20010NCT06401330Map
DCChildren's National Medical CenterWashington D.C.20010NCT06620302Map
DCGeorge Washington University Medical CenterWashington D.C.20037NCT05677490Map
DCGeorgetown Univ Medical Center Lombardi Cancer CenterWashington D.C.20007NCT06662786Map
DCGeorgetown University HospitalWashington D.C.20007NCT05382559Map
DCGeorgetown University Medical CenterWashington D.C.20007NCT01042379Map
DCMedStar Georgetown University HospitalWashington D.C.20007NCT04322318Map
DCMedStar Georgetown University HospitalWashington D.C.20007NCT05677490Map
DCMedStar Washington Hospital CenterWashington D.C.20010NCT05677490Map
DCMedStar Washington Hospital CenterWashington D.C.20010NCT06958328Map
DCSibley Memorial HospitalWashington D.C.20016NCT06586515Map
DCSibley Memorial HospitalWashington D.C.20016NCT05677490Map
FLMount Sinai Comprehensive Cancer Center at AventuraAventura33180NCT05677490Map
FLUM Sylvester Comprehensive Cancer Center at AventuraAventura33180NCT05863195Map
FLSchulze Family Foundation Cancer Clinic - Bonita Health CenterBonita Springs34135NCT05677490Map
FLUM Sylvester Comprehensive Cancer Center at Coral GablesCoral Gables33146NCT05863195Map
FLUM Sylvester Comprehensive Cancer Center at Deerfield BeachDeerfield Beach33442NCT05863195Map
FLBroward Health Medical CenterFort Lauderdale33316NCT04322318Map
FLBroward Health Medical CenterFort Lauderdale33316NCT06172296Map
FLBroward Health Medical CenterFort Lauderdale33316NCT06401330Map
FLHoly Cross HospitalFort Lauderdale33308NCT04205968Map
FLHoly Cross HospitalFort Lauderdale33308NCT05677490Map
FLFlorida Cancer SpecialistsFort Myers33901NCT04657068Map
FLFlorida Cancer Specialists SouthFort Myers33901NCT06662786Map
FLFlorida Cancer Specialists SouthFort Myers33901NCT06750094Map
FLGolisano Children's Hospital of Southwest FloridaFort Myers33908NCT04322318Map
FLGolisano Children's Hospital of Southwest FloridaFort Myers33908NCT05999994Map
FLGolisano Children's Hospital of Southwest FloridaFort Myers33908NCT06172296Map
FLGolisano Children's Hospital of Southwest FloridaFort Myers33908NCT06401330Map
FLRegional Cancer Center-Lee Memorial Health SystemFort Myers33905NCT05677490Map
FLUF Health Cancer Institute - GainesvilleGainesville32610NCT04322318Map
FLUF Health Cancer Institute - GainesvilleGainesville32610NCT06172296Map
FLUF Health Cancer Institute - GainesvilleGainesville32610NCT06401330Map
FLUF Health Cancer Institute - GainesvilleGainesville32610NCT06958328Map
FLUniversity of FloridaGainesville32610NCT05669339Map
FLUniversity of FloridaGainesville32611NCT06541262Map
FLUniversity of FloridaGainesville32610NCT07194044Map
FLUniversity of Florida, Davis Cancer CenterGainesville32610NCT05382559Map
FLMemorial Regional Hospital/Joe DiMaggio Children's HospitalHollywood33021NCT04322318Map
FLMemorial Regional Hospital/Joe DiMaggio Children's HospitalHollywood33021NCT05677490Map
FLMemorial Regional Hospital/Joe DiMaggio Children's HospitalHollywood33021NCT06172296Map
FLMemorial Regional Hospital/Joe DiMaggio Children's HospitalHollywood33021NCT06401330Map
FLUM Sylvester Comprehensive Cancer Center at HollywoodHollywood33021NCT05863195Map
FLBaptist MD Anderson Cancer InstituteJacksonville32207NCT07409272Map
FLCancer Specialists of North FloridaJacksonville32256NCT04657068Map
FLMayo Clinic (Florida)Jacksonville32224NCT04657068Map
FLMayo Clinic in FloridaJacksonville32224-9980NCT04329494Map
FLMayo Clinic in FloridaJacksonville32224NCT05999994Map
FLNemours Children's Clinic-JacksonvilleJacksonville32207NCT04322318Map
FLNemours Children's Clinic-JacksonvilleJacksonville32207NCT06172296Map
FLNemours Children's Clinic-JacksonvilleJacksonville32207NCT06401330Map
FLJupiter Medical CenterJupiter33458NCT05677490Map
FLFlorida Cancer SpecialistLake Mary32746NCT05382559Map
FLThe Watson ClinicLakeland33805NCT05677490Map
FLThe Watson ClinicLakeland33805NCT06998940Map
FLNicklaus Children's HospitalMiami33155NCT04322318Map
FLNicklaus Children's HospitalMiami33155NCT06172296Map
FLNicklaus Children's HospitalMiami33155NCT06401330Map
FLNicklaus Children's HospitalMiami33155NCT06541262Map
FLUM Sylvester Comprehensive Cancer Center at KendallMiami33176NCT05863195Map
FLUniversity of MiamiMiami33136NCT05412082Map
FLUniversity of MiamiMiami33136NCT07096362Map
FLUniversity of MiamiMiami33136NCT07194044Map
FLUniversity of Miami Miller School of Medicine-Sylvester Cancer CenterMiami33136NCT04322318Map
FLUniversity of Miami Miller School of Medicine-Sylvester Cancer CenterMiami33136NCT05863195Map
FLUniversity of Miami Miller School of Medicine-Sylvester Cancer CenterMiami33136NCT06172296Map
FLUniversity of Miami Miller School of Medicine-Sylvester Cancer CenterMiami33136NCT06401330Map
FLMount Sinai Medical CenterMiami Beach33140NCT05677490Map
FLAdventHealth Cancer InstituteOrlando32804NCT06750094Map
FLAdventHealth Medical Group Oncology and Hematology at OrlandoOrlando32804NCT06662786Map
FLAdventHealth OrlandoOrlando32803NCT06172296Map
FLArnold Palmer Hospital for ChildrenOrlando32806NCT04322318Map
FLArnold Palmer Hospital for ChildrenOrlando32806NCT06172296Map
FLArnold Palmer Hospital for ChildrenOrlando32806NCT06401330Map
FLArnold Palmer Hospital for ChildrenOrlando32806NCT06541262Map
FLFlorida Cancer Specialists - Lake Nona - Sarah Cannon Research InstituteOrlando32827NCT06586515Map
FLNemours Children's HospitalOrlando32827NCT04322318Map
FLNemours Children's HospitalOrlando32827NCT06172296Map
FLNemours Children's HospitalOrlando32827NCT06401330Map
FLMemorial Hospital WestPembroke Pines33028NCT05677490Map
FLNemours Children's Clinic - PensacolaPensacola32504NCT04322318Map
FLNemours Children's Clinic - PensacolaPensacola32504NCT06401330Map
FLUM Sylvester Comprehensive Cancer Center at PlantationPlantation33324NCT05863195Map
FLFlorida Cancer SpecialistsSarasota34232NCT04657068Map
FLFlorida Cancer Specialists & Research Institute SarasotaSarasota34232-6422NCT05382559Map
FLAll Children's Hospital Johns Hopkins MedicineSt. Petersburg33701NCT06541262Map
FLFlorida Cancer Specialists North RegionSt. Petersburg33701-4553NCT06662786Map
FLFlorida Cancer Specialists North RegionSt. Petersburg33701-4553NCT06750094Map
FLJohns Hopkins All Children's HospitalSt. Petersburg33701NCT04322318Map
FLJohns Hopkins All Children's HospitalSt. Petersburg33701NCT06172296Map
FLJohns Hopkins All Children's HospitalSt. Petersburg33701NCT06401330Map
FLH. Lee Moffitt Cancer Center and Research InstituteTampa33612NCT01042379Map
FLInvestigative Site #128Tampa33612NCT06974110Map
FLMoffitt Cancer CenterTampa33612NCT01042379Map
FLMoffitt Cancer CenterTampa33612NCT06835387Map
FLMoffitt Cancer CenterTampa33612NCT07194044Map
FLSaint Joseph's Hospital/Children's Hospital-TampaTampa33607NCT04322318Map
FLSaint Joseph's Hospital/Children's Hospital-TampaTampa33607NCT06401330Map
FLSt. Joseph's Children's HospitalTampa33614NCT06541262Map
FLTampa General HospitalTampa33606NCT04322318Map
FLFlorida Cancer SpecialistsWest Palm Beach33401NCT04657068Map
FLFlorida Cancer Specialists EastWest Palm Beach33401-3406NCT06662786Map
FLFlorida Cancer Specialists EastWest Palm Beach33401-3406NCT06750094Map
FLSaint Mary's Medical CenterWest Palm Beach33407NCT04322318Map
FLSaint Mary's Medical CenterWest Palm Beach33407NCT06172296Map
FLSaint Mary's Medical CenterWest Palm Beach33407NCT06401330Map
GAUniversity Cancer And Blood Center LLCAthens30607NCT06750094Map
GAChildren's Healthcare of AtlantaAtlanta30322NCT05400603Map
GAChildren's Healthcare of Atlanta - Arthur M Blank HospitalAtlanta30329NCT04322318Map
GAChildren's Healthcare of Atlanta - Arthur M Blank HospitalAtlanta30329NCT06172296Map
GAChildren's Healthcare of Atlanta - Arthur M Blank HospitalAtlanta30329NCT06401330Map
GAChildren's Healthcare of Atlanta - Arthur M Blank HospitalAtlanta30329NCT06620302Map
GAEmory Saint Joseph's HospitalAtlanta30342NCT05863195Map
GAEmory Saint Joseph's HospitalAtlanta30342NCT06958328Map
GAEmory Saint Joseph's HospitalAtlanta30342NCT06998940Map
GAEmory University - Winship Cancer InstituteAtlanta30322NCT03715933Map
GAEmory University Hospital MidtownAtlanta30308NCT06958328Map
GAEmory University Hospital MidtownAtlanta30308NCT06998940Map
GAEmory University Hospital/Winship Cancer InstituteAtlanta30322NCT05863195Map
GAEmory University Hospital/Winship Cancer InstituteAtlanta30322NCT06958328Map
GAEmory University Hospital/Winship Cancer InstituteAtlanta30322NCT06998940Map
GAEmory University School of MedicineAtlanta30322NCT06586515Map
GAGrady Health SystemAtlanta30303NCT06958328Map
GAGrady Memorial HospitalAtlanta30303NCT06662786Map
GAGrady Memorial HospitalAtlanta30303NCT06750094Map
GAPiedmont Cancer InstituteAtlanta30318NCT06750094Map
GAPiedmont HospitalAtlanta30309NCT06958328Map
GAWinship Cancer Institute Emory UniversityAtlanta30322NCT06662786Map
GAWinship Cancer Institute Emory UniversityAtlanta30322NCT06750094Map
GAWinship Cancer Institute of Emory UniversityAtlanta30322NCT01042379Map
GAAugusta University Medical CenterAugusta30912NCT04322318Map
GAAugusta University Medical CenterAugusta30912NCT06401330Map
GAEmory Decatur HospitalDecatur30033NCT06998940Map
GAEmory Johns Creek HospitalJohns Creek30097NCT06998940Map
GAAtrium Health NavicentMacon31201NCT04322318Map
GAAtrium Health NavicentMacon31201NCT06401330Map
GAMemorial Health University Medical CenterSavannah31404NCT04322318Map
GAMemorial Health University Medical CenterSavannah31404NCT06172296Map
GAMemorial Health University Medical CenterSavannah31404NCT06401330Map
GAMemorial Health University Medical CenterSavannah31404NCT06958328Map
GATift Regional Medical CenterTifton31794NCT05677490Map
HIHawaii Cancer Care - Westridge‘Aiea96701NCT05677490Map
HIHawaii Cancer Care - Westridge‘Aiea96701NCT06958328Map
HIPali Momi Medical Center‘Aiea96701NCT05677490Map
HIPali Momi Medical Center‘Aiea96701NCT06958328Map
HIQueen's Cancer Center - Pearlridge‘Aiea96701NCT05677490Map
HIQueen's Cancer Center - Pearlridge‘Aiea96701NCT06958328Map
HIThe Cancer Center of Hawaii-Pali Momi‘Aiea96701NCT06958328Map
HIThe Queen's Medical Center - West Oahu‘Ewa Beach96706NCT05677490Map
HIThe Queen's Medical Center - West Oahu‘Ewa Beach96706NCT06958328Map
HIHawaii Cancer Care Inc - Waterfront PlazaHonolulu96813NCT05677490Map
HIHawaii Cancer Care Inc - Waterfront PlazaHonolulu96813NCT06958328Map
HIKaiser Permanente Moanalua Medical CenterHonolulu96819NCT05677490Map
HIKapiolani Medical Center for Women and ChildrenHonolulu96826NCT04322318Map
HIKapiolani Medical Center for Women and ChildrenHonolulu96826NCT06172296Map
HIKapiolani Medical Center for Women and ChildrenHonolulu96826NCT06401330Map
HIKapiolani Medical Center for Women and ChildrenHonolulu96813NCT06541262Map
HIKapiolani Medical Center for Women and ChildrenHonolulu96826NCT06958328Map
HIKuakini Medical CenterHonolulu96817NCT06958328Map
HIQueen's Cancer Cenrer - POB IHonolulu96813NCT05677490Map
HIQueen's Cancer Cenrer - POB IHonolulu96813NCT06958328Map
HIQueen's Cancer Center - KuakiniHonolulu96817NCT05677490Map
HIQueen's Cancer Center - KuakiniHonolulu96817NCT06958328Map
HIQueen's Medical CenterHonolulu96813NCT05677490Map
HIQueen's Medical CenterHonolulu96813NCT06958328Map
HIStraub Clinic and HospitalHonolulu96813NCT05677490Map
HIStraub Clinic and HospitalHonolulu96813NCT06958328Map
HIThe Cancer Center of Hawaii-LilihaHonolulu96817NCT06958328Map
HIUniversity of Hawaii Cancer CenterHonolulu96813NCT06958328Map
HIStraub Medical Center - Kahului ClinicKahului96732NCT05677490Map
HIWilcox Memorial Hospital and Kauai Medical ClinicLihue96766NCT06958328Map
IDSaint Alphonsus Cancer Care Center-BoiseBoise83706NCT04205968Map
IDSaint Alphonsus Cancer Care Center-BoiseBoise83706NCT05677490Map
IDSaint Luke's Cancer Institute - BoiseBoise83712NCT04205968Map
IDSaint Luke's Cancer Institute - BoiseBoise83712NCT04322318Map
IDSaint Luke's Cancer Institute - BoiseBoise83712NCT05677490Map
IDSaint Luke's Cancer Institute - BoiseBoise83712NCT06401330Map
IDSaint Luke's Cancer Institute - BoiseBoise83712NCT06998940Map
IDSaint Alphonsus Cancer Care Center-CaldwellCaldwell83605NCT04205968Map
IDSaint Alphonsus Cancer Care Center-CaldwellCaldwell83605NCT05677490Map
IDKootenai Health - Coeur d'AleneCoeur d'Alene83814NCT04205968Map
IDKootenai Health - Coeur d'AleneCoeur d'Alene83814NCT05677490Map
IDKootenai Health - Coeur d'AleneCoeur d'Alene83814NCT06998940Map
IDSaint Luke's Cancer Institute - FruitlandFruitland83619NCT04205968Map
IDSaint Luke's Cancer Institute - FruitlandFruitland83619NCT05677490Map
IDSaint Luke's Cancer Institute - FruitlandFruitland83619NCT06998940Map
IDIdaho Urologic Institute-MeridianMeridian83642NCT04205968Map
IDIdaho Urologic Institute-MeridianMeridian83642NCT05677490Map
IDSaint Luke's Cancer Institute - MeridianMeridian83642NCT04205968Map
IDSaint Luke's Cancer Institute - MeridianMeridian83642NCT05677490Map
IDSaint Luke's Cancer Institute - MeridianMeridian83642NCT06998940Map
IDSaint Alphonsus Cancer Care Center-NampaNampa83687NCT04205968Map
IDSaint Alphonsus Cancer Care Center-NampaNampa83687NCT05677490Map
IDSaint Luke's Cancer Institute - NampaNampa83687NCT04205968Map
IDSaint Luke's Cancer Institute - NampaNampa83687NCT05677490Map
IDSaint Luke's Cancer Institute - NampaNampa83687NCT06998940Map
IDKootenai Clinic Cancer Services - Post FallsPost Falls83854NCT04205968Map
IDKootenai Clinic Cancer Services - Post FallsPost Falls83854NCT05677490Map
IDKootenai Clinic Cancer Services - Post FallsPost Falls83854NCT06998940Map
IDKootenai Clinic Cancer Services - SandpointSandpoint83864NCT04205968Map
IDKootenai Clinic Cancer Services - SandpointSandpoint83864NCT05677490Map
IDKootenai Clinic Cancer Services - SandpointSandpoint83864NCT06998940Map
IDSaint Luke's Cancer Institute - Twin FallsTwin Falls83301NCT04205968Map
IDSaint Luke's Cancer Institute - Twin FallsTwin Falls83301NCT05677490Map
IDSaint Luke's Cancer Institute - Twin FallsTwin Falls83301NCT06998940Map
ILOSF Saint Anthony's Health CenterAlton62002NCT04205968Map
ILOSF Saint Anthony's Health CenterAlton62002NCT05677490Map
ILIllinois Cancer SpecialistsArlington Heights60005NCT06662786Map
ILIllinois Cancer SpecialistsArlington Heights60005NCT06750094Map
ILIllinois Cancer SpecialistsArlington Heights60005NCT07011576Map
ILAdvocate Outpatient Center - AuroraAurora60506NCT05677490Map
ILRush-Copley Medical CenterAurora60504NCT04205968Map
ILRush-Copley Medical CenterAurora60504NCT05677490Map
ILRush-Copley Medical CenterAurora60504NCT06958328Map
ILAdvocate Good Shepherd HospitalBarrington60010NCT05677490Map
ILIllinois CancerCare-BloomingtonBloomington61704NCT04205968Map
ILIllinois CancerCare-BloomingtonBloomington61704NCT05677490Map
ILIllinois CancerCare-BloomingtonBloomington61704NCT06958328Map
ILIllinois CancerCare-BloomingtonBloomington61704NCT06998940Map
ILIllinois CancerCare-CantonCanton61520NCT04205968Map
ILIllinois CancerCare-CantonCanton61520NCT05677490Map
ILIllinois CancerCare-CantonCanton61520NCT06958328Map
ILIllinois CancerCare-CantonCanton61520NCT06998940Map
ILMemorial Hospital of CarbondaleCarbondale62902NCT04205968Map
ILMemorial Hospital of CarbondaleCarbondale62902NCT05677490Map
ILMemorial Hospital of CarbondaleCarbondale62902NCT06998940Map
ILSIH Cancer InstituteCarterville62918NCT04205968Map
ILSIH Cancer InstituteCarterville62918NCT05677490Map
ILSIH Cancer InstituteCarterville62918NCT06998940Map
ILIllinois CancerCare-CarthageCarthage62321NCT04205968Map
ILIllinois CancerCare-CarthageCarthage62321NCT05677490Map
ILIllinois CancerCare-CarthageCarthage62321NCT06958328Map
ILIllinois CancerCare-CarthageCarthage62321NCT06998940Map
ILCentralia Oncology ClinicCentralia62801NCT04205968Map
ILCentralia Oncology ClinicCentralia62801NCT05677490Map
ILCentralia Oncology ClinicCentralia62801NCT06958328Map
ILCentralia Oncology ClinicCentralia62801NCT06998940Map
ILSaint Mary's HospitalCentralia62801NCT04205968Map
ILAdvocate Illinois Masonic Medical CenterChicago60657NCT05677490Map
ILAnn & Robert H Lurie Children's Hospital of ChicagoChicago60611NCT05999994Map
ILAnn & Robert H. Lurie Children's Hospital of ChicagoChicago60611NCT04796012Map
ILJohn H Stroger Jr Hospital of Cook CountyChicago60612NCT05677490Map
ILLurie Children's Hospital-ChicagoChicago60611NCT04322318Map
ILLurie Children's Hospital-ChicagoChicago60611NCT06172296Map
ILLurie Children's Hospital-ChicagoChicago60611NCT06401330Map
ILLurie Children's Hospital-ChicagoChicago60611NCT06620302Map
ILMount Sinai Hospital Medical CenterChicago60608NCT05677490Map
ILNorthwestern UniversityChicago60611NCT05365581Map
ILNorthwestern UniversityChicago60611NCT05863195Map
ILNorthwestern UniversityChicago60611NCT06958328Map
ILThe University of ChicagoChicago60637NCT04361708Map
ILUniversity of ChicagoChicago60453NCT01042379Map
ILUniversity of Chicago Comprehensive Cancer CenterChicago60637NCT04205968Map
ILUniversity of Chicago Comprehensive Cancer CenterChicago60637NCT04322318Map
ILUniversity of Chicago Comprehensive Cancer CenterChicago60637NCT05677490Map
ILUniversity of Chicago Comprehensive Cancer CenterChicago60637NCT05863195Map
ILUniversity of Chicago Comprehensive Cancer CenterChicago60637NCT06172296Map
ILUniversity of Chicago Comprehensive Cancer CenterChicago60637NCT06401330Map
ILUniversity of IllinoisChicago60612NCT05677490Map
ILUniversity of IllinoisChicago60612NCT06172296Map
ILUniversity of IllinoisChicago60612NCT06401330Map
ILUniversity of IllinoisChicago60612NCT06958328Map
ILUniversity of Illinois Cancer CenterChicago60612NCT06835387Map
ILAMG Crystal Lake - OncologyCrystal Lake60014NCT05677490Map
ILCarle at The RiverfrontDanville61832NCT04205968Map
ILCarle at The RiverfrontDanville61832NCT05677490Map
ILCarle at The RiverfrontDanville61832NCT06958328Map
ILCarle at The RiverfrontDanville61832NCT06998940Map
ILCancer Care Specialists of Illinois - DecaturDecatur62526NCT04205968Map
ILCancer Care Specialists of Illinois - DecaturDecatur62526NCT05677490Map
ILCancer Care Specialists of Illinois - DecaturDecatur62526NCT06958328Map
ILCancer Care Specialists of Illinois - DecaturDecatur62526NCT06998940Map
ILDecatur Memorial HospitalDecatur62526NCT04205968Map
ILDecatur Memorial HospitalDecatur62526NCT05677490Map
ILDecatur Memorial HospitalDecatur62526NCT06958328Map
ILDecatur Memorial HospitalDecatur62526NCT06998940Map
ILNorthwestern Medicine Cancer Center KishwaukeeDeKalb60115NCT06958328Map
ILIllinois CancerCare-DixonDixon61021NCT04205968Map
ILIllinois CancerCare-DixonDixon61021NCT05677490Map
ILIllinois CancerCare-DixonDixon61021NCT06998940Map
ILAdvocate Good Samaritan HospitalDowners Grove60515NCT05677490Map
ILCarle Physician Group-EffinghamEffingham62401NCT04205968Map
ILCarle Physician Group-EffinghamEffingham62401NCT05677490Map
ILCarle Physician Group-EffinghamEffingham62401NCT06958328Map
ILCarle Physician Group-EffinghamEffingham62401NCT06998940Map
ILCrossroads Cancer CenterEffingham62401NCT04205968Map
ILCrossroads Cancer CenterEffingham62401NCT05677490Map
ILCrossroads Cancer CenterEffingham62401NCT06958328Map
ILCrossroads Cancer CenterEffingham62401NCT06998940Map
ILAdvocate Sherman HospitalElgin60123NCT05677490Map
ILIllinois CancerCare-EurekaEureka61530NCT04205968Map
ILIllinois CancerCare-EurekaEureka61530NCT05677490Map
ILIllinois CancerCare-EurekaEureka61530NCT06958328Map
ILIllinois CancerCare-EurekaEureka61530NCT06998940Map
ILIllinois CancerCare-GalesburgGalesburg61401NCT04205968Map
ILIllinois CancerCare-GalesburgGalesburg61401NCT05677490Map
ILIllinois CancerCare-GalesburgGalesburg61401NCT06958328Map
ILIllinois CancerCare-GalesburgGalesburg61401NCT06998940Map
ILNorthwestern Medicine Cancer Center DelnorGeneva60134NCT06958328Map
ILNorthwestern Medicine Glenview Outpatient CenterGlenview60026NCT06958328Map
ILNorthwestern Medicine Grayslake Outpatient CenterGrayslake60030NCT06958328Map
ILIngalls Memorial HospitalHarvey60426NCT05677490Map
ILAdvocate South Suburban HospitalHazel Crest60429NCT05677490Map
ILHope and Healing Cancer ServicesHinsdale60521NCT04657068Map
ILIllinois CancerCare-Kewanee ClinicKewanee61443NCT04205968Map
ILIllinois CancerCare-Kewanee ClinicKewanee61443NCT05677490Map
ILIllinois CancerCare-Kewanee ClinicKewanee61443NCT06958328Map
ILIllinois CancerCare-Kewanee ClinicKewanee61443NCT06998940Map
ILNorthwestern Medicine Lake Forest HospitalLake Forest60045NCT06958328Map
ILAMG Libertyville - OncologyLibertyville60048NCT05677490Map
ILCondell Memorial HospitalLibertyville60048NCT05677490Map
ILIllinois CancerCare-MacombMacomb61455NCT04205968Map
ILIllinois CancerCare-MacombMacomb61455NCT05677490Map
ILIllinois CancerCare-MacombMacomb61455NCT06958328Map
ILIllinois CancerCare-MacombMacomb61455NCT06998940Map
ILCarle Physician Group-Mattoon/CharlestonMattoon61938NCT04205968Map
ILCarle Physician Group-Mattoon/CharlestonMattoon61938NCT05677490Map
ILCarle Physician Group-Mattoon/CharlestonMattoon61938NCT06958328Map
ILCarle Physician Group-Mattoon/CharlestonMattoon61938NCT06998940Map
ILLoyola UniversityMaywood60153NCT01042379Map
ILLoyola University Medical CenterMaywood60153NCT04322318Map
ILTrinity Medical CenterMoline61265NCT05677490Map
ILSSM Health Good SamaritanMount Vernon62864NCT04205968Map
ILSSM Health Good SamaritanMount Vernon62864NCT05677490Map
ILUC Comprehensive Cancer Center at Silver CrossNew Lenox60451NCT04205968Map
ILUC Comprehensive Cancer Center at Silver CrossNew Lenox60451NCT05677490Map
ILCarle BroMenn Medical CenterNormal61761NCT06998940Map
ILCarle Cancer Institute NormalNormal61761NCT05677490Map
ILCarle Cancer Institute NormalNormal61761NCT06998940Map
ILCancer Care Center of O'FallonO'Fallon62269NCT04205968Map
ILCancer Care Center of O'FallonO'Fallon62269NCT05677490Map
ILCancer Care Center of O'FallonO'Fallon62269NCT06958328Map
ILCancer Care Center of O'FallonO'Fallon62269NCT06998940Map
ILHSHS Saint Elizabeth's HospitalO'Fallon62269NCT04205968Map
ILHSHS Saint Elizabeth's HospitalO'Fallon62269NCT05677490Map
ILHSHS Saint Elizabeth's HospitalO'Fallon62269NCT06958328Map
ILHSHS Saint Elizabeth's HospitalO'Fallon62269NCT06998940Map
ILNorthwestern Medicine Oak BrookOak Brook60523NCT06958328Map
ILAdvocate Children's Hospital-Oak LawnOak Lawn60453NCT04322318Map
ILAdvocate Children's Hospital-Oak LawnOak Lawn60453NCT06172296Map
ILAdvocate Children's Hospital-Oak LawnOak Lawn60453NCT06401330Map
ILAdvocate Christ Medical CenterOak Lawn60453-2699NCT05677490Map
ILUniversity of Chicago Medicine-Orland ParkOrland Park60462NCT04205968Map
ILUniversity of Chicago Medicine-Orland ParkOrland Park60462NCT05677490Map
ILIllinois CancerCare-Ottawa ClinicOttawa61350NCT04205968Map
ILIllinois CancerCare-Ottawa ClinicOttawa61350NCT05677490Map
ILIllinois CancerCare-Ottawa ClinicOttawa61350NCT06958328Map
ILIllinois CancerCare-Ottawa ClinicOttawa61350NCT06998940Map
ILAdvocate Children's Hospital-Park RidgePark Ridge60068NCT04322318Map
ILAdvocate Children's Hospital-Park RidgePark Ridge60068NCT06172296Map
ILAdvocate Children's Hospital-Park RidgePark Ridge60068NCT06401330Map
ILAdvocate Lutheran General HospitalPark Ridge60068NCT05677490Map
ILIllinois CancerCare-PekinPekin61554NCT04205968Map
ILIllinois CancerCare-PekinPekin61554NCT05677490Map
ILIllinois CancerCare-PekinPekin61554NCT06958328Map
ILIllinois CancerCare-PekinPekin61554NCT06998940Map
ILIllinois CancerCarePeoria61615NCT06662786Map
ILIllinois CancerCarePeoria61615NCT06750094Map
ILIllinois CancerCare-PeoriaPeoria61615NCT04205968Map
ILIllinois CancerCare-PeoriaPeoria61615NCT05677490Map
ILIllinois CancerCare-PeoriaPeoria61615NCT06958328Map
ILIllinois CancerCare-PeoriaPeoria61615NCT06998940Map
ILMethodist Medical Center of IllinoisPeoria61636NCT04205968Map
ILMethodist Medical Center of IllinoisPeoria61636NCT05677490Map
ILOSF Children's Hospital of IllinoisPeoria61637NCT06172296Map
ILOSF Saint Francis Medical CenterPeoria61637NCT06958328Map
ILSaint Jude Midwest AffiliatePeoria61637NCT04322318Map
ILSaint Jude Midwest AffiliatePeoria61637NCT06401330Map
ILIllinois CancerCare-PeruPeru61354NCT04205968Map
ILIllinois CancerCare-PeruPeru61354NCT05677490Map
ILIllinois CancerCare-PeruPeru61354NCT06958328Map
ILIllinois CancerCare-PeruPeru61354NCT06998940Map
ILValley Radiation OncologyPeru61354NCT04205968Map
ILValley Radiation OncologyPeru61354NCT05677490Map
ILValley Radiation OncologyPeru61354NCT06998940Map
ILIllinois CancerCare-PrincetonPrinceton61356NCT04205968Map
ILIllinois CancerCare-PrincetonPrinceton61356NCT05677490Map
ILIllinois CancerCare-PrincetonPrinceton61356NCT06958328Map
ILIllinois CancerCare-PrincetonPrinceton61356NCT06998940Map
ILUW Health Carbone Cancer Center RockfordRockford61114NCT05677490Map
ILMemorial Hospital EastShiloh62269NCT05863195Map
ILSouthern Illinois University School of MedicineSpringfield62702NCT04205968Map
ILSouthern Illinois University School of MedicineSpringfield62702NCT04322318Map
ILSouthern Illinois University School of MedicineSpringfield62702NCT05677490Map
ILSouthern Illinois University School of MedicineSpringfield62702NCT06172296Map
ILSouthern Illinois University School of MedicineSpringfield62702NCT06958328Map
ILSouthern Illinois University School of MedicineSpringfield62702NCT06998940Map
ILSpringfield ClinicSpringfield62702NCT04205968Map
ILSpringfield ClinicSpringfield62702NCT05677490Map
ILSpringfield ClinicSpringfield62702NCT06958328Map
ILSpringfield ClinicSpringfield62702NCT06998940Map
ILSpringfield Memorial HospitalSpringfield62781NCT04205968Map
ILSpringfield Memorial HospitalSpringfield62781NCT05677490Map
ILSpringfield Memorial HospitalSpringfield62781NCT06958328Map
ILSpringfield Memorial HospitalSpringfield62781NCT06998940Map
ILCarle Cancer CenterUrbana61801NCT04205968Map
ILCarle Cancer CenterUrbana61801NCT05677490Map
ILCarle Cancer CenterUrbana61801NCT06958328Map
ILCarle Cancer CenterUrbana61801NCT06998940Map
ILThe Carle Foundation HospitalUrbana61801NCT04205968Map
ILNorthwestern Medicine Cancer Center WarrenvilleWarrenville60555NCT06958328Map
ILIllinois CancerCare - WashingtonWashington61571NCT04205968Map
ILIllinois CancerCare - WashingtonWashington61571NCT05677490Map
ILIllinois CancerCare - WashingtonWashington61571NCT06958328Map
ILIllinois CancerCare - WashingtonWashington61571NCT06998940Map
ILRush-Copley Healthcare CenterYorkville60560NCT04205968Map
ILRush-Copley Healthcare CenterYorkville60560NCT05677490Map
ILCity Of Hope - Chicago /ID# 279814Zion60099NCT07490301Map
INIU Health North HospitalCarmel46032NCT05863195Map
INNorthwest Cancer Center - Crown PointCrown Point46307NCT05677490Map
INUChicago Medicine Northwest IndianaCrown Point46307NCT05677490Map
INNorthwest Oncology LLCDyer46311NCT05677490Map
INFort Wayne Medical Oncology & HematologyFort Wayne46804NCT06662786Map
INGoshen Center for Cancer CareGoshen46526NCT06958328Map
INNorthwest Cancer Center - HobartHobart46342NCT05677490Map
INSaint Mary Medical CenterHobart46342NCT05677490Map
INAscension Saint Vincent Indianapolis HospitalIndianapolis46260NCT04322318Map
INCommunity Health NetworkIndianapolis46250NCT04657068Map
INCommunity Health NetworkIndianapolis46250NCT06586515Map
INFranciscan HealthIndianapolis46237NCT06750094Map
INIndiana University/Melvin and Bren Simon Cancer CenterIndianapolis46202NCT05863195Map
INRiley Hospital for ChildrenIndianapolis46202NCT04322318Map
INRiley Hospital for ChildrenIndianapolis46202NCT06172296Map
INRiley Hospital for ChildrenIndianapolis46202NCT06401330Map
INRiley Hospital for ChildrenIndianapolis46202NCT06620302Map
INSaint Catherine HospitalIndianapolis46312NCT05677490Map
INThe Community HospitalMunster46321NCT05677490Map
INWomen's Diagnostic Center - MunsterMunster46321NCT05677490Map
INNorthwest Cancer Center - ValparaisoValparaiso46383NCT05677490Map
IAMary Greeley Medical CenterAmes50010NCT05677490Map
IAMary Greeley Medical CenterAmes50010NCT06998940Map
IAMcFarland Clinic - AmesAmes50010NCT05677490Map
IAMcFarland Clinic - AmesAmes50010NCT06998940Map
IAUI Health Care Mission Cancer and Blood - Ankeny ClinicAnkeny50023NCT04205968Map
IAUI Health Care Mission Cancer and Blood - Ankeny ClinicAnkeny50023NCT05677490Map
IAUI Health Care Mission Cancer and Blood - Ankeny ClinicAnkeny50023NCT06958328Map
IAUniversity of Iowa Healthcare Cancer Services Quad CitiesBettendorf52722NCT04205968Map
IAUniversity of Iowa Healthcare Cancer Services Quad CitiesBettendorf52722NCT05677490Map
IASaint Anthony Regional HospitalCarroll51401NCT04205968Map
IAMercy HospitalCedar Rapids52403NCT05677490Map
IAMercy HospitalCedar Rapids52403NCT06998940Map
IAOncology Associates at Mercy Medical CenterCedar Rapids52403NCT05677490Map
IAOncology Associates at Mercy Medical CenterCedar Rapids52403NCT06998940Map
IAMercy Cancer Center-West LakesClive50325NCT04205968Map
IAMercy Cancer Center-West LakesClive50325NCT06998940Map
IAUI Health Care Mission Cancer and Blood - West Des Moines ClinicClive50325NCT04205968Map
IAUI Health Care Mission Cancer and Blood - West Des Moines ClinicClive50325NCT05677490Map
IAUI Health Care Mission Cancer and Blood - West Des Moines ClinicClive50325NCT06958328Map
IAHeartland Oncology and Hematology LLPCouncil Bluffs51503NCT05677490Map
IAMethodist Jennie Edmundson HospitalCouncil Bluffs51503NCT05677490Map
IAGreater Regional Medical CenterCreston50801NCT04205968Map
IAGreater Regional Medical CenterCreston50801NCT06998940Map
IABlank Children's HospitalDes Moines50309NCT04322318Map
IABlank Children's HospitalDes Moines50309NCT06172296Map
IABlank Children's HospitalDes Moines50309NCT06401330Map
IABroadlawns Medical CenterDes Moines50314NCT04205968Map
IAIowa Lutheran HospitalDes Moines50316NCT04205968Map
IAIowa Methodist Medical CenterDes Moines50309NCT04205968Map
IAIowa Methodist Medical CenterDes Moines50309NCT05677490Map
IAIowa Methodist Medical CenterDes Moines50309NCT06958328Map
IAMercy Medical Center - Des MoinesDes Moines50314NCT04205968Map
IAMercy Medical Center - Des MoinesDes Moines50314NCT06998940Map
IAUI Health Care Mission Cancer and Blood - Des Moines ClinicDes Moines50309NCT04205968Map
IAUI Health Care Mission Cancer and Blood - Des Moines ClinicDes Moines50309NCT05677490Map
IAUI Health Care Mission Cancer and Blood - Des Moines ClinicDes Moines50309NCT06958328Map
IAUI Health Care Mission Cancer and Blood - Laurel ClinicDes Moines50314NCT04205968Map
IAUI Health Care Mission Cancer and Blood - Laurel ClinicDes Moines50314NCT05677490Map
IAUI Health Care Mission Cancer and Blood - Laurel ClinicDes Moines50314NCT06958328Map
IAMcFarland Clinic - Trinity Cancer CenterFort Dodge50501NCT05677490Map
IAMcFarland Clinic - Trinity Cancer CenterFort Dodge50501NCT06998940Map
IAUI Healthcare Mission Cancer and Blood - Fort DodgeFort Dodge50501NCT04205968Map
IAUniversity of Iowa HospitalIowa City52242NCT06662786Map
IAUniversity of Iowa Hospitals and ClinicsIowa City52242NCT06750094Map
IAUniversity of Iowa/Holden Comprehensive Cancer CenterIowa City52242NCT04205968Map
IAUniversity of Iowa/Holden Comprehensive Cancer CenterIowa City52242NCT04322318Map
IAUniversity of Iowa/Holden Comprehensive Cancer CenterIowa City52242NCT05677490Map
IAUniversity of Iowa/Holden Comprehensive Cancer CenterIowa City52242NCT06172296Map
IAUniversity of Iowa/Holden Comprehensive Cancer CenterIowa City52242NCT06401330Map
IAMcFarland Clinic - MarshalltownMarshalltown50158NCT05677490Map
IAMcFarland Clinic - MarshalltownMarshalltown50158NCT06998940Map
IAUI Healthcare Mission Cancer and Blood - PellaPella50219NCT05677490Map
IAMission Cancer BloodWaukee50263NCT06662786Map
IAMission Cancer BloodWaukee50263NCT06750094Map
IAUI Health Care Mission Cancer and Blood - Waukee ClinicWaukee50263NCT04205968Map
IAUI Health Care Mission Cancer and Blood - Waukee ClinicWaukee50263NCT05677490Map
IAUI Health Care Mission Cancer and Blood - Waukee ClinicWaukee50263NCT06958328Map
IAMercy Medical Center-West LakesWest Des Moines50266NCT04205968Map
IAMercy Medical Center-West LakesWest Des Moines50266NCT06998940Map
IAMethodist West HospitalWest Des Moines50266-7700NCT04205968Map
IAThe Iowa Clinic PCWest Des Moines50266NCT04205968Map
KSCentral Care Cancer Center - Garden CityGarden City67846NCT04205968Map
KSCentral Care Cancer Center - Garden CityGarden City67846NCT05677490Map
KSCentral Care Cancer Center - Great BendGreat Bend67530NCT04205968Map
KSCentral Care Cancer Center - Great BendGreat Bend67530NCT05677490Map
KSHaysMedHays67601NCT05677490Map
KSUniversity of Kansas Cancer CenterKansas City66160NCT06958328Map
KSLawrence Memorial HospitalLawrence66044NCT05677490Map
KSLawrence Memorial HospitalLawrence66044NCT06958328Map
KSThe University of Kansas Cancer Center - OlatheOlathe66061NCT05677490Map
KSThe University of Kansas Cancer Center - OlatheOlathe66061NCT06958328Map
KSUniversity of Kansas Cancer Center-Overland ParkOverland Park66210NCT06958328Map
KSFreeman Physician Group of PittsburgPittsburg66762NCT05677490Map
KSMercy Hospital PittsburgPittsburg66762NCT04205968Map
KSMercy Hospital PittsburgPittsburg66762NCT05677490Map
KSSalina Regional Health CenterSalina67401NCT05677490Map
KSSalina Regional Health CenterSalina67401NCT06958328Map
KSUniversity of Kansas Health System Saint Francis CampusTopeka66606NCT05677490Map
KSUniversity of Kansas Health System Saint Francis CampusTopeka66606NCT06958328Map
KSUniversity of Kansas Cancer CenterWestwood66205NCT05365581Map
KSUniversity of Kansas Hospital-Westwood Cancer CenterWestwood66205NCT06958328Map
KSUniversity of Kansas Medical CenterWestwood66205NCT05382559Map
KSCancer Center of KansasWichita67214NCT06662786Map
KSCancer Center of KansasWichita67214NCT06750094Map
KSWesley Medical CenterWichita67214NCT06172296Map
KYFlaget Memorial HospitalBardstown40004NCT06998940Map
KYCommonwealth Cancer Center-CorbinCorbin40701NCT06998940Map
KYSaint Elizabeth Medical Center, Inc. DBA St. Elizabeth Health CareEdgewood41017NCT07409272Map
KYSaint Joseph HospitalLexington40504NCT06998940Map
KYSaint Joseph Hospital EastLexington40509NCT06998940Map
KYSaint Joseph Radiation Oncology Resource CenterLexington40504NCT06998940Map
KYUniversity of KentuckyLexington40506NCT05391126Map
KYUniversity of Kentucky/Markey Cancer CenterLexington40536NCT04322318Map
KYUniversity of Kentucky/Markey Cancer CenterLexington40536NCT05863195Map
KYUniversity of Kentucky/Markey Cancer CenterLexington40536NCT06172296Map
KYUniversity of Kentucky/Markey Cancer CenterLexington40536NCT06958328Map
KYSaint Joseph LondonLondon40741NCT06998940Map
KYNorton Children's HospitalLouisville40202NCT04322318Map
KYNorton Children's HospitalLouisville40202NCT06172296Map
KYNorton Children's Research Institute/Affiliated with University of Louisville School of MedicineLouisville40202NCT06541262Map
KYResearch SiteLouisville40202NCT06219941Map
KYThe James Graham Brown Cancer Center at University of LouisvilleLouisville40202NCT05677490Map
KYUofL Health Medical Center NortheastLouisville40245NCT05677490Map
KYSaint Joseph Mount SterlingMount Sterling40353NCT06998940Map
LALSU Health Baton Rouge-North ClinicBaton Rouge70805NCT06998940Map
LAMary Bird Perkins Cancer CenterBaton Rouge70809NCT06750094Map
LAOur Lady of the LakeBaton Rouge70808NCT04657068Map
LAOur Lady of The LakeBaton Rouge70808NCT06998940Map
LAOur Lady of the Lake Physician GroupBaton Rouge70808NCT06998940Map
LAChildren's Hospital New OrleansNew Orleans70118NCT04322318Map
LAChildren's Hospital New OrleansNew Orleans70118NCT06172296Map
LAChildren's Hospital New OrleansNew Orleans70118NCT06401330Map
LAOchsner Clinic FoundationNew Orleans70121NCT06662786Map
LAOchsner Medical Center JeffersonNew Orleans70121NCT06401330Map
LAUniversity Medical Center New OrleansNew Orleans70112NCT05677490Map
MEEastern Maine Medical CenterBangor04401NCT04322318Map
MEEastern Maine Medical CenterBangor04401NCT06172296Map
MEMaineHealth Coastal Cancer Treatment CenterBath04530NCT06958328Map
MELafayette Family Cancer Center-EMMCBrewer04412NCT04205968Map
MEMaineHealth Maine Medical Center - PortlandPortland04102NCT06958328Map
MEMaineHealth Cancer Care Center of York CountySanford04073NCT06958328Map
MEMaine Children's Cancer ProgramScarborough04074NCT04322318Map
MEMaine Children's Cancer ProgramScarborough04074NCT06172296Map
MEMaine Children's Cancer ProgramScarborough04074NCT06401330Map
MEMaineHealth Maine Medical Center- ScarboroughScarborough04074NCT06958328Map
MEMaineHealth Cancer Care and IV Therapy - South PortlandSouth Portland04106NCT06958328Map
MDJohns Hopkins University/Sidney Kimmel Cancer CenterBaltimore21287NCT04322318Map
MDJohns Hopkins University/Sidney Kimmel Cancer CenterBaltimore21287NCT05677490Map
MDJohns Hopkins University/Sidney Kimmel Cancer CenterBaltimore21287NCT06172296Map
MDJohns Hopkins University/Sidney Kimmel Cancer CenterBaltimore21287NCT06401330Map
MDMedStar Franklin Square Medical CenterBaltimore21237NCT06662786Map
MDMedStar Franklin Square Medical CenterBaltimore21237NCT06750094Map
MDResearch SiteBaltimore21224NCT06792695Map
MDSidney Kimmel Comprehensive Cancer CenterBaltimore21231NCT06941857Map
MDSinai Hospital of BaltimoreBaltimore21215NCT04322318Map
MDSinai Hospital of BaltimoreBaltimore21215NCT06172296Map
MDSinai Hospital of BaltimoreBaltimore21215NCT06401330Map
MDSinai Hospital of BaltimoreBaltimore21215NCT06958328Map
MDSinai Hospital of BaltimoreBaltimore21215NCT06998940Map
MDUniversity of Maryland/Greenebaum Cancer CenterBaltimore21201NCT06172296Map
MDUniversity of Maryland/Greenebaum Cancer CenterBaltimore21201NCT06401330Map
MDNational Institutes of Health Clinical CenterBethesda20892NCT06995872Map
MDWalter Reed National Military Medical CenterBethesda20889-5600NCT06172296Map
MDMaryland Oncology HematologyColumbia21044NCT07011576Map
MDMaryland Oncology Hematology - PrimaryColumbia21044NCT04657068Map
MDChristiana Care - Union HospitalElkton21921NCT05677490Map
MDChristiana Care - Union HospitalElkton21921NCT06998940Map
MDFrederick Health Hospital - James M Stockman Cancer InstituteFrederick21702-4337NCT06662786Map
MDFrederick Health Hospital - James M Stockman Cancer InstituteFrederick21702NCT06750094Map
MDNorthwest Hospital CenterRandallstown21133NCT06998940Map
MDWilliam E Kahlert Regional Cancer Center/Sinai HospitalWestminster21157NCT06958328Map
MDWilliam E Kahlert Regional Cancer Center/Sinai HospitalWestminster21157NCT06998940Map
MABeth Israel Deaconess Medical CenterBoston02215NCT05382559Map
MABoston Children's HospitalBoston02115NCT04796012Map
MABoston Children's HospitalBoston02115NCT07027748Map
MABoston Medical CenterBoston02118NCT05677490Map
MADana Farber Cancer InstituteBoston02215NCT05382559Map
MADana-Farber Cancer InstituteBoston02215NCT06586515Map
MADana-Farber Cancer InstituteBoston02215NCT04322318Map
MADana-Farber Cancer InstituteBoston02215NCT05677490Map
MADana-Farber Cancer InstituteBoston02215NCT06172296Map
MADana-Farber Cancer InstituteBoston02215NCT06401330Map
MADana-Farber Cancer InstituteBoston02215NCT06620302Map
MADana-Farber Cancer InstituteBoston02115NCT07027748Map
MAMassachusetts General HospitalBoston02114NCT07024615Map
MAMassachusetts General Hospital Cancer CenterBoston02114NCT06172296Map
MAMassachusetts General Hospital Cancer CenterBoston02114NCT06401330Map
MADana-Farber Cancer Institute at Boston Medical Center - BrightonBrighton02135NCT05677490Map
MADana-Farber Cancer Institute at FoxboroughFoxborough02035NCT05677490Map
MADana Farber-Merrimack ValleyMethuen01844NCT05677490Map
MADana-Farber/Brigham and Women's Cancer Center at Milford RegionalMilford01757NCT05677490Map
MADana-Farber/Brigham and Women's Cancer Center at South ShoreSouth Weymouth02190NCT05677490Map
MABaystate Medical CenterSpringfield01199NCT06401330Map
MAUMass Memorial Medical Center - University CampusWorcester01655NCT04322318Map
MAUMass Memorial Medical Center - University CampusWorcester01655NCT06401330Map
MIMyMichigan Medical Center GratiotAlma48801NCT04205968Map
MIMyMichigan Medical Center GratiotAlma48801NCT05677490Map
MIMyMichigan Medical Center AlpenaAlpena49707NCT04205968Map
MIMyMichigan Medical Center AlpenaAlpena49707NCT05677490Map
MIC S Mott Children's HospitalAnn Arbor48109NCT04322318Map
MIC S Mott Children's HospitalAnn Arbor48109NCT06172296Map
MIC S Mott Children's HospitalAnn Arbor48109NCT06401330Map
MIC S Mott Children's HospitalAnn Arbor48109NCT06620302Map
MITrinity Health Saint Joseph Mercy Hospital Ann ArborAnn Arbor48106NCT04205968Map
MITrinity Health Saint Joseph Mercy Hospital Ann ArborAnn Arbor48106NCT05677490Map
MITrinity Health Saint Joseph Mercy Hospital Ann ArborAnn Arbor48106NCT06958328Map
MIUniversity of MichiganAnn Arbor48109NCT03715933Map
MIUniversity of MichiganAnn Arbor48109NCT06662786Map
MIUniversity of Michigan Comprehensive Cancer CenterAnn Arbor48109NCT04205968Map
MIUniversity of Michigan Health SystemAnn Arbor48103NCT05379595Map
MIUniversity of Michigan Rogel Cancer CenterAnn Arbor48109NCT05863195Map
MIUniversity of Michigan Rogel Cancer CenterAnn Arbor48109NCT06750094Map
MIUniversity of Michigan Rogel Cancer CenterAnn Arbor48109NCT06958328Map
MIVA Ann Arbor Healthcare SystemAnn Arbor48105NCT06662786Map
MIBronson Battle CreekBattle Creek49017NCT04205968Map
MIBronson Battle CreekBattle Creek49017NCT06998940Map
MIMcLaren Cancer Institute-Bay CityBay City48706NCT05677490Map
MITrinity Health IHA Medical Group Hematology Oncology - BrightonBrighton48114NCT04205968Map
MITrinity Health IHA Medical Group Hematology Oncology - BrightonBrighton48114NCT05677490Map
MITrinity Health IHA Medical Group Hematology Oncology - BrightonBrighton48114NCT06958328Map
MITrinity Health Medical Center - BrightonBrighton48114NCT04205968Map
MITrinity Health Medical Center - BrightonBrighton48114NCT05677490Map
MITrinity Health Medical Center - BrightonBrighton48114NCT06958328Map
MIUniversity of Michigan - Brighton Center for Specialty CareBrighton48116NCT06958328Map
MIHenry Ford Cancer Institute-DownriverBrownstown48183NCT04205968
MIHenry Ford Cancer Institute-DownriverBrownstown48183NCT06958328
MITrinity Health IHA Medical Group Hematology Oncology - CantonCanton48188NCT04205968Map
MITrinity Health IHA Medical Group Hematology Oncology - CantonCanton48188NCT05677490Map
MITrinity Health IHA Medical Group Hematology Oncology - CantonCanton48188NCT06958328Map
MITrinity Health Medical Center - CantonCanton48188NCT04205968Map
MITrinity Health Medical Center - CantonCanton48188NCT05677490Map
MITrinity Health Medical Center - CantonCanton48188NCT06958328Map
MIChelsea HospitalChelsea48118NCT04205968Map
MIChelsea HospitalChelsea48118NCT05677490Map
MIChelsea HospitalChelsea48118NCT06958328Map
MITrinity Health IHA Medical Group Hematology Oncology - Chelsea HospitalChelsea48118NCT04205968Map
MITrinity Health IHA Medical Group Hematology Oncology - Chelsea HospitalChelsea48118NCT05677490Map
MITrinity Health IHA Medical Group Hematology Oncology - Chelsea HospitalChelsea48118NCT06958328Map
MIHematology Oncology Consultants-ClarkstonClarkston48346NCT04205968Map
MIHematology Oncology Consultants-ClarkstonClarkston48346NCT05677490Map
MIMcLaren Cancer Institute-ClarkstonClarkston48346NCT05677490Map
MINewland Medical Associates-ClarkstonClarkston48346NCT04205968Map
MINewland Medical Associates-ClarkstonClarkston48346NCT05677490Map
MIHenry Ford Macomb Hospital-Clinton TownshipClinton Township48038NCT04205968Map
MIHenry Ford Macomb Hospital-Clinton TownshipClinton Township48038NCT06958328Map
MICorewell Health Dearborn HospitalDearborn48124NCT05677490Map
MIHenry Ford Medical Center-FairlaneDearborn48126NCT04205968Map
MIHenry Ford Medical Center-FairlaneDearborn48126NCT06958328Map
MIBarbara Ann Karmanos Cancer InstituteDetroit48201NCT06586515Map
MIChildren's Hospital of MichiganDetroit48201NCT04322318Map
MIChildren's Hospital of MichiganDetroit48201NCT06172296Map
MIChildren's Hospital of MichiganDetroit48201NCT06401330Map
MIHenry Ford Health Saint John HospitalDetroit48236NCT04205968Map
MIHenry Ford Health Saint John HospitalDetroit48236NCT05677490Map
MIHenry Ford Health SystemDetroit48202NCT06644781Map
MIHenry Ford HospitalDetroit48202NCT04205968Map
MIHenry Ford HospitalDetroit48202NCT06662786Map
MIHenry Ford HospitalDetroit48202NCT06750094Map
MIHenry Ford HospitalDetroit48202NCT06958328Map
MIInvestigative Site #120Detroit48201NCT06974110Map
MIWayne State University/Karmanos Cancer InstituteDetroit48201NCT05677490Map
MIHenry Ford River District HospitalEast China Township48054NCT04205968
MIHenry Ford River District HospitalEast China Township48054NCT05677490
MIOSF Saint Francis Hospital and Medical GroupEscanaba49829NCT05677490Map
MIOSF Saint Francis Hospital and Medical GroupEscanaba49829NCT06998940Map
MICorewell Health Farmington Hills HospitalFarmington Hills48336NCT05677490Map
MIWeisberg Cancer Treatment CenterFarmington Hills48334NCT05677490Map
MICancer Hematology Centers - FlintFlint48503NCT04205968Map
MICancer Hematology Centers - FlintFlint48503NCT05677490Map
MIGenesee Hematology Oncology PCFlint48503NCT04205968Map
MIGenesee Hematology Oncology PCFlint48503NCT05677490Map
MIGenesys Hurley Cancer InstituteFlint48503NCT04205968Map
MIGenesys Hurley Cancer InstituteFlint48503NCT05677490Map
MIHurley Medical CenterFlint48503NCT04205968Map
MIHurley Medical CenterFlint48503NCT05677490Map
MIMcLaren Cancer Institute-FlintFlint48532NCT05677490Map
MIMyMichigan Medical Center GladwinGladwin48624NCT04205968Map
MIMyMichigan Medical Center GladwinGladwin48624NCT05677490Map
MICancer And Hematology Centers of Western Michigan PCGrand Rapids49503NCT06750094Map
MICorewell Health Grand Rapids Hospitals - Butterworth HospitalGrand Rapids49503NCT04205968Map
MICorewell Health Grand Rapids Hospitals - Butterworth HospitalGrand Rapids49503NCT05863195Map
MICorewell Health Grand Rapids Hospitals - Butterworth HospitalGrand Rapids49503NCT06958328Map
MICorewell Health Grand Rapids Hospitals - Butterworth HospitalGrand Rapids49503NCT06998940Map
MICorewell Health Grand Rapids Hospitals - Helen DeVos Children's HospitalGrand Rapids49503NCT04205968Map
MICorewell Health Grand Rapids Hospitals - Helen DeVos Children's HospitalGrand Rapids49503NCT04322318Map
MICorewell Health Grand Rapids Hospitals - Helen DeVos Children's HospitalGrand Rapids49503NCT06172296Map
MICorewell Health Grand Rapids Hospitals - Helen DeVos Children's HospitalGrand Rapids49503NCT06401330Map
MICorewell Health Grand Rapids Hospitals - Helen DeVos Children's HospitalGrand Rapids49503NCT06958328Map
MICorewell Health Grand Rapids Hospitals - Helen DeVos Children's HospitalGrand Rapids49503NCT06998940Map
MIHelen DeVos Children's HospitalGrand Rapids48503NCT01356290Map
MISouth Texas Accelerated Research Therapeutics (START) MidwestGrand Rapids49546NCT06586515Map
MIStart MidwestGrand Rapids49503NCT06662786Map
MISTART Midwest Michigan, PCGrand Rapids49546NCT03715933Map
MITrinity Health Grand Rapids HospitalGrand Rapids49503NCT04205968Map
MITrinity Health Grand Rapids HospitalGrand Rapids49503NCT06958328Map
MITrinity Health Grand Rapids HospitalGrand Rapids49503NCT06998940Map
MIHenry Ford Saint John Hospital - AcademicGrosse Pointe Woods48236NCT04205968Map
MIHenry Ford Saint John Hospital - AcademicGrosse Pointe Woods48236NCT05677490Map
MIHenry Ford Saint John Hospital - BreastGrosse Pointe Woods48236NCT04205968Map
MIHenry Ford Saint John Hospital - BreastGrosse Pointe Woods48236NCT05677490Map
MIHenry Ford Saint John Hospital - Van ElslanderGrosse Pointe Woods48236NCT04205968Map
MIHenry Ford Saint John Hospital - Van ElslanderGrosse Pointe Woods48236NCT05677490Map
MIAllegiance HealthJackson49201NCT04205968Map
MIAllegiance HealthJackson49201NCT06958328Map
MIBeacon KalamazooKalamazoo49048NCT04205968Map
MIBeacon KalamazooKalamazoo49048NCT06958328Map
MIBeacon KalamazooKalamazoo49048NCT06998940Map
MIBeacon Kalamazoo Cancer CenterKalamazoo49009NCT04205968Map
MIBeacon Kalamazoo Cancer CenterKalamazoo49009NCT06998940Map
MIBronson Methodist HospitalKalamazoo49007NCT04205968Map
MIBronson Methodist HospitalKalamazoo49007NCT04322318Map
MIBronson Methodist HospitalKalamazoo49007NCT06172296Map
MIBronson Methodist HospitalKalamazoo49007NCT06401330Map
MIBronson Methodist HospitalKalamazoo49007NCT06958328Map
MIBronson Methodist HospitalKalamazoo49007NCT06998940Map
MIWest Michigan Cancer CenterKalamazoo49007NCT04205968Map
MIWest Michigan Cancer CenterKalamazoo49007NCT06958328Map
MIWest Michigan Cancer CenterKalamazoo49007NCT06998940Map
MIHerbert-Herman Cancer Center, Sparrow HospitalLansing48912NCT01042379Map
MIKarmanos Cancer Institute at McLaren Greater LansingLansing48910NCT05677490Map
MIUniversity of Michigan Health - Sparrow LansingLansing48912NCT04205968Map
MIUniversity of Michigan Health - Sparrow LansingLansing48912NCT05677490Map
MIUniversity of Michigan Health - Sparrow LansingLansing48912NCT06958328Map
MIMcLaren Cancer Institute-Lapeer RegionLapeer48446NCT05677490Map
MITrinity Health Saint Mary Mercy Livonia HospitalLivonia48154NCT04205968Map
MITrinity Health Saint Mary Mercy Livonia HospitalLivonia48154NCT05677490Map
MITrinity Health Saint Mary Mercy Livonia HospitalLivonia48154NCT06958328Map
MIHenry Ford Saint John Hospital - Macomb MedicalMacomb48044NCT04205968Map
MIHenry Ford Saint John Hospital - Macomb MedicalMacomb48044NCT05677490Map
MIHenry Ford Warren Hospital - Breast MacombMacomb48044NCT04205968Map
MIHenry Ford Warren Hospital - Breast MacombMacomb48044NCT05677490Map
MIMyMichigan Medical Center MidlandMidland48670NCT04205968Map
MIMyMichigan Medical Center MidlandMidland48670NCT05677490Map
MIMcLaren Cancer Institute-MacombMount Clemens48043NCT05677490Map
MIMyMichigan Medical Center Mount PleasantMount Pleasant48858NCT04205968Map
MIMyMichigan Medical Center Mount PleasantMount Pleasant48858NCT05677490Map
MITrinity Health Muskegon HospitalMuskegon49444NCT04205968Map
MITrinity Health Muskegon HospitalMuskegon49444NCT06998940Map
MICorewell Health Lakeland Hospitals - Niles HospitalNiles49120NCT04205968Map
MICorewell Health Lakeland Hospitals - Niles HospitalNiles49120NCT06998940Map
MICancer and Hematology Centers of Western Michigan - Norton ShoresNorton Shores49444NCT04205968Map
MICancer and Hematology Centers of Western Michigan - Norton ShoresNorton Shores49444NCT06998940Map
MIHenry Ford Health Providence Novi HospitalNovi48374NCT04205968Map
MIHenry Ford Medical Center-ColumbusNovi48377NCT04205968Map
MIHenry Ford Medical Center-ColumbusNovi48377NCT06958328Map
MIMcLaren Cancer Institute-Northern MichiganPetoskey49770NCT05677490Map
MIHope Cancer CenterPontiac48341NCT04205968Map
MIHope Cancer CenterPontiac48341NCT05677490Map
MIMichigan Healthcare Professionals PontiacPontiac48341NCT04205968Map
MIMichigan Healthcare Professionals PontiacPontiac48341NCT05677490Map
MIMichigan Healthcare Professionals PontiacPontiac48341NCT06958328Map
MINewland Medical Associates-PontiacPontiac48341NCT04205968Map
MINewland Medical Associates-PontiacPontiac48341NCT05677490Map
MITrinity Health Saint Joseph Mercy Oakland HospitalPontiac48341NCT04205968Map
MITrinity Health Saint Joseph Mercy Oakland HospitalPontiac48341NCT05677490Map
MITrinity Health Saint Joseph Mercy Oakland HospitalPontiac48341NCT06958328Map
MIMcLaren-Port HuronPort Huron48060NCT05677490Map
MICorewell Health Reed City HospitalReed City49677NCT04205968Map
MICorewell Health Reed City HospitalReed City49677NCT06998940Map
MICancer Care Associates PCRoyal Oak48073NCT05677490Map
MIComprehensive Medical Center PLLCRoyal Oak48073NCT05677490Map
MICorewell Health Children'sRoyal Oak48073NCT04322318Map
MICorewell Health Children'sRoyal Oak48073NCT06172296Map
MICorewell Health William Beaumont University HospitalRoyal Oak48073NCT05677490Map
MIHematology Oncology Consultants PC-Royal OakRoyal Oak48073NCT05677490Map
MIOakland Colon Rectal AssociatesRoyal Oak48067NCT05677490Map
MIOakland Medical GroupRoyal Oak48073NCT05677490Map
MIMyMichigan Medical Center SaginawSaginaw48601NCT04205968Map
MIMyMichigan Medical Center SaginawSaginaw48601NCT05677490Map
MIMyMichigan Medical Center SaginawSaginaw48601NCT06958328Map
MICorewell Health Lakeland Hospitals - Marie Yeager Cancer CenterSaint Joseph49085NCT04205968Map
MICorewell Health Lakeland Hospitals - Marie Yeager Cancer CenterSaint Joseph49085NCT06998940Map
MICorewell Health Lakeland Hospitals - Saint Joseph HospitalSaint Joseph49085NCT04205968Map
MICorewell Health Lakeland Hospitals - Saint Joseph HospitalSaint Joseph49085NCT06998940Map
MIHenry Ford Health Providence Southfield HospitalSouthfield48075NCT04205968Map
MIPremier Hematology Oncology CareSterling Heights48312NCT05677490Map
MIMyMichigan Medical Center TawasTawas City48764NCT04205968Map
MIMyMichigan Medical Center TawasTawas City48764NCT05677490Map
MIMyMichigan Medical Center TawasTawas City48764NCT06958328Map
MIMunson Medical CenterTraverse City49684NCT04205968Map
MIMunson Medical CenterTraverse City49684NCT06998940Map
MICorewell Health Beaumont Troy HospitalTroy48085NCT05677490Map
MIHematology Oncology Consultants PC-TroyTroy48098NCT05677490Map
MIMichigan Institute of Urology-Town CenterTroy48084NCT05677490Map
MIHenry Ford Health Warren HospitalWarren48093NCT04205968Map
MIHenry Ford Health Warren HospitalWarren48093NCT05677490Map
MIHenry Ford Madison Heights Hospital - BreastWarren48093NCT04205968Map
MIHenry Ford Madison Heights Hospital - BreastWarren48093NCT05677490Map
MIHenry Ford Warren Hospital - GLCMSWarren48093NCT04205968Map
MIHenry Ford Warren Hospital - GLCMSWarren48093NCT05677490Map
MIHenry Ford West Bloomfield HospitalWest Bloomfield48322NCT04205968Map
MIHenry Ford West Bloomfield HospitalWest Bloomfield48322NCT06958328Map
MIHenry Ford Wyandotte HospitalWyandotte48192NCT04205968Map
MIHenry Ford Wyandotte HospitalWyandotte48192NCT06958328Map
MIUniversity of Michigan Health - WestWyoming49519NCT04205968Map
MIUniversity of Michigan Health - WestWyoming49519NCT06958328Map
MIUniversity of Michigan Health - WestWyoming49519NCT06998940Map
MIHuron Gastroenterology PCYpsilanti48106NCT04205968Map
MIHuron Gastroenterology PCYpsilanti48106NCT05677490Map
MITrinity Health Ann Arbor HospitalYpsilanti48197NCT05382559Map
MITrinity Health IHA Medical Group Hematology Oncology Ann Arbor CampusYpsilanti48197NCT04205968Map
MITrinity Health IHA Medical Group Hematology Oncology Ann Arbor CampusYpsilanti48197NCT05677490Map
MITrinity Health IHA Medical Group Hematology Oncology Ann Arbor CampusYpsilanti48197NCT06958328Map
MNRiverwood Healthcare CenterAitkin56431NCT04205968Map
MNRiverwood Healthcare CenterAitkin56431NCT05677490Map
MNRiverwood Healthcare CenterAitkin56431NCT06998940Map
MNEssentia Health - Baxter ClinicBaxter56425NCT04205968Map
MNEssentia Health - Baxter ClinicBaxter56425NCT05677490Map
MNEssentia Health - Baxter ClinicBaxter56425NCT06998940Map
MNSanford Joe Lueken Cancer CenterBemidji56601NCT05677490Map
MNSanford Joe Lueken Cancer CenterBemidji56601NCT06958328Map
MNEssentia Health Saint Joseph's Medical CenterBrainerd56401NCT04205968Map
MNEssentia Health Saint Joseph's Medical CenterBrainerd56401NCT05677490Map
MNEssentia Health Saint Joseph's Medical CenterBrainerd56401NCT06998940Map
MNMinnesota Oncology - BurnsvilleBurnsville55337NCT04205968Map
MNMinnesota Oncology - BurnsvilleBurnsville55337NCT05677490Map
MNCambridge Medical CenterCambridge55008NCT04205968Map
MNCambridge Medical CenterCambridge55008NCT05677490Map
MNMinnesota Oncology Hematology PA-ChaskaChaska55318NCT05677490Map
MNMercy HospitalCoon Rapids55433NCT04205968Map
MNMercy HospitalCoon Rapids55433NCT05677490Map
MNMinnesota Oncology - Coon RapidsCoon Rapids55433NCT05677490Map
MNEssentia Health - Saint Joseph's Crosslake ClinicCrosslake56442NCT04205968Map
MNEssentia Health - Saint Joseph's Crosslake ClinicCrosslake56442NCT05677490Map
MNEssentia Health - Saint Joseph's Crosslake ClinicCrosslake56442NCT06998940Map
MNEssentia Health - Deer River ClinicDeer River56636NCT04205968Map
MNEssentia Health - Deer River ClinicDeer River56636NCT05677490Map
MNEssentia Health - Deer River ClinicDeer River56636NCT06998940Map
MNEssentia Health Saint Mary's - Detroit Lakes ClinicDetroit Lakes56501NCT04205968Map
MNEssentia Health Saint Mary's - Detroit Lakes ClinicDetroit Lakes56501NCT05677490Map
MNEssentia Health Saint Mary's - Detroit Lakes ClinicDetroit Lakes56501NCT06998940Map
MNEssentia Health Cancer CenterDuluth55805NCT04205968Map
MNEssentia Health Cancer CenterDuluth55805NCT05677490Map
MNEssentia Health Cancer CenterDuluth55805NCT06998940Map
MNEssentia Health Saint Mary's Medical CenterDuluth55805NCT04205968Map
MNEssentia Health Saint Mary's Medical CenterDuluth55805NCT05677490Map
MNEssentia Health Saint Mary's Medical CenterDuluth55805NCT06998940Map
MNMiller-Dwan HospitalDuluth55805NCT04205968Map
MNMiller-Dwan HospitalDuluth55805NCT05677490Map
MNMiller-Dwan HospitalDuluth55805NCT06998940Map
MNFairview Southdale HospitalEdina55435NCT04205968Map
MNFairview Southdale HospitalEdina55435NCT05677490Map
MNMinnesota Oncology - EdinaEdina55435NCT05677490Map
MNEssentia Health - Ely ClinicEly55731NCT04205968Map
MNEssentia Health - Ely ClinicEly55731NCT05677490Map
MNEssentia Health - Ely ClinicEly55731NCT06998940Map
MNEssentia Health - FosstonFosston56542NCT04205968Map
MNEssentia Health - FosstonFosston56542NCT05677490Map
MNEssentia Health - FosstonFosston56542NCT06998940Map
MNEssentia Health Hibbing ClinicHibbing55746NCT04205968Map
MNEssentia Health Hibbing ClinicHibbing55746NCT05677490Map
MNEssentia Health Hibbing ClinicHibbing55746NCT06998940Map
MNEssentia Health - International Falls ClinicInternational Falls56649NCT04205968Map
MNEssentia Health - International Falls ClinicInternational Falls56649NCT05677490Map
MNEssentia Health - International Falls ClinicInternational Falls56649NCT06998940Map
MNFairview Clinics and Surgery Center Maple GroveMaple Grove55369NCT04205968Map
MNFairview Clinics and Surgery Center Maple GroveMaple Grove55369NCT05677490Map
MNMinnesota Oncology - Maple GroveMaple Grove55369NCT05677490Map
MNMinnesota Oncology HematologyMaple Grove55369NCT04657068Map
MNMinnesota Oncology Hematology - PrimaryMaple Grove55369NCT07011576Map
MNMinnesota Oncology Hematology PA-MaplewoodMaplewood55109NCT04205968Map
MNMinnesota Oncology Hematology PA-MaplewoodMaplewood55109NCT05677490Map
MNSaint John's Hospital - HealtheastMaplewood55109NCT04205968Map
MNSaint John's Hospital - HealtheastMaplewood55109NCT05677490Map
MNAbbott-Northwestern HospitalMinneapolis55407NCT04205968Map
MNAbbott-Northwestern HospitalMinneapolis55407NCT05677490Map
MNChildren's Hospitals and Clinics of Minnesota - MinneapolisMinneapolis55404NCT04322318Map
MNChildren's Hospitals and Clinics of Minnesota - MinneapolisMinneapolis55404NCT06172296Map
MNChildren's Hospitals and Clinics of Minnesota - MinneapolisMinneapolis55404NCT06401330Map
MNHealth Partners IncMinneapolis55454NCT04205968Map
MNHealth Partners IncMinneapolis55454NCT05677490Map
MNHennepin County Medical CenterMinneapolis55415NCT04205968Map
MNHennepin County Medical CenterMinneapolis55415NCT05677490Map
MNUniversity of MinnesotaMinneapolis55455NCT01042379Map
MNUniversity of Minnesota/Masonic Cancer CenterMinneapolis55455NCT04322318Map
MNUniversity of Minnesota/Masonic Cancer CenterMinneapolis55455NCT06172296Map
MNUniversity of Minnesota/Masonic Cancer CenterMinneapolis55455NCT06401330Map
MNUniversity of Minnesota/Masonic Cancer CenterMinneapolis55455NCT06620302Map
MNMonticello Cancer CenterMonticello55362NCT04205968Map
MNMonticello Cancer CenterMonticello55362NCT05677490Map
MNEssentia Health - Moose Lake ClinicMoose Lake55767NCT04205968Map
MNEssentia Health - Moose Lake ClinicMoose Lake55767NCT05677490Map
MNEssentia Health - Moose Lake ClinicMoose Lake55767NCT06998940Map
MNNew Ulm Medical CenterNew Ulm56073NCT04205968Map
MNNew Ulm Medical CenterNew Ulm56073NCT05677490Map
MNEssentia Health - Park RapidsPark Rapids56470NCT04205968Map
MNEssentia Health - Park RapidsPark Rapids56470NCT05677490Map
MNEssentia Health - Park RapidsPark Rapids56470NCT06998940Map
MNEssentia Health - Saint Joseph's Pequot Lakes ClinicPequot Lakes56472NCT04205968Map
MNEssentia Health - Saint Joseph's Pequot Lakes ClinicPequot Lakes56472NCT05677490Map
MNEssentia Health - Saint Joseph's Pequot Lakes ClinicPequot Lakes56472NCT06998940Map
MNEssentia Health - Saint Joseph's Pine River ClinicPine River56474NCT04205968Map
MNEssentia Health - Saint Joseph's Pine River ClinicPine River56474NCT05677490Map
MNEssentia Health - Saint Joseph's Pine River ClinicPine River56474NCT06998940Map
MNFairview Northland Medical CenterPrinceton55371NCT04205968Map
MNFairview Northland Medical CenterPrinceton55371NCT05677490Map
MNNorth Memorial Medical Health CenterRobbinsdale55422NCT04205968Map
MNNorth Memorial Medical Health CenterRobbinsdale55422NCT05677490Map
MNMayo ClinicRochester55905NCT01042379Map
MNMayo Clinic (Minnesota)Rochester55905NCT04657068Map
MNMayo Clinic in RochesterRochester55905NCT04322318Map
MNMayo Clinic in RochesterRochester55905NCT05863195Map
MNMayo Clinic in RochesterRochester55905NCT06172296Map
MNMayo Clinic in RochesterRochester55905NCT06381154Map
MNMayo Clinic in RochesterRochester55905NCT06401330Map
MNMayo Clinic in Rochester, MinnesotaRochester55905NCT07415031Map
MNResearch SiteRochester55905NCT06792695Map
MNCoborn Cancer Center at Saint Cloud HospitalSaint Cloud56303NCT05677490Map
MNHealthPartners Frauenshuh Cancer CenterSaint Louis Park55426NCT07409272Map
MNMetro Minnesota Community Oncology Research Consortium, Hennepin County Medical CenterSaint Louis Park55416NCT01042379Map
MNPark Nicollet Clinic - Saint Louis ParkSaint Louis Park55416NCT04205968Map
MNPark Nicollet Clinic - Saint Louis ParkSaint Louis Park55416NCT05677490Map
MNHealthPartners Cancer Center at Regions HospitalSaint Paul55101NCT07409272Map
MNRegions HospitalSaint Paul55101NCT04205968Map
MNRegions HospitalSaint Paul55101NCT05677490Map
MNUnited HospitalSaint Paul55102NCT04205968Map
MNUnited HospitalSaint Paul55102NCT05677490Map
MNEssentia Health SandstoneSandstone55072NCT04205968Map
MNEssentia Health SandstoneSandstone55072NCT05677490Map
MNEssentia Health SandstoneSandstone55072NCT06998940Map
MNSaint Francis Regional Medical CenterShakopee55379NCT04205968Map
MNSaint Francis Regional Medical CenterShakopee55379NCT05677490Map
MNEssentia Health - Saint Joseph's Staples ClinicStaples56479NCT04205968Map
MNEssentia Health - Saint Joseph's Staples ClinicStaples56479NCT05677490Map
MNEssentia Health - Saint Joseph's Staples ClinicStaples56479NCT06998940Map
MNLakeview HospitalStillwater55082NCT04205968Map
MNLakeview HospitalStillwater55082NCT05677490Map
MNSanford Thief River Falls Medical CenterThief River Falls56701NCT05677490Map
MNEssentia Health Virginia ClinicVirginia55792NCT04205968Map
MNEssentia Health Virginia ClinicVirginia55792NCT05677490Map
MNEssentia Health Virginia ClinicVirginia55792NCT06998940Map
MNRidgeview Medical CenterWaconia55387NCT04205968Map
MNRidgeview Medical CenterWaconia55387NCT05677490Map
MNRice Memorial HospitalWillmar56201NCT04205968Map
MNRice Memorial HospitalWillmar56201NCT05677490Map
MNMinnesota Oncology Hematology PA-WoodburyWoodbury55125NCT04205968Map
MNMinnesota Oncology Hematology PA-WoodburyWoodbury55125NCT05677490Map
MNSanford Cancer Center WorthingtonWorthington56187NCT05677490Map
MNFairview Lakes Medical CenterWyoming55092NCT04205968Map
MNFairview Lakes Medical CenterWyoming55092NCT05677490Map
MSBaptist Memorial Hospital and Cancer Center-Golden TriangleColumbus39705NCT06958328Map
MSBaptist Memorial Hospital and Cancer Center-Golden TriangleColumbus39705NCT06998940Map
MSBaptist Cancer Center-GrenadaGrenada38901NCT04205968Map
MSBaptist Cancer Center-GrenadaGrenada38901NCT06958328Map
MSBaptist Cancer Center-GrenadaGrenada38901NCT06998940Map
MSHattiesburg ClinicHattiesburg39401NCT05379595Map
MSHattiesburg ClinicHattiesburg39401NCT06662786Map
MSHattiesburg ClinicHattiesburg39401NCT06750094Map
MSUniversity of Mississippi Medical CenterJackson39216NCT04322318Map
MSUniversity of Mississippi Medical CenterJackson39216NCT06172296Map
MSUniversity of Mississippi Medical CenterJackson39216NCT06401330Map
MSBaptist Memorial Hospital and Cancer Center-Union CountyNew Albany38652NCT04205968Map
MSBaptist Memorial Hospital and Cancer Center-Union CountyNew Albany38652NCT06958328Map
MSBaptist Memorial Hospital and Cancer Center-Union CountyNew Albany38652NCT06998940Map
MSBaptist Memorial Hospital and Cancer Center-OxfordOxford38655NCT04205968Map
MSBaptist Memorial Hospital and Cancer Center-OxfordOxford38655NCT06958328Map
MSBaptist Memorial Hospital and Cancer Center-OxfordOxford38655NCT06998940Map
MSBaptist Memorial Hospital and Cancer Center-DesotoSouthhaven38671NCT04205968Map
MSBaptist Memorial Hospital and Cancer Center-DesotoSouthhaven38671NCT06958328Map
MSBaptist Memorial Hospital and Cancer Center-DesotoSouthhaven38671NCT06998940Map
MOMercy Oncology and Hematology - Clayton-ClarksonBallwin63011NCT04205968Map
MOMercy Oncology and Hematology - Clayton-ClarksonBallwin63011NCT05677490Map
MOCentral Care Cancer Center - BolivarBolivar65613NCT04205968Map
MOCentral Care Cancer Center - BolivarBolivar65613NCT05677490Map
MOCox Cancer Center BransonBranson65616NCT04205968Map
MOCox Cancer Center BransonBranson65616NCT05677490Map
MOMercy Cancer Center - Cape GirardeauCape Girardeau63703NCT04205968Map
MOMercy Cancer Center - Cape GirardeauCape Girardeau63703NCT05677490Map
MOSaint Francis Medical CenterCape Girardeau63703NCT04205968Map
MOSaint Francis Medical CenterCape Girardeau63703NCT05677490Map
MOSaint Francis Medical CenterCape Girardeau63703NCT06998940Map
MOSiteman Cancer Center at Saint Peters HospitalCity of Saint Peters63376NCT05863195Map
MOMissouri Cancer AssociatesColumbia65201NCT07011576Map
MOUniversity of Missouri Children's HospitalColumbia65212NCT04322318Map
MOUniversity of Missouri Children's HospitalColumbia65212NCT06172296Map
MOUniversity of Missouri Children's HospitalColumbia65212NCT06401330Map
MOSiteman Cancer Center at West County HospitalCreve Coeur63141NCT05863195Map
MOParkland Health Center - FarmingtonFarmington63640NCT04205968Map
MOParkland Health Center - FarmingtonFarmington63640NCT05677490Map
MOParkland Health Center - FarmingtonFarmington63640NCT06998940Map
MOFreeman Health SystemJoplin64804NCT04205968Map
MOFreeman Health SystemJoplin64804NCT05677490Map
MOMercy Hospital JoplinJoplin64804NCT04205968Map
MOMercy Hospital JoplinJoplin64804NCT05677490Map
MOChildren's Mercy HospitalKansas City64108NCT05999994Map
MOChildren's Mercy Hospitals and ClinicsKansas City64108NCT04322318Map
MOChildren's Mercy Hospitals and ClinicsKansas City64108NCT06172296Map
MOChildren's Mercy Hospitals and ClinicsKansas City64108NCT06401330Map
MOChildren's Mercy Hospitals and ClinicsKansas City64108NCT06541262Map
MOUniversity Health Truman Medical CenterKansas City64108NCT05677490Map
MOUniversity of Kansas Cancer Center - NorthKansas City64154NCT06958328Map
MOUniversity of Kansas Cancer Center - Lee's SummitLee's Summit64064NCT06958328Map
MOLake Regional HospitalOsage Beach65065NCT04205968Map
MOLake Regional HospitalOsage Beach65065NCT05677490Map
MOMercy Clinic-Rolla-Cancer and HematologyRolla65401NCT04205968Map
MOMercy Clinic-Rolla-Cancer and HematologyRolla65401NCT05677490Map
MOPhelps Health Delbert Day Cancer InstituteRolla65401NCT04205968Map
MOPhelps Health Delbert Day Cancer InstituteRolla65401NCT05677490Map
MOHeartland Regional Medical CenterSaint Joseph64506NCT04205968Map
MOHeartland Regional Medical CenterSaint Joseph64506NCT05677490Map
MOSainte Genevieve County Memorial HospitalSainte Genevieve63670NCT04205968Map
MOSainte Genevieve County Memorial HospitalSainte Genevieve63670NCT05677490Map
MOSainte Genevieve County Memorial HospitalSainte Genevieve63670NCT06998940Map
MOCoxHealth South HospitalSpringfield65807NCT04205968Map
MOCoxHealth South HospitalSpringfield65807NCT05677490Map
MOMercy Hospital SpringfieldSpringfield65804NCT04205968Map
MOMercy Hospital SpringfieldSpringfield65804NCT05677490Map
MOCardinal Glennon Children's Medical CenterSt Louis63104NCT04322318Map
MOCardinal Glennon Children's Medical CenterSt Louis63104NCT06401330Map
MOCardinal Glennon Children's Medical CenterSt Louis63104NCT06541262Map
MOInvestigative Site #110St Louis63108NCT06974110Map
MOMercy Hospital Saint LouisSt Louis63141NCT04205968Map
MOMercy Hospital Saint LouisSt Louis63141NCT04322318Map
MOMercy Hospital Saint LouisSt Louis63141NCT05677490Map
MOMercy Hospital Saint LouisSt Louis63141NCT06172296Map
MOMercy Hospital SouthSt Louis63128NCT04205968Map
MOMercy Hospital SouthSt Louis63128NCT05677490Map
MOMercy Infusion Center - ChippewaSt Louis63109NCT04205968Map
MOMercy Infusion Center - ChippewaSt Louis63109NCT05677490Map
MOMissouri Baptist Medical CenterSt Louis63131NCT04205968Map
MOMissouri Baptist Medical CenterSt Louis63131NCT05677490Map
MOMissouri Baptist Medical CenterSt Louis63131NCT06998940Map
MOSiteman Cancer Center at Christian HospitalSt Louis63136NCT05863195Map
MOSiteman Cancer Center-South CountySt Louis63129NCT05863195Map
MOWashington UniversitySt Louis63110NCT04657068Map
MOWashington University School of MedicineSt Louis63110NCT05382559Map
MOWashington University School of MedicineSt Louis63110NCT04322318Map
MOWashington University School of MedicineSt Louis63110NCT05863195Map
MOWashington University School of MedicineSt Louis63110NCT06172296Map
MOWashington University School of MedicineSt Louis63110NCT06401330Map
MOWashington University School of MedicineSt Louis63110NCT06620302Map
MOWashington University School of MedicineSt Louis63110NCT06835387Map
MOWashington University School of MedicineSt Louis63110NCT07155200Map
MOWashington University School Of MedicineSt Louis63110NCT06662786Map
MOWashington University School Of MedicineSt Louis63110NCT06750094Map
MOMissouri Baptist Sullivan HospitalSullivan63080NCT04205968Map
MOMissouri Baptist Sullivan HospitalSullivan63080NCT05677490Map
MOMissouri Baptist Sullivan HospitalSullivan63080NCT06998940Map
MOBJC Outpatient Center at Sunset HillsSunset Hills63127NCT04205968Map
MOBJC Outpatient Center at Sunset HillsSunset Hills63127NCT05677490Map
MOBJC Outpatient Center at Sunset HillsSunset Hills63127NCT06998940Map
MOMercy Hospital WashingtonWashington63090NCT04205968Map
MOMercy Hospital WashingtonWashington63090NCT05677490Map
MTCommunity Hospital of AnacondaAnaconda59711NCT04205968Map
MTCommunity Hospital of AnacondaAnaconda59711NCT05677490Map
MTCommunity Hospital of AnacondaAnaconda59711NCT06998940Map
MTBillings Clinic Cancer CenterBillings59101NCT04205968Map
MTBillings Clinic Cancer CenterBillings59101NCT05677490Map
MTBillings Clinic Cancer CenterBillings59101NCT06998940Map
MTIntermountain Health West End ClinicBillings59106NCT04205968Map
MTSaint Vincent Frontier Cancer CenterBillings59102NCT04205968Map
MTSaint Vincent Frontier Cancer CenterBillings59102NCT05677490Map
MTSaint Vincent HealthcareBillings59101NCT04205968Map
MTBozeman Health Deaconess HospitalBozeman59715NCT04205968Map
MTBozeman Health Deaconess HospitalBozeman59715NCT05677490Map
MTBozeman Health Deaconess HospitalBozeman59715NCT06998940Map
MTSaint James Community Hospital and Cancer Treatment CenterButte59701NCT04205968Map
MTSaint James Community Hospital and Cancer Treatment CenterButte59701NCT05677490Map
MTBenefis Sletten Cancer InstituteGreat Falls59405NCT04205968Map
MTBenefis Sletten Cancer InstituteGreat Falls59405NCT05677490Map
MTBenefis Sletten Cancer InstituteGreat Falls59405NCT06998940Map
MTGreat Falls ClinicGreat Falls59405NCT04205968Map
MTGreat Falls ClinicGreat Falls59405NCT05677490Map
MTGreat Falls ClinicGreat Falls59405NCT06998940Map
MTHi-Line Sletten Cancer CenterHavre59501NCT04205968Map
MTHi-Line Sletten Cancer CenterHavre59501NCT05677490Map
MTHi-Line Sletten Cancer CenterHavre59501NCT06998940Map
MTBenefis Helena Specialty CenterHelena59601NCT05677490Map
MTBenefis Helena Specialty CenterHelena59601NCT06998940Map
MTLogan Health Medical CenterKalispell59901NCT04205968Map
MTLogan Health Medical CenterKalispell59901NCT05677490Map
MTLogan Health Medical CenterKalispell59901NCT06998940Map
MTCommunity Medical CenterMissoula59804NCT04205968Map
MTCommunity Medical CenterMissoula59804NCT05677490Map
MTCommunity Medical CenterMissoula59804NCT06998940Map
MTSaint Patrick Hospital - Community HospitalMissoula59802NCT04205968Map
MTSaint Patrick Hospital - Community HospitalMissoula59802NCT05677490Map
MTSaint Patrick Hospital - Community HospitalMissoula59802NCT06998940Map
NENebraska Medicine-BellevueBellevue68123NCT05677490Map
NECHI Health Saint FrancisGrand Island68803NCT06998940Map
NECHI Health Good SamaritanKearney68847NCT06998940Map
NEAlegent Health Bergan Mercy Medical CenterOmaha68124NCT06998940Map
NEAlegent Health Immanuel Medical CenterOmaha68122NCT06998940Map
NEAlegent Health Lakeside HospitalOmaha68130NCT06998940Map
NEChildren's Hospital and Medical Center of OmahaOmaha68114NCT04322318Map
NEChildren's Hospital and Medical Center of OmahaOmaha68114NCT06172296Map
NEChildren's Hospital and Medical Center of OmahaOmaha68114NCT06401330Map
NECreighton University Medical CenterOmaha68131NCT06998940Map
NENebraska Cancer SpecialistsOmaha68130NCT06750094Map
NENebraska Cancer Specialists Midwest Cancer CenterOmaha68130NCT06662786Map
NENebraska Cancer Specialists/Oncology Hematology West PC - MECCOmaha68114NCT05677490Map
NENebraska Medicine-Village PointeOmaha68118NCT05677490Map
NENebraska Medicine-Village PointeOmaha68118NCT06958328Map
NENebraska Methodist HospitalOmaha68114NCT05677490Map
NEUniversity of Nebraska Medical CenterOmaha68198NCT04322318Map
NEUniversity of Nebraska Medical CenterOmaha68198NCT05677490Map
NEUniversity of Nebraska Medical CenterOmaha68198NCT06172296Map
NEUniversity of Nebraska Medical CenterOmaha68198NCT06401330Map
NEUniversity of Nebraska Medical CenterOmaha68198NCT06958328Map
NVCarson Tahoe Regional Medical CenterCarson City89703NCT04205968Map
NVCarson Tahoe Regional Medical CenterCarson City89703NCT05677490Map
NVCancer and Blood Specialists-HendersonHenderson89052NCT04205968Map
NVCancer and Blood Specialists-HendersonHenderson89052NCT05677490Map
NVComprehensive Cancer Centers of Nevada - HendersonHenderson89052NCT04205968Map
NVComprehensive Cancer Centers of Nevada - HendersonHenderson89052NCT05677490Map
NVComprehensive Cancer Centers of Nevada-Horizon RidgeHenderson89052NCT04205968Map
NVComprehensive Cancer Centers of Nevada-Horizon RidgeHenderson89052NCT05677490Map
NVComprehensive Cancer Centers of Nevada-Southeast HendersonHenderson89074NCT04205968Map
NVComprehensive Cancer Centers of Nevada-Southeast HendersonHenderson89074NCT05677490Map
NVLas Vegas Urology - Green ValleyHenderson89074NCT04205968Map
NVLas Vegas Urology - Green ValleyHenderson89074NCT05677490Map
NVLas Vegas Urology - PebbleHenderson89074NCT04205968Map
NVLas Vegas Urology - PebbleHenderson89074NCT05677490Map
NVOncology Las Vegas - HendersonHenderson89074NCT04205968Map
NVOncology Las Vegas - HendersonHenderson89074NCT05677490Map
NVOptumCare Cancer Care at Seven HillsHenderson89052NCT04205968Map
NVUrology Specialists of Nevada - Green ValleyHenderson89074NCT04205968Map
NVUrology Specialists of Nevada - Green ValleyHenderson89074NCT05677490Map
NVAlliance for Childhood Diseases/Cure 4 the Kids FoundationLas Vegas89135NCT04205968Map
NVAlliance for Childhood Diseases/Cure 4 the Kids FoundationLas Vegas89135NCT04322318Map
NVAlliance for Childhood Diseases/Cure 4 the Kids FoundationLas Vegas89135NCT05677490Map
NVAlliance for Childhood Diseases/Cure 4 the Kids FoundationLas Vegas89135NCT06172296Map
NVAlliance for Childhood Diseases/Cure 4 the Kids FoundationLas Vegas89135NCT06401330Map
NVAnn M Wierman MD LTDLas Vegas89128NCT04205968Map
NVComprehensive Cancer Centers of NevadaLas Vegas89148NCT04205968Map
NVComprehensive Cancer Centers of NevadaLas Vegas89148NCT05677490Map
NVComprehensive Cancer Centers of NevadaLas Vegas89169NCT06662786Map
NVComprehensive Cancer Centers of Nevada - Central ValleyLas Vegas89169NCT04205968Map
NVComprehensive Cancer Centers of Nevada - Central ValleyLas Vegas89169NCT05677490Map
NVComprehensive Cancer Centers of Nevada - NorthwestLas Vegas89128NCT04205968Map
NVComprehensive Cancer Centers of Nevada - NorthwestLas Vegas89128NCT05677490Map
NVComprehensive Cancer Centers of Nevada - Town CenterLas Vegas89144NCT04205968Map
NVComprehensive Cancer Centers of Nevada - Town CenterLas Vegas89144NCT05677490Map
NVComprehensive Cancer Centers of Nevada-SummerlinLas Vegas89144NCT04205968Map
NVComprehensive Cancer Centers of Nevada-SummerlinLas Vegas89144NCT05677490Map
NVHope Cancer Care of NevadaLas Vegas89103NCT04205968Map
NVHope Cancer Care of NevadaLas Vegas89103NCT05677490Map
NVLas Vegas Prostate Cancer CenterLas Vegas89113NCT04205968Map
NVLas Vegas Prostate Cancer CenterLas Vegas89113NCT05677490Map
NVLas Vegas Urology - Cathedral RockLas Vegas89128NCT04205968Map
NVLas Vegas Urology - Cathedral RockLas Vegas89128NCT05677490Map
NVLas Vegas Urology - PecosLas Vegas89074NCT04205968Map
NVLas Vegas Urology - PecosLas Vegas89074NCT05677490Map
NVLas Vegas Urology - Smoke RanchLas Vegas89128NCT04205968Map
NVLas Vegas Urology - Smoke RanchLas Vegas89128NCT05677490Map
NVLas Vegas Urology - SunsetLas Vegas89113NCT04205968Map
NVLas Vegas Urology - SunsetLas Vegas89113NCT05677490Map
NVOncology Las Vegas - TenayaLas Vegas89128NCT04205968Map
NVOncology Las Vegas - TenayaLas Vegas89128NCT05677490Map
NVOptumCare Cancer Care at CharlestonLas Vegas89102NCT04205968Map
NVOptumCare Cancer Care at CharlestonLas Vegas89102NCT05677490Map
NVOptumCare Cancer Care at Fort ApacheLas Vegas89148NCT04205968Map
NVOptumCare Cancer Care at Fort ApacheLas Vegas89183NCT05677490Map
NVOptumCare Cancer Care at MountainViewLas Vegas89128NCT04205968Map
NVOptumCare Cancer Care at MountainViewLas Vegas89128NCT05677490Map
NVRadiation Oncology Centers of Nevada CentralLas Vegas89106NCT04205968Map
NVRadiation Oncology Centers of Nevada CentralLas Vegas89106NCT05677490Map
NVRadiation Oncology Centers of Nevada SoutheastLas Vegas89119NCT04205968Map
NVRadiation Oncology Centers of Nevada SoutheastLas Vegas89119NCT05677490Map
NVSummerlin Hospital Medical CenterLas Vegas89144NCT04205968Map
NVSummerlin Hospital Medical CenterLas Vegas89144NCT04322318Map
NVSummerlin Hospital Medical CenterLas Vegas89144NCT05677490Map
NVSunrise Hospital and Medical CenterLas Vegas89109NCT04205968Map
NVSunrise Hospital and Medical CenterLas Vegas89109NCT04322318Map
NVSunrise Hospital and Medical CenterLas Vegas89109NCT05677490Map
NVUniversity Cancer CenterLas Vegas89169NCT04205968Map
NVUniversity Cancer CenterLas Vegas89169NCT05677490Map
NVUniversity Medical Center of Southern NevadaLas Vegas89102NCT04205968Map
NVUniversity Medical Center of Southern NevadaLas Vegas89102NCT04322318Map
NVUniversity Medical Center of Southern NevadaLas Vegas89102NCT05677490Map
NVUrology Specialists of Nevada - CentralLas Vegas89106NCT04205968Map
NVUrology Specialists of Nevada - CentralLas Vegas89106NCT05677490Map
NVUrology Specialists of Nevada - NorthwestLas Vegas89128NCT04205968Map
NVUrology Specialists of Nevada - NorthwestLas Vegas89128NCT05677490Map
NVUrology Specialists of Nevada - SouthwestLas Vegas89113NCT04205968Map
NVUrology Specialists of Nevada - SouthwestLas Vegas89113NCT05677490Map
NVHope Cancer Care of Nevada-PahrumpPahrump89048NCT04205968Map
NVHope Cancer Care of Nevada-PahrumpPahrump89048NCT05677490Map
NVRadiation Oncology AssociatesReno89509NCT04205968Map
NVRadiation Oncology AssociatesReno89509NCT05677490Map
NVRenown Regional Medical CenterReno89502NCT04205968Map
NVRenown Regional Medical CenterReno89502NCT04322318Map
NVRenown Regional Medical CenterReno89502NCT05677490Map
NVRenown Regional Medical CenterReno89502NCT06958328Map
NVSaint Mary's Regional Medical CenterReno89503NCT04205968Map
NVSaint Mary's Regional Medical CenterReno89503NCT05677490Map
NHDartmouth Hitchcock Medical Center/Dartmouth Cancer CenterLebanon03756NCT04205968Map
NHDartmouth Hitchcock Medical Center/Dartmouth Cancer CenterLebanon03756NCT04322318Map
NHDartmouth Hitchcock Medical Center/Dartmouth Cancer CenterLebanon03756NCT06172296Map
NHDartmouth Hitchcock Medical Center/Dartmouth Cancer CenterLebanon03756NCT06401330Map
NHDartmouth Hitchcock Medical Center/Dartmouth Cancer CenterLebanon03756NCT06958328Map
NHThe Dana-Farber Cancer Institute at LondonderryLondonderry03053NCT05677490Map
NJMemorial Sloan Kettering Basking RidgeBasking Ridge07920NCT05863195Map
NJMemorial Sloan Kettering Basking RidgeBasking Ridge07920NCT06958328Map
NJCooper Hospital University Medical CenterCamden08103NCT06958328Map
NJJefferson Cherry Hill HospitalCherry Hill08002NCT05677490Map
NJJefferson Cherry Hill HospitalCherry Hill08002NCT06958328Map
NJAstera Cancer CareEast Brunswick08816NCT06662786Map
NJAstera Cancer CareEast Brunswick08816NCT06750094Map
NJTrinitas Hospital and Comprehensive Cancer CenterElizabeth07202NCT05806931Map
NJHackensack University Medical CenterHackensack07601NCT04322318Map
NJHackensack University Medical CenterHackensack07601NCT06172296Map
NJHackensack University Medical CenterHackensack07601NCT06401330Map
NJHackensack University Medical CenterHackensack07601NCT06541262Map
NJRWJBarnabas Health Jersey City Medical CenterJersey City07302NCT05806931Map
NJRWJBarnabas Health - Monmouth Medical Center Southern CampusLakewood08701NCT05806931Map
NJCooperman Barnabas Medical Center (Saint Barnabas Medical Center)Livingston07039NCT05806931Map
NJRWJBarnabas Health - Monmouth Medical CenterLong Branch07740NCT05806931Map
NJMemorial Sloan Kettering MonmouthMiddletown07748NCT05863195Map
NJMemorial Sloan Kettering MonmouthMiddletown07748NCT06958328Map
NJMemorial Sloan Kettering BergenMontvale07645NCT05863195Map
NJMemorial Sloan Kettering BergenMontvale07645NCT06958328Map
NJAtlantic Health SystemMorristown07960NCT06835387Map
NJMorristown Medical CenterMorristown07960NCT04322318Map
NJMorristown Medical CenterMorristown07960NCT06172296Map
NJMorristown Medical CenterMorristown07960NCT06401330Map
NJJersey Shore Medical CenterNeptune City07753NCT06401330Map
NJRutgers Cancer InstituteNew Brunswick08901NCT06662786Map
NJRutgers Cancer Institute of New JerseyNew Brunswick08903NCT01042379Map
NJRutgers Cancer Institute of New JerseyNew Brunswick08903NCT05806931Map
NJRutgers Cancer Institute of New Jersey-Robert Wood Johnson University HospitalNew Brunswick08903NCT04322318Map
NJRutgers Cancer Institute of New Jersey-Robert Wood Johnson University HospitalNew Brunswick08903NCT06172296Map
NJRutgers Cancer Institute of New Jersey-Robert Wood Johnson University HospitalNew Brunswick08903NCT06401330Map
NJRWJBarnabas Health - Robert Wood Johnson University HospitalNew Brunswick08903NCT05806931Map
NJSaint Peter's University HospitalNew Brunswick08901NCT04322318Map
NJSaint Peter's University HospitalNew Brunswick08901NCT06172296Map
NJSaint Peter's University HospitalNew Brunswick08901NCT06401330Map
NJNewark Beth Israel Medical CenterNewark07112NCT04322318Map
NJNewark Beth Israel Medical CenterNewark07112NCT06401330Map
NJSaint Joseph's Regional Medical CenterPaterson07503NCT04322318Map
NJSaint Joseph's Regional Medical CenterPaterson07503NCT06172296Map
NJSidney Kimmel Cancer Center Washington TownshipSewell08080NCT05677490Map
NJRWJBarnabas Health - Robert Wood Johnson University HospitalSomerset08873NCT05806931Map
NJRWJBarnabas Health - Community Medical CenterToms River08755NCT05806931Map
NMUniversity of New Mexico Cancer CenterAlbuquerque87106NCT04322318Map
NMUniversity of New Mexico Cancer CenterAlbuquerque87102NCT06662786Map
NYAlbany Medical CenterAlbany12208NCT04322318Map
NYAlbany Medical CenterAlbany12208NCT06172296Map
NYAlbany Medical CenterAlbany12208NCT06401330Map
NYNew York-Presbyterian/Brooklyn Methodist HospitalBrooklyn11215NCT05677490Map
NYNew York-Presbyterian/Brooklyn Methodist HospitalBrooklyn11215NCT06958328Map
NYRoswell Park Cancer InstituteBuffalo14263NCT01042379Map
NYRoswell Park Cancer InstituteBuffalo14263NCT05382559Map
NYRoswell Park Cancer InstituteBuffalo14263NCT04322318Map
NYRoswell Park Cancer InstituteBuffalo14263NCT05863195Map
NYRoswell Park Cancer InstituteBuffalo14263NCT06172296Map
NYRoswell Park Cancer InstituteBuffalo14263NCT06401330Map
NYRoswell Park Cancer InstituteBuffalo14263NCT06821997Map
NYRoswell Park Cancer InstituteBuffalo14263NCT07214298Map
NYMemorial Sloan Kettering CommackCommack11725NCT05863195Map
NYMemorial Sloan Kettering CommackCommack11725NCT06958328Map
NYResearch SiteCommack11725NCT06219941Map
NYHematology Oncology Associates of Central New YorkEast Syracuse13057NCT04657068Map
NYHematology-Oncology Associates of Central NY, P.C. ( Site 4925)East Syracuse13057NCT05319730Map
NYMemorial Sloan Kettering WestchesterEast White Plains10604NCT05863195Map
NYMemorial Sloan Kettering WestchesterEast White Plains10604NCT06958328Map
NYThe New York Hospital Medical Center of QueensFlushing11355NCT05677490Map
NYGlens Falls HospitalGlens Falls12801NCT05677490Map
NYNorthwell Health Cancer Institute at HuntingtonGreenlawn11740NCT04329494Map
NYNorthwell Health Cancer Institute at HuntingtonGreenlawn11740NCT05677490Map
NYNorthwell Health Cancer InstituteLake Success11042NCT04657068Map
NYNorthwell Health/Center for Advanced MedicineLake Success11042NCT05677490Map
NYNYU Langone Hospital - Long IslandMineola11501NCT06172296Map
NYNYU Langone Hospital - Long IslandMineola11501NCT06401330Map
NYNYU Langone Hospital - Long IslandMineola11501NCT06958328Map
NYNYU Long Island MineolaMineola11501NCT07409272Map
NYPerlmutter Cancer Center at NYU Long IslandMineola11501NCT06662786Map
NYPerlmutter Cancer Center at NYU Long IslandMineola11501NCT06750094Map
NYNorthern Westchester HospitalMount Kisco10549NCT05677490Map
NYThe Steven and Alexandra Cohen Children's Medical Center of New YorkNew Hyde Park11040NCT04322318Map
NYThe Steven and Alexandra Cohen Children's Medical Center of New YorkNew Hyde Park11040NCT06172296Map
NYThe Steven and Alexandra Cohen Children's Medical Center of New YorkNew Hyde Park11040NCT06401330Map
NYColumbia University - Herbert Irving Comprehensive Cancer CenterNew York10032NCT05382559Map
NYColumbia University Medical CenterNew York10032NCT01042379Map
NYDavid H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer CenterNew York10021NCT03715933Map
NYDavid H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer CenterNew York10065NCT06586515Map
NYHerbert Irving Comprehensive Cancer Center Columbia University Medical CenterNew York10032NCT05379595Map
NYHerbert Irving Comprehensive Cancer Center Columbia University Medical CenterNew York10032NCT06662786Map
NYLaura and Isaac Perlmutter Cancer Center / NYU Langone HealthNew York10016NCT01042379Map
NYLaura and Isaac Perlmutter Cancer Center at NYU LangoneNew York10016NCT06172296Map
NYLaura and Isaac Perlmutter Cancer Center at NYU LangoneNew York10016NCT06401330Map
NYLaura and Isaac Perlmutter Cancer Center at NYU LangoneNew York10016NCT06958328Map
NYLaura and Isaac Perlmutter Cancer Center at NYU LangoneNew York10016NCT07409272Map
NYLenox Hill HospitalNew York10075NCT05677490Map
NYManhattan Eye Ear and Throat HospitalNew York10065NCT05677490Map
NYMemorial Sloan Kettering Cancer CenterNew York10065NCT05365581Map
NYMemorial Sloan Kettering Cancer CenterNew York10065NCT05382559Map
NYMemorial Sloan Kettering Cancer CenterNew York10065NCT04322318Map
NYMemorial Sloan Kettering Cancer CenterNew York10065NCT05863195Map
NYMemorial Sloan Kettering Cancer CenterNew York10065NCT05999994Map
NYMemorial Sloan Kettering Cancer CenterNew York10065NCT06401330Map
NYMemorial Sloan Kettering Cancer CenterNew York10065NCT06528496Map
NYMemorial Sloan Kettering Cancer CenterNew York10065NCT06620302Map
NYMemorial Sloan Kettering Cancer CenterNew York10065NCT06958328Map
NYMemorial Sloan Kettering Cancer CenterNew York10065NCT07024615Map
NYMemorial Sloan Kettering Cancer Center (All Protocol Activities)New York10065NCT05004116Map
NYMount SinaiNew York10003NCT06662786Map
NYMount Sinai HospitalNew York10029NCT04322318Map
NYMount Sinai HospitalNew York10029NCT05863195Map
NYMount Sinai HospitalNew York10029NCT06958328Map
NYMount Sinai WestNew York10009NCT06662786Map
NYMount Sinai WestNew York10019NCT06958328Map
NYNew York University (NYU) Langone Medical CenterNew York10016NCT06586515Map
NYNYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer CenterNew York10032NCT04322318Map
NYNYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer CenterNew York10032NCT06172296Map
NYNYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer CenterNew York10032NCT06620302Map
NYNYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer CenterNew York10032NCT06958328Map
NYNYP/Weill Cornell Medical CenterNew York10065NCT04322318Map
NYNYP/Weill Cornell Medical CenterNew York10065NCT05677490Map
NYNYU Langone Long Island Clinical Research AssociatesNew York10016NCT05379595Map
NYNYU Langone Medical Center - NYU Medical Oncology AssociatesNew York10016NCT05365581Map
NYNYU Langone Medical Center NYU Hematology AssociatesNew York10016NCT06662786Map
NYNYU Langone Medical Center NYU Hematology AssociatesNew York10016NCT06750094Map
NYQueens Cancer CenterRego Park11374NCT05677490Map
NYResearch SiteRochester14618NCT06792695Map
NYUniversity of RochesterRochester14642NCT04205968Map
NYUniversity of RochesterRochester14642NCT04322318Map
NYUniversity of RochesterRochester14642NCT05677490Map
NYUniversity of RochesterRochester14642NCT06172296Map
NYUniversity of RochesterRochester14642NCT06401330Map
NYUniversity of Rochester Wilmot Cancer InstituteRochester14642NCT01042379Map
NYNew York Cancer and Blood SpecialistsShirley11967NCT06662786Map
NYNew York Cancer and Blood SpecialistsShirley11967NCT06750094Map
NYPhelps Memorial Hospital CenterSleepy Hollow10591NCT05677490Map
NYStony Brook University Medical CenterStony Brook11794NCT04322318Map
NYStony Brook University Medical CenterStony Brook11794NCT05677490Map
NYStony Brook University Medical CenterStony Brook11794NCT06401330Map
NYState University of New York Upstate Medical UniversitySyracuse13210NCT04322318Map
NYState University of New York Upstate Medical UniversitySyracuse13210NCT06172296Map
NYState University of New York Upstate Medical UniversitySyracuse13210NCT06401330Map
NYMontefiore Einstein Comprehensive Cancer CenterThe Bronx10461NCT06662786Map
NYMontefiore Einstein Comprehensive Cancer CenterThe Bronx10461NCT06750094Map
NYMontefiore Medical CenterThe Bronx10467NCT01042379Map
NYMontefiore Medical Center - Moses CampusThe Bronx10467NCT04322318Map
NYMontefiore Medical Center - Moses CampusThe Bronx10467NCT06172296Map
NYMontefiore Medical Center - Moses CampusThe Bronx10467NCT06958328Map
NYMontefiore Medical Center-Einstein CampusThe Bronx10461NCT05677490Map
NYMontefiore Medical Center-Einstein CampusThe Bronx10461NCT06958328Map
NYMontefiore Medical Center-Weiler HospitalThe Bronx10461NCT05677490Map
NYMemorial Sloan Kettering NassauUniondale11553NCT05863195Map
NYMemorial Sloan Kettering NassauUniondale11553NCT06958328Map
NYNew York Medical CollegeValhalla10595NCT04322318Map
NYNew York Medical CollegeValhalla10595NCT06172296Map
NYNew York Medical CollegeValhalla10595NCT06401330Map
NYWilmot Cancer Institute at WebsterWebster14580NCT05677490Map
NYWhite Plains Hospital Center for Cancer Care - OncologyWhite Plains10601NCT07409272Map
NCAtrium Health Stanly/LCI-AlbemarleAlbemarle28002NCT04205968Map
NCMission HospitalAsheville28801NCT04322318Map
NCMission HospitalAsheville28801NCT06172296Map
NCDuke Cancer Center CaryCary27518NCT04205968Map
NCUNC Lineberger Comprehensive Cancer CenterChapel Hill27599NCT05677490Map
NCUNC Lineberger Comprehensive Cancer CenterChapel Hill27599NCT06172296Map
NCUNC Lineberger Comprehensive Cancer CenterChapel Hill27599NCT06401330Map
NCUNC Lineberger Comprehensive Cancer CenterChapel Hill27599NCT06958328Map
NCUniversity of North Carolina at Chapel HillChapel Hill27599NCT06662786Map
NCUniversity of North Carolina at Chapel Hill Lineberger Comprehensive Cancer CenterChapel Hill27599NCT03977233Map
NCAtrium Health Pineville/LCI-PinevilleCharlotte28210NCT04205968Map
NCAtrium Health University City/LCI-UniversityCharlotte28262NCT04205968Map
NCCarolinas Medical Center/Levine Cancer InstituteCharlotte28203NCT04205968Map
NCCarolinas Medical Center/Levine Cancer InstituteCharlotte28203NCT04322318Map
NCCarolinas Medical Center/Levine Cancer InstituteCharlotte28203NCT06172296Map
NCCarolinas Medical Center/Levine Cancer InstituteCharlotte28203NCT06401330Map
NCLevine Cancer Institute-SouthParkCharlotte28211NCT04205968Map
NCNovant Health Presbyterian Medical CenterCharlotte28204NCT04322318Map
NCNovant Health Presbyterian Medical CenterCharlotte28204NCT06172296Map
NCNovant Health Presbyterian Medical CenterCharlotte28204NCT06401330Map
NCSoutheastern Medical Oncology Center-ClintonClinton28328NCT05677490Map
NCSoutheastern Medical Oncology Center-ClintonClinton28328NCT06998940Map
NCAtrium Health Cabarrus/LCI-ConcordConcord28025NCT04205968Map
NCDuke Children's Hospital and Health CenterDurham27710NCT05365581Map
NCDuke University Medical CenterDurham27710NCT04205968Map
NCDuke University Medical CenterDurham27710NCT06586515Map
NCDuke University Medical CenterDurham27710NCT04322318Map
NCDuke University Medical CenterDurham27710NCT05863195Map
NCDuke University Medical CenterDurham27710NCT06172296Map
NCDuke University Medical CenterDurham27710NCT06401330Map
NCDuke University Medical Center - Duke Cancer CenterDurham27710NCT07024615Map
NCSoutheastern Medical Oncology Center-GoldsboroGoldsboro27534NCT05677490Map
NCSoutheastern Medical Oncology Center-GoldsboroGoldsboro27534NCT06998940Map
NCEast Carolina UniversityGreenville27834NCT04322318Map
NCEast Carolina UniversityGreenville27834NCT05677490Map
NCEast Carolina UniversityGreenville27834NCT06172296Map
NCEast Carolina UniversityGreenville27834NCT06401330Map
NCMargaret R Pardee Memorial HospitalHendersonville28791NCT05677490Map
NCUniversity of North Carolina-Hillsborough CampusHillsborough27278NCT05677490Map
NCSoutheastern Medical Oncology Center-JacksonvilleJacksonville28546NCT05677490Map
NCSoutheastern Medical Oncology Center-JacksonvilleJacksonville28546NCT06998940Map
NCAtrium Health Union/LCI-UnionMonroe28112NCT04205968Map
NCFirstHealth of the Carolinas-Moore Regional HospitalPinehurst28374NCT05677490Map
NCFirstHealth of the Carolinas-Moore Regional HospitalPinehurst28374NCT06998940Map
NCDuke Cancer Center RaleighRaleigh27609NCT04205968Map
NCDuke Cancer Center RaleighRaleigh27609NCT05863195Map
NCInvestigative Site #131Raleigh27710NCT06974110Map
NCWake Forest Baptist Comprehensive Cancer CenterWinston-Salem27157NCT01042379Map
NCWake Forest University Baptist HealthWinston-Salem27103NCT05365581Map
NCWake Forest University Health SciencesWinston-Salem27157NCT04322318Map
NCWake Forest University Health SciencesWinston-Salem27157NCT05863195Map
NCWake Forest University Health SciencesWinston-Salem27157NCT06172296Map
NCWake Forest University Health SciencesWinston-Salem27157NCT06401330Map
NDSanford Bismarck Medical CenterBismarck58501NCT05677490Map
NDSanford Bismarck Medical CenterBismarck58501NCT06958328Map
NDEssentia Health Cancer Center-South University ClinicFargo58103NCT04205968Map
NDEssentia Health Cancer Center-South University ClinicFargo58103NCT05677490Map
NDEssentia Health Cancer Center-South University ClinicFargo58103NCT06998940Map
NDSanford Broadway Medical CenterFargo58122NCT04322318Map
NDSanford Broadway Medical CenterFargo58122NCT05677490Map
NDSanford Broadway Medical CenterFargo58122NCT06172296Map
NDSanford Broadway Medical CenterFargo58122NCT06958328Map
NDSanford Medical Center FargoFargo58104NCT05677490Map
NDSanford Roger Maris Cancer CenterFargo58122NCT05677490Map
NDSanford Roger Maris Cancer CenterFargo58122NCT06958328Map
NDSanford South University Medical CenterFargo58103NCT05677490Map
NDSouthpointe-Sanford Medical Center FargoFargo58103NCT05677490Map
NDEssentia Health - Jamestown ClinicJamestown58401NCT04205968Map
NDEssentia Health - Jamestown ClinicJamestown58401NCT05677490Map
NDEssentia Health - Jamestown ClinicJamestown58401NCT06998940Map
OHChildren's Hospital Medical Center of AkronAkron44308NCT04322318Map
OHChildren's Hospital Medical Center of AkronAkron44308NCT06172296Map
OHChildren's Hospital Medical Center of AkronAkron44308NCT06401330Map
OHStrecker Cancer Center-BelpreBelpre45714NCT05677490Map
OHGabrail Cancer CenterCanton44718NCT06662786Map
OHGabrail Cancer CenterCanton44718NCT06750094Map
OHMiami Valley Hospital SouthCenterville45459NCT05677490Map
OHMiami Valley Hospital SouthCenterville45459NCT06958328Map
OHMiami Valley Hospital SouthCenterville45459NCT06998940Map
OHAdena Regional Medical CenterChillicothe45601NCT05677490Map
OHBethesda North HospitalCincinnati45242NCT06998940Map
OHCincinnati Children's HospitalCincinnati45229NCT04796012Map
OHCincinnati Children's Hospital Medical CenterCincinnati45229NCT03715933Map
OHCincinnati Children's Hospital Medical CenterCincinnati45229NCT04322318Map
OHCincinnati Children's Hospital Medical CenterCincinnati45229NCT06172296Map
OHCincinnati Children's Hospital Medical CenterCincinnati45229NCT06401330Map
OHCincinnati Children's Hospital Medical CenterCincinnati45229NCT06620302Map
OHGood Samaritan Hospital - CincinnatiCincinnati45220NCT06998940Map
OHOncology Hematology Care PrimaryCincinnati45242NCT04657068Map
OHTriHealth Cancer Institute-AndersonCincinnati45255NCT06998940Map
OHTriHealth Cancer Institute-WestsideCincinnati45247NCT06998940Map
OHUniversity of Cincinnati (UC) - Cancer InstituteCincinnati45267NCT06586515Map
OHUniversity of Cincinnati Cancer Center-UC Medical CenterCincinnati45219NCT06958328Map
OHUniversity of Cincinnati Cancer Center-UC Medical CenterCincinnati45219NCT06998940Map
OHCase WesternCleveland44106NCT05382559Map
OHCleveland ClinicCleveland44106NCT01042379Map
OHCleveland ClinicCleveland44195NCT06586515Map
OHCleveland Clinic Cancer Center Fairview Hospital Moll PavilionCleveland44111NCT06662786Map
OHCleveland Clinic FoundationCleveland44195NCT04322318Map
OHCleveland Clinic FoundationCleveland44195NCT06172296Map
OHRainbow Babies and Childrens HospitalCleveland44106NCT04322318Map
OHRainbow Babies and Childrens HospitalCleveland44106NCT06172296Map
OHRainbow Babies and Childrens HospitalCleveland44106NCT06401330Map
OHTaussig Cancer Insititute Cleveland ClinicCleveland44195NCT06662786Map
OHUniversity Hospital of ClevelandCleveland44106NCT06750094Map
OHUniversity Hospitals Cleveland Medical CenterCleveland44106NCT06662786Map
OHMount Carmel East HospitalColumbus43213NCT05677490Map
OHMount Carmel Health Center WestColumbus43222NCT05677490Map
OHNationwide Children's HospColumbus43205-2664NCT05999994Map
OHNationwide Children's HospitalColumbus43205NCT04211675Map
OHNationwide Children's HospitalColumbus43205NCT04322318Map
OHNationwide Children's HospitalColumbus43205NCT06172296Map
OHNationwide Children's HospitalColumbus43205NCT06450041Map
OHNationwide Children's HospitalColumbus43205NCT07194044Map
OHOhio State University Comprehensive Cancer CenterColumbus43210NCT05677490Map
OHOhio State University Comprehensive Cancer CenterColumbus43210NCT05863195Map
OHOhio State University Comprehensive Cancer CenterColumbus43210NCT06958328Map
OHThe Mark H Zangmeister CenterColumbus43219NCT05677490Map
OHThe Ohio State University, Stefanie Spielman Comprehensive Breast CenterColumbus43212NCT01042379Map
OHDayton Children's HospitalDayton45404NCT04322318Map
OHDayton Children's HospitalDayton45404NCT06172296Map
OHDayton Children's HospitalDayton45404NCT06401330Map
OHMiami Valley HospitalDayton45409NCT05677490Map
OHMiami Valley HospitalDayton45409NCT06958328Map
OHMiami Valley HospitalDayton45409NCT06998940Map
OHMiami Valley Hospital NorthDayton45415NCT05677490Map
OHMiami Valley Hospital NorthDayton45415NCT06958328Map
OHMiami Valley Hospital NorthDayton45415NCT06998940Map
OHPremier Blood and Cancer CenterDayton45409NCT05677490Map
OHPremier Blood and Cancer CenterDayton45409NCT06958328Map
OHPremier Blood and Cancer CenterDayton45409NCT06998940Map
OHDublin Methodist HospitalDublin43016NCT06958328Map
OHAtrium Medical Center-Middletown Regional HospitalFranklin45005-1066NCT05677490Map
OHAtrium Medical Center-Middletown Regional HospitalFranklin45005-1066NCT06958328Map
OHAtrium Medical Center-Middletown Regional HospitalFranklin45005-1066NCT06998940Map
OHCentral Ohio Breast and Endocrine SurgeryGahanna43230NCT05677490Map
OHMiami Valley Cancer Care and InfusionGreenville45331NCT05677490Map
OHMiami Valley Cancer Care and InfusionGreenville45331NCT06958328Map
OHMiami Valley Cancer Care and InfusionGreenville45331NCT06998940Map
OHMount Carmel Grove City HospitalGrove City43123NCT05677490Map
OHZangmeister Center Grove CityGrove City43123NCT05677490Map
OHCleveland Clinic Cancer Center Independence Family Health CenterIndependence44131NCT06662786Map
OHFairfield Medical CenterLancaster43130NCT05677490Map
OHSaint Rita's Medical CenterLima45801NCT05677490Map
OHCleveland Clinic Cancer Center MansfieldMansfield44906NCT06662786Map
OHMarietta Memorial HospitalMarietta45750NCT05677490Map
OHMemorial HospitalMarysville43040NCT05677490Map
OHTaylor Cancer Research CenterMaumee43537NCT04657068Map
OHCleveland Clinic Cancer Center Hillcrest HospitalMayfield Heights44124NCT06662786Map
OHKnox Community HospitalMount Vernon43050NCT05677490Map
OHMount Carmel New Albany Surgical HospitalNew Albany43054NCT05677490Map
OHLicking Memorial HospitalNewark43055NCT05677490Map
OHNewark Radiation OncologyNewark43055NCT05677490Map
OHMercy Health - Perrysburg HospitalPerrysburg43551NCT05677490Map
OHSouthern Ohio Medical CenterPortsmouth45662NCT05677490Map
OHCleveland Clinic Cancer Centers SanduskySandusky44870NCT06662786Map
OHSpringfield Regional Cancer CenterSpringfield45504NCT05677490Map
OHSpringfield Regional Medical CenterSpringfield45504NCT05677490Map
OHCleveland Clinic Cancer Center StrongsvilleStrongsville44136NCT06662786Map
OHProMedica Flower HospitalSylvania43560NCT06958328Map
OHMercy Health - Saint Anne HospitalToledo43623NCT05677490Map
OHMercy Health - Saint Vincent HospitalToledo43608NCT05677490Map
OHMercy Health Sylvania Radiation Oncology CenterToledo43623NCT05677490Map
OHProMedica Toledo Hospital/Russell J Ebeid Children's HospitalToledo43606NCT04322318Map
OHProMedica Toledo Hospital/Russell J Ebeid Children's HospitalToledo43606NCT06172296Map
OHProMedica Toledo Hospital/Russell J Ebeid Children's HospitalToledo43606NCT06401330Map
OHProMedica Toledo Hospital/Russell J Ebeid Children's HospitalToledo43606NCT06958328Map
OHUpper Valley Medical CenterTroy45373NCT05677490Map
OHUpper Valley Medical CenterTroy45373NCT06958328Map
OHUpper Valley Medical CenterTroy45373NCT06998940Map
OHCleveland Clinic Cancer Center South Pointe HospitalWarrensville Heights44122NCT06662786Map
OHUniversity of Cincinnati Cancer Center-West ChesterWest Chester45069NCT06958328Map
OHUniversity of Cincinnati Cancer Center-West ChesterWest Chester45069NCT06998940Map
OHSaint Ann's HospitalWesterville43081NCT05677490Map
OHClinton Memorial Hospital/Foster J Boyd Regional Cancer CenterWilmington45177NCT05677490Map
OHWooster Milltown Specialty and Surgery CenterWooster44691NCT06662786Map
OHSaint Elizabeth Youngstown HospitalYoungstown44501NCT05863195Map
OHGenesis Healthcare System Cancer Care CenterZanesville43701NCT05677490Map
OKCancer Centers of Southwest Oklahoma ResearchLawton73505NCT04205968Map
OKMercy Hospital Oklahoma CityOklahoma City73120NCT04205968Map
OKMercy Hospital Oklahoma CityOklahoma City73120NCT05677490Map
OKStephenson Cancer CenterOklahoma City73104NCT04657068Map
OKUniversity of Oklahoma Health Sciences CenterOklahoma City73104NCT04205968Map
OKUniversity of Oklahoma Health Sciences CenterOklahoma City73104NCT04322318Map
OKUniversity of Oklahoma Health Sciences CenterOklahoma City73104NCT05677490Map
OKUniversity of Oklahoma Health Sciences CenterOklahoma City73104NCT06172296Map
OKUniversity of Oklahoma Health Sciences CenterOklahoma City73104NCT06401330Map
OKNatalie Warren Bryant Cancer Center at Saint FrancisTulsa74136NCT06172296Map
ORSaint Alphonsus Cancer Care Center-Baker CityBaker City97814NCT04205968Map
ORSaint Alphonsus Cancer Care Center-Baker CityBaker City97814NCT05677490Map
ORSaint Charles Health SystemBend97701NCT04205968Map
ORSaint Charles Health SystemBend97701NCT05677490Map
ORSaint Charles Health SystemBend97701NCT06998940Map
ORClackamas Radiation Oncology CenterClackamas97015NCT04205968Map
ORClackamas Radiation Oncology CenterClackamas97015NCT05677490Map
ORClackamas Radiation Oncology CenterClackamas97015NCT06998940Map
ORBay Area HospitalCoos Bay97420NCT04205968Map
ORBay Area HospitalCoos Bay97420NCT05677490Map
ORBay Area HospitalCoos Bay97420NCT06998940Map
OROncology Associates of Oregon - PrimaryEugene97401NCT07011576Map
ORProvidence Hood River Memorial HospitalHood River97031NCT04205968Map
ORProvidence Hood River Memorial HospitalHood River97031NCT05677490Map
ORProvidence Hood River Memorial HospitalHood River97031NCT06998940Map
ORProvidence Newberg Medical CenterNewberg97132NCT04205968Map
ORProvidence Newberg Medical CenterNewberg97132NCT05677490Map
ORProvidence Newberg Medical CenterNewberg97132NCT06998940Map
ORSaint Alphonsus Cancer Care Center-OntarioOntario97914NCT04205968Map
ORSaint Alphonsus Cancer Care Center-OntarioOntario97914NCT05677490Map
ORProvidence Willamette Falls Medical CenterOregon City97045NCT04205968Map
ORProvidence Willamette Falls Medical CenterOregon City97045NCT05677490Map
ORProvidence Willamette Falls Medical CenterOregon City97045NCT06998940Map
ORInvestigative Site #121Portland97239NCT06974110Map
ORLegacy Emanuel Children's HospitalPortland97227NCT04322318Map
ORLegacy Emanuel Children's HospitalPortland97227NCT06172296Map
ORLegacy Emanuel Children's HospitalPortland97227NCT06401330Map
ORNorthwest Cancer Specialists - CompassPortland97213NCT07011576Map
OROregon Health & Science Institute (OHSU)Portland97239NCT01042379Map
OROregon Health & Science UniversityPortland97239NCT04657068Map
OROregon Health & Science UniversityPortland97239NCT03715933Map
OROregon Health and Science UniversityPortland97239NCT05382559Map
OROregon Health and Science UniversityPortland97239NCT04322318Map
OROregon Health and Science UniversityPortland97239NCT05863195Map
OROregon Health and Science UniversityPortland97239NCT06172296Map
OROregon Health and Science UniversityPortland97239NCT06401330Map
OROregon Health and Science UniversityPortland97239NCT06958328Map
OROregon Health And Science UniversityPortland97239NCT06662786Map
OROregon Health And Science UniversityPortland97239NCT06750094Map
ORProvidence Portland Medical CenterPortland97213NCT04205968Map
ORProvidence Portland Medical CenterPortland97213NCT05677490Map
ORProvidence Portland Medical CenterPortland97213NCT06998940Map
ORProvidence Saint Vincent Medical CenterPortland97225NCT04205968Map
ORProvidence Saint Vincent Medical CenterPortland97225NCT05677490Map
ORProvidence Saint Vincent Medical CenterPortland97225NCT06998940Map
ORSaint Charles Health System-RedmondRedmond97756NCT04205968Map
ORSaint Charles Health System-RedmondRedmond97756NCT05677490Map
ORSaint Charles Health System-RedmondRedmond97756NCT06998940Map
PALehigh Valley Hospital-Cedar CrestAllentown18103NCT04205968Map
PALehigh Valley Hospital-Cedar CrestAllentown18103NCT04322318Map
PALehigh Valley Hospital-Cedar CrestAllentown18103NCT05677490Map
PALehigh Valley Hospital-Cedar CrestAllentown18103NCT05863195Map
PALehigh Valley Hospital-Cedar CrestAllentown18103NCT06172296Map
PALehigh Valley Hospital - MuhlenbergBethlehem18017NCT04205968Map
PALehigh Valley Hospital - MuhlenbergBethlehem18017NCT05677490Map
PAChristiana Care Health System-Concord Health CenterChadds Ford19317NCT05677490Map
PAChristiana Care Health System-Concord Health CenterChadds Ford19317NCT06958328Map
PAChristiana Care Health System-Concord Health CenterChadds Ford19317NCT06998940Map
PAGeisinger Medical CenterDanville17822NCT04322318Map
PAGeisinger Medical CenterDanville17822NCT05677490Map
PAGeisinger Medical CenterDanville17822NCT06172296Map
PAGeisinger Medical CenterDanville17822NCT06401330Map
PAGeisinger Medical CenterDanville17822NCT06958328Map
PAGeisinger Cancer Center Dickson CityDickson City18519NCT05677490Map
PAPocono Medical CenterEast Stroudsburg18301NCT04205968Map
PAPocono Medical CenterEast Stroudsburg18301NCT05677490Map
PASaint Vincent HospitalErie16544NCT05863195Map
PAGeisinger Medical Center-Cancer Center HazletonHazleton18201NCT05677490Map
PALehigh Valley Hospital-HazletonHazleton18201NCT04205968Map
PALehigh Valley Hospital-HazletonHazleton18201NCT05677490Map
PAPenn State Children's HospitalHershey17033NCT04322318Map
PAPenn State Children's HospitalHershey17033NCT06401330Map
PAPenn State Milton S. Hershey Medical Center and Children's HospitalHershey17033NCT06541262Map
PAJefferson HospitalJefferson Hills15025NCT05863195Map
PAJefferson HospitalJefferson Hills15025NCT06958328Map
PAGeisinger Medical Oncology-LewisburgLewisburg17837NCT05677490Map
PAGeisinger Medical Oncology-LewisburgLewisburg17837NCT06958328Map
PALewistown HospitalLewistown17044NCT05677490Map
PAForbes HospitalMonroeville15146NCT05863195Map
PAForbes HospitalMonroeville15146NCT06958328Map
PAPaoli Memorial HospitalPaoli19301NCT06958328Map
PAAlliance Cancer Specialists at Main LinePenn Wynne19096NCT06750094Map
PAChildren's Hospital of PhiladelphiaPhiladelphia19104NCT04796012Map
PAChildren's Hospital of PhiladelphiaPhiladelphia19104NCT04322318Map
PAChildren's Hospital of PhiladelphiaPhiladelphia19104NCT06172296Map
PAChildren's Hospital of PhiladelphiaPhiladelphia19104NCT06401330Map
PAChildren's Hospital of PhiladelphiaPhiladelphia19104-4318NCT06450041Map
PAChildren's Hospital of PhiladelphiaPhiladelphia19104NCT06620302Map
PAChildren's Hospital of PhiladelphiaPhiladelphia19104NCT07549321Map
PAChildren's Hospital of Philadelphia- Center for Childhood Cancer ResearchPhiladelphia19104NCT03715933Map
PAEinstein Medical Center PhiladelphiaPhiladelphia19141NCT05677490Map
PAFox Chase Cancer CenterPhiladelphia19111NCT05800587Map
PAFox Chase Cancer CenterPhiladelphia19111NCT05863195Map
PAFox Chase Cancer CenterPhiladelphia19111NCT06662786Map
PAFox Chase Cancer CenterPhiladelphia19111NCT06750094Map
PAJefferson Torresdale HospitalPhiladelphia19114NCT06958328Map
PASaint Christopher's Hospital for ChildrenPhiladelphia19134NCT04322318Map
PASaint Christopher's Hospital for ChildrenPhiladelphia19134NCT06172296Map
PAThomas Jefferson UniversityPhiladelphia19107NCT06662786Map
PAThomas Jefferson UniversityPhiladelphia19107NCT06750094Map
PAThomas Jefferson University HospitalPhiladelphia19107NCT06958328Map
PAThomas Jefferson University, Sidney Kimmel Cancer Center, Clinical Research OrganizationPhiladelphia19107NCT04657068Map
PAUniversity of Pennsylvania (U Penn)Philadelphia19104NCT01042379Map
PAUniversity of Pennsylvania / Abramson Cancer CenterPhiladelphia19104NCT04657068Map
PAUniversity of Pennsylvania Abramson Cancer CenterPhiladelphia19106NCT03715933Map
PAAllegheny General HospitalPittsburgh15212NCT05863195Map
PAAllegheny General HospitalPittsburgh15212NCT06958328Map
PAChildren's Hospital of Pittsburgh of UPMCPittsburgh15224NCT04322318Map
PAChildren's Hospital of Pittsburgh of UPMCPittsburgh15224NCT06172296Map
PAChildren's Hospital of Pittsburgh of UPMCPittsburgh15224NCT06401330Map
PAChildren's Hospital of Pittsburgh of UPMCPittsburgh15224NCT06620302Map
PAUniversity of Pittsburgh Medical Center (UPMC) - Hillman Cancer CenterPittsburgh15232NCT06586515Map
PAUniversity Of Pittsburgh Medical Center UPMC Hillman Cancer CenterPittsburgh15232 1301NCT06662786Map
PAUniversity Of Pittsburgh Medical Center UPMC Hillman Cancer CenterPittsburgh15232 1301NCT06750094Map
PAUPMC Children's Hospital of PittsburghPittsburgh15224NCT05999994Map
PAUPMC Hillman Cancer Center-UPMC ( Site 4904)Pittsburgh15232NCT05319730Map
PAWest Penn HospitalPittsburgh15224NCT05863195Map
PAWest Penn HospitalPittsburgh15224NCT06958328Map
PAGeisinger Cancer Services-PottsvillePottsville17901NCT05677490Map
PACommunity Medical CenterScranton18510NCT05677490Map
PAReading HospitalWest Reading19611NCT05677490Map
PAReading HospitalWest Reading19611NCT06958328Map
PAWexford Health and Wellness PavilionWexford15090NCT05863195Map
PAGeisinger Wyoming Valley/Henry Cancer CenterWilkes-Barre18711NCT05677490Map
PAGeisinger Wyoming Valley/Henry Cancer CenterWilkes-Barre18711NCT06958328Map
PAAsplundh Cancer PavilionWillow Grove19090NCT05677490Map
PAAlliance Cancer SpecialistsWynnewood19096NCT07011576Map
RIHasbro Children's HospitalProvidence02903NCT06541262Map
RILifespan Cancer InstituteProvidence02906NCT05999994Map
RIResearch SiteProvidence02903NCT06219941Map
RIRhode Island HospitalProvidence02903NCT04322318Map
RIRhode Island HospitalProvidence02903NCT06172296Map
RIRhode Island HospitalProvidence02903NCT06401330Map
SCPrisma Health Cancer Institute - SpartanburgBoiling Springs29316NCT04205968Map
SCHollings Cancer Center at Medical University of South CarolinaCharleston29425NCT07076212Map
SCMedical University of South CarolinaCharleston29425NCT04322318Map
SCMedical University of South CarolinaCharleston29425NCT05677490Map
SCMedical University of South CarolinaCharleston29425NCT06172296Map
SCMedical University of South CarolinaCharleston29425NCT06958328Map
SCMedical University of South Carolina Hollings Cancer CenterCharleston29425NCT07076212Map
SCPrisma Health Richland HospitalColumbia29203NCT04322318Map
SCPrisma Health Richland HospitalColumbia29203NCT06172296Map
SCPrisma Health Richland HospitalColumbia29203NCT06401330Map
SCPrisma Health Cancer Institute - EasleyEasley29640NCT04205968Map
SCBI-LO Charities Children's Cancer CenterGreenville29605NCT04322318Map
SCBI-LO Charities Children's Cancer CenterGreenville29605NCT06172296Map
SCBI-LO Charities Children's Cancer CenterGreenville29605NCT06401330Map
SCPrisma Health Cancer Institute - ButternutGreenville29605NCT04205968Map
SCPrisma Health Cancer Institute - EastsideGreenville29615NCT04205968Map
SCPrisma Health Cancer Institute - FarisGreenville29605NCT04205968Map
SCSaint Francis Cancer CenterGreenville29607NCT06958328Map
SCSaint Francis HospitalGreenville29601NCT06958328Map
SCPrisma Health Cancer Institute - GreerGreer29650NCT04205968Map
SCLevine Cancer Institute-Rock HillRock Hill29732NCT04205968Map
SCPrisma Health Cancer Institute - SenecaSeneca29672NCT04205968Map
SDAvera Cancer Institute-AberdeenAberdeen57401NCT05677490Map
SDAvera Cancer Institute - MitchellMitchell57301NCT05677490Map
SDAvera Cancer Institute at PierrePierre57501NCT05677490Map
SDRapid City Regional HospitalRapid City57701NCT05677490Map
SDRapid City Regional HospitalRapid City57701NCT06998940Map
SDAvera Cancer InstituteSioux Falls57105NCT05677490Map
SDSanford Cancer Center Oncology ClinicSioux Falls57104NCT05677490Map
SDSanford Cancer Center Oncology ClinicSioux Falls57104NCT06958328Map
SDSanford Clinical ResearchSioux Falls57104NCT01042379Map
SDSanford USD Medical Center - Sioux FallsSioux Falls57117-5134NCT04322318Map
SDSanford USD Medical Center - Sioux FallsSioux Falls57117-5134NCT05677490Map
SDSanford USD Medical Center - Sioux FallsSioux Falls57117-5134NCT06172296Map
SDSanford USD Medical Center - Sioux FallsSioux Falls57117-5134NCT06401330Map
SDSanford USD Medical Center - Sioux FallsSioux Falls57117-5134NCT06958328Map
SDAvera Cancer Institute at YanktonYankton57078NCT05677490Map
TNT C Thompson Children's HospitalChattanooga37403NCT06401330Map
TNTennessee Oncology ChattanoogaChattanooga37404NCT06750094Map
TNTennessee Oncology, PLLCChattanooga37404NCT04657068Map
TNBaptist Memorial Hospital and Cancer Center-ColliervilleCollierville38017NCT04205968Map
TNBaptist Memorial Hospital and Cancer Center-ColliervilleCollierville38017NCT06958328Map
TNBaptist Memorial Hospital and Cancer Center-ColliervilleCollierville38017NCT06998940Map
TNEast Tennessee Childrens HospitalKnoxville37916NCT04322318Map
TNEast Tennessee Childrens HospitalKnoxville37916NCT06172296Map
TNEast Tennessee Childrens HospitalKnoxville37916NCT06401330Map
TNBaptist Cancer CenterMemphis38120NCT06644781Map
TNBaptist Memorial Hospital and Cancer Center-MemphisMemphis38120NCT04205968Map
TNBaptist Memorial Hospital and Cancer Center-MemphisMemphis38120NCT06958328Map
TNBaptist Memorial Hospital and Cancer Center-MemphisMemphis38120NCT06998940Map
TNSaint Jude Children's Research HospitalMemphis38105NCT04322318Map
TNSaint Jude Children's Research HospitalMemphis38105NCT06172296Map
TNSaint Jude Children's Research HospitalMemphis38105NCT06401330Map
TNSaint Jude Children's Research HospitalMemphis38105NCT06620302Map
TNSt. Jude Children's Research HospitalMemphis38105NCT06023641Map
TNSt. Jude Children's Research HospitalMemphis38105NCT06450041Map
TNSt. Jude Children's Research HospitalMemphis38105NCT07085338Map
TNMonroe Carrell Jr. Children's Hospital at VanderbiltNashville37232NCT06541262Map
TNSarah Cannon Research InstituteNashville37203NCT06586515Map
TNSCRI Oncology PartnersNashville37203NCT04657068Map
TNSCRI Oncology PartnersNashville37203NCT06644781Map
TNSCRI Oncology PartnersNashville37203NCT06662786Map
TNSCRI Oncology PartnersNashville37203NCT06750094Map
TNSCRI Oncology PartnersNashville37203NCT07011576Map
TNTennessee OncologyNashville37203NCT06750094Map
TNThe Children's Hospital at TriStar CentennialNashville37203NCT04322318Map
TNThe Children's Hospital at TriStar CentennialNashville37203NCT06172296Map
TNUSO - US Oncology Research NetworkNashville37203NCT06586515Map
TNVanderbilt Ingram Cancer CenterNashville37232NCT05379595Map
TNVanderbilt University Medical CenterNashville37232NCT05382559Map
TNVanderbilt University Medical CenterNashville37232NCT06750094Map
TNVanderbilt University School of MedicineNashville37232NCT03715933Map
TNVanderbilt University School of MedicineNashville37215NCT06586515Map
TNVanderbilt University/Ingram Cancer CenterNashville37232NCT04322318Map
TNVanderbilt University/Ingram Cancer CenterNashville37232NCT05863195Map
TNVanderbilt University/Ingram Cancer CenterNashville37232NCT06172296Map
TNVanderbilt University/Ingram Cancer CenterNashville37232NCT06401330Map
TXTexas Oncology West TexasAbilene79606NCT06662786Map
TXTexas Oncology West TexasAbilene79606NCT06750094Map
TXTexas Tech University Health Sciences Center-AmarilloAmarillo79106NCT04322318Map
TXTexas Tech University Health Sciences Center-AmarilloAmarillo79106NCT06401330Map
TXDell Children's Medical Center of Central TexasAustin78723NCT04322318Map
TXDell Children's Medical Center of Central TexasAustin78723NCT06172296Map
TXDell Children's Medical Center of Central TexasAustin78723NCT06401330Map
TXDell Children's Medical Group SFC-HEM/ONCAustin78723NCT01356290Map
TXTexas Oncology - Central/South TexasAustin78705NCT04657068Map
TXTexas Oncology - Central/South TexasAustin78705NCT07011576Map
TXHouston Methodist San Jacinto HospitalBaytown77521NCT06958328Map
TXTexas Oncology - Gulf CoastBeaumont77702NCT07011576Map
TXMD Anderson in The WoodlandsConroe77384NCT06958328Map
TXDriscoll Children's HospitalCorpus Christi78411NCT04322318Map
TXDriscoll Children's HospitalCorpus Christi78411NCT06172296Map
TXDriscoll Children's HospitalCorpus Christi78411NCT06401330Map
TXHouston Methodist Cypress HospitalCypress77429NCT06958328Map
TXChildren's Medical CenterDallas75235NCT06541262Map
TXInvestigative Site #127Dallas75230NCT06974110Map
TXMary Crowley Cancer ResearchDallas75230NCT04657068Map
TXMedical City Dallas HospitalDallas75230NCT04322318Map
TXMedical City Dallas HospitalDallas75230NCT06172296Map
TXMedical City Dallas HospitalDallas75230NCT06401330Map
TXParkland Health and Hospital SystemDallas75235NCT06750094Map
TXParkland Memorial HospitalDallas75235NCT05677490Map
TXParkland Memorial HospitalDallas75235NCT05863195Map
TXTexas Oncology - Baylor Charles A. Sammons Cancer CenterDallas75246NCT04657068Map
TXTexas Oncology DFWDallas75246NCT06662786Map
TXTexas Oncology DFWDallas75246NCT06750094Map
TXThe University of Texas Southwestern Medical CenterDallas75235NCT04796012Map
TXUniversity of Texas SouthwesternDallas75235NCT06450041Map
TXUniversity of Texas Southwestern Medical CenterDallas75390NCT06835387Map
TXUniversity of Texas Southwestern Medical Center at DallasDallas75390-9063NCT05999994Map
TXUT SouthwesternDallas75390NCT06662786Map
TXUT Southwestern Medical CenterDallas75390NCT05365581Map
TXUT Southwestern Medical CenterDallas75390NCT06750094Map
TXUT Southwestern Medical Center at DallasDallas75390NCT07409272Map
TXUT Southwestern Simmons Cancer Center - RedBirdDallas75237NCT05677490Map
TXUT Southwestern Simmons Cancer Center - RedBirdDallas75237NCT05863195Map
TXUT Southwestern/Simmons Cancer Center-DallasDallas75390NCT04322318Map
TXUT Southwestern/Simmons Cancer Center-DallasDallas75390NCT05863195Map
TXUT Southwestern/Simmons Cancer Center-DallasDallas75390NCT06172296Map
TXUT Southwestern/Simmons Cancer Center-DallasDallas75390NCT06401330Map
TXEl Paso Children's HospitalEl Paso79905NCT04322318Map
TXEl Paso Children's HospitalEl Paso79905NCT06172296Map
TXTexas Oncology - Northeast TexasFlower Mound75028NCT04657068Map
TXCook Children's Medical CenterFort Worth76104NCT04322318Map
TXCook Children's Medical CenterFort Worth76104NCT06172296Map
TXCook Children's Medical CenterFort Worth76104NCT06401330Map
TXCook Children's Medical CenterFort Worth76104NCT06450041Map
TXJohn Peter Smith HospitalFort Worth76104NCT06644781Map
TXTarrant County Hospital District/JPS Health NetworkFort Worth76104NCT05677490Map
TXUT Southwestern/Simmons Cancer Center-Fort WorthFort Worth76104NCT05677490Map
TXUT Southwestern/Simmons Cancer Center-Fort WorthFort Worth76104NCT05863195Map
TXBaylor College of Medicine/Dan L Duncan Comprehensive Cancer CenterHouston77030NCT04322318Map
TXBaylor College of Medicine/Dan L Duncan Comprehensive Cancer CenterHouston77030NCT06172296Map
TXBaylor College of Medicine/Dan L Duncan Comprehensive Cancer CenterHouston77030NCT06401330Map
TXBaylor College of Medicine/Dan L Duncan Comprehensive Cancer CenterHouston77030NCT06620302Map
TXBaylor College of Medicine/Dan L Duncan Comprehensive Cancer CenterHouston77030NCT06958328Map
TXBen Taub General HospitalHouston77030NCT06958328Map
TXHouston Methodist HospitalHouston77030NCT06958328Map
TXHouston Methodist West HospitalHouston77094NCT06958328Map
TXInvestigative Site #129Houston77030NCT06974110Map
TXM D Anderson Cancer CenterHouston77030NCT05062317Map
TXM D Anderson Cancer CenterHouston77030NCT04199026Map
TXM D Anderson Cancer CenterHouston77030NCT04205968Map
TXM D Anderson Cancer CenterHouston77030NCT04322318Map
TXM D Anderson Cancer CenterHouston77030NCT06006273Map
TXM D Anderson Cancer CenterHouston77030NCT06958328Map
TXMD Anderson Cancer CenterHouston77030NCT05379595Map
TXMD Anderson Cancer CenterHouston77030NCT06586515Map
TXMD Anderson Cancer CenterHouston77030NCT06662786Map
TXMD Anderson Cancer CenterHouston77030NCT06750094Map
TXMD Anderson West HoustonHouston77079NCT06958328Map
TXMethodist Willowbrook HospitalHouston77070NCT06958328Map
TXResearch SiteHouston77030NCT06219941Map
TXResearch SiteHouston77030NCT06792695Map
TXTexas Children's HospitalHouston77030NCT04796012Map
TXUniversity of Texas MD Anderson Cancer CenterHouston77030NCT05999994Map
TXUT MD Anderson Cancer CenterHouston77030NCT03715933Map
TXUT MD Anderson Cancer CenterHouston77030NCT06172296Map
TXMD Anderson League CityLeague City77573NCT06958328Map
TXCovenant Children's HospitalLubbock79410NCT04322318Map
TXCovenant Children's HospitalLubbock79410NCT06172296Map
TXCovenant Children's HospitalLubbock79410NCT06401330Map
TXUMC Cancer Center / UMC Health SystemLubbock79415NCT04322318Map
TXUMC Cancer Center / UMC Health SystemLubbock79415NCT06172296Map
TXUMC Cancer Center / UMC Health SystemLubbock79415NCT06401330Map
TXHouston Methodist Saint John HospitalNassau Bay77058NCT06958328Map
TXUT Southwestern Clinical Center at Richardson/PlanoRichardson75080NCT05677490Map
TXUT Southwestern Clinical Center at Richardson/PlanoRichardson75080NCT05863195Map
TXBaylor Scott & White Medical CenterRound Rock77845NCT06750094Map
TXBaylor Scott and White Health 1Round Rock78665NCT06662786Map
TXChildren's Hospital of San AntonioSan Antonio78207NCT04322318Map
TXChildren's Hospital of San AntonioSan Antonio78207NCT06172296Map
TXChildren's Hospital of San AntonioSan Antonio78207NCT06401330Map
TXMethodist Children's Hospital of South TexasSan Antonio78229NCT04322318Map
TXMethodist Children's Hospital of South TexasSan Antonio78229NCT06172296Map
TXMethodist Children's Hospital of South TexasSan Antonio78229NCT06401330Map
TXNEXT OncologySan Antonio78229NCT05382559Map
TXSouth Texas Accelerated Research Therapeutics (START)San Antonio78229NCT06586515Map
TXTexas Oncology - San AntonioSan Antonio78240NCT04657068Map
TXTexas Oncology - San AntonioSan Antonio78240NCT06662786Map
TXTexas Oncology - San AntonioSan Antonio78240NCT06750094Map
TXUniversity of Texas Health Science Center at San AntonioSan Antonio78229NCT04322318Map
TXUniversity of Texas Health Science Center at San AntonioSan Antonio78229NCT06172296Map
TXUniversity of Texas Health Science Center at San AntonioSan Antonio78229NCT06401330Map
TXUniversity of Texas Health Science Center at San AntonioSan Antonio78229NCT06958328Map
TXHouston Methodist Sugar Land HospitalSugar Land77479NCT06958328Map
TXMD Anderson in Sugar LandSugar Land77478NCT06958328Map
TXBaylor Scott and White HealthTemple76508NCT06662786Map
TXScott And White Memorial HospitalTemple76508NCT06750094Map
TXHouston Methodist The Woodlands HospitalThe Woodlands77385NCT06958328Map
TXTexas Oncology - Northeast TexasTyler75702NCT07011576Map
TXTexas Oncology - Northeast Texas /ID# 280417Tyler75702NCT07490301Map
TXUT Health East Texas HOPE Cancer CenterTyler75701NCT06750094Map
UTFarmington Health CenterFarmington84025NCT05677490Map
UTHuntsman Cancer InstituteSalt Lake City84112NCT06586515Map
UTHuntsman Cancer Institute, University of UtahSalt Lake City84112NCT01042379Map
UTHuntsman Cancer Institute/University of UtahSalt Lake City84112NCT05677490Map
UTPrimary Children's HospitalSalt Lake City84113NCT04322318Map
UTPrimary Children's HospitalSalt Lake City84113NCT06172296Map
UTPrimary Children's HospitalSalt Lake City84113NCT06401330Map
UTPrimary Children's HospitalSalt Lake City84113NCT06541262Map
UTUniversity of Utah Sugarhouse Health CenterSalt Lake City84106NCT05677490Map
UTUtah Cancer SpecialistsSalt Lake City84106NCT04657068Map
UTUtah Cancer SpecialistsSalt Lake City84106NCT07409272Map
VTCentral Vermont Medical Center/National Life Cancer TreatmentBerlin Corners05602NCT05677490Map
VTUniversity of Vermont and State Agricultural CollegeBurlington05405NCT05677490Map
VTUniversity of Vermont and State Agricultural CollegeBurlington05405NCT06172296Map
VTUniversity of Vermont and State Agricultural CollegeBurlington05405NCT06401330Map
VTUniversity of Vermont Medical CenterBurlington05401NCT05677490Map
VTDartmouth Cancer Center - NorthSaint Johnsbury05819NCT04205968Map
VTDartmouth Cancer Center - NorthSaint Johnsbury05819NCT06958328Map
VAInova Alexandria HospitalAlexandria22304NCT06958328Map
VAVirginia Cancer SpecialistsArlington22201NCT06662786Map
VAVirginia Cancer SpecialistsArlington22201NCT06750094Map
VAUniversity of VirginiaCharlottesville22903NCT03715933Map
VAUniversity of Virginia Cancer CenterCharlottesville22908NCT04322318Map
VAUniversity of Virginia Cancer CenterCharlottesville22908NCT05677490Map
VAUniversity of Virginia Cancer CenterCharlottesville22908NCT06172296Map
VAUniversity of Virginia Cancer CenterCharlottesville22908NCT06401330Map
VAUVA Emily Couric Cancer CenterCharlottesville22903NCT07409272Map
VAInova Fair Oaks HospitalFairfax22033NCT05677490Map
VAInova Fair Oaks HospitalFairfax22033NCT06958328Map
VAInova Fair Oaks HospitalFairfax22033NCT06998940Map
VAInova Schar Cancer InstituteFairfax22031NCT05677490Map
VAInova Schar Cancer InstituteFairfax22031NCT06958328Map
VAInova Schar Cancer InstituteFairfax22031NCT06998940Map
VAInova Schar Cancer Institute Dept of Fairfax HospitalFairfax22031NCT06662786Map
VANEXT Oncology - VirginiaFairfax22031NCT03715933Map
VANEXT Oncology - Virginia Cancer SpecialistsFairfax22031NCT05382559Map
VAVirginia Cancer SpecialistsFairfax22031NCT04657068Map
VAVirginia Cancer SpecialistsFairfax22031NCT06644781Map
VAVirginia Cancer SpecialistsFairfax22031NCT07409272Map
VAVirginia Cancer Specialists - Fairfax /ID# 280415Fairfax22031NCT07490301Map
VAInova Fairfax HospitalFalls Church22042NCT04322318Map
VAInova Fairfax HospitalFalls Church22042NCT05677490Map
VAInova Fairfax HospitalFalls Church22042NCT06401330Map
VAInova Fairfax HospitalFalls Church22042NCT06958328Map
VAInova Loudoun HospitalLeesburg20176NCT06958328Map
VACentra Alan B Pearson Regional Cancer CenterLynchburg24501NCT05677490Map
VABon Secours Memorial Regional Medical CenterMechanicsville23116NCT06958328Map
VABon Secours Saint Francis Medical CenterMidlothian23114NCT06958328Map
VAChildren's Hospital of The King's DaughtersNorfolk23507NCT04322318Map
VAChildren's Hospital of The King's DaughtersNorfolk23507NCT06401330Map
VAVirginia Oncology AssociatesNorfolk23502NCT07011576Map
VANaval Medical Center - PortsmouthPortsmouth23708-2197NCT06172296Map
VABon Secours Cancer Institute at Reynolds CrossingRichmond23230NCT06958328Map
VABon Secours Saint Mary's HospitalRichmond23226NCT06958328Map
VARichmond VA Medical CenterRichmond23249NCT06662786Map
VARichmond VA Medical CenterRichmond23249NCT06750094Map
VAVCU Massey Cancer Center at Stony PointRichmond23235NCT05677490Map
VAVCU Massey Comprehensive Cancer CenterRichmond23298NCT04322318Map
VAVCU Massey Comprehensive Cancer CenterRichmond23298NCT05677490Map
VAVCU Massey Comprehensive Cancer CenterRichmond23298NCT06401330Map
VAVCU Massey Comprehensive Cancer CenterRichmond23298NCT06662786Map
VAVCU Massey Comprehensive Cancer CenterRichmond23298NCT06750094Map
VAVirginia Cancer InstituteRichmond23229NCT05677490Map
VAVirginia Commonwealth UniversityRichmond23284NCT06541262Map
VAVirginia Commonwealth UniversityRichmond23298NCT06835387Map
VACarilion Children'sRoanoke24014NCT04322318Map
VACarilion Children'sRoanoke24014NCT06401330Map
VABlue Ridge Cancer Care (Oncology & Hematology Associates of Southwest VA)Salem24153NCT07011576Map
VAVCU Community Memorial Health CenterSouth Hill23970NCT05677490Map
WAProvidence Regional Cancer System-AberdeenAberdeen98520NCT04205968Map
WAProvidence Regional Cancer System-AberdeenAberdeen98520NCT05677490Map
WAProvidence Regional Cancer System-AberdeenAberdeen98520NCT06998940Map
WAPeaceHealth Saint Joseph Medical CenterBellingham98225NCT04205968Map
WAPeaceHealth Saint Joseph Medical CenterBellingham98225NCT05677490Map
WAPeaceHealth Saint Joseph Medical CenterBellingham98225NCT06998940Map
WAProvidence Regional Cancer System-CentraliaCentralia98531NCT04205968Map
WAProvidence Regional Cancer System-CentraliaCentralia98531NCT05677490Map
WAProvidence Regional Cancer System-CentraliaCentralia98531NCT06998940Map
WASwedish Cancer Institute EdmondsEdmonds98026NCT06662786Map
WASwedish Cancer Institute-EdmondsEdmonds98026NCT04205968Map
WASwedish Cancer Institute-EdmondsEdmonds98026NCT05677490Map
WASwedish Cancer Institute-EdmondsEdmonds98026NCT06998940Map
WAProvidence Regional Cancer PartnershipEverett98201NCT04205968Map
WAProvidence Regional Cancer PartnershipEverett98201NCT05677490Map
WAProvidence Regional Cancer PartnershipEverett98201NCT06998940Map
WASwedish Cancer Institute IssaquahIssaquah98029NCT06662786Map
WASwedish Cancer Institute-IssaquahIssaquah98029NCT04205968Map
WASwedish Cancer Institute-IssaquahIssaquah98029NCT05677490Map
WASwedish Cancer Institute-IssaquahIssaquah98029NCT06998940Map
WAKadlec Clinic Hematology and OncologyKennewick99336NCT04205968Map
WAKadlec Clinic Hematology and OncologyKennewick99336NCT05677490Map
WAKadlec Clinic Hematology and OncologyKennewick99336NCT06998940Map
WAProvidence Regional Cancer SystemLacey98503NCT06750094Map
WAProvidence Regional Cancer System-LaceyLacey98503NCT04205968Map
WAProvidence Regional Cancer System-LaceyLacey98503NCT05677490Map
WAProvidence Regional Cancer System-LaceyLacey98503NCT06998940Map
WAPeaceHealth Saint John Medical CenterLongview98632NCT04205968Map
WAPeaceHealth Saint John Medical CenterLongview98632NCT05677490Map
WAPeaceHealth Saint John Medical CenterLongview98632NCT06998940Map
WASkagit Regional Health Cancer Care CenterMount Vernon98274NCT04205968Map
WASkagit Regional Health Cancer Care CenterMount Vernon98274NCT05677490Map
WASkagit Regional Health Cancer Care CenterMount Vernon98274NCT06998940Map
WAValley Medical CenterRenton98055NCT04205968Map
WAValley Medical CenterRenton98055NCT05677490Map
WAFred Hutchinson Cancer CenterSeattle98109NCT06586515Map
WAFred Hutchinson Cancer CenterSeattle98109NCT06958328Map
WAFred Hutchinson Cancer CenterSeattle98109NCT06998940Map
WAFred Hutchinson Cancer Research CenterSeattle98109NCT06662786Map
WAFred Hutchinson Cancer Research CenterSeattle98109NCT06750094Map
WASeattle Children'sSeattle98105NCT04796012Map
WASeattle Children's HospitalSeattle98105NCT04322318Map
WASeattle Children's HospitalSeattle98105NCT06172296Map
WASeattle Children's HospitalSeattle98105NCT06401330Map
WASeattle Children's HospitalSeattle98105NCT06620302Map
WASeattle Children's Hospital Research FoundationSeattle98105NCT05999994Map
WASwedish Cancer InstituteSeattle98104NCT06662786Map
WASwedish Medical Center-Ballard CampusSeattle98107NCT04205968Map
WASwedish Medical Center-Ballard CampusSeattle98107NCT05677490Map
WASwedish Medical Center-Ballard CampusSeattle98107NCT06998940Map
WASwedish Medical Center-Cherry HillSeattle98122-5711NCT04205968Map
WASwedish Medical Center-Cherry HillSeattle98122-5711NCT05677490Map
WASwedish Medical Center-Cherry HillSeattle98122-5711NCT06998940Map
WASwedish Medical Center-First HillSeattle98122NCT04205968Map
WASwedish Medical Center-First HillSeattle98122NCT05677490Map
WASwedish Medical Center-First HillSeattle98122NCT06998940Map
WAUniversity of Washington Medical Center - MontlakeSeattle98195NCT06958328Map
WAUniversity of Washington Medical Center - MontlakeSeattle98195NCT06998940Map
WAVirginia Mason Franciscan Health - Virginia Mason Medical CenterSeattle98101NCT07409272Map
WAVirginia Mason Medical CenterSeattle98101NCT05365581Map
WAPeaceHealth United General Medical CenterSedro-Woolley98284NCT04205968Map
WAPeaceHealth United General Medical CenterSedro-Woolley98284NCT05677490Map
WAPeaceHealth United General Medical CenterSedro-Woolley98284NCT06998940Map
WASaint Michael Cancer CenterSilverdale98383NCT06998940Map
WACancer Care Northwest - Spokane SouthSpokane99202NCT04205968Map
WACancer Care Northwest - Spokane SouthSpokane99202NCT05677490Map
WACancer Care Northwest - Spokane SouthSpokane99202NCT06998940Map
WACancer Care Northwest-North SpokaneSpokane99218NCT04205968Map
WACancer Care Northwest-North SpokaneSpokane99218NCT05677490Map
WACancer Care Northwest-North SpokaneSpokane99218NCT06998940Map
WACancer Care Northwest-ValleySpokane99216NCT04205968Map
WACancer Care Northwest-ValleySpokane99216NCT05677490Map
WACancer Care Northwest-ValleySpokane99216NCT06998940Map
WAProvidence Sacred Heart Medical Center and Children's HospitalSpokane99204NCT04322318Map
WAProvidence Sacred Heart Medical Center and Children's HospitalSpokane99204NCT06172296Map
WAProvidence Sacred Heart Medical Center and Children's HospitalSpokane99204NCT06401330Map
WAMadigan Army Medical CenterTacoma98431NCT04322318Map
WAMary Bridge Children's Hospital and Health CenterTacoma98405NCT04322318Map
WAMary Bridge Children's Hospital and Health CenterTacoma98405NCT06172296Map
WAMary Bridge Children's Hospital and Health CenterTacoma98405NCT06401330Map
WAPeaceHealth Southwest Medical CenterVancouver98664NCT04205968Map
WAPeaceHealth Southwest Medical CenterVancouver98664NCT05677490Map
WAPeaceHealth Southwest Medical CenterVancouver98664NCT06998940Map
WAProvidence Saint Mary Regional Cancer CenterWalla Walla99362NCT04205968Map
WAProvidence Saint Mary Regional Cancer CenterWalla Walla99362NCT05677490Map
WAProvidence Saint Mary Regional Cancer CenterWalla Walla99362NCT06998940Map
WANorth Star Lodge Cancer Center at Yakima Valley Memorial HospitalYakima98902NCT04205968Map
WANorth Star Lodge Cancer Center at Yakima Valley Memorial HospitalYakima98902NCT05677490Map
WVWest Virginia University Charleston DivisionCharleston25304NCT04322318Map
WVWest Virginia University Charleston DivisionCharleston25304NCT05677490Map
WVEdwards Comprehensive Cancer CenterHuntington25701NCT04322318Map
WVEdwards Comprehensive Cancer CenterHuntington25701NCT06172296Map
WVEdwards Comprehensive Cancer CenterHuntington25701NCT06958328Map
WVWest Virginia University HealthcareMorgantown26506NCT06172296Map
WILanglade Hospital and Cancer CenterAntigo54409NCT05677490Map
WILanglade Hospital and Cancer CenterAntigo54409NCT06958328Map
WIDuluth Clinic AshlandAshland54806NCT04205968Map
WIDuluth Clinic AshlandAshland54806NCT05677490Map
WIDuluth Clinic AshlandAshland54806NCT06998940Map
WINorthwest Wisconsin Cancer CenterAshland54806NCT04205968Map
WINorthwest Wisconsin Cancer CenterAshland54806NCT05677490Map
WINorthwest Wisconsin Cancer CenterAshland54806NCT06998940Map
WIAurora Cancer Care-Southern Lakes VLCCBurlington53105NCT05677490Map
WIMarshfield Clinic-Chippewa CenterChippewa Falls54729NCT04205968Map
WIMarshfield Clinic-Chippewa CenterChippewa Falls54729NCT05677490Map
WIAurora Saint Luke's South ShoreCudahy53110NCT05677490Map
WIMarshfield Medical Center-EC Cancer CenterEau Claire54701NCT04205968Map
WIMarshfield Medical Center-EC Cancer CenterEau Claire54701NCT05677490Map
WIMarshfield Medical Center-EC Cancer CenterEau Claire54701NCT06958328Map
WIAurora Health Care Germantown Health CenterGermantown53022NCT05677490Map
WIAurora Cancer Care-GraftonGrafton53024NCT05677490Map
WIAurora BayCare Medical CenterGreen Bay54311NCT05677490Map
WISaint Vincent Hospital Cancer Center at Saint Mary'sGreen Bay54303NCT05677490Map
WISaint Vincent Hospital Cancer Center at Saint Mary'sGreen Bay54303NCT06998940Map
WISaint Vincent Hospital Cancer Center Green BayGreen Bay54301NCT04322318Map
WISaint Vincent Hospital Cancer Center Green BayGreen Bay54301NCT05677490Map
WISaint Vincent Hospital Cancer Center Green BayGreen Bay54301NCT06401330Map
WISaint Vincent Hospital Cancer Center Green BayGreen Bay54301NCT06998940Map
WIEssentia Health-Hayward ClinicHayward54843NCT04205968Map
WIEssentia Health-Hayward ClinicHayward54843NCT05677490Map
WIEssentia Health-Hayward ClinicHayward54843NCT06998940Map
WITamarack Health Hayward Medical CenterHayward54843NCT04205968Map
WITamarack Health Hayward Medical CenterHayward54843NCT05677490Map
WITamarack Health Hayward Medical CenterHayward54843NCT06998940Map
WIAurora Cancer Care-Kenosha SouthKenosha53142NCT05677490Map
WIGundersen Lutheran Medical CenterLa Crosse54601NCT05677490Map
WIGundersen Lutheran Medical CenterLa Crosse54601NCT06998940Map
WIMarshfield Medical Center - LadysmithLadysmith54848NCT04205968Map
WIMarshfield Medical Center - LadysmithLadysmith54848NCT05677490Map
WIUniversity of Wisconsin - Carbone Cancer CenterMadison53792NCT06586515Map
WIUniversity of Wisconsin Carbone Cancer CenterMadison52792NCT05854498Map
WIUniversity of Wisconsin Carbone Cancer Center - Eastpark Medical CenterMadison53718NCT05863195Map
WIUniversity of Wisconsin Carbone Cancer Center - University HospitalMadison53792NCT04322318Map
WIUniversity of Wisconsin Carbone Cancer Center - University HospitalMadison53792NCT05863195Map
WIUniversity of Wisconsin Carbone Cancer Center - University HospitalMadison53792NCT06172296Map
WIUniversity of Wisconsin Carbone Cancer Center - University HospitalMadison53792NCT06401330Map
WIUniversity of Wisconsin HospitalMadison53792NCT05382559Map
WIWilliam S. Middleton Memorial VAMadison53705NCT06662786Map
WIAurora Bay Area Medical Group-MarinetteMarinette54143NCT05677490Map
WIMarshfield Medical Center-MarshfieldMarshfield54449NCT04205968Map
WIMarshfield Medical Center-MarshfieldMarshfield54449NCT04322318Map
WIMarshfield Medical Center-MarshfieldMarshfield54449NCT05677490Map
WIMarshfield Medical Center-MarshfieldMarshfield54449NCT06172296Map
WIMarshfield Medical Center-MarshfieldMarshfield54449NCT06958328Map
WIAspirus Medford HospitalMedford54451NCT05677490Map
WIFroedtert Menomonee Falls HospitalMenomonee Falls53051NCT06958328Map
WIAurora Cancer Care-MilwaukeeMilwaukee53209NCT05677490Map
WIAurora Saint Luke's Medical CenterMilwaukee53215NCT05677490Map
WIAurora Sinai Medical CenterMilwaukee53233NCT05677490Map
WIChildren's Hospital of WisconsinMilwaukee53226NCT04322318Map
WIChildren's Hospital of WisconsinMilwaukee53226NCT06172296Map
WIChildren's Hospital of WisconsinMilwaukee53226NCT06401330Map
WIFroedtert Hospital and the Medical College of WisconsinMilwaukee53226NCT05365581Map
WIMedical College of WisconsinMilwaukee53226NCT06958328Map
WIMedical College Of WisconsinMilwaukee53226NCT06750094Map
WIMarshfield Medical Center - MinocquaMinocqua54548NCT04205968Map
WIMarshfield Medical Center - MinocquaMinocqua54548NCT05677490Map
WIProHealth D N Greenwald CenterMukwonago53149NCT04205968Map
WIProHealth D N Greenwald CenterMukwonago53149NCT05677490Map
WIMarshfield Medical Center - NeillsvilleNeillsville54456NCT05677490Map
WICancer Center of Western WisconsinNew Richmond54017NCT04205968Map
WICancer Center of Western WisconsinNew Richmond54017NCT05677490Map
WIDrexel Town Square Health CenterOak Creek53154NCT06958328Map
WIProHealth Oconomowoc Memorial HospitalOconomowoc53066NCT04205968Map
WIProHealth Oconomowoc Memorial HospitalOconomowoc53066NCT05677490Map
WISaint Vincent Hospital Cancer Center at Oconto FallsOconto Falls54154NCT05677490Map
WISaint Vincent Hospital Cancer Center at Oconto FallsOconto Falls54154NCT06998940Map
WIVince Lombardi Cancer Clinic - OshkoshOshkosh54904NCT05677490Map
WIAurora Cancer Care-RacineRacine53406NCT05677490Map
WIAspirus Cancer Care - James Beck Cancer CenterRhinelander54501NCT05677490Map
WIAspirus Cancer Care - James Beck Cancer CenterRhinelander54501NCT06958328Map
WIMarshfield Medical Center-Rice LakeRice Lake54868NCT04205968Map
WIMarshfield Medical Center-Rice LakeRice Lake54868NCT05677490Map
WIMarshfield Medical Center-Rice LakeRice Lake54868NCT06958328Map
WISaint Vincent Hospital Cancer Center at SheboyganSheboygan53081NCT05677490Map
WISaint Vincent Hospital Cancer Center at SheboyganSheboygan53081NCT06998940Map
WISheboygan Physicians GroupSheboygan53081NCT05677490Map
WISheboygan Physicians GroupSheboygan53081NCT06998940Map
WIVince Lombardi Cancer Clinic-SheboyganSheboygan53081NCT05677490Map
WIEssentia Health-Spooner ClinicSpooner54801NCT04205968Map
WIEssentia Health-Spooner ClinicSpooner54801NCT05677490Map
WIEssentia Health-Spooner ClinicSpooner54801NCT06998940Map
WIAspirus Cancer Care - Stevens PointStevens Point54481NCT05677490Map
WIAspirus Cancer Care - Stevens PointStevens Point54481NCT06958328Map
WIMarshfield Medical Center-River Region at Stevens PointStevens Point54482NCT04205968Map
WIMarshfield Medical Center-River Region at Stevens PointStevens Point54482NCT05677490Map
WIMarshfield Medical Center-River Region at Stevens PointStevens Point54482NCT06958328Map
WISaint Vincent Hospital Cancer Center at Sturgeon BaySturgeon Bay54235-1495NCT05677490Map
WISaint Vincent Hospital Cancer Center at Sturgeon BaySturgeon Bay54235-1495NCT06998940Map
WIAurora Medical Center in SummitSummit53066NCT05677490
WIEssentia Health Saint Mary's Hospital - SuperiorSuperior54880NCT04205968Map
WIEssentia Health Saint Mary's Hospital - SuperiorSuperior54880NCT05677490Map
WIEssentia Health Saint Mary's Hospital - SuperiorSuperior54880NCT06998940Map
WIVince Lombardi Cancer Clinic-Two RiversTwo Rivers54241NCT05677490Map
WIProHealth Waukesha Memorial HospitalWaukesha53188NCT04205968Map
WIProHealth Waukesha Memorial HospitalWaukesha53188NCT05677490Map
WIUW Cancer Center at ProHealth CareWaukesha53188NCT04205968Map
WIUW Cancer Center at ProHealth CareWaukesha53188NCT05677490Map
WIAspirus Regional Cancer CenterWausau54401NCT05677490Map
WIAspirus Regional Cancer CenterWausau54401NCT06958328Map
WIMarshfield Clinic-Wausau CenterWausau54401NCT04205968Map
WIMarshfield Clinic-Wausau CenterWausau54401NCT05677490Map
WIAurora Cancer Care-Milwaukee WestWauwatosa53226NCT05677490Map
WIAurora West Allis Medical CenterWest Allis53227NCT05677490Map
WIFroedtert West Bend Hospital/Kraemer Cancer CenterWest Bend53095NCT06958328Map
WIMarshfield Medical Center - WestonWeston54476NCT04205968Map
WIMarshfield Medical Center - WestonWeston54476NCT05677490Map
WIMarshfield Medical Center - WestonWeston54476NCT06958328Map
WIAspirus Cancer Care - Wisconsin RapidsWisconsin Rapids54494NCT05677490Map
WIAspirus Cancer Care - Wisconsin RapidsWisconsin Rapids54494NCT06958328Map
WIMarshfield Clinic - Wisconsin Rapids CenterWisconsin Rapids54494NCT04205968Map
WIMarshfield Clinic - Wisconsin Rapids CenterWisconsin Rapids54494NCT05677490Map
WYMemorial Hospital of Laramie CountyCheyenne82001NCT05677490Map
WYMemorial Hospital of Laramie CountyCheyenne82001NCT06998940Map
WYBillings Clinic-CodyCody82414NCT04205968Map
WYBillings Clinic-CodyCody82414NCT05677490Map
WYBillings Clinic-CodyCody82414NCT06998940Map

Irinotecan clinical trials at a glance: phase × recruitment status

Phaserecruitingactive not recruitingenrolling by invitationcompletedterminatedwithdrawnsuspendednot yet recruitingunknownTotal
Early P1351211
P12410185243614266
P1/P22961531981211139
P2724213087916338125684
P2/P332101420
P33518681211325172
P42515215
N/A1143441137

Recruiting Irinotecan clinical trials (257)

Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).

NCT IDTitlePhaseIndicationEnrollmentStarted
NCT06450041NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) TrialP2Neuroblastoma62Dec 2024
NCT06023641Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk DiseaseP2Rhabdomyosarcoma135Mar 2024
NCT06208657Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent CancerP1/P2Childhood Cancer90Jul 2024
NCT06541262CX-4945Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid TumorsP1/P2Neuroblastoma104Oct 2024
NCT07521605Short-Course Radiotherapy, Nal-IRI, Capecitabine, and Camrelizumab for Locally Advanced MSS Rectal CancerP2Rectal Cancer Patients44May 2026
NCT05863195Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP TrialP3Metastatic Colorectal Carcinoma408Oct 2023
NCT04221035HR-NBL2High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)P3High-Risk Neuroblastoma800Nov 2019
NCT07444918Liposomal Irinotecan, Vincristine, Temozolomide, and Anlotinib for R/R Pediatric Solid TumorsP2Relapsed or Refractory Pediatric Malignant Solid Tumors (Including Neuroblastoma, Rhabdomyosarcoma, Ewing Sarcoma, Osteosarcoma)33Mar 2026
NCT07570914Hepatic Arterial Infusion of Liposomal Irinotecan Plus Oxaliplatin and Capecitabine as Adjuvant Therapy for Colorectal Cancer Liver MetastasesP2Colorectal Cancer Liver Metastases (CRLM)28May 2026
NCT07281157Liposomal Irinotecan, Capecitabine and Enlonstobart With Short-Course Radiotherapy for Locally Advanced Rectal CancerP2Advanced Rectal Cancer30Nov 2025
NCT07585279A Clinical Study of Liposomal Irinotecan for Second-Line Therapy in Metastatic Colorectal CancerP2/P3Metastatic Colorectal Cancer (CRC)408May 2026
NCT06662786OrigAMI-2A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal CancerP3Colorectal Neoplasms1,000Oct 2024
NCT01042379I-SPYI-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast CancerP2Breast Neoplasms5,000Mar 2010
NCT06620302Testing the Addition of an Anti-cancer Drug, DT2216, to the Usual Chemotherapy Treatment for Relapsed or Refractory Solid Tumors and Fibrolamellar CarcinomaP1/P2Childhood Fibrolamellar Carcinoma81Jun 2025
NCT05314998Adjuvant Trial in Patients With Resected PDAC Randomized to Allocation of Oxaliplatin- or Gemcitabine-based Chemotherapy by Standard Clinical Criteria or by a Transcriptomic Treatment Specific Stratification SignatureP3Pancreatic Ductal Adenocarcinoma394Jan 2025
NCT07490301IVA Study to Assess Intravenous (IV) Telisotuzumab Adizutecan in Combination With Fluorouracil, Folinic Acid, and Oxaliplatin (FOLFOX) Compared to Standard of Care in Adult Participants With First-Line Metastatic Pancreatic Ductal AdenocarcinomaP2/P3Metastatic Pancreatic Ductal Adenocarcinoma900Apr 2026
NCT07466316IR RMSA Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)P3Rhabdomyosarcoma342Jun 2026
NCT07549321SHINEA Safety and Efficacy Study of hu14 in High-Risk Neuroblastoma PatientsP2/P3High-Risk Neuroblastoma144Apr 2026
NCT07346157PNOC044Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual DiseaseP1/P2Medulloblastoma69Jul 2026
NCT07381764ROMANCE - GOIMROMANCE: "Irinotecan Plus Cetuximab Rechallenge Versus Trifluridine/Tipiracil Plus Bevacizumab in Molecularly Selected Metastatic Colorectal Cancer"P2Metastatic Colorectal Cancer (CRC)150Mar 2026
NCT07271355Pressurized Intraperitoneal Aerosolized Chemotherapy With Mitomycin for the Treatment of Unresectable Appendix or Colorectal Cancer With Peritoneal Metastases, The IMPACT TrialP3Metastatic Appendix Carcinoma129Jul 2026
NCT02813135ESMARTEuropean Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory TumorsP1/P2Pediatric Cancer472Aug 2016
NCT06401330FHWTA Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)P3Stage I Mixed Cell Type Kidney Wilms Tumor1,656Apr 2025
NCT06998940Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS MutationsP3Locally Advanced Pancreatic Adenocarcinoma94May 2026
NCT07328919Efficacy and Safety of TT-00420 (Tinengotinib) Tablets Versus Chemotherapy in Patients With Advanced Intrahepatic Cholangiocarcinoma Harboring FGFR2 Fusions/Rearrangements or MutationsP3Intrahepatic Cholangiocarcinoma (Icc)138Jan 2026
NCT07141771An Umbrella Study of Recurrent, Extensive Stage Small Cell Lung Cancer Based on Molecular TypingP1/P2SCLC, Extensive Stage100Dec 2025
NCT07334301BEACON2A Multi-Arm, Platform Trial For Relapsed NeuroblastomaP1/P2Relapsed Neuroblastoma160Nov 2024
NCT07194044METTSEOMetastatic Ewing's Trial Testing Schedule Enhancement to Improve OutcomesP1Metastatic Ewing Sarcoma15Feb 2026
NCT07389265CAPRI-3 GOIMContinuation of Cetuximab Beyond First-Line Progression in Metastatic Colorectal CancerP3Metastatic Colorectal Cancer (mCRC)480Oct 2025
NCT05379595OrigAMI-1A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal CancerP1/P2Advanced or Metastatic Colorectal Cancer225Jul 2022
NCT06958328LAP100Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic CancerP3Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma356Aug 2025
NCT07328425ISG-TULIPSClinical Study in Adult and Young Adult Patients With Advanced Desmoplastic Small Round Cell Tumor (DSRCT) ISG-TULIPSP2Desmoplastic Small Round Cell Tumor20Nov 2025
NCT07096362Utility of ctDNA in Early Switch of First-line mFOLFIRINOX in Metastatic Pancreatic Ductal AdenocarcinomaP2Metastatic Pancreatic Ductal Adenocarcinoma50Sep 2025
NCT04625907FaR-RMSFaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcomaP1/P2Rhabdomyosarcoma1,672Sep 2020
NCT07591831Liposomal Irinotecan Plus Enlonstobart for Platinum-Resistant Recurrent Ovarian CancerP2Platinum-resistant Recurrent Ovarian Cancer30May 2026
NCT06963502A Phase Ib Study of HS-10370 in Addition to Other Anti-cancer Therapies in Patients With Advanced Solid TumorsP1Advanced Solid Tumors762May 2025
NCT01356290MEMMATAntiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS TumorsP2Medulloblastoma Recurrent232Apr 2014
NCT07094893ARIEL-ENGICAnti-EGFR Agents in Patients With Right-sided Advanced Colorectal Cancer With Wild-type RAS and AREG/EREG High StatusP4Colorectal Cancer280Apr 2026
NCT06928584Hypofractionated Radiotherapy Plus Immunotherapy Versus Conventional Radiotherapy in Locally Recurrent Rectal CancerP2Locally Recurrent Rectal Cancer221Mar 2025
NCT07183865NOVELTY-RHypofractionated Radiotherapy Combined With NALIRIF, PD-1 Antibody in Locally Recurrent Rectal Cancer(NOVELTY-R)P2Locally Recurrent Rectal Cancer44Mar 2025
NCT03977233Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic CancerP2Pancreatic Ductal Adenocarcinoma (PDAC)45Jun 2019
NCT06897644PANThEONGemcitabine Plus Nab-paclitaxel as Switch Maintenance Versus Continuation of Modified FOLFIRINOX as 1st Line Chemotherapy in Patients With Advanced Pancreatic Cancer.P3Pancreatic Adenocarcinoma Advanced or Metastatic340Mar 2025
NCT07518147CLDNA Study Comparing BL-M05D1 With the Investigator's Choice of Treatment Regimen in Patients With Claudin (CLDN)18.2-Positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma (GC/GEJC) Who Have Received Prior First-Line TreatmentP3Gastric Cancer438May 2026
NCT07356973OPTICALIrinotecan-ChemoSeed in Surgically Resectable GlioblastomaP2Glioblastoma147Mar 2026
NCT07417735SYS6010 Versus Chemotherapy in Locally Advanced or Metastatic/Recurrent Esophageal Squamous Cell CarcinomaP3Locally Advanced/Metastatic/Recurrent ESCC436Mar 2026
NCT06692491SPRINGStudy of Precision Treatment for Rare Tumours in China Guided by PDO and NGSP2Rare Tumour200Jan 2025
NCT06172296Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk NeuroblastomaP3Ganglioneuroblastoma, Nodular478Apr 2024
NCT04861558EFFIPECEfficacy of Hyperthermic Intraperitoneal ChemotherapyP3Colorectal Cancer213May 2021
NCT06381154Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advanced or Metastatic Pancreatic CancerP2Locally Advanced Pancreatic Adenocarcinoma25Dec 2024
NCT07076212Evaluating NALIRIFOX vs Modified Gemcitabine, Nab-Paclitaxel and Cisplatin in Patients With Locally Advanced and Metastatic Pancreatic AdenocarcinomaP2Metastatic Pancreatic Adenocarcinoma52Apr 2026
NCT06644781ESCCA Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)P3Esophageal Squamous Cell Carcinoma510Mar 2025
NCT07325214Chemotherapy With or Without IMD10 (Focused Ultrasound) in the Treatment of Borderline Resectable or Locally Advanced Pancreatic CancerN/APancreatic Cancer136Apr 2026
NCT07409272A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic CancerP3Pancreatic Cancer614Feb 2026
NCT07099794IIA Randomized, Two-cohort, Prospective Phase II Clinical Study of the Second-line Treatment of Advanced Biliary System Tumors With Liposomal Irinotecan (II) Combination RegimenP2Biliary Tract Cancer (BTC)90Aug 2025
NCT05800587Dose Attenuated Chemotherapy in Compromised Patients With Lung CancerP2Lung Cancer280Feb 2023
NCT06547203Cetuximab, Irinotecan, Toripalimab in RAS/BRAF Wild-type Ultraselected Right-sided Colorectal Cancer StudyP2Colorectal Cancer Metastatic34Jul 2024
NCT06528496N10N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With NeuroblastomaP2High-risk Neuroblastoma45Jul 2024
NCT07463573QLC5508 vs. Chemotherapy in Pretreated Advanced or Metastatic Esophageal Squamous Cell CarcinomaP3Esophageal Squamous Cell Carcinoma (ESCC)466Apr 2026
NCT07397819Intraperitoneal Injection of Liposomal Irinotecan as Monotherapy or in Combination With Recombinant Mutant Human Tumor Necrosis Factor or Bevacizumab for the Treatment of Malignant Ascites Following Failure of Prior Standard TherapyP1/P2Malignant Ascites48Nov 2025
NCT03715933Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including SarcomasP1Ewing Sarcoma411Oct 2018
NCT06995872Phase I Trial of rhIL-15 Plus Dinutuximab Plus Irinotecan/Temozolomide for Children and Young Adults With Relapsed/Refractory NeuroblastomaP1Neuroblastoma40Oct 2025
NCT07559760New Second-Line Combo Therapy for MSS Metastatic Colorectal CancerP2Metastatic Colorectal Cancer30Nov 2025
NCT06750094OrigAMI-3A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received ChemotherapyP3Colorectal Neoplasms700Dec 2024
NCT05319730MK-3475A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)P1/P2Esophageal Squamous Cell Carcinoma230May 2023
NCT06733038AtezoTRIBE2FOLFOXIRI Plus Bevacizumab With or Without Atezolizumab as 1st Line Treatment of pMMR and IS IC-High Metastatic Colorectal Cancer Patients.P3Colorectal Cancer238Nov 2024
NCT06571461Liposomal Irinotecan in Combination With Oxaliplatin and S-1 Versus Gemcitabine Combined With Capecitabine as Postoperative Adjuvant Therapy for Pancreatic CancerP3Pancreatic Cancer408Sep 2024
NCT06586515MOONRAY-01MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid TumorsP1Pancreatic Ductal Adenocarcinoma630Sep 2024
NCT07364422To Evaluate the Safety and Tolerability of Study Drug as a Third-line and Beyond Therapy for Recurrent or Metastatic Gastric CancerP1/P2Gastric Cancer (GC)49Feb 2026
NCT07395063A Clinical Study on the Treatment of Metastatic Colorectal Cancer at the Second-line or Beyond.P2Metastatic Colorectal Cancer (CRC)68Feb 2026
NCT07085338A Phase II Study With a Safety Run-In of the Addition of N-803 to a Chemoimmunotherapy Backbone for the Treatment of Patients With Relapsed or Refractory NeuroblastomaP2Neuroblastoma Recurrent54Nov 2025
NCT07155200Small Cell Lung Cancer Irinotecan and CDC2-like Kinase Inhibition Trial (SLICK Trial)P1/P2Small-cell Lung Cancer42Dec 2025
NCT06951503AK112 and Chemotherapy in First-line Metastatic Colorectal CancerP3Colorectal Adenocarcinoma560May 2025
NCT07595913A Study of ZG006 for Injection Versus Investigator-Selected Chemotherapy in Participants With Advanced Neuroendocrine CarcinomaP3Neuroendocrine Carcinoma240Jul 2026
NCT07606599A Study of BL-M07D1 Versus Physician's Choice of Chemotherapy in Patients With HER2-expressing Locally Advanced or Metastatic Biliary Tract Cancer After Platinum-containing Chemotherapy FailureP3Biliary Tract Cancer398May 2026
NCT07582315PANKU-BTC01A Study Comparing BL-B01D1 With Treatment of Physician's Choice in Patients With Locally Advanced or Metastatic Biliary Tract Cancer After Failure of Platinum-based Chemotherapy and PD-1/PD-L1 Monoclonal Antibody Therapy(PANKU-BTC01)P3Biliary Tract Cancer538May 2026
NCT07487896A Study of YL201 Versus Investigator's Choice of Chemotherapy in Participants With Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma After Failure of First-Line TherapyP3Advanced Esophageal Squamous Cell Carcinoma440Apr 2026
NCT07391566LPM6690176 in Combination With Chemotherapy and Bevacizumab in Metastatic Colorectal Cancer Patients With RAS MutationP1/P2Metastatic Colorectal Cancer (mCRC)99Mar 2026
NCT07318831Phase II Study of Chidamide-Dinutuximab Beta-Irinotecan-Temozolomide for Refractory/Relapsed Neuroblastoma in ChildrenP2Neuroblastoma (NB)27Jan 2026
NCT07238283IIIrinotecan Hydrochloride Liposome Injection (II)in Combination With Oxaliplatin, 5-FU/LV Versus AG for First-line Treatment of Metastatic Pancreatic CancerP3First-line Treatment of Metastatic Pancreatic Cancer662Dec 2025
NCT07474103SCRT-NALIRIXELOX+Sintilimab as TNT for High-Risk LARCN/ARectal Cancer, Adenocarcinoma49Nov 2025
NCT06941857NC410 and FOLFIRINOX in Combination With Nivolumab With or Without Ipilimumab in Patients With Untreated Metastatic Pancreatic CancerP2Pancreatic Cancer20Sep 2025
NCT04199026Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent SarcomaN/AMetastatic Sarcoma20Feb 2025
NCT06751394TRACERPreoperative Chemoradiotherapy and Toripalimab in Locally Recurrent Rectal CancerP2Recurrent Rectal Cancer44Jan 2025
NCT06006273A Phase Ib Trial of Eribulin in Combination With Irinotecan and Temozolamide in Children With Relapsed or Refractory Solid TumorsP1Refractory Solid Tumors48Aug 2023
NCT05382559A Study of ASP3082 in Adults With Advanced Solid TumorsP1Solid Tumor681Jun 2022
NCT07258147Safety and Efficacy of Radiotherapy Combined With Immunochemotherapy in Pre-treated SCLC Patients With Liver MetastasesP2Lung Cancer (SCLC)30Oct 2026
NCT07059338HERBICDual EGFR/HER2 Blockade Combined With Irinotecan for the Treatment of HER2-Positive Metastatic Colorectal CancerP2HER2 Positive34Jul 2025
NCT07235202PDACA Study of MR001 Combined With Chemotherapy in Patients With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) After First-line TherapyP1/P2Pancreatic Ductal Adenocarcinoma (PDAC)45Dec 2025
NCT06652412CGA Guided Ultrafractionated RT and Systemic Treatment in Elderly or Frail Patients with Inoperable Localized CRCP2Colon Cancer124Nov 2024
NCT07375563NB-NK-2026Chemoimmunotherapy Combined With Autologous NK Cell Therapy for Pediatric Patients With Refractory and Relapsed High-Risk Neuroblastoma and GanglioneuroblastomaP3Neuroblastoma (NB)5Nov 2025
NCT05677490mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric AdenocarcinomaP3Advanced Esophageal Adenocarcinoma382Jan 2023
NCT07150403Second-line Doublet Chemotherapy (FOLFOX or FOLFIRI) Plus Fruquintinib Versus Doublet Chemotherapy (FOLFOX or FOLFIRI) Plus Bevacizumab in Metastatic Colorectal CancerP2Metastatic Colorectal Carcinoma (mCRC)74Dec 2025
NCT06128837Study of LY01610 in Patients With Recurrent Small Cell Lung CancerP3Relapsed Small Cell Lung Cancer686Mar 2024
NCT05412082SMART TNTSMART TNT for the Conservative Management of Locally Advanced Rectal CancerP1Locally Advanced Rectal Cancer25Oct 2022
NCT05384821MetroWilmsMetronomic Chemotherapy in Wilms Tumor (MetroWilms-1906)P1/P2Wilms Tumor28Sep 2022
NCT07284134JS107 vs Investigator's Choice as Second-line or Later Therapy for Advanced CLDN18.2-Positive Gastricor GEJ Adenocarcinoma.P3Advanced Gastric or Gastroesophageal Junction Adenocarcinoma560Dec 2025
NCT07214298Pegcetacoplan in Combination With Modified FOLFIRINOX for the Treatment of Metastatic Pancreatic Ductal AdenocarcinomaP1/P2Metastatic Pancreatic Ductal Adenocarcinoma35Feb 2026
NCT07134205The Study of JMT101 Combined With Irinotecan as a ≥3rd-Line Treatment in Metastatic Colorectal CancerP3Metastatic Colorectal Cancer (mCRC)252Oct 2025
NCT06846346GRACIETesting Ivonescimab in Combination With Chemotherapy in Advanced or Metastatic Gastric/Gastroesophageal AdenocarcinomaP2Metastatic Esophageal Adenocarcinoma88Nov 2025
NCT02885753OSCARSystemic Oxaliplatin or Intra-arterial Chemotherapy Combined With LV5FU2 +/- Irinotecan and an Target Therapy in First Line Treatment of Metastatic Colorectal Cancer Restricted to the LiverP3Colorectal Neoplasms348Dec 2016
NCT06467786Study on the Therapeutic Effect of Irinotecan Liposomes in Small Cell Lung CancerP4Small Cell Lung Cancer24Mar 2024
NCT07123441IIA Study on the Efficacy and Safety of Irinotecan Liposome (II), 5-FU/LV in Combination With Bevacizumab for the Treatment of Advanced Colorectal CancerP2Colorectal Cancer300Sep 2025
NCT07004712Efficacy and Biomarkers of the Second-line Treatment of Adebelizumab Combined With Irinotecan Liposome in Advanced Small Cell Lung CancerP2Small Cell Lung Cancer46Jun 2025
NCT06490536The Sagittarius TrialP3Colon Cancer Stage II700Oct 2024
NCT06485739Irinotecan Liposomes for the Treatment of Neuroendocrine CarcinomaP4Neuroendocrine Tumors20Jul 2024
NCT06835387Study of NALIRIFOX in Advanced Unresectable Small Bowel TumorsP2Small Bowel Adenocarcinoma36Jun 2025
NCT07543744A Comparative Study of Pharmacokinetics, Safety, and Immunogenicity of RPH-030 and Vectibix® in Patients With Metastatic Colorectal Cancer With Wild-type RAS as First-line Therapy in Combination With FOLFIRIP1Metastatic Colorectal Cancer180Apr 2025
NCT05004116A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor CancerP1/P2Advanced Cancer77Aug 2021
NCT07309185Adebrelimab Combined With Famitinib and Irinotecan in Advanced Gastric Cancer After Failure of First-Line TherapyP2Stomach Neoplasms66Jul 2024
NCT06361316Irinotecan Liposome Combined With Oxaliplatin and Tegafur as Adjuvant Therapy for Pancreatic CancerN/APancreatic Cancer53Apr 2024
NCT05854498Liposomal Irinotecan With TAS102 and Bevacizumab for Patients With Metastatic Colorectal CancerP2Metastatic Colorectal Cancer50Oct 2023
NCT07051785ARKFruquintinib vs Bevacizumab Combined With Irinotecan Liposome and Capecitabine as Second-Line Therapy for Advanced Metastatic Colorectal CancerP2Colorectal Cancer (CRC)68Jul 2025
NCT06210971Neoadjuvant Chemoradiation With Nal-IRI and Capecitabine Guided by UGT1A1 Status in Patients With Rectal CancerP2Rectal Cancer60Feb 2024
NCT07150247Safety and Efficacy of IB-FOLFIRI in BRAF V600E-Mutant Metastatic Colorectal CancerP2BRAF V600 Colorectal Cancer20Jun 2025
NCT06496048Lurbinectedin or in Combination with Irinotecan Versus Topotecan in Patients with Relapsed SCLCP3Relapsed Small Cell Lung Cancer180Sep 2024
NCT06509126IMPROVE-2Intermittent or Continuous Panitumumab Plus FOLFIRI for Left Sided RAS/B-RAF Wild-type Metastatic Colorectal CancerP3Colorectal Cancer Stage IV500Jun 2024
NCT06792695CANTORA Study of Novel Study Interventions and Combinations in Participants With Colorectal CancerP2Metastatic Colorectal Cancer120Mar 2025
NCT06974110Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid TumorsP1Advanced Solid Tumor132Jul 2025
NCT05365581A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic CancerP1Gastric Adenocarcinoma398Jun 2022
NCT06250972PTCA199-11Radiotherapy to Patients With CA19-9-elevated Advanced Pancreatic CancerP3Pancreatic Adenocarcinoma210May 2024
NCT06954246A Study of MHB088C Injection Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung CancerP3Small Cell Lung Cancer Extensive Stage450Jun 2025
NCT06648525Adebrelimab Combined with Irinotecan Liposomes, 5-FU, CF ± Lenvatinib As First-line Treatment for Advanced ICCP2Intrahepatic Cholangiocarcinoma (Icc)68Oct 2024
NCT07062536mFOLFOX/mFOLFIRI vs. mFOLFOX in Advanced or Recurrent Biliary Tract Cancer Second-lineP2Biliary Cancer Metastatic130Jun 2026
NCT07524374IISHR-1701 in Combination With Irinotecan Liposome (II) for Second-line Treatment of ESCC After ImmunotherapyP2ESCC33Mar 2026
NCT06649292SHR-A1904 Compared With Investigator's Choice of Therapy in Claudin18.2 Positive Patitens With Second-line Advanced or Metastatic Gastric or Gastroesophageal Junction AdenocarcinomaP3Second-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma524Nov 2024
NCT07229846QL1706A Single-arm, Single-center, Phase II Clinical Study of Aipalolitovorelizumab (QL1706) Combined With Bevacizumab and Standard Chemotherapy as First-line Treatment for MSS/pMMR Metastatic Colorectal Cancer With BRAF V600E MutationP2Colorectal Cancer30Feb 2026
NCT06827717IIPhase II Study of Irinotecan Liposome (II) Combined With Temozolomide and Fluzoparib in Recurrent or Metastatic Ewing SarcomaP2Ewing Sarcoma29Apr 2025
NCT07474727A Phase II Study of AMT-676 Combination Therapies in Advanced Colorectal CancerP2Colorectal Cancer180Apr 2026
NCT06491134Liposomal Irinotecan With Cisplatin and Concurrent Radiotherapy in Locally Advanced Esophageal Squamous Cell CarcinomaP1Esophageal Squamous Cell Carcinoma12Jun 2024
NCT07415031A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib StudiesP2Solid Tumors170May 2026
NCT06745193A Prospective, Randomized, Open, Phase II Clinical Study of Chidamide in Combination with Camrelizumab and Apatinib for Advanced Esophageal CancerP2Advanced Esophageal Carcinoma63Feb 2025
NCT07457775Liposomal Irinotecan in Combination With Temozolomide and Bevacizumab in Patients With Advanced STSP2Soft Tissue Sarcoma (Excluding GIST)24Mar 2026
NCT07024615A Study of ASP2138 Given Before Surgery, Then Chemotherapy After Surgery, in People With Pancreatic Ductal CancerP1Pancreatic Ductal Adenocarcinoma25Oct 2025
NCT05694715Combination Therapy in Cancers With Mutations in DNA Repair GenesP1Metastatic Solid Tumor24May 2023
NCT07070479Combination Therapy for PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma: A Bayesian Adaptive Phase II TrialP2Recurrent or Metastatic Nasopharyngeal Carcinoma208Jun 2025
NCT04920032Study of ctDNA Guided Change in Tx for Refractory Minimal Residual Disease in Colon AdenocarcinomasP1Colon Adenocarcinoma22Aug 2021
NCT04329494PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric CancerP1Clinical Stage IV Gastric Cancer AJCC v849Aug 2020
NCT07479732Apatinib Combined With Liposomal Irinotecan for Refractory or Metastatic OsteosarcomaP1/P2Osteosarcoma56Mar 2026
NCT07314385NH002-mediated Sonoporation With Chemotherapy in Advanced Pancreatic CancerP1Pancreatic Adenocarcinoma Metastatic24Jan 2026
NCT07014540A Irinotecan Liposome Trial of in Advanced Neuroendocrine CarcinomaP4Neuroendocrine Carcinomas (NEC)45Jun 2025
NCT06820762IIIrinotecan Liposome(II) Combined With Ivonescimab as Second-line Treatment for Small Cell Lung Cancer : A Prospective, Single-arm, Multicenter Clinical StudyP2SCLC40Feb 2025
NCT06749691LIAESLiposomal Irinotecan and Apatinib in ES-SCLCP2Small Cell Lung Cancer Extensive Stage30Dec 2024
NCT06513455Irinotecan Liposome,Albumin Paclitaxel and Gemcitabine First-line Treatment for Pancreatic CancerP1/P2Pancreatic Cancer132Sep 2024
NCT06578052Irinotecan Liposome in Combination With CapecitabineN/APancreatic Cancer20Aug 2024
NCT06013618Clinical Analysis of Naxitamab (hu3F8) in the Treatment of Pediatric High Risk or Refractory/ Relapsed NeuroblastomaP2Neuroblastoma120Jun 2023
NCT04211675STINGNK Cells Infusions With Irinotecan, Temozolomide, and DinutuximabP1/P2Relapsed Neuroblastoma31Sep 2022
NCT05472259NALPACA Study Evaluating the Efficacy of 5-FU + NALIRI and 5-FU + NALIRINOX for PDAC (NALPAC)P2Metastatic Pancreatic Ductal Adenocarcinoma134May 2022
NCT04657068A Study of ART0380 for the Treatment of Advanced or Metastatic Solid TumorsP1/P2Advanced Cancer442Jan 2021
NCT06739928IIIrinotecan Liposome (II) or Etoposide Combined With Adebrelimab and Carboplatin in the Treatment of ES-SCLCP2Small Cell Lung Cancer Extensive Stage120Jan 2025
NCT06194734A Study of KC1036 Versus Investigator's Choice of Chemotherapy in Patients With Advanced Esophageal CancerP3Esophageal Squamous Cell Carcinoma490Feb 2024
NCT07027748Feasibility Study of Prolonged Administration of Naxitamab, Irinotecan, and Temozolomide for Patients With Relapsed or Refractory NeuroblastomaP1Neuroblastoma18Jun 2025
NCT06259058Stereotactic Body Radiation Therapy Followed by NALIRIFOX vs NALIRIFOX for Borderline Resectable Pancreatic CancerP1/P2Pancreatic Cancer96Apr 2024
NCT06501664Liposomal Irinotecan and 5-FU as Second-line Therapy for Patients With ESCCP3Esophageal Cancer360Aug 2024
NCT06894797Preoperative Chemoradiotherapy Combined With Consolidation or Induction NALIRIFOX in Rectal Cancer.N/ALocally Advanced Rectal Cancer68Apr 2025
NCT06540326Clinical Study of Second-line Treatment in Advanced Colorectal Cancer With Chemotherapy With Bevacizumab or CetuximabP2Colorectal Cancer Metastatic100Nov 2024
NCT06657690Irinotecan Liposome Combined with S-1 in PD-1/L1 Inhibitor Refractory Recurrent or Metastatic NPCP2Recurrent or Metastatic Nasopharyngeal Carcinoma56Nov 2024
NCT06499610Clinical Study of Irinotecan Liposome Combination Therapy for Advanced Gastric CancerP4Gastric Cancer44Jul 2024
NCT06365008Sintilimab Plus FOLFIRI as Salvage Therapy for Patients With Advanced Gastric CancerP2Unresectable/Metastatic Gastric Cancer40Apr 2024
NCT06219941AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2P2Gastric Cancer224Dec 2023
NCT04478292A Multi-institutional Study for Treatment of Children With Newly Diagnosed Hepatoblastoma Using a Modified PHITT StrategyP3Hepatoblastoma330Mar 2021
NCT06478043A Study to Investigate the Efficacy and Safety of Ivonescimab Combined With Irinotecan Liposome as Second-line Regimen for ES-SCLCP2Extensive-stage Small-cell Lung Cancer54Sep 2024
NCT05424692PTCDrug Sensitivity Detection of Micro Tumor (PTC) to Guide Postoperative Adjuvant Treatment Strategy of Colorectal CancerN/AColon Cancer200Sep 2021
NCT06577376A PhaseⅠ/Ⅱ Study of Simmitinib or Irinotecan Liposomes Combined With DP303c in Gastric Adenocarcinoma or Gastroesophageal Junction AdenocarcinomaP1/P2Localized Advanced or Metastatic Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma252Aug 2024
NCT07047560IILiposomal Irinotecan (II) Fractionated Dosing Combined With 5-FU/LV (FOLFIRInali-3) and Bevacizumab in Second-line Treatment of Advanced Colorectal Cancer: A Single-arm, Phase II Clinical StudyP2Colorectal Cancer (CRC)46Sep 2024
NCT04205968Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel CancersP2Metastatic Small Intestinal Adenocarcinoma94Jun 2020
NCT07044921IIClinical Study of Irinotecan Liposome (II)-Based Combination Treatment for Irinotecan-resistant Colorectal Cancer.P2Colorectal Cancer Metastatic30Sep 2024
NCT07363408Ivonescimab and ADG126, Alone, and in Combination With Leucovorin and Fluorouracil or FOLFIRI Regimen for the Treatment of Microsatellite Stable Advanced/Metastatic Colorectal CancerP1Advanced Microsatellite Stable Colorectal Carcinoma30Jul 2026
NCT04322318A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWTP2Anaplastic Kidney Wilms Tumor256Oct 2020
NCT07376499Prospective, Single-arm, Phase II Clinical Study of Irinotecan Hydrochloride Liposome Injection Combined With Platinum and Immune Checkpoint Inhibitors Combined With Anlotinib for the Maintenance of Extensive Small Cell Lung Cancer After First-line InductionP2Small Cell Lung Cancer31Jan 2026
NCT07011576FRUITFULA Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)P2Colon Cancer60Sep 2025
NCT07085273Irinotecan Liposome II + 5-FU/LV + Oxaliplatin + Karelizumab in Neoadjuvant Treatment of Gastric CancerP2Gastric Cancer33Aug 2025
NCT07104604Study on the Efficacy and Safety of Neoadjuvant Radiotherapy Combined With Toripalimab, Liposomal Irinotecan, and Capecitabine in the Treatment of pMMR Locally Advanced Rectal Adenocarcinoma With Low Rectal InvolvementP1Rectal Cancer59Aug 2025
NCT05733689Response Adapted Neoadjuvant Therapy in Gastroesophageal Cancers (RANT-GC Trial)P1Gastroesophageal Adenocarcinoma20Jun 2025
NCT06951841Prospective, Single-arm, Phase II Clinical Study of Irinotecan Hydrochloride Liposome Injection Combined With Platinum and Immune Checkpoint Inhibitors Combined With Anlotinib for the Maintenance of Extensive Small Cell Lung Cancer After First-line InductionP4Small Cell Lung Cancer31Apr 2025
NCT06462105Liposomal Irinotecan Combination Regimen for First-line Treatment of Small Cell Lung CancerN/ASmall Cell Lung Cancer60Jul 2024
NCT06123494SHR-A1811 for Subjects With Her2-positive Gastric Cancer and Gastroesophageal Junction Adenocarcinoma After Progression on or After First-line Anti-HER2 Therapy-containing RegimenP3HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma360Jan 2024
NCT06714357VICTORIAValproIc Acid to Potentiate Anti-EGFR Treatment Efficacy and Prevent/Revert Resistance in Colorectal CancerP2Colorectal Cancer Metastatic130Mar 2025
NCT05391126GENOCAREGENOCARE: A Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual CareN/AColorectal Cancer178Sep 2022
NCT04361708I-FLOATSafety of Combining Irinotecan With 5-FU, Leucovorin/Folinic Acid, Oxaliplatin, and Docetaxel ChemotherapiesP1Pancreatic Adenocarcinoma54May 2020
NCT05999994CAMPFIREA Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With CancerP2Neoplasms105Jan 2020
NCT07092306NALIRI-VTA Randomized Controlled Study Comparing the Safety and Efficacy of Irinotecan Hydrochloride Liposome Injection Combined With Temozolomide and Vincristine (NALIRI-VT) Versus Irinotecan Combined With Temozolomide and Vincristine (VIT) in Patients With Advanced Ewing's SarcomaP2Ewing's Sarcoma74Aug 2025
NCT05806931SCOTISequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal CancerP2Colon Cancer50May 2023
NCT07441369Abemaciclib Combined With FOLFOX/FOLFIRI Regimen in Patients With Advanced Colorectal Liver Metastases CancerP2Liver Metastases From Colorectal Cancer (mCRC)16May 2026
NCT05669339AD HOC Trial: Artificial Intelligence-Based Drug Dosing In Hepatocellular CarcinomaP2Hepatocellular Carcinoma12Dec 2024
NCT06405139Nanoliposomal Irinotecan, Oxaliplatin Plus Capecitabine As Conversion Therapy of Locally Advanced Colorectal CancerP2Colorectal Cancer36May 2024
NCT06370754FD-IMPACTNewly Emerging Immunotherapy for Pancreatic Cancer TreatmentP1/P2Pancreatic Cancer117Apr 2024
NCT06375473MA-PC-RWS-011Treatment of Irinotecan Hydrochloride Liposome Injection II in China: a Real World Study of Pancreatic Cancer PatientsPancreatic Cancer3,000Apr 2024
NCT05381038Optimizing and Personalising Azacitidine Combination Therapy for Treating Solid Tumours QPOP and CURATE.AIP1/P2Solid Tumor10Feb 2023
NCT06332950IISafety and Efficacy of Adebrelimab Plus Irinotecan Liposome (II) With or Without Famitinib in ES-SCLC Pre-treated With ImmunotherapyP1/P2Extensive-stage Small-cell Lung Cancer80Apr 2024
NCT06210360Perioperative Treatment in High-risk Resectable Pancreatic Cancer With NALIRIFOXP2Pancreatic Cancer134Feb 2024
NCT06782685Liposomal Irinotecan + Oxaliplatin + Bevacizumab Versus Liposomal Irinotecan + 5-FU/LVP1/P2Advanced Pancreatic Cancer (Part 1)138Jun 2024
NCT05688215Zimberelimab and Quemliclustat in Combination With Chemotherapy for the Treatment of Patients With Borderline Resectable and Locally Advanced Pancreatic AdenocarcinomaP1/P2Borderline Resectable Pancreatic Adenocarcinoma56Mar 2023
NCT06821997NALIRIFOX Before Surgery for the Treatment of Borderline Resectable Pancreatic Ductal Adenocarcinoma, Nectar TrialP2Borderline Resectable Pancreatic Ductal Adenocarcinoma20Mar 2026
NCT06184698Liposomal Irinotecan and Leucovorin/5-fluorouracil Plus Bevacizumab in Metastatic Colorectal CancerP2Colorectal Cancer173Jan 2024
NCT05062317ctDNA-Directed Post-Hepatectomy Chemotherapy for Patients With Resectable Colorectal Liver MetastasesP2Liver Metastases120Apr 2022
NCT04796012VITASVITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid TumorsP1/P2Solid Tumor23Apr 2023
NCT046893475FU/LV, Irinotecan, Temozolomide and Bevacizumab for MGMT Silenced, Microsatellite Stable Metastatic Colorectal Cancer.P1/P2Metastatic Colorectal Cancer27Jan 2021
NCT06656091A Study of Simmitinib Versus Chemotherapy for Participants With Advanced Oesophageal Squamous Cell CarcinomaP3Advanced Oesophageal Squamous Cell Carcinoma450Oct 2024
NCT06172036CAPT-02Irinotecan Liposome for Resectable Pancreatic Cancer With or Without AddebelizumabP2Neoadjuvant Chemotherapy180Jan 2024
NCT06166589Second-line Zimberelimab and SIRIOX Chemotherapy for Patient With Previously AG Chemotherapy Treated Pancreatic CancerP2Previously AG Chemotherapy Treated Pancreatic Cancer19Jan 2024
NCT07060014NALIRIFOX (Nal-IRI Plus 5-FU/LV Plus Oxaliplatin) as First-Line Treatment for Patients With Advanced Small Intestine and Appendiceal CancersP1Advanced Small Intestine Cancer22Jul 2025
NCT06763029VICPROIRIIrinotecan Liposomes Combined with Cetuximab + Vermofenib in First-line Failure of Advanced Colorectal CancerP2Colorectal Cancer Metastatic36Feb 2025
NCT06710821Irinotecan Liposomes Combined with Temozolomide and Vincristine in the Treatment of Pediatric Patients with Solid TumorsP1Solid Tumor Cancer40Dec 2024
NCT06700603Second-line Irinotecan Liposome Combination Regimen for Irinotecan-treated Pancreatic CancerP2Pancreatic Cancer48Nov 2024
NCT06643793IIEvaluation of Irinotecan Liposome (II) Combined With 5-FU, LV, and Bevacizumab for mCRCP2Colorectal Neoplasms Malignant30Nov 2024
NCT06531278Adebelimab Combined With Irinotecan Liposomal Injection, Oxaliplatin, Fluorouracil and Calcium Folinate Are Used in the First-line Treatment of Pancreatic Cancer Liver Metastasis Efficacy and SafetyP2Pancreatic Cancer Metastatic to Liver40Jul 2024
NCT06463548Irinotecan Hydrochloride Liposome Combined With Capecitabine and Lenvatinib in Patients With Biliary Tract CarcinomaN/ABiliary Tract Carcinoma30Jul 2024
NCT06341296Phase II Study of Irinotecan Liposomes in First-line Treatment of Metastatic Colorectal CancerP2Metastatic Colorectal Cancer86Jun 2024
NCT06258642Irinotecan Liposome Combined With Anlotinib as Second-line Regimen for SCLCN/ASmall Cell Lung Cancer Recurrent39Apr 2024
NCT05400603Aflac-NBL-2002Allogeneic Expanded Gamma Delta T Cells With GD2 Chemoimmunotherapy in Relapsed /Refractory Neuroblastoma or Refractory/ Relapsed OsteosarcomaP1Neuroblastoma24Nov 2023
NCT05727163FOLFOX Via HAI Plus Intravenous Irinotecan With or Without Bevacizumab Versus Systemic FOLFOXIRI With or Without Bevacizumab in Initially Unresectable RAS-mutated CRLM PatientsP2Colorectal Cancer Metastatic194Jul 2022
NCT04443543An Adaptive-design Prospective Cohort Study of Watch and Wait Strategy in Patients With Locally Advanced Rectal CancerP2Rectal Cancer222Jun 2020
NCT06405490NALIRI-XELOX+AK104 for First-line Treatment of Advanced PDACP2Nanoliposomal Irinotecan30Apr 2024
NCT05962502Cetuximab Plus Irinotecan in Patients With NeoRAS Wild-type Metastatic Colorectal Cancer In Third-line TherapyP2Metastatic Colorectal Cancer54Aug 2023
NCT05148767UGT1A1-Based Irinotecan Therapy for Locally Advanced Rectal CancerP4Rectal Cancer Stage III606Jan 2022
NCT04415853Study of Larotinib in Unresectable Advanced or Recurrent Esophageal CancerP3Esophageal Cancer416Jan 2021
NCT06340204Weekly Irinotecan Liposomes in Recurrent or Refractory Ewing SarcomaP1Ewing Sarcoma44Mar 2024
NCT06801730NALIRIBVRGIrinotecan Liposomes Combined With Bevacizumab in the Treatment of Recurrent GliomaP2Glioma38Jan 2025
NCT06394713A Study to Evaluate the Efficacy and Safety of QLF31907 Combination Therapy in Patients With Advanced Malignant TumorsP1/P2Advanced Malignant Neoplasm60Jun 2024
NCT06514313Clinical Trial of VIM With VIT in Children With Relapsed and Refractory Soft Tissue Sarcoma.P2Soft Tissue Sarcoma110Jul 2024
NCT06055179XCHT for Irinotecan-Induced Gut Toxicities (Randomized Controlled Trial)N/AXiao Chai Hu Tang98Mar 2024
NCT06438822Cadonilimab Combined With Liposomal Irinotecan Plus Leucovorin and Fluorouracil for Advanced CholangiocarcinomaP2Cholangiocarcinoma51Aug 2024
NCT05427383KN026 in Combination With Chemotherapy in HER2 Positive Gastric Cancer Subjects Who Have Failed First-line TherapyP2/P3Stomach Cancer286Apr 2022
NCT06697366Liposomal Irinotecan Combined with Sintilimab for Second-line Treatment of Progressive Gastric CancerP2Gastric Cancer27Nov 2024
NCT06699459NICRRBTCIrinotecan Liposomes +5-FU/LV Versus Capecitabine in Patients of Recurrence After Resection of Resectable BTCP2Biliary Tract Carcinoma76Nov 2024
NCT05462236MNK Inhibitor AUM001 in Combination With Either Pembrolizumab or Irinotecan to Treat Metastatic Colorectal CancerP2Metastatic Colorectal Cancer120Apr 2023
NCT06192680Liposomal Irinotecan and Capecitabine Plus Bevacizumab as Second-line Therapy in Metastatic Colorectal CancerP2Colorectal Cancer63Apr 2024
NCT06202001Irinotecan, TAS-102 Plus Bevacizumab as a Second-Line Therapy in mCRC PatientsP1/P2Metastatic Colorectal Cancer70Oct 2022
NCT04342910Study to Evaluate the Efficacy and Safety of Camrelizumab and Apatinib in Patients With GC/GEJCP3Gastric Cancer550Sep 2020
NCT06769425HS-10502HS-10502 Combination Treatment in Patients With Advanced Solid TumorsP1Recurrent Ovarian Cancer157May 2025
NCT06321081ICE Study: Combination of Irinotecan Plus Cetuximab and Envafolimab as a Rechallenge Regimen in mCRCP2RAS Mutation60Mar 2024
NCT06341309Exploratory Study of Irinotecan Liposomes in Maintenance Therapy of Metastatic Colorectal CancerP1/P2Metastatic Colorectal Cancer20Aug 2024
NCT06443307Real-world Study to Evaluate the Efficacy and Safety of Liposome IrinotecanColorectal Cancer933Jul 2024
NCT04034173Optimal Anti-EGFR Treatment of mCRC Patients With Low-Frequency RAS MutationP2Treatment Related Cancer120Aug 2019
NCT05457829Doxorubicin Hydrochloride Liposome Combined With Irinotecan (AI Regimen) Versus VIT Regimen in the Treatment of Relapsed and Refractory Pediatric Rhabdomyosarcoma: a Prospective, Open-label, Randomized Controlled, Multicenter, Phase II Clinical StudyP2Rhabdomyosarcoma, Child88Dec 2023
NCT06434090Liposomal Irinotecan Plus Bevacizumab in Irinotecan-refractory Metastatic Colorectal CancerP1/P2Colorectal Cancer74Jun 2024
NCT07056777Evaluation of the Preliminary Efficacy and Safety of DR30206 in Combination With Standard Therapy in Patients With Gastrointestinal CancerP1/P2Gastrointestinal Cancer186Mar 2025
NCT06387810undeterminedIrinotecan Liposome II in Combination With 5-FU/LV and Oxaliplatin in Perioperative Treatment of Borderline Resectable Pancreatic CancerP2Borderline Resectable Pancreatic Cancer45Apr 2024
NCT05978492A Study of TXN10128 in Subjects With Solid TumorsP1Locally Advanced (Unresectable) or Metastatic Solid Tumors96Jul 2023
NCT07542002Liposomal Irinotecan, 5-fluorouracil/Calcium Folinate, Oxaliplatin, and Adebrelimab in Combination With Radiotherapy for Resectable or Borderline Resectable Pancreatic Cancer With Risk Factors:A Prospective Exploratory StudyP2Pancreatic Cancer37Mar 2025
NCT04776655LIBImAbStudy in mCRC Patients RAS/BRAF wt Tissue and RAS Mutated LIquid BIopsy to Compare FOLFIRI Plus CetuxiMAb or BevacizumaBP3Colorectal Cancer280Apr 2021
NCT05027386Apatinib Mesylate Combined With IT Regimen for the Treatment of Recurrent or Refractory Pediatric Neuroblastoma: A Single-arm, Phase I/II,Multi-center, Clinical Study.P1/P2Neuroblastoma125Aug 2021
NCT06486545Liposomal Irinotecan Combination Regimen for Second-line Treatment of Advanced Gastric CancerN/AAdvanced Gastric Cancer18Aug 2024
NCT06512428A Study of Simmitinib Plus Irinotecan in Advanced Esophageal Squamous Cell CarcinomaP2Advanced Esophageal Squamous Cell Carcinoma138Mar 2024
NCT06139211A Phase Ib/II Study Of JS015 Combination Therapy in Advanced Solid TumorsP1/P2Advanced Solid Tumor186Jan 2024
NCT05385861Nal-IRI (ONIVYDE® ) and Carboplatin in Patients With Advanced or Metastatic GEP-NETP1/P2GEP-NET52Aug 2025
NCT07204574The Phase 1b/IIa, Open-label, Dose Escalation and Dose Expansion to Evaluate Safety, Tolerability, and Preliminary Efficacy of the Combination of HCB101, Cetuximab/Bevacizumab, and FOLFOX/FOLFIRI in Advanced or Metastatic Colorectal CancerP1/P2CRC40May 2025
NCT06475326Adebrelimab in Combination With NALIRIFOX in Locally Advanced Pancreatic CancerP2Pancreatic Cancer87Jun 2024
NCT06467565NALIRIFOX as Induction Therapy in LAPCP2Pancreatic Ductal Adenocarcinoma20Dec 2023
NCT05859750A Study of AK104 With Chemotherapy as First-line Treatment in Patients With Advanced Pancreatic CancerP2Pancreatic Cancer78May 2023
NCT05319639POFIPhase I/II Study of the Combination of Irinotecan and POF (POFI) and TislelizumabP1/P2Gastric Cancer Stage IV51Feb 2023
NCT05229003Irinotecan Plus Anlotinib or Further in Combination With Penpulimab for Second-line Treatment of mCRCP2Metastatic Colorectal Cancer44Mar 2022
NCT06760117UGT1A1 Genotype-drien Phase I Study of Irinotecan in VIT Regimen for the Treatment of Pediatric R/R Solid TumorsP1Pediatric Solid Tumor39Jan 2022
NCT04267978Study of Recombinant Human Endostatin Combined with Temozolomide and Irinotecan in Recurrent GliomasP2Glioblastoma, Recurrent109Feb 2020
NCT06766266Irinotecan Liposomes Combined with Epirubicin in Recurrent Non-muscle Invasive Bladder Urothelium Carcinoma After Anthracyclines TreatmentP1Non-Muscle Invasive Bladder Urothelial Carcinoma18Jan 2025
NCT05628038TORCH-RThe Combination of Hypofractionated Radiotherapy and Immunotherapy in Locally Recurrent Rectal CancerP2Recurrent Rectal Cancer93Nov 2022
NCT03866525OH2 Oncolytic Viral Therapy in Solid TumorsP1/P2Solid Tumor300Apr 2019

Irinotecan clinical trials by indication

Colorectal Cancer (182)

NCTAcronymPhaseStatusTitle
NCT07094893ARIEL-ENGICP4not yet recruitingAnti-EGFR Agents in Patients With Right-sided Advanced Colorectal Cancer With Wild-type RAS and AREG/EREG High Status
NCT04861558EFFIPECP3recruitingEfficacy of Hyperthermic Intraperitoneal Chemotherapy
NCT06733038AtezoTRIBE2P3recruitingFOLFOXIRI Plus Bevacizumab With or Without Atezolizumab as 1st Line Treatment of pMMR and IS IC-High Metastatic Colorectal Cancer Patients.
NCT07123441IIP2not yet recruitingA Study on the Efficacy and Safety of Irinotecan Liposome (II), 5-FU/LV in Combination With Bevacizumab for the Treatment of Advanced Colorectal Cancer
NCT07229846QL1706P2not yet recruitingA Single-arm, Single-center, Phase II Clinical Study of Aipalolitovorelizumab (QL1706) Combined With Bevacizumab and Standard Chemotherapy as First-line Treatment for MSS/pMMR Metastatic Colorectal Cancer With BRAF V600E Mutation
NCT07474727P2not yet recruitingA Phase II Study of AMT-676 Combination Therapies in Advanced Colorectal Cancer
NCT05391126GENOCAREN/ArecruitingGENOCARE: A Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care
NCT00492999P2active not recruitingHepatic Arterial Infusion With Floxuridine and Dexamethasone Combined With Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver
+ 174 more, see All trials below.

Metastatic Colorectal Cancer (89)

NCTAcronymPhaseStatusTitle
NCT04587128P2active not recruitingEarly-Line Anti-EGFR Therapy to Facilitate Retreatment for Select Patients With mCRC
NCT07559760P2recruitingNew Second-Line Combo Therapy for MSS Metastatic Colorectal Cancer
NCT07543744P1recruitingA Comparative Study of Pharmacokinetics, Safety, and Immunogenicity of RPH-030 and Vectibix® in Patients With Metastatic Colorectal Cancer With Wild-type RAS as First-line Therapy in Combination With FOLFIRI
NCT05382442P2active not recruitingA Study of AK112 With or Without AK117 in Metastatic Colorectal Cancer
NCT05854498P2recruitingLiposomal Irinotecan With TAS102 and Bevacizumab for Patients With Metastatic Colorectal Cancer
NCT06792695CANTORP2recruitingA Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
NCT04689347P1/P2recruiting5FU/LV, Irinotecan, Temozolomide and Bevacizumab for MGMT Silenced, Microsatellite Stable Metastatic Colorectal Cancer.
NCT06341296P2recruitingPhase II Study of Irinotecan Liposomes in First-line Treatment of Metastatic Colorectal Cancer
+ 81 more, see All trials below.

Pancreatic Cancer (50)

NCTAcronymPhaseStatusTitle
NCT07325214N/Anot yet recruitingChemotherapy With or Without IMD10 (Focused Ultrasound) in the Treatment of Borderline Resectable or Locally Advanced Pancreatic Cancer
NCT07409272P3recruitingA Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
NCT04927780PREOPANC-3P3active not recruitingPerioperative or Adjuvant mFOLFIRINOX for Resectable Pancreatic Cancer
NCT06571461P3not yet recruitingLiposomal Irinotecan in Combination With Oxaliplatin and S-1 Versus Gemcitabine Combined With Capecitabine as Postoperative Adjuvant Therapy for Pancreatic Cancer
NCT07173387RAD-NALIRIFOXP2active not recruitingStereotactic Body Radiotherapy and NALIRIFOX for Locally Advanced Pancreatic Cancer
NCT06941857P2recruitingNC410 and FOLFIRINOX in Combination With Nivolumab With or Without Ipilimumab in Patients With Untreated Metastatic Pancreatic Cancer
NCT06361316N/ArecruitingIrinotecan Liposome Combined With Oxaliplatin and Tegafur as Adjuvant Therapy for Pancreatic Cancer
NCT06625320RASolute 302P3active not recruitingPhase 3 Study of Daraxonrasib (RMC-6236) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
+ 42 more, see All trials below.

Gastric Cancer (39)

NCTAcronymPhaseStatusTitle
NCT07518147CLDNP3recruitingA Study Comparing BL-M05D1 With the Investigator's Choice of Treatment Regimen in Patients With Claudin (CLDN)18.2-Positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma (GC/GEJC) Who Have Received Prior First-Line Treatment
NCT06499610P4not yet recruitingClinical Study of Irinotecan Liposome Combination Therapy for Advanced Gastric Cancer
NCT06219941P2recruitingAZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
NCT07085273P2not yet recruitingIrinotecan Liposome II + 5-FU/LV + Oxaliplatin + Karelizumab in Neoadjuvant Treatment of Gastric Cancer
NCT04725994P1/P2active not recruitingStudy to Assess the Safety, Tolerability, and Efficacy of IDX-1197 in Combination With XELOX or Irinotecan in Patients With Advanced Gastric Cancer
NCT06697366P2not yet recruitingLiposomal Irinotecan Combined with Sintilimab for Second-line Treatment of Progressive Gastric Cancer
NCT06346392P3active not recruitingAZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2
NCT04342910P3recruitingStudy to Evaluate the Efficacy and Safety of Camrelizumab and Apatinib in Patients With GC/GEJC
+ 31 more, see All trials below.

Esophageal Cancer (36)

NCTAcronymPhaseStatusTitle
NCT06501664P3not yet recruitingLiposomal Irinotecan and 5-FU as Second-line Therapy for Patients With ESCC
NCT04415853P3recruitingStudy of Larotinib in Unresectable Advanced or Recurrent Esophageal Cancer
NCT03764553LyRICXP2active not recruitingLiposomal iRInotecan, Carboplatin or oXaliplatin for Esophagogastric Cancer
NCT00137852P2completedCisplatin, CPT-11 and Celecoxib With Radiation Therapy and Surgery for Operable Esophageal Cancer
NCT02358863mEGAN/AterminatedMolecularly Tailored Therapy for Patients With Metastatic Cancer of the Esophagus and Stomach
NCT00394433TPCAP2completedDocetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer
NCT00400114P2completedSutent Following Chemotherapy, Radiation and Surgery For Resectable Esophageal Cancer
NCT00524186P1terminatedSunitinib, Irinotecan, Fluorouracil, and Leucovorin In Treating Patients With Advanced Stomach Cancer or Gastroesophageal Cancer
+ 28 more, see All trials below.

Unspecified Adult Solid Tumor, Protocol Specific (31)

NCTAcronymPhaseStatusTitle
NCT00731276P1completedIrinotecan in Treating Asian Patients With Solid Tumors
NCT00547547P1completedHigh-Selenium Brassica Juncea, Irinotecan, and Capecitabine in Treating Patients With Advanced Cancer
NCT00005791P1completedCombination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid Tumors
NCT00004051P1completedIrinotecan in Treating Patients With Advanced Solid Tumors
NCT00054288P1completedIrinotecan and Gemcitabine in Treating Patients With Refractory Advanced Solid Tumors
NCT00112892P1completedIrinotecan and Selenium in Treating Patients With Advanced Solid Tumors
NCT00544063P1unknownCapecitabine, Irinotecan, and Oxaliplatin in Treating Patients With Metastatic Cancer
NCT00026195P1completedIrinotecan in Treating Aging Patients With Solid Tumors
+ 23 more, see All trials below.

Lung Cancer (30)

NCTAcronymPhaseStatusTitle
NCT05800587P2recruitingDose Attenuated Chemotherapy in Compromised Patients With Lung Cancer
NCT00620269P2unknownInduction Chemotherapy Followed by CCRT According to EGFR Mutation Status in NSCLC III
NCT01654081P2withdrawnA Protocol of Irinotecan for Carcinoma of the Lung
NCT00465907P2terminatedStudy of Weekly Paclitaxel, Carboplatin and Irinotecan to Treat Lung Cancer
NCT00059761P1completedChemotherapy Combined With Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
NCT00072527P2completedCisplatin and Irinotecan Followed by Carboplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
NCT00469898P2completedIrinotecan and Carboplatin as First-Line Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
NCT00045162S0124P3completedS0124: Cisplatin Combined With Irinotecan or Etoposide For Extensive-Stage Small Cell Lung Cancer
+ 22 more, see All trials below.

Colorectal Neoplasms (28)

NCTAcronymPhaseStatusTitle
NCT06662786OrigAMI-2P3recruitingA Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
NCT06750094OrigAMI-3P3recruitingA Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
NCT02885753OSCARP3recruitingSystemic Oxaliplatin or Intra-arterial Chemotherapy Combined With LV5FU2 +/- Irinotecan and an Target Therapy in First Line Treatment of Metastatic Colorectal Cancer Restricted to the Liver
NCT05239741MK-3475P3active not recruitingStudy of Pembrolizumab (MK-3475) Versus Chemotherapy in Chinese Participants With Stage IV Colorectal Cancer (MK-3475-C66)
NCT02087475P3unknownPerioperative FOLFIRI VS Adjuvant FOLFIRI in Resectable Advanced CRC Failed to Oxaliplatin
NCT03142516OPALOP2completedFOLFIRI + Panitumumab First-line Treatment in Elderly Patients With Unresectable Metastatic Colorectal Cancer, RAS/BRAF Wild-type and Good Performance Status
NCT01930864P2unknownMetformin Plus Irinotecan for Refractory Colorectal Cancer
NCT02842580HIGH-LIGHTP2terminatedDe-escalation Chemotherapies Versus Escalation in Non Pre-treated Unresectable Patients With Metastatic Colorectal Cancer
+ 20 more, see All trials below.

Small Cell Lung Cancer (20)

NCTAcronymPhaseStatusTitle
NCT06467786P4recruitingStudy on the Therapeutic Effect of Irinotecan Liposomes in Small Cell Lung Cancer
NCT07004712P2not yet recruitingEfficacy and Biomarkers of the Second-line Treatment of Adebelizumab Combined With Irinotecan Liposome in Advanced Small Cell Lung Cancer
NCT07376499P2not yet recruitingProspective, Single-arm, Phase II Clinical Study of Irinotecan Hydrochloride Liposome Injection Combined With Platinum and Immune Checkpoint Inhibitors Combined With Anlotinib for the Maintenance of Extensive Small Cell Lung Cancer After First-line Induction
NCT06951841P4not yet recruitingProspective, Single-arm, Phase II Clinical Study of Irinotecan Hydrochloride Liposome Injection Combined With Platinum and Immune Checkpoint Inhibitors Combined With Anlotinib for the Maintenance of Extensive Small Cell Lung Cancer After First-line Induction
NCT06462105N/Anot yet recruitingLiposomal Irinotecan Combination Regimen for First-line Treatment of Small Cell Lung Cancer
NCT05731518ES-SCLCP1/P2unknownSC0245 and Irinotecan in Treating Patients With Relapsed Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
NCT05595889P2unknownSurufatinib Combined With Irinotecan as a Second-line Treatment for Small Cell Lung Cancer
NCT04985201P2unknownCombined Simvastatin and Irinotecan in Treating ES-SCLC Patients Relapsed From 1st Chemotherapy
+ 12 more, see All trials below.

Brain and Central Nervous System Tumors (18)

NCTAcronymPhaseStatusTitle
NCT00099125P2completedRadiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
NCT00562419P2unknownCT-322 in Treating Patients With Recurrent Glioblastoma Multiforme and Combination Therapy With Irinotecan
NCT00138216P1completedTemozolomide, Vincristine, and Irinotecan in Treating Young Patients With Refractory Solid Tumors
NCT00003484P1completedRadiolabeled Monoclonal Antibody Therapy After Radiation Therapy in Treating Patients With Primary Brain Tumors
NCT00268359P2completedBevacizumab and Irinotecan in Treating Patients With Recurrent or Refractory Gliomas
NCT00352521DCE-MRIP2completedDynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) With Bevacizumab and Irinotecan for Malignant Glioma
NCT00027612P1/P2completedIrinotecan Plus Radiation Therapy Followed By Chemotherapy in Treating Patients With Glioblastoma Multiforme
NCT00003134P2completedIrinotecan in Treating Patients With Recurrent Glioma
+ 10 more, see All trials below.

Neuroblastoma (17)

NCTAcronymPhaseStatusTitle
NCT06450041P2recruitingNANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial
NCT06541262CX-4945P1/P2recruitingSilmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
NCT06995872P1recruitingPhase I Trial of rhIL-15 Plus Dinutuximab Plus Irinotecan/Temozolomide for Children and Young Adults With Relapsed/Refractory Neuroblastoma
NCT06013618P2recruitingClinical Analysis of Naxitamab (hu3F8) in the Treatment of Pediatric High Risk or Refractory/ Relapsed Neuroblastoma
NCT07027748P1recruitingFeasibility Study of Prolonged Administration of Naxitamab, Irinotecan, and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma
NCT05400603Aflac-NBL-2002P1recruitingAllogeneic Expanded Gamma Delta T Cells With GD2 Chemoimmunotherapy in Relapsed /Refractory Neuroblastoma or Refractory/ Relapsed Osteosarcoma
NCT02308527BEACONP2completedActivity Study of Bevacizumab With Temozolomide ± Irinotecan for Neuroblastoma in Children
NCT05027386P1/P2recruitingApatinib Mesylate Combined With IT Regimen for the Treatment of Recurrent or Refractory Pediatric Neuroblastoma: A Single-arm, Phase I/II,Multi-center, Clinical Study.
+ 9 more, see All trials below.

Colorectal Cancer Metastatic (17)

NCTAcronymPhaseStatusTitle
NCT06547203P2recruitingCetuximab, Irinotecan, Toripalimab in RAS/BRAF Wild-type Ultraselected Right-sided Colorectal Cancer Study
NCT06540326P2recruitingClinical Study of Second-line Treatment in Advanced Colorectal Cancer With Chemotherapy With Bevacizumab or Cetuximab
NCT07044921IIP2recruitingClinical Study of Irinotecan Liposome (II)-Based Combination Treatment for Irinotecan-resistant Colorectal Cancer.
NCT06714357VICTORIAP2recruitingValproIc Acid to Potentiate Anti-EGFR Treatment Efficacy and Prevent/Revert Resistance in Colorectal Cancer
NCT06763029VICPROIRIP2recruitingIrinotecan Liposomes Combined with Cetuximab + Vermofenib in First-line Failure of Advanced Colorectal Cancer
NCT05727163P2recruitingFOLFOX Via HAI Plus Intravenous Irinotecan With or Without Bevacizumab Versus Systemic FOLFOXIRI With or Without Bevacizumab in Initially Unresectable RAS-mutated CRLM Patients
NCT04595266LIVERPEARLP2active not recruitingChemoembolization (Lifepearls-Irinotecan) in Patients With Colorectal Cancer and Metastatic Disease
NCT01910610STRATEGIC-1P3unknownMulti-Line Therapy Trial in Unresectable Metastatic Colorectal Cancer
+ 9 more, see All trials below.

Esophageal Squamous Cell Carcinoma (13)

NCTAcronymPhaseStatusTitle
NCT06644781ESCCP3recruitingA Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)
NCT05319730MK-3475P1/P2recruitingA Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)
NCT06491134P1not yet recruitingLiposomal Irinotecan With Cisplatin and Concurrent Radiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma
NCT06194734P3recruitingA Study of KC1036 Versus Investigator's Choice of Chemotherapy in Patients With Advanced Esophageal Cancer
NCT06304974P3active not recruitingA Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma(PANKU-Esophagus01)
NCT05461794P2terminatedStudy To Investigate the Efficacy and Safety of Sitravatinib in Combination With Tislelizumab in Participants With Esophageal Squamous Cell Carcinoma
NCT03387904P2unknownStudy of Anlotinib Plus Irinotecan in Patients With Esophageal Squamous Cell Carcinoma
NCT03797625P2completedEndostar Combined With IP Second-line Treatment of Advanced Esophageal Squamous Cell Carcinomas
+ 5 more, see All trials below.

Pancreatic Adenocarcinoma (13)

NCTAcronymPhaseStatusTitle
NCT06250972PTCA199-11P3recruitingRadiotherapy to Patients With CA19-9-elevated Advanced Pancreatic Cancer
NCT04361708I-FLOATP1recruitingSafety of Combining Irinotecan With 5-FU, Leucovorin/Folinic Acid, Oxaliplatin, and Docetaxel Chemotherapies
NCT04539808P2active not recruitingNeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer
NCT03483038P2active not recruitingA Study of the Safety and Activity of Liposomal Irinotecan in Combination With the 5-FU and Oxaliplatin in the Preoperative Treatment of Pancreatic Adenocarcinoma
NCT03528785nITRoP2unknownA Study of Nal-IRI With 5-FU, Levofolinic Acid and Oxaliplatin in Patients With Resectable Pancreatic Cancer
NCT02562716S1505P2completedS1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
NCT03665441Trybeca-1P3completedStudy of Eryaspase in Combination With Chemotherapy Versus Chemotherapy Alone as 2nd-Line Treatment in PAC
NCT01897454P2terminatedGemcitabine Hydrochloride, and Radiation Therapy in Patients With Borderline Resectable Pancreatic Cancer
+ 5 more, see All trials below.

Glioblastoma (11)

NCTAcronymPhaseStatusTitle
NCT07356973OPTICALP2not yet recruitingIrinotecan-ChemoSeed in Surgically Resectable Glioblastoma
NCT01086345Early P1terminatedRadiosurgery Plus Bevacizumab in Glioblastoma
NCT00921167P2completedA Study to Evaluate the Efficacy of Bevacizumab Plus Irinotecan in Recurrent Gliomas
NCT00762255P1completedA Phase I Trial of Vorinostat in Combination With Bevacizumab & Irinotecan in Recurrent Glioblastoma
NCT00597402XRTP2completedAvastin in Combination With Radiation (XRT) & Temozolomide, Followed by Avastin, Temozolomide and Irinotecan for Glioblastoma (GBM) and Gliosarcomas
NCT01308632P2/P3unknownMetronomic Temozolamide in Patients With Recurrent Glioblastoma
NCT00132158P1completedZD1839 and Oral Irinotecan in Treating Young Patients With Refractory Solid Tumors
NCT00611728P1completedPh I SU011248 + Irinotecan in Treatment of Pts w MG
+ 3 more, see All trials below.

Sarcoma (11)

NCTAcronymPhaseStatusTitle
NCT00077285P2active not recruitingIrinotecan and Carboplatin as Upfront Window Therapy in Treating Patients With Newly Diagnosed Intermediate-Risk or High-Risk Rhabdomyosarcoma
NCT01189643Early P1active not recruitingIrinotecan, Temozolomide and Bevacizumab in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Newly Diagnosed Patients With Desmoplastic Small Round Cell Tumor
NCT03139331P1completedPAZIT Study for Children and Young Adults With Relapsed or Refractory Sarcoma
NCT00354744P3completedHigh-Dose Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Metastatic Rhabdomyosarcoma or Ectomesenchymoma
NCT01380275DIP2unknownTrial of Docetaxel and Irinotecan (DI) for Recurrent or Refractory Bone and Soft Tissue Sarcomas.
NCT00996346P1terminatedPhase I/II Study of Irinotecan and Temsirolimus in Patients With Refractory Sarcomas
NCT00509860P2completedIrinotecan (Camptosar) in Patients With Advanced Sarcomas
NCT00003955P2completedCombination Chemotherapy Plus Radiation Therapy in Treating Patients With Metastatic Rhabdomyosarcoma or Sarcoma
+ 3 more, see All trials below.

Metastatic Pancreatic Adenocarcinoma (10)

NCTAcronymPhaseStatusTitle
NCT07076212P2recruitingEvaluating NALIRIFOX vs Modified Gemcitabine, Nab-Paclitaxel and Cisplatin in Patients With Locally Advanced and Metastatic Pancreatic Adenocarcinoma
NCT04233866P2active not recruitingComparing Two Treatment Combinations, Gemcitabine and Nab-Paclitaxel With 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan for Older Patients With Pancreatic Cancer That Has Spread
NCT05383352SIRACUSAP1completedA Study to Compare Onivyde Manufactured at Two Different Production Sites in Adult Participants With Advanced Cancer in the Pancreas
NCT01959139S1313P1/P2completedS1313, PEGPH20 in Treating Patients With Newly Diagnosed Metastatic Pancreatic Cancer
NCT02890355P2completedFOLFIRI or Modified FOLFIRI and Veliparib as Second Line Therapy in Treating Patients With Metastatic Pancreatic Cancer
NCT02620865P1/P2completedBATS With in Combination With Low Dose IL-1 and GM-CSF for Advanced Pancreatic Cancer
NCT02231723P1completedA Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Pancreatic Cancer
NCT02324543GTXP1/P2completedStudy of Gemcitabine/Taxotere/Xeloda (GTX) in Combination With Cisplatin and Irinotecan in Subjects With Metastatic Pancreatic Cancer
+ 2 more, see All trials below.

Rectal Cancer (10)

NCTAcronymPhaseStatusTitle
NCT06210971P2recruitingNeoadjuvant Chemoradiation With Nal-IRI and Capecitabine Guided by UGT1A1 Status in Patients With Rectal Cancer
NCT07104604P1recruitingStudy on the Efficacy and Safety of Neoadjuvant Radiotherapy Combined With Toripalimab, Liposomal Irinotecan, and Capecitabine in the Treatment of pMMR Locally Advanced Rectal Adenocarcinoma With Low Rectal Involvement
NCT04443543P2not yet recruitingAn Adaptive-design Prospective Cohort Study of Watch and Wait Strategy in Patients With Locally Advanced Rectal Cancer
NCT06300489P1unknownGenotype-driven Weekly Irinotecan Liposomes in Combination With Capecitabine-based Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer
NCT05868317P2unknownInduction Chemotherapy Followed by Short Course Radiotherapy in Rectal Cancer
NCT01650428BACCHUSP2completedBevacizumab And Combination Chemotherapy in Rectal Cancer Until Surgery
NCT00972881EXCITEP1/P2completedCapecitabine, Irinotecan Hydrochloride, Cetuximab, and Radiation Therapy in Treating Patients Undergoing Surgery for Locally Advanced Rectal Cancer
NCT01269216FLP2completedA Study of Neoadjuvant Chemoradiotherapy With 5-FU/Leucovorin (FL) vs. TS-1/Irinotecan in Patients With Locally Advanced Rectal Cancer
+ 2 more, see All trials below.

Solid Tumors (9)

NCTAcronymPhaseStatusTitle
NCT07415031P2recruitingA Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies
NCT01528046P1completedMetformin in Children With Relapsed or Refractory Solid Tumors
NCT03503604P1unknownA Study of Anti-VEGF Monoclonal Antibody hPV19 in Patients With Solid Tumors
NCT01634555IMC-1121BP2completedA Study to Assess the Pharmacokinetics of Ramucirumab (IMC-1121B) in Combination With FOLFIRI
NCT01593228P3completedTreatment Extension Study for Patients Who Have Previously Participated and Have Benefited From Iniparib in a Clinical Trial
NCT02395068P1unknownPharmacokinetics Study of Nimotuzumab in Patients With Solid Tumors
NCT01009073P1completedA Study Evaluating ABT-263 With Erlotinib, ABT-263 With Irinotecan, and ABT-263 Monotherapy in Cancer Subjects
NCT00186979P1completedStudy of ZD1839 Combined With Irinotecan and Vincristine in Pediatric Patients With Refractory Solid Tumors
+ 1 more, see All trials below.

Colon Cancer (9)

NCTAcronymPhaseStatusTitle
NCT06652412P2not yet recruitingCGA Guided Ultrafractionated RT and Systemic Treatment in Elderly or Frail Patients with Inoperable Localized CRC
NCT05722327MRTX849P1active not recruitingPhase I Trial of Adagrasib (MRTX849) in Combination With Cetuximab and Irinotecan in Patients With Colorectal Cancer
NCT05424692PTCN/ArecruitingDrug Sensitivity Detection of Micro Tumor (PTC) to Guide Postoperative Adjuvant Treatment Strategy of Colorectal Cancer
NCT07011576FRUITFULP2recruitingA Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)
NCT05806931SCOTIP2recruitingSequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal Cancer
NCT02138617P2completedGenotype-Directed Study Of Irinotecan Dosing In FOLFIRI + BevacizumabTreated Metastatic Colorectal Cancer
NCT00766220P2withdrawnYttrium Microspheres With Cetuximab Plus Irinotecan for Patients With Advanced Colorectal Cancer Mets to Liver
NCT00336856P2completedIrinotecan and Cetuximab for Colorectal Cancer as Second Line Therapy
+ 1 more, see All trials below.

Advanced Solid Tumors (9)

NCTAcronymPhaseStatusTitle
NCT06963502P1not yet recruitingA Phase Ib Study of HS-10370 in Addition to Other Anti-cancer Therapies in Patients With Advanced Solid Tumors
NCT05083481P1/P2terminatedA Study of ASP1570 Taken by Itself, or ASP1570 Taken Together With Either Pembrolizumab, Standard Therapies, or Both, in Adults With Solid Tumors
NCT02611024P1/P2completedPharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors
NCT05824455JS109P1/P2terminatedA Clinical Study of IMP4297 Capsule (JS109) Combined With Irinotecan in the Treatment of Advanced Malignant Solid Tumors
NCT05086848P1completedA Study of Irinotecan Hydrochloride Liposome in Combination With 5-FU/LV in Advanced Solid Tumors
NCT05086822P1completedA Study of Irinotecan Hydrochloride Liposome in Advanced Solid Tumors
NCT01520389P1completedSafety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment
NCT00861328P1completedSafety Study of ON 01910.Na in Combination With Irinotecan or Oxaliplatin
+ 1 more, see All trials below.

Neoplasms (9)

NCTAcronymPhaseStatusTitle
NCT06967155P2active not recruitingA Study of Irinotecan With Dabrafenib Plus Trametinib and Anti-EGFR in the Second Line of Therapy in People With Metastatic Colorectal Cancer
NCT04607421P3active not recruitingA Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer
NCT05999994CAMPFIREP2recruitingA Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
NCT02720068MK-4280P1completedStudy of Favezelimab (MK-4280) as Monotherapy and in Combination With Pembrolizumab (MK-3475) With or Without Chemotherapy or Lenvatinib (MK-7902) AND Favezelimab/Pembrolizumab (MK-4280A) as Monotherapy in Adults With Advanced Solid Tumors (MK-4280-001)
NCT00811993P1terminatedA Study of R1507 in Combination With Multiple Standard Chemotherapy Treatments in Patients With Advanced Solid Tumors
NCT00954512P1/P2terminatedStudy of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Participants With Advanced Solid Tumors (P04722, MK-7454-004)
NCT00960063P1terminatedA Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Pediatric Participants With Advanced Solid Tumors (P05883, MK-7454-006)
NCT00057473P2completedA Phase II Study of Carboplatin Plus Irinotecan Versus Irinotecan in Children With Refractory Solid Tumors
+ 1 more, see All trials below.

Stomach Neoplasms (9)

NCTAcronymPhaseStatusTitle
NCT07309185P2recruitingAdebrelimab Combined With Famitinib and Irinotecan in Advanced Gastric Cancer After Failure of First-Line Therapy
NCT04393584RusGCG-01P2/P3unknownFOLFIRINOX vs FLOT Chemotherapy for Resectable Gastric or Esophagogastric Junction Adenocarcinoma
NCT03061058P3unknownIndividualized Intraperitoneal and System Chemotherapy Versus System Chemotherapy as First-line Chemotherapy for AGC
NCT01928290FOLFIRINOXP2completedCombination Chemotherapy in Treating Patients With Advanced Stomach, Gastroesophageal, or Esophageal Cancer
NCT03400592NIEGAP2unknownStudy of Nimotuzumab and Irinotecan as Second Line With Recurrent or Metastatic Gastric Adenocarcinoma
NCT02662959P2unknownIrinotecan as 3rd Line Therapy in Gastric Cancer
NCT00813072P2completedStudy of PEP02, Irinotecan or Docetaxel in Gastric or Gastroesophageal Junction Adenocarcinoma
NCT00512681TIROX2P2completedA Phase II Study of Irinotecan, Oxaliplatin, Plus TS-1 in Untreated Metastatic Gastric Cancer
+ 1 more, see All trials below.

Cancer (9)

NCTAcronymPhaseStatusTitle
NCT03678883P2active not recruiting9-ING-41 in Patients With Advanced Cancers
NCT03368859P2terminatedA Study of ABT-165 Plus FOLFIRI vs Bevacizumab Plus FOLFIRI in Subjects With Metastatic Colorectal Cancer Previously Treated With Fluoropyrimidine, Oxaliplatin and Bevacizumab
NCT01653470P1completedStudy to Evaluate Safety & Tolerability of BMS-906024 in Combination With Chemotherapy & to Define DLTs & MTD of BMS-906024 in Combination With One of the Following Chemotherapy Regimens; Weekly Paclitaxel, 5FU+Irinotecan or Carboplatin+Paclitaxel in Subjects With Advanced / Metastatic Solid Tumors
NCT00418938P2completedSPIRITT - Second-Line Panitumumab Irinotecan Treatment Trial
NCT00060567P1completedDose-Finding Study of E7070 in Combination With Irinotecan
NCT00364143P1completedSafety Study of IHL-305 (Irinotecan Liposome Injection) to Treat Advanced Solid Tumors
NCT00110357P1completedStudy of Erbitux™ (Cetuximab) in Pediatric Patients With Refractory Solid Tumors
NCT00062842P1completedStudy of Irinotecan on a Weekly Schedule in Children
+ 1 more, see All trials below.

Breast Cancer (9)

NCTAcronymPhaseStatusTitle
NCT03562390P2unknownIrinotecan for Advanced and Metastatic Breast Cancer
NCT00617539P2completedIrinotecan and Temozolomide in Treating Patients With Breast Cancer Who Have Received Previous Treatment for Brain Metastases
NCT00693719P2completedIrinotecan and Etoposide in Treating Patients With Recurrent, Locally Advanced, or Metastatic Breast Cancer
NCT00303992P2completedTrastuzumab and Irinotecan in Treating Patients With HER2/Neu Positive Metastatic Breast Cancer
NCT00079118P2completedIrinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
NCT00275041P2completedIrinotecan and Cetuximab in Treating Patients With Metastatic Breast Cancer
NCT00003351P2completedIrinotecan in Treating Patients With Refractory Metastatic Breast Cancer
NCT00083148P1completedIrinotecan and Capecitabine in Treating Women With Advanced Breast Cancer
+ 1 more, see All trials below.

Biliary Tract Cancer (8)

NCTAcronymPhaseStatusTitle
NCT07606599P3not yet recruitingA Study of BL-M07D1 Versus Physician's Choice of Chemotherapy in Patients With HER2-expressing Locally Advanced or Metastatic Biliary Tract Cancer After Platinum-containing Chemotherapy Failure
NCT07582315PANKU-BTC01P3not yet recruitingA Study Comparing BL-B01D1 With Treatment of Physician's Choice in Patients With Locally Advanced or Metastatic Biliary Tract Cancer After Failure of Platinum-based Chemotherapy and PD-1/PD-L1 Monoclonal Antibody Therapy(PANKU-BTC01)
NCT03785873P1/P2completedPhase Ib/II Trial of Nal-Irinotecan and Nivolumab as Second-Line Treatment in Patients With Advanced Biliary Tract Cancer
NCT03778593P2completedFOLFIRINOX for 2nd-line Treatment of BTC
NCT02720601P2withdrawnIrinotecan and Capecitabine as Second-line Treatment for Advanced/Metastatic Biliary Tract Cancers
NCT03110510BTCP2withdrawnFOLFIRI as Salvage Treatment in Metastatic Biliary Tract Cancer (BTC) Patients Who Were Failed After Gemcitabine Containing Chemotherapy: A Phase II Single Arm Prospective Study
NCT01494363P2unknownPhase II Study of FOLFOXIRI in Patients With Locally Advanced or Metastatic Biliary Tract Cancer
NCT00832689P2completedIrinotecan, Gemcitabine, Chemotherapy for Biliary Tract Cancer

Pancreatic Ductal Adenocarcinoma (8)

NCTAcronymPhaseStatusTitle
NCT05314998P3not yet recruitingAdjuvant Trial in Patients With Resected PDAC Randomized to Allocation of Oxaliplatin- or Gemcitabine-based Chemotherapy by Standard Clinical Criteria or by a Transcriptomic Treatment Specific Stratification Signature
NCT06607185P1active not recruitingA Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors
NCT06586515MOONRAY-01P1recruitingMOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
NCT07024615P1recruitingA Study of ASP2138 Given Before Surgery, Then Chemotherapy After Surgery, in People With Pancreatic Ductal Cancer
NCT06467565P2recruitingNALIRIFOX as Induction Therapy in LAPC
NCT05546853LAP-NET1P1completedStudy Investigating the Association of NP137 With mFOLFIRINOX in Locally Advanced Pancreatic Ductal Adenocarcinoma
NCT04752696P2completedOnvansertib in Combination With Nanoliposomal Irinotecan, Leucovorin, and Fluorouracil for Second-Line Treatment of Participants With Metastatic Pancreatic Ductal Adenocarcinoma
NCT03316326P2unknownS-1, Irinotecan, and Oxaliplatin in Locally-Advanced Pancreatic Cancer

Ewing Sarcoma (8)

NCTAcronymPhaseStatusTitle
NCT03715933P1recruitingPhase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
NCT06827717IIP2recruitingPhase II Study of Irinotecan Liposome (II) Combined With Temozolomide and Fluzoparib in Recurrent or Metastatic Ewing Sarcoma
NCT06340204P1recruitingWeekly Irinotecan Liposomes in Recurrent or Refractory Ewing Sarcoma
NCT01858168P1completedPhase I Study of Olaparib and Temozolomide for Ewings Sarcoma or Rhabdoomyosarcoma
NCT03709680P2active not recruitingStudy Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors
NCT04067115U01CA236220P1/P2completedSARC037: A Phase I/II Study to Evaluate the Safety of Trabectedin in Combination With Irinotecan in Ewing Sarcoma Patients
NCT03495921VITAP3terminatedA Trial For Participants With Ewing's Sarcoma Treated With Vigil in Combination With Irinotecan and Temozolomide
NCT02044120P1completedESP1/SARC025 Global Collaboration: A Phase I Study of a Combination of the PARP Inhibitor, Niraparib and Temozolomide and/or Irinotecan Patients With Previously Treated, Incurable Ewing Sarcoma

Locally Advanced Rectal Cancer (8)

NCTAcronymPhaseStatusTitle
NCT05412082SMART TNTP1recruitingSMART TNT for the Conservative Management of Locally Advanced Rectal Cancer
NCT05253846ShorTripP2active not recruitingShort-course Radiotherapy Followed by Consolidation Chemotherapy. 2021-001206-29
NCT06894797N/ArecruitingPreoperative Chemoradiotherapy Combined With Consolidation or Induction NALIRIFOX in Rectal Cancer.
NCT02605265CinClareP3completedTrial of Capecitabine With or Without Irinotecan Driven by UGT1A1
NCT04411537P2unknownThe Combination of Immunotherapy and Neoadjuvant Chemoradiotherapy in MSS Locally Advanced Rectal Cancer
NCT04411524P2unknownThe Combination of Immunotherapy and Neoadjuvant Chemoradiotherapy in MSI-H Locally Advanced Rectal Cancer
NCT04394598P2unknownA Study of Chinese Herbal Compound Dendrobium Huoshanense Granules in NCRT for Patients With Locally Advanced Rectal Cancer
NCT03702985P2unknownRadiation-protection Effect of Amifostine in Locally Advanced Rectal Cancer

Solid Tumor (8)

NCTAcronymPhaseStatusTitle
NCT05382559P1recruitingA Study of ASP3082 in Adults With Advanced Solid Tumors
NCT05381038P1/P2recruitingOptimizing and Personalising Azacitidine Combination Therapy for Treating Solid Tumours QPOP and CURATE.AI
NCT04796012VITASP1/P2recruitingVITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors
NCT03872947P1active not recruitingA Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors
NCT03866525P1/P2recruitingOH2 Oncolytic Viral Therapy in Solid Tumors
NCT04569916P2unknownRadiotherapy Combined With Irinotecan and Apatinib Followed by PD-1 Antibody and Apatinib for Advanced Solid Tumors
NCT00786669VITACP1completedA Pilot Study of the Addition of Bevacizumab to VOIT Regimen for Relapsed/Refractory Pediatric Solid Tumors
NCT00215501P1completedCapecitabine or 5-Fluorouracil in Combination With Irinotecan and Cisplatin in Patients With Solid Tumor Malignancies

Advanced Solid Tumor (7)

NCTAcronymPhaseStatusTitle
NCT06974110P1recruitingStudy of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
NCT06139211P1/P2recruitingA Phase Ib/II Study Of JS015 Combination Therapy in Advanced Solid Tumors
NCT06509906P1terminatedM9466 in Combination With Topoisomerase 1 Inhibitors-based Regimens in Advanced Solid Tumors and Colorectal Cancer (DDRiver 511)
NCT05148195P2terminatedA Phase II Study of Envofolimab and BD0801 With/Without Chemotherapy in Patients With Advanced Solid Tumors
NCT04088604LY01610P1completedIrinotecan Hydrochloride Liposome Injection (LY01610) For Advanced Solid Tumors
NCT02157792P1completedM6620 First in Human Study
NCT00502567P1completedA Study to Assess Safety, Tolerability and PK of AZD2171 and Chemotherapy on Patients With Solid Tumors

Metastatic Pancreatic Cancer (7)

NCTAcronymPhaseStatusTitle
NCT06532344P1active not recruitingAn Open-label, Uncontrolled Study of ONO-7913 and ONO-4538 in Combination With Modified FOLFIRINOX Therapy, the Standard of Care, as First-line Treatment in Patients With Metastatic Pancreatic Cancer
NCT04753879P2active not recruitingMulti-agent Low Dose Chemotherapy GAX-CI Followed by Olaparib and Pembro in Metastatic Pancreatic Ductal Cancer.
NCT06538207P1completedAn Open-label, Uncontrolled Study of ONO-4578 and ONO-4538 in Combination With Standard-of-care Modified FOLFIRINOX (mFFX) or Gemcitabine Plus Nab-paclitaxel (GnP) Therapy as First-line Treatment in Patients With Metastatic Pancreatic Cancer
NCT03693677FUNGEMAXP2completedFirst Line Metastatic Pancreatic Cancer : 5FU/LV+Nal-IRI, Gemcitabine+Nab-paclitaxel or a Sequential Regimen of 2 Months 5FU/LV+Nal-IRI
NCT05363007SINAIP2unknownSpleen Irradiation With Nanoliposomal Irinotecan Plus 5-FU and Leucovorin in Metastatic Pancreatic Adenocarcinoma
NCT03487016FOOTPATHP2unknownFirst-line Therapy in Metastatic PDAC
NCT04101929P2unknownApatinib, Irinotecan and S-1 (ApaIRIS) in Treating Patients With Metastatic Pancreatic Cancer After AG Regimen

Advanced Cancer (7)

NCTAcronymPhaseStatusTitle
NCT05004116P1/P2recruitingA Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer
NCT04657068P1/P2recruitingA Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
NCT04943627BRAVAP3withdrawnBalstilimab Versus Investigator Choice Chemotherapy in Patients With Recurrent Cervical Cancer (BRAVA)
NCT02331251P1/P2terminatedStudy of Pembrolizumab Plus Chemotherapy in Patients With Advanced Cancer (PembroPlus)
NCT02423954NivoPlusP1/P2terminatedStudy of Nivolumab Plus Chemotherapy in Patients With Advanced Cancer (NivoPlus)
NCT00708773P1completedGenotype-Directed Dose-Escalation Study of Irinotecan in Patients With Advanced Solid Tumors
NCT01347866P1terminatedClinical Study Of PI3K/mTOR Inhibitors In Combination With An Oral MEK Inhibitor Or Irinotecan In Patients With Advanced Cancer

Advanced Colorectal Cancer (7)

NCTAcronymPhaseStatusTitle
NCT04929652P1/P2unknownSurufatinib Combine With Immunotherapy and Chemotherapy for Second-line Treatment in Advanced Colorectal Cancer
NCT04324476P2unknownA Study of Bevacizumab Plus XELOX/XELIRI for First-line Treatment in Unresectable Advanced Colorectal Cancer
NCT03126071P2unknownRaltitrexed-based Chemotherapy Plus Bevacizumab in Retreated Patients With Advanced Colorectal Cancer
NCT04337879P1/P2unknownA Study of AL2846 Capsule Combined With Standard Chemotherapy Regimen in Subjects With Advanced Colorectal Cancer
NCT01859858P1completedEffect of Curcumin on Dose Limiting Toxicity and Pharmacokinetics of Irinotecan in Patients With Solid Tumors
NCT00637091EGFRP2completedEfficacy Analysis of Cetuximab Plus Irinotecan in Patients With Wild-type KRAS Without Regard to Epidermal Growth Factor Receptor (EGFR) Expressions
NCT00312000P3completedSequential Versus Combination Chemotherapy in Advanced Colorectal Carcinoma

Colorectal Carcinoma (7)

NCTAcronymPhaseStatusTitle
NCT04988191P1/P2unknownToripalimab Plus Bevacizumab and Chemotherapy as Neoadjuvant Therapy in Advanced MSI-H or dMMR Colorectal Cancer
NCT02376452P2unknownPhase II Study of 2-weekly RAILIRI Versus FOLFIRI as Second-line Treatment in Advanced Colorectal Cancer Patients
NCT02935764P3unknownFOLFIRI Versus Irinotecan as Second-line Treatment in Metastatic Colorectal Cancer Patients
NCT01394939P1/P2completedRecombinant Vaccinia Virus Administered Intravenously in Patients With Metastatic, Refractory Colorectal Carcinoma
NCT01286818FOLFIRIP1completedA Study of Irinotecan, Levofolinate, and 5-Fluorouracil (FOLFIRI) Plus Ramucirumab (IMC-1121B)
NCT00361244P1/P2terminatedSU011248 in Combination With Irinotecan and Cetuximab as a Second Line Regimen for Stage IV Colorectal Cancer
NCT00176774P2completedIrinotecan, 5-Fluorouracil, and Leucovorin in Colorectal Carcinoma

Glioblastoma Multiforme (6)

NCTAcronymPhaseStatusTitle
NCT03119064329P1/P2terminatedBrUOG 329 Onivyde & Metronomic Temozolomide in Recurrent Glioblastoma
NCT02060955P2terminatedRandomized Phase 2 Study to Investigate Efficacy of ALECSAT in Patients With GBM Measured Compared to Avastin/Irinotecan
NCT00967330P2completedA Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma
NCT00979017P2completedAvastin/Temozolomide/Irinotecan for Unresectable/Multifocal Glioblastoma Multiforme
NCT00817284GBMP2completedBevacizumab and Irinotecan or Bevacizumab and Temozolomide With Concomitant Radiotherapy for Primary Glioblastoma Multiforme (GBM)
NCT00984438BCNUP1/P2withdrawnSurgery With Implantable Biodegradable Carmustine (BCNU) Wafer Followed by Chemo for Patients With Recurrent Glioblastoma Multiforme

Adenocarcinoma of the Gastroesophageal Junction (6)

NCTAcronymPhaseStatusTitle
NCT01498289S1201P2completedS1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer
NCT02485834P2terminatedFDG-PET Directed Treatment in Improving Response in Patients With Locally Advanced Stomach or Gastroesophageal Junction Cancer
NCT00991952P2completedIrinotecan Hydrochloride With or Without Alvocidib in Treating Patients With Advanced Stomach or Gastroesophageal Junction Cancer That Cannot Be Removed By Surgery
NCT00061932P2completedBortezomib With or Without Irinotecan in Treating Patients With Cancer of the Gastroesophageal Junction or Stomach
NCT00084617P2completedPhase II Study of Oxaliplatin, Irinotecan, and Capecitabine in Advanced Gastric/Gastroesophageal Junction Carcinoma
NCT00084604P2completedIrinotecan, Cisplatin, and Bevacizumab in Treating Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

Adenocarcinoma of the Colon (6)

NCTAcronymPhaseStatusTitle
NCT02046538P2withdrawnPhase II Study of Zaltrap and Chemotherapy for Advanced Resectable Colorectal Cancer
NCT00079274P3completedComparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
NCT00551421P1/P2completedPertuzumab and Cetuximab in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal Cancer
NCT00052585P2terminatedGefitinib and Combination Chemotherapy in Treating Patients With Advanced or Recurrent Colorectal Cancer
NCT00005818P1/P2completedSU5416 and Irinotecan in Treating Patients With Advanced Colorectal Cancer
NCT00003835P3completedCombination Chemotherapy in Treating Patients With Stage III Colon Cancer

Unspecified Childhood Solid Tumor, Protocol Specific (6)

NCTAcronymPhaseStatusTitle
NCT01141244P1completedTemsirolimus, Irinotecan Hydrochloride, and Temozolomide in Treating Younger Patients With Relapsed or Refractory Solid Tumors
NCT00008424P1completedIrinotecan in Treating Children With Refractory or Advanced Solid Tumors Who Are Receiving Anticonvulsants
NCT00006095P1completedCombination Chemotherapy in Treating Children With Solid Tumors That Have Not Responded to Previous Therapy
NCT00016861P1completedIrinotecan in Treating Children With Refractory or Progressive Solid Tumors
NCT00024284P1completedCarboplatin and Irinotecan in Treating Children With Refractory Solid Tumors
NCT00004919P1completedIrinotecan and Cisplatin With or Without Amifostine in Treating Children With Solid Tumors That Have Not Responded to Previous Therapy

Metastatic Colorectal Cancer (mCRC) (5)

NCTAcronymPhaseStatusTitle
NCT07389265CAPRI-3 GOIMP3recruitingContinuation of Cetuximab Beyond First-Line Progression in Metastatic Colorectal Cancer
NCT07391566P1/P2not yet recruitingLPM6690176 in Combination With Chemotherapy and Bevacizumab in Metastatic Colorectal Cancer Patients With RAS Mutation
NCT07134205P3not yet recruitingThe Study of JMT101 Combined With Irinotecan as a ≥3rd-Line Treatment in Metastatic Colorectal Cancer
NCT03829462NEXT-REGIRIP3active not recruitingAssessing a Regorafenib-irinotecan Combination Versus Regorafenib Alone in Metastatic Colorectal Cancer Patients
NCT06089330P2unknownA Study of JMT101 in Patients With Metastatic Colorectal Cancer

Colorectal Adenocarcinoma (5)

NCTAcronymPhaseStatusTitle
NCT06951503P3recruitingAK112 and Chemotherapy in First-line Metastatic Colorectal Cancer
NCT04094688SOLARISP3active not recruitingVitamin D3 With Chemotherapy and Bevacizumab in Treating Patients With Advanced or Metastatic Colorectal Cancer
NCT03368963P1/P2active not recruitingTAS102 in Combination With NAL-IRI in Advanced GI Cancers
NCT03369041N/AunknownStudy of the Practice of Debiri in France
NCT02292758P2completedIrinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With RAS Wild-Type Locally Advanced or Metastatic Colorectal Cancer That Cannot Be Removed by Surgery

Relapsed Small Cell Lung Cancer (5)

NCTAcronymPhaseStatusTitle
NCT06128837P3recruitingStudy of LY01610 in Patients With Recurrent Small Cell Lung Cancer
NCT06496048P3recruitingLurbinectedin or in Combination with Irinotecan Versus Topotecan in Patients with Relapsed SCLC
NCT04543916P1/P2withdrawnVenetoclax and Irinotecan in Relapsed/Refractory SCLC
NCT05153239LAGOONP3completedClinical Trial of Lurbinectedin as Single-agent or in Combination With Irinotecan Versus Topotecan or Irinotecan in Patients With Relapsed Small-cell Lung Cancer (LAGOON)
NCT04757779P2unknownA Single-arm, Phase Ⅱ Clinical Trial of Anlotinib Hydrochloride Combined With Irinotecan or Docetaxel for Second Line Treatment of Nonsensitive Relapsed Small-cell Lung Cancer

Gastric Adenocarcinoma (5)

NCTAcronymPhaseStatusTitle
NCT04581473P1/P2active not recruitingStudy to Evaluate the Efficacy, Safety and Pharmacokinetics of CT041 Autologous CAR T-cell Injection
NCT05365581P1recruitingA Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer
NCT03141034P2completedRamucirumab Plus Irinotecan for Previously Treated Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma
NCT04074343P1completedTAS-102 and Irinotecan in 2L+ Gastric and Gastroesophageal Adenocarcinoma
NCT00062374P2completedIrinotecan and Cisplatin in Treating Patients Who Are Undergoing Surgery For Locally Advanced Cancer of the Stomach or Gastroesophageal Junction

Liver Metastases (5)

NCTAcronymPhaseStatusTitle
NCT05062317P2recruitingctDNA-Directed Post-Hepatectomy Chemotherapy for Patients With Resectable Colorectal Liver Metastases
NCT02110953P1terminatedIrinotecan-Eluting Beads in Treating Patients With Refractory Metastatic Colon or Rectal Cancer That Has Spread to the Liver
NCT01631539N/AwithdrawnChemoembolisation With CPT11 Loaded DC Bead With Cetuximab and 5FU/LV in First Line in Patients With KRAS Wildtype mCRC
NCT01320683P2terminatedCombination Chemotherapy and Bevacizumab Before Surgery and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal Cancer
NCT01285102P1terminatedChemoembolization Using Irinotecan in Treating Patients With Liver Metastases From Metastatic Colon or Rectal Cancer

Recurrent Colon Cancer (5)

NCTAcronymPhaseStatusTitle
NCT01941173N/AwithdrawnShort-Infusion Ziv-aflibercept in Treating Patients With Metastatic Colorectal Cancer Receiving Combination Chemotherapy
NCT01205022P1completedRadiolabeled Monoclonal Antibody Therapy, Combination Chemotherapy, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
NCT00499369P3terminatedIrinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy
NCT00134069P1completedSorafenib, Cetuximab, and Irinotecan in Treating Patients With Advanced or Metastatic Colorectal Cancer
NCT00077298P2completedBevacizumab and Cetuximab With or Without Irinotecan in Treating Patients With Irinotecan-Refractory Metastatic Colorectal Cancer

Rhabdomyosarcoma (4)

NCTAcronymPhaseStatusTitle
NCT06023641P2recruitingTreatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease
NCT07466316IR RMSP3not yet recruitingA Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
NCT04625907FaR-RMSP1/P2recruitingFaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma
NCT01871766P2active not recruitingRisk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy

Metastatic Pancreatic Ductal Adenocarcinoma (4)

NCTAcronymPhaseStatusTitle
NCT07490301IVP2/P3recruitingA Study to Assess Intravenous (IV) Telisotuzumab Adizutecan in Combination With Fluorouracil, Folinic Acid, and Oxaliplatin (FOLFOX) Compared to Standard of Care in Adult Participants With First-Line Metastatic Pancreatic Ductal Adenocarcinoma
NCT07096362P2recruitingUtility of ctDNA in Early Switch of First-line mFOLFIRINOX in Metastatic Pancreatic Ductal Adenocarcinoma
NCT07214298P1/P2recruitingPegcetacoplan in Combination With Modified FOLFIRINOX for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma
NCT05472259NALPACP2recruitingA Study Evaluating the Efficacy of 5-FU + NALIRI and 5-FU + NALIRINOX for PDAC (NALPAC)

Small-cell Lung Cancer (4)

NCTAcronymPhaseStatusTitle
NCT07155200P1/P2recruitingSmall Cell Lung Cancer Irinotecan and CDC2-like Kinase Inhibition Trial (SLICK Trial)
NCT05049863P1terminatedChemotherapy in Patients With Relapsed Small Cell Lung Cancer in Combination With Allopurinol and MycoPhenolate (CLAMP Trial)
NCT04173325P1terminatedFeasibility and Safety Study of Nivolumab With Irinotecan for Small Cell Lung Cancer
NCT03613753P2unknownIrinotecan Plus Lobaplatin Versus Irinotecan in the Second-line Treatment of Small Cell Lung Cancer

Pancreatic Neoplasms (4)

NCTAcronymPhaseStatusTitle
NCT06538623HAICP2completedOxaliplatin Combined With Irinotecan Liposome Injection II Through Hepatic Artery Infusion (HAIC) Followed by 5-FU/LV (HAIC) or Tegorgor Oral Combination Therapy for Hepatic Metastasis of Pancreatic Cancer
NCT02558868P2completedSecond-Line Oxaliplatin and Irinotecan Versus Irinotecan Alone for Gemcitabine and S-1 Refractory Pancreatic Cancer
NCT01413022P1completedFOLFIRINOX Plus PF-04136309 in Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma
NCT00220649P1completedSafety Study of Combination Chemotherapy in Patients With Metastatic Solid Tumors or Adenocarcinoma of the Pancreas

Small Cell Lung Carcinoma (4)

NCTAcronymPhaseStatusTitle
NCT04453930P2unknownA Study of Sequential Therapy of Camrelizumab Combined With Chemotherapy(Irinotecan Plus Platinum)and With Apatinib in Participants With Untreated Advanced Small Cell Lung Cancer(SCLC)
NCT01941316P1/P2completedStudy of Carfilzomib With Irinotecan in Irinotecan-Sensitive Malignancies and Small Cell Lung Cancer Patients
NCT01977235TDICCP2unknownTwo Different Dosages of Irinotecan Combined With Cisplatin Scheme in Extensive Disease-Small Cell Lung Cancer
NCT00143455RP3completedStudy Of Irinotecan Hydrochloride (Campto(R)) And Cisplatin Versus Etoposide And Cisplatin In Small Cell Lung Cancer

Liver Cancer (4)

NCTAcronymPhaseStatusTitle
NCT03668418xenoZN/AunknownXenotransplantation of Primary Cancer Samples in Zebrafish Embryos
NCT00980239P1completedHAI Irinotecan + IV Bevacizumab, Bevacizumab & Oxaliplatin or Bevacizumab & Cetuximab in Advanced Cancers Metastatic to Liver
NCT00087282P2completedIrinotecan and Flavopiridol in Treating Patients With Advanced Liver Cancer
NCT00287976P2unknownIrinotecan in Treating Young Patients With Refractory or Recurrent Hepatoblastoma

Esophageal Carcinoma (4)

NCTAcronymPhaseStatusTitle
NCT03933449MK-3475P3completedStudy of Pembrolizumab (MK-3475) Versus Investigator's Choice of Chemotherapy for Participants With Advanced Esophageal/Esophagogastric Junction Carcinoma That Progressed After First-Line Therapy (MK-3475-181/KEYNOTE-181)-China Extension Study
NCT02564263MK-3475P3completedStudy of Pembrolizumab (MK-3475) Versus Investigator's Choice Standard Therapy for Participants With Advanced Esophageal/ Esophagogastric Junction Carcinoma That Progressed After First-Line Therapy (MK-3475-181/KEYNOTE-181)
NCT03099382P3completedStudy of SHR-1210 Versus Investigator's Choice of Chemotherapy for Participants With Advanced Esophageal Cancer
NCT00590031P2completedPhase II Trial of Preoperative Combined Modality Therapy for Esophageal Carcinoma: Cisplatin-Irinotecan Followed by Radiation Therapy With Concurrent Cisplatin and Irinotecan.

Stomach Neoplasm (4)

NCTAcronymPhaseStatusTitle
NCT02527785P2completedStudy of Oxaliplatin, Irinotecan, and S-1 in Gastric Cancer
NCT00509964P2unknownSecond-Line Irinotecan vs. ILF for AGC
NCT00320294P2unknownILF With/Without Cisplatin for Advanced Gastric Cancer
NCT00144378P3completedIrinotecan Versus Only Best Supportive Care for Gastric Cancer

Acinar Cell Adenocarcinoma of the Pancreas (4)

NCTAcronymPhaseStatusTitle
NCT02047474P2completedCombination Chemotherapy Before and After Surgery in Treating Patients With Localized Pancreatic Cancer
NCT01835041P1completedCPI-613 and Combination Chemotherapy in Treating Patients With Metastatic Pancreatic Cancer
NCT01643499P1completedGenotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies
NCT01821612Early P1completedChemotherapy and Radiation Therapy Before Surgery Followed by Gemcitabine in Treating Patients with Pancreatic Cancer

Metastatic Colorectal Cancer (CRC) (3)

NCTAcronymPhaseStatusTitle
NCT07585279P2/P3not yet recruitingA Clinical Study of Liposomal Irinotecan for Second-Line Therapy in Metastatic Colorectal Cancer
NCT07381764ROMANCE - GOIMP2not yet recruitingROMANCE: "Irinotecan Plus Cetuximab Rechallenge Versus Trifluridine/Tipiracil Plus Bevacizumab in Molecularly Selected Metastatic Colorectal Cancer"
NCT07395063P2not yet recruitingA Clinical Study on the Treatment of Metastatic Colorectal Cancer at the Second-line or Beyond.

Advanced Esophageal Squamous Cell Carcinoma (3)

NCTAcronymPhaseStatusTitle
NCT07487896P3not yet recruitingA Study of YL201 Versus Investigator's Choice of Chemotherapy in Participants With Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma After Failure of First-Line Therapy
NCT05818982P2unknownTo Evaluate the Efficacy and Safety of Afatinib for Advanced ALTRK-negative ESCC
NCT06512428P2recruitingA Study of Simmitinib Plus Irinotecan in Advanced Esophageal Squamous Cell Carcinoma

Esophageal Squamous Cell Carcinoma (ESCC) (3)

NCTAcronymPhaseStatusTitle
NCT07463573P3recruitingQLC5508 vs. Chemotherapy in Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma
NCT05342636MK-3475P1/P2completedA Study of Combination Therapies With or Without Pembrolizumab (MK-3475) and/or Chemotherapy in Participants With Advanced Esophageal Cancer (MK-3475-06A)
NCT03430843BGB-A317P3completedA Study of Tislelizumab (BGB-A317) Versus Chemotherapy as Second Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma

Neuroblastoma (NB) (3)

NCTAcronymPhaseStatusTitle
NCT07318831P2recruitingPhase II Study of Chidamide-Dinutuximab Beta-Irinotecan-Temozolomide for Refractory/Relapsed Neuroblastoma in Children
NCT07375563NB-NK-2026P3recruitingChemoimmunotherapy Combined With Autologous NK Cell Therapy for Pediatric Patients With Refractory and Relapsed High-Risk Neuroblastoma and Ganglioneuroblastoma
NCT03189706Early P1active not recruitingStudy of Chemoimmunotherapy for High-Risk Neuroblastoma

Pancreatic Ductal Adenocarcinoma (PDAC) (3)

NCTAcronymPhaseStatusTitle
NCT03977233P2recruitingTumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer
NCT07235202PDACP1/P2recruitingA Study of MR001 Combined With Chemotherapy in Patients With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) After First-line Therapy
NCT02782182P1terminatedPerioperative FOLFIRINOX for Patients With Resectable Pancreatic Adenocarcinoma: A Pilot Study

Neuroblastoma Recurrent (3)

NCTAcronymPhaseStatusTitle
NCT07085338P2recruitingA Phase II Study With a Safety Run-In of the Addition of N-803 to a Chemoimmunotherapy Backbone for the Treatment of Patients With Relapsed or Refractory Neuroblastoma
NCT04560166P2terminatedNaxitamab and GM-CSF in Combination With IT in Patients With High-Risk Neuroblastoma
NCT01467986RIST-rNB-2011P2completedMultimodal Molecular Targeted Therapy to Treat Relapsed or Refractory High-risk Neuroblastoma

Colorectal Cancer (CRC) (3)

NCTAcronymPhaseStatusTitle
NCT07051785ARKP2not yet recruitingFruquintinib vs Bevacizumab Combined With Irinotecan Liposome and Capecitabine as Second-Line Therapy for Advanced Metastatic Colorectal Cancer
NCT07047560IIP2recruitingLiposomal Irinotecan (II) Fractionated Dosing Combined With 5-FU/LV (FOLFIRInali-3) and Bevacizumab in Second-line Treatment of Advanced Colorectal Cancer: A Single-arm, Phase II Clinical Study
NCT00851045P2completedPh II Trial of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Second-line Treatment of Metastatic Colorectal Cancer

Small Cell Lung Cancer Extensive Stage (3)

NCTAcronymPhaseStatusTitle
NCT06954246P3recruitingA Study of MHB088C Injection Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
NCT06749691LIAESP2recruitingLiposomal Irinotecan and Apatinib in ES-SCLC
NCT06739928IIP2recruitingIrinotecan Liposome (II) or Etoposide Combined With Adebrelimab and Carboplatin in the Treatment of ES-SCLC

Biliary Tract Carcinoma (3)

NCTAcronymPhaseStatusTitle
NCT06463548N/Anot yet recruitingIrinotecan Hydrochloride Liposome Combined With Capecitabine and Lenvatinib in Patients With Biliary Tract Carcinoma
NCT06699459NICRRBTCP2not yet recruitingIrinotecan Liposomes +5-FU/LV Versus Capecitabine in Patients of Recurrence After Resection of Resectable BTC
NCT06430827P2unknownClinical Study of Irinotecan Hydrochloride Liposome Combined With Capecitabine for Second-line Treatment in Patients With Advanced or Metastatic Biliary Tract Carcinoma

Advanced Gastric Cancer (3)

NCTAcronymPhaseStatusTitle
NCT06486545N/Anot yet recruitingLiposomal Irinotecan Combination Regimen for Second-line Treatment of Advanced Gastric Cancer
NCT01084330P2completedPhase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer
NCT01136031TI-2ndAGCP1/P2completedPaclitaxel and Irinotecan in Advanced Gastric Cancer

Cervical Cancer (3)

NCTAcronymPhaseStatusTitle
NCT06459180MK-2870P3active not recruitingA Study to Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of Physician's Choice as Second-line Treatment for Participants With Recurrent or Metastatic Cervical Cancer (MK-2870-020/TroFuse-020/Gog-3101/ENGOT-cx20)
NCT04697628innovaTV 301P3completedTisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer
NCT00106262P2terminatedStudy of Velcade and Irinotecan in Advanced Cervical, Vulvar, or Vaginal Cancer

Colo-rectal Cancer (3)

NCTAcronymPhaseStatusTitle
NCT06011772Early P1active not recruitingEGF-Depleting Therapy CIMAvax-EGF in Combination With Standard Therapy for RAS- and BRAF Wild-Type Metastatic Colorectal Cancer
NCT03493061P2completedA Study of Systemic Chemotherapy With CPT-11 Plus HAI (FUDR+L-OHP) in Patients With Initially Unresectable CRCLM
NCT03545711P1/P2unknownSafety and Efficacy of Anlotinib in Combination With Irinotecan in Patients With Pretreated Advanced Colorectal Cancer

Metastatic Colorectal Carcinoma (3)

NCTAcronymPhaseStatusTitle
NCT05863195P3recruitingTesting Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
NCT02595931P1active not recruitingM6620 and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
NCT03290937P1completedUtomilumab, Cetuximab, and Irinotecan Hydrochloride in Treating Patients With Metastatic Colorectal Cancer

Borderline Resectable Pancreatic Adenocarcinoma (3)

NCTAcronymPhaseStatusTitle
NCT05688215P1/P2recruitingZimberelimab and Quemliclustat in Combination With Chemotherapy for the Treatment of Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma
NCT04481204P2withdrawnNew and Emerging Therapies for the Treatment of Resectable, Borderline Resectable, or Locally Advanced Pancreatic Cancer, PIONEER-Panc Study
NCT03970252Early P1completedNivolumab in Combination With Chemotherapy Pre-Surgery in Treating Patients With Borderline Resectable Pancreatic Cancer

Rectal Neoplasms (3)

NCTAcronymPhaseStatusTitle
NCT06417476P2active not recruitingShort-course Radiotherapy or Long-course Chemoradiation Followed by mFOLFOXIRI Consolidation Chemotherapy for Organ Preservation in Low Rectal Cancer
NCT01609231MK-0646-025P2terminatedA Trial of Dalotuzumab in Combination With Irinotecan Versus Cetuximab and Irinotecan for Participants With Metastatic Rectal Cancers (mRC) (MK-0646-025)
NCT00506844ERBIRIXP2unknownPreoperative Chemoradiotherapy With Cetuximab in Rectal Cancer

Pancreas Cancer (3)

NCTAcronymPhaseStatusTitle
NCT04141995P2terminatedFOLFIRINOX With Digoxin in Patients With Resectable Pancreatic Cancer
NCT05417386P1terminatedFOLFIRINOX + NIS793 in Pancreatic Cancer
NCT02021422P1completedA Pilot, Prospective, Non-randomized Evaluation of the Safety of Anakinra Plus Standard Chemotherapy

Stomach Cancer (3)

NCTAcronymPhaseStatusTitle
NCT05427383P2/P3recruitingKN026 in Combination With Chemotherapy in HER2 Positive Gastric Cancer Subjects Who Have Failed First-line Therapy
NCT04486651P3unknownHX008 Plus Irinotecan Versus Placebo Plus Irinotecan as Second-line Treatment in Advanced Gastric Cancer
NCT04770623P2completedDocetaxel and Irinotecan in Gastric Cancer

Colon Adenocarcinoma (3)

NCTAcronymPhaseStatusTitle
NCT04920032P1recruitingStudy of ctDNA Guided Change in Tx for Refractory Minimal Residual Disease in Colon Adenocarcinomas
NCT03365882S1613P2completedS1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
NCT02575508P1/P2withdrawnPan FGFR Kinase Inhibitor BGJ398 and Combination Chemotherapy in Treating Patients With Untreated Metastatic Pancreatic Cancer

Advanced Pancreatic Cancer (3)

NCTAcronymPhaseStatusTitle
NCT04796948P1completedA Study of Irinotecan Liposome in Advanced Pancreatic Cancer
NCT03336216P2completedA Study of Cabiralizumab Given With Nivolumab With and Without Chemotherapy in Patients With Advanced Pancreatic Cancer
NCT04482257P1unknownBioequivalence Study of Irinotecan Liposome Injection in Chinese Advanced Pancreatic Cancer.

Metastatic Cancer (3)

NCTAcronymPhaseStatusTitle
NCT04641871P1completedSym021 in Combination With Either Sym022 or Sym023 or Sym023 and Irinotecan in Patients With Recurrent Advanced Selected Solid Tumor Malignancies
NCT02049593P1completedPARP Inhibitor BMN-673 and Temozolomide or Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic Solid Tumors
NCT03009058MODULATEP1/P2terminatedStudy of IMM 101 in Combination With Standard of Care in Patients With Metastatic or Unresectable Cancer

Recurrent Colorectal Carcinoma (3)

NCTAcronymPhaseStatusTitle
NCT03823079P2unknownComparison of Interleukin-11 and rhTPO for Recurrent Colorectal Cancer Patients With Thrombocytopenia
NCT02508077P2terminatedFOLFIRI and Panitumumab in Treating Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer
NCT00545545P1/P2completedSafety/Efficacy Study of Imprime PGG With Cetuximab in Patients With Recurrent/Progressive Colorectal Carcinoma

Neoplasm Metastasis (3)

NCTAcronymPhaseStatusTitle
NCT02677116P1completedA Study of Olaratumab Alone and in Combination With Standard Chemotherapies in Children With Cancer
NCT00433927FOLFIRIP3unknown5-FU, Folinic Acid and Irinotecan (FOLFIRI) Plus Cetuximab Versus FOLFIRI Plus Bevacizumab in First Line Treatment Colorectal Cancer (CRC)
NCT00037180P2terminatedFor Prevention of Diarrhea in Patients Diagnosed With Metastatic Colorectal Cancer Treated With Chemotherapy

Mucinous Adenocarcinoma of the Colon (3)

NCTAcronymPhaseStatusTitle
NCT01814501P2completedPanitumumab and Chemotherapy in Patients With Advanced Colorectal Cancer After Prior Therapy With Bevacizumab
NCT01923337P1completedIrinotecan and Alisertib in Treating Patients With Advanced Solid Tumors or Colorectal Cancer
NCT00005036P3completedIrinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer

Head and Neck Cancer (3)

NCTAcronymPhaseStatusTitle
NCT00040807P2completedIrinotecan and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer
NCT00100828P2terminatedIrinotecan in Treating Patients With Metastatic or Inoperable Thyroid Cancer
NCT00639769P2completedIrinotecan and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Carcinoma of Unknown Primary (3)

NCTAcronymPhaseStatusTitle
NCT00066781P2completedGemcitabine and Irinotecan in Treating Patients With Cancer of Unknown Primary
NCT00004005P2completedIrinotecan Followed By Fluorouracil and Leucovorin in Treating Patients With Stage III or Stage IV Colorectal Carcinoma (Cancer), Other Refractory Carcinoma, or Metastatic Adenoma (Cancer) of Unknown Primary Origin
NCT00004922P2completedIrinotecan in Treating Patients With Advanced Neuroendocrine Tumors

Bladder Cancer (3)

NCTAcronymPhaseStatusTitle
NCT00066612S0306P2completedS0306, Irinotecan in Treating Patients With Recurrent or Refractory Advanced Transitional Cell Cancer of the Urothelium Previously Treated With Chemotherapy
NCT00089128P2terminatedGemcitabine and Irinotecan in Treating Patients With Locally Advanced or Metastatic Bladder Cancer
NCT00004095P1completedIrinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors

Neuroendocrine Carcinoma (2)

NCTAcronymPhaseStatusTitle
NCT07595913P3not yet recruitingA Study of ZG006 for Injection Versus Investigator-Selected Chemotherapy in Participants With Advanced Neuroendocrine Carcinoma
NCT03168594IPP2terminatedStudy to Compare Irinotecan Combined With Cisplatin (IP) Versus Etoposide Combined With Cisplatin (EP) in Advanced and Metastatic Gastrointestinal Pancreatic and Esophageal Neuroendocrine Carcinoma

Biliary Cancer Metastatic (2)

NCTAcronymPhaseStatusTitle
NCT07062536P2not yet recruitingmFOLFOX/mFOLFIRI vs. mFOLFOX in Advanced or Recurrent Biliary Tract Cancer Second-line
NCT03464968P2completedmFOLFOX vs. mFOLFIRI in Advanced or Recurrent Biliary Tract Cancer Refractory to First Line

Locally Advanced Pancreatic Adenocarcinoma (2)

NCTAcronymPhaseStatusTitle
NCT06998940P3recruitingStudying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
NCT06381154P2recruitingPhotoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advanced or Metastatic Pancreatic Cancer

High-Risk Neuroblastoma (2)

NCTAcronymPhaseStatusTitle
NCT04221035HR-NBL2P3recruitingHigh-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
NCT07549321SHINEP2/P3recruitingA Safety and Efficacy Study of hu14 in High-Risk Neuroblastoma Patients

Metastatic Ewing Sarcoma (2)

NCTAcronymPhaseStatusTitle
NCT07194044METTSEOP1recruitingMetastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes
NCT05042934P1/P2withdrawnLurbinectedin With or Without Irinotecan in Treating Patients With Relapsed or High Risk Metastatic Ewing Sarcoma

Intrahepatic Cholangiocarcinoma (Icc) (2)

NCTAcronymPhaseStatusTitle
NCT07328919P3not yet recruitingEfficacy and Safety of TT-00420 (Tinengotinib) Tablets Versus Chemotherapy in Patients With Advanced Intrahepatic Cholangiocarcinoma Harboring FGFR2 Fusions/Rearrangements or Mutations
NCT06648525P2not yet recruitingAdebrelimab Combined with Irinotecan Liposomes, 5-FU, CF ± Lenvatinib As First-line Treatment for Advanced ICC

Desmoplastic Small Round Cell Tumor (2)

NCTAcronymPhaseStatusTitle
NCT07328425ISG-TULIPSP2recruitingClinical Study in Adult and Young Adult Patients With Advanced Desmoplastic Small Round Cell Tumor (DSRCT) ISG-TULIPS
NCT04095221P1/P2completedA Study of the Drugs Prexasertib, Irinotecan, and Temozolomide in People With Desmoplastic Small Round Cell Tumor and Rhabdomyosarcoma

Ewing's Sarcoma (2)

NCTAcronymPhaseStatusTitle
NCT07092306NALIRI-VTP2not yet recruitingA Randomized Controlled Study Comparing the Safety and Efficacy of Irinotecan Hydrochloride Liposome Injection Combined With Temozolomide and Vincristine (NALIRI-VT) Versus Irinotecan Combined With Temozolomide and Vincristine (VIT) in Patients With Advanced Ewing's Sarcoma
NCT02511132P2completedA Two-part Phase IIb Trial of Vigil (Bi-shRNAfurin and GMCSF Augmented Autologous Tumor Cell Immunotherapy) in Ewing's Sarcoma

Recurrent or Metastatic Nasopharyngeal Carcinoma (2)

NCTAcronymPhaseStatusTitle
NCT07070479P2recruitingCombination Therapy for PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma: A Bayesian Adaptive Phase II Trial
NCT06657690P2recruitingIrinotecan Liposome Combined with S-1 in PD-1/L1 Inhibitor Refractory Recurrent or Metastatic NPC

Gastrointestinal Cancer (2)

NCTAcronymPhaseStatusTitle
NCT07056777P1/P2recruitingEvaluation of the Preliminary Efficacy and Safety of DR30206 in Combination With Standard Therapy in Patients With Gastrointestinal Cancer
NCT00353015P2completedIrinotecan and Cisplatin for High Grade Neuroendocrine Carcinoma of the Gastrointestinal Tract

Locally Recurrent Rectal Cancer (2)

NCTAcronymPhaseStatusTitle
NCT06928584P2recruitingHypofractionated Radiotherapy Plus Immunotherapy Versus Conventional Radiotherapy in Locally Recurrent Rectal Cancer
NCT07183865NOVELTY-RP2recruitingHypofractionated Radiotherapy Combined With NALIRIF, PD-1 Antibody in Locally Recurrent Rectal Cancer(NOVELTY-R)

Glioma (2)

NCTAcronymPhaseStatusTitle
NCT06801730NALIRIBVRGP2recruitingIrinotecan Liposomes Combined With Bevacizumab in the Treatment of Recurrent Glioma
NCT00404495P2completedCombination of Irinotecan and Temozolomide in Children With Brain Tumors.

Recurrent Rectal Cancer (2)

NCTAcronymPhaseStatusTitle
NCT06751394TRACERP2not yet recruitingPreoperative Chemoradiotherapy and Toripalimab in Locally Recurrent Rectal Cancer
NCT05628038TORCH-RP2recruitingThe Combination of Hypofractionated Radiotherapy and Immunotherapy in Locally Recurrent Rectal Cancer

Relapsed Neuroblastoma (2)

NCTAcronymPhaseStatusTitle
NCT07334301BEACON2P1/P2recruitingA Multi-Arm, Platform Trial For Relapsed Neuroblastoma
NCT04211675STINGP1/P2recruitingNK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab

Colorectal Neoplasms Malignant (2)

NCTAcronymPhaseStatusTitle
NCT06643793IIP2recruitingEvaluation of Irinotecan Liposome (II) Combined With 5-FU, LV, and Bevacizumab for mCRC
NCT05278351P2unknownTislelizumab Plus Cetuximab and Irinotecan vs Third-line Standard-of-care in Refractory mCRC

Extensive-stage Small-cell Lung Cancer (2)

NCTAcronymPhaseStatusTitle
NCT06478043P2not yet recruitingA Study to Investigate the Efficacy and Safety of Ivonescimab Combined With Irinotecan Liposome as Second-line Regimen for ES-SCLC
NCT06332950IIP1/P2not yet recruitingSafety and Efficacy of Adebrelimab Plus Irinotecan Liposome (II) With or Without Famitinib in ES-SCLC Pre-treated With Immunotherapy

Cholangiocarcinoma (2)

NCTAcronymPhaseStatusTitle
NCT06438822P2recruitingCadonilimab Combined With Liposomal Irinotecan Plus Leucovorin and Fluorouracil for Advanced Cholangiocarcinoma
NCT04059562TRITICCP2completedTrifluridine/Tipiracil in Combination With Irinotecan as a Second Line Therapy in Patients With Cholangiocarcinoma

Metastatic Adenocarcinoma of the Pancreas (2)

NCTAcronymPhaseStatusTitle
NCT06225999P2completedPhase 2 Study of Irinotecan Liposome Injection, Oxaliplatin, 5-fluorouracil/Levoleucovorin in Japanese Participants Not Previously Treated for Metastatic Adenocarcinoma of the Pancreas
NCT04083235NAPOLI 3P3completedA Study to Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously Treated for Metastatic Pancreatic Cancer, Compared to Nab-paclitaxel+Gemcitabine Treatment

Ganglioneuroblastoma, Nodular (2)

NCTAcronymPhaseStatusTitle
NCT06172296P3recruitingDinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
NCT04385277GM-CSFP2active not recruitingTreatment With Dinutuximab, Sargramostim (GM-CSF), and Isotretinoin in Combination With Irinotecan and Temozolomide After Intensive Therapy for People With High-Risk Neuroblastoma (NBL)

Borderline Resectable Pancreatic Cancer (2)

NCTAcronymPhaseStatusTitle
NCT06387810undeterminedP2recruitingIrinotecan Liposome II in Combination With 5-FU/LV and Oxaliplatin in Perioperative Treatment of Borderline Resectable Pancreatic Cancer
NCT06345300P2unknownNALIRIFOX in Combination With Camrelizumab for BRPC: a Prospective, Exploratory Study

Unresectable Metastatic Colorectal Cancer (2)

NCTAcronymPhaseStatusTitle
NCT06107413IVP2active not recruitingStudy to Assess Adverse Events and Change in Disease Activity in Previously Treated Adult Participants Receiving Intravenous (IV) ABBV-400 With Unresectable Metastatic Colorectal Cancer in Combination With IV Fluorouracil, Folinic Acid, and Bevacizumab
NCT04160416TRICAPP2unknownmXELOXIRI Combined With Molecular Targeted Drug in mCRC

Refractory Solid Tumors (2)

NCTAcronymPhaseStatusTitle
NCT06006273P1recruitingA Phase Ib Trial of Eribulin in Combination With Irinotecan and Temozolamide in Children With Relapsed or Refractory Solid Tumors
NCT03810742P1completedNanoliposomal Irinotecan (Nal-IRI, ONIVYDE®) in Combination With TAS-102 (LONSURF®) in Refractory Solid Tumors

Pediatric Solid Tumor (2)

NCTAcronymPhaseStatusTitle
NCT06760117P1recruitingUGT1A1 Genotype-drien Phase I Study of Irinotecan in VIT Regimen for the Treatment of Pediatric R/R Solid Tumors
NCT05620862P1active not recruitingPhase I Dose Escalation and Pharmacokinetics Clinical Trial of Mitoxantrone Hydrochloride Liposome in Children With Relapsed and Refractory Lymphoma and Solid Tumors

Small Cell Lung Cancer (SCLC) (2)

NCTAcronymPhaseStatusTitle
NCT05027100N/AunknownTislelizumab Combined With Anlotinib and 2-cycles Irinotecan as Second Line Treatment of SCLC
NCT04727853SCLCP2completedStudy of Irinotecan Liposome Injection as Second-line Regimen in Patients With Small Cell Lung Cancer (SCLC)

Advanced Biliary Tract Cancer (2)

NCTAcronymPhaseStatusTitle
NCT04005339NAPOLI-2P2active not recruitingNAPOLI-2: Fluorouracil, Leucovorin, and Nanoliposomal Irinotecan in Biliary Cancer
NCT05009953P2terminatedStudy of Irinotecan Liposome Injection in Patients With Advanced Biliary Tract Cancer

Advanced Colorectal Carcinoma (2)

NCTAcronymPhaseStatusTitle
NCT04535401P1unknownTesting the Addition of an Anticancer Drug, BAY 1895344, to the Usual Chemotherapy With FOLFIRI in Advanced or Metastatic Cancers of the Stomach and Intestines
NCT04109924TAS-102P2completedTAS-102, Irinotecan, and Bevacizumab for the Treatment of Pre-treated Metastatic or Unresectable Colorectal Cancer, the TABAsCO Study

Hepatoblastoma (2)

NCTAcronymPhaseStatusTitle
NCT03017326PHITTP3active not recruitingPaediatric Hepatic International Tumour Trial
NCT04478292P3recruitingA Multi-institutional Study for Treatment of Children With Newly Diagnosed Hepatoblastoma Using a Modified PHITT Strategy

Oncology (2)

NCTAcronymPhaseStatusTitle
NCT03837977NET02P2completedSecond-line Therapy for Patients With Progressive Poorly Differentiated Extra-pulmonary Neuroendocrine Carcinoma
NCT04299880P1completedRollover Study to Provide Continued Access to Napabucasin for Patients Enrolled in Boston Biomedical-sponsored Protocols

Treatment Related Cancer (2)

NCTAcronymPhaseStatusTitle
NCT04034173P2not yet recruitingOptimal Anti-EGFR Treatment of mCRC Patients With Low-Frequency RAS Mutation
NCT05217069P2completedFOLFIRI + Cetuximab + Avelumab RAS Wild-type CRC

Adenocarcinoma of the Stomach (2)

NCTAcronymPhaseStatusTitle
NCT03722108REGIRIP1/P2terminatedRegorafenib Combined With Irinotecan as Second-line in Patients With Metastatic Gastro-oesophageal Adenocarcinomas
NCT01640782ITACA-SP3completedIntergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the Stomach

Adenocarcinoma (2)

NCTAcronymPhaseStatusTitle
NCT03535727P1/P2completedA Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic Cancer
NCT00183859P1completedClinical and Pharmacokinetic Trial of Intra-Abdominal Irinotecan

Previously Treated Metastatic Colorectal Cancer (2)

NCTAcronymPhaseStatusTitle
NCT03522649GB201P3unknownA Phase III Clinical Study of Napabucasin (GB201) Plus FOLFIRI in Adult Patients With Metastatic Colorectal Cancer
NCT01896856P1/P2completedPhase I/II Study of SGI-110 With Irinotecan Versus Regorafenib or TAS-102 in Metastatic Colorectal Cancer

Breast Cancer Metastatic (2)

NCTAcronymPhaseStatusTitle
NCT03328884PhenomenalP2completedEvaluation of the Efficacy and Safety of Nal-IRI for Progressing Brain Metastases in Breast Cancer Patients
NCT00532714P2completedPhase II Study of Irinotecan/Capecitabine in Patients With Antracycline/Taxane Pretreated MBC

Advanced Gastric Cancer Adenocarcinoma of Esophagogastric Junction (2)

NCTAcronymPhaseStatusTitle
NCT03045770N/AunknownmFOLFOX Versus mFOLFIRI Versus FOLFPTX as First-line Treatment in AGC or EGJA
NCT03030937P2unknownClinical Trial to Compare Apatinib Plus Irinotecan Versus Single Irinotecan as Second-line Treatment in AGC or EGJA

Pediatric Solid Tumors (2)

NCTAcronymPhaseStatusTitle
NCT02747537P2withdrawnTreating Relapsed/Recurrent/Refractory Pediatric Solid Tumors With Sorafenib in Combination With Irinotecan
NCT00990912P1/P2completedA Study to Document Long-Term Safety and Continued Benefit of Irinotecan and Carboplatin or Irinotecan in Subjects With Refractory Solid Tumors (Rollover Study -001, -002)

Advanced Malignant Solid Neoplasm (2)

NCTAcronymPhaseStatusTitle
NCT02419495KPT-330P1terminatedPhase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies
NCT00576654P1completedVeliparib and Irinotecan Hydrochloride in Treating Patients With Cancer That Is Metastatic or Cannot Be Removed by Surgery

Esophageal Neoplasms (2)

NCTAcronymPhaseStatusTitle
NCT02319187P3unknownIrinotecan Plus S1 Versus S1 in Patients With Previously Treated Advanced Esophageal Cancer: ESWN 01 Trial
NCT00213486P2completedWeekly Cisplatin/Irinotecan and Radiotherapy in Patients With Locally Advanced Esophageal Cancer: Phase II Trial

Colorectal Neoplasm (2)

NCTAcronymPhaseStatusTitle
NCT02244632P1/P2completedModufolin (Arfolitixorin) in Combination With 5-Fluorouracil Alone or Together With Oxaliplatin or Irinotecan in Colorectal Cancer
NCT00506207TIROXP1unknownA Phase I Study of S-1 Plus Irinotecan and Oxaliplatin in Advanced Gastrointestinal Malignancy

Biliary Cancer (2)

NCTAcronymPhaseStatusTitle
NCT01859728GAMBITP2unknownGAMBIT Trial: Cisplatin Plus Irinotecan in the Treatment of Gallbladder or Biliary Tract Cancer
NCT00948935P2completedStudy of Gemcitabine, Irinotecan and Panitumumab in Patients With Advanced and Metastatic Biliary Tract Adenocarcinoma

Non-small Cell Lung Cancer (2)

NCTAcronymPhaseStatusTitle
NCT01607554P1/P2terminatedIrinotecan for Previously Treated, Advanced, Non-Small Cell Lung Cancer
NCT00264134P1/P2terminatedDocetaxel, Irinotecan, and Carboplatin in Extensive Stage Non-Small Cell Lung Cancer

Stage IV Colorectal Cancer (2)

NCTAcronymPhaseStatusTitle
NCT01271582P4unknownInvestigation of Association Between UGT1A1 Polymorphisms and Irinotecan Toxicity in Korean Patients
NCT01550510P1/P2terminatedResearch Study of IV Vitamin C in Combination With Irinotecan vs Irinotecan Alone for Advanced Colorectal CA

Metastatic Breast Cancer (2)

NCTAcronymPhaseStatusTitle
NCT00248287CA225200P2active not recruitingPhII ICb With/Without Erbitux in MBC Pts
NCT01501669PROCEEDP3unknownIrinotecan/Capecitabine Versus Capecitabine in Patients Treated With A/T for HER2 Negative Metastatic Breast Cancer

Refractory Solid Tumors in Children (2)

NCTAcronymPhaseStatusTitle
NCT00993044VIT-BP1completedA Study of Vincristine, Escalating Doses of Irinotecan, Temozolomide and Bevacizumab (Vit-b) in Pediatric and Adolescent Patients With Recurrent or Refractory Solid Tumors of Non-hematopoietic Origin
NCT01282697RAPIRIP1completedClinical Trial of Rapamycin and Irinotecan in Pediatric Patients With Refractory Solid Tumors

Breast Neoplasms (2)

NCTAcronymPhaseStatusTitle
NCT01042379I-SPYP2recruitingI-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
NCT00072852P2completedIrinotecan in Patients With Advanced Metastatic Breast Cancer Who Have Experienced Failure of an Anthracycline, a Taxane, and Capecitabine

Adult Rhabdomyosarcoma (2)

NCTAcronymPhaseStatusTitle
NCT00354835P3completedCombination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
NCT01055314P2completedTemozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma

Advanced Solid Malignancies (2)

NCTAcronymPhaseStatusTitle
NCT00986843P1completedClinical Trial to Evaluate Safety and Tolerability of OratecanTM in Patients With Advanced Solid Malignancies (Oratecan-102)
NCT00979563Oratecan-101P1completedClinical Trial to Evaluate Safety and Tolerability of OratecanTM in Patients With Advanced Solid Malignancies

Anal Cancer (2)

NCTAcronymPhaseStatusTitle
NCT00654160P1completedIrinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer
NCT00003427P1completedOxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer

Malignant Gliomas (2)

NCTAcronymPhaseStatusTitle
NCT00671801P1terminatedIrinotecan Plus Lenalidomide in Adult Patients With Recurrent Glioblastoma Multiforme: Phase I
NCT00463073P2completedCetuximab, Bevacizumab and Irinotecan for Patients With Malignant Glioblastomas

Carcinoma, Small Cell Lung (2)

NCTAcronymPhaseStatusTitle
NCT00308529P2completedIrinotecan, Carboplatin, Bevacizumab, and Radiation Therapy in the Treatment of Limited Stage Small Cell Lung Cancer
NCT00294931P2completedIrinotecan, Carboplatin, Bevacizumab in the Treatment of Patients With Extensive Stage Small Cell Lung Cancer

Non-Small Cell Lung Cancer (2)

NCTAcronymPhaseStatusTitle
NCT00240097SCLCP2completedStudy of Sequential Topoisomerase, Irinotecan/Oxaliplatin - Etoposide /Carboplatin in Extensive Small Cell Lung Cancer (SCLC)
NCT00319800P2unknownSecond-Line Irinotecan or Gefitinib in Docetaxel Pretreated NSCLC

Extensive Stage Small Cell Lung Cancer (2)

NCTAcronymPhaseStatusTitle
NCT00057837P2completedComparison of Two Combination Chemotherapy Regimens in Treating Patients With Extensive-Stage Small Cell Lung Cancer
NCT00118235P2completedCisplatin, Irinotecan, and Bevacizumab, in Treating Patients With Small Cell Lung Cancer

Kidney Cancer (2)

NCTAcronymPhaseStatusTitle
NCT00089102P2terminatedGemcitabine and Irinotecan in Treating Patients With Locally Advanced Unresectable or Metastatic Kidney Cancer
NCT00401128P2completedGemcitabine and Irinotecan in Treating Patients With Metastatic Kidney Cancer

Fallopian Tube Cancer (2)

NCTAcronymPhaseStatusTitle
NCT00053833P2terminatedS0025 Irinotecan in Treating Patients With Refractory Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
NCT00003345P2completedCisplatin Plus Irinotecan in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer

Carcinoma, Non-Small-Cell Lung (2)

NCTAcronymPhaseStatusTitle
NCT00139711P2completedThree Combinations Of Docetaxel And Irinotecan For Recurrent Or Metastatic Non Small Cell Lung Cancer
NCT00819728CPT-11P2completedTrial of Weekly Taxotere and Irinotecan (CPT-11) in Patients With Advanced Non-small Cell Lung Cancer

Upper Gastrointestinal Tumours (2)

NCTAcronymPhaseStatusTitle
NCT00220064P2completedA Phase II Trial Evaluating Irinotecan Plus 5FU/LV in Patients With Relapsed/Refractory Upper GI Tumours
NCT00220168P4completedPhase II Trial Evaluating Irinotecan and Capecitabine Relapsed/Refractory Upper GI Tumours

Leukemia (2)

NCTAcronymPhaseStatusTitle
NCT00005626P2completedPhase II Trial With Correlative Laboratory Studies of Single Agent Irinotecan (Camptosar CPT-11)
NCT00053144P1completedIrinotecan and Cytarabine in Treating Patients With Refractory or Recurrent Acute Myeloid Leukemia or Chronic Myelogenous Leukemia

Lymphoma (2)

NCTAcronymPhaseStatusTitle
NCT00003368P1completedIrinotecan in Treating Patients With Solid Tumors or Lymphoma Who Have Abnormal Liver or Kidney Function or Who Have Received Radiation Therapy to the Pelvis
NCT00003245P2completedIrinotecan in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma

Lung Cancer (SCLC) (1)

NCTAcronymPhaseStatusTitle
NCT07258147P2not yet recruitingSafety and Efficacy of Radiotherapy Combined With Immunochemotherapy in Pre-treated SCLC Patients With Liver Metastases

Advanced Microsatellite Stable Colorectal Carcinoma (1)

NCTAcronymPhaseStatusTitle
NCT07363408P1not yet recruitingIvonescimab and ADG126, Alone, and in Combination With Leucovorin and Fluorouracil or FOLFIRI Regimen for the Treatment of Microsatellite Stable Advanced/Metastatic Colorectal Cancer

Metastatic Appendix Carcinoma (1)

NCTAcronymPhaseStatusTitle
NCT07271355P3not yet recruitingPressurized Intraperitoneal Aerosolized Chemotherapy With Mitomycin for the Treatment of Unresectable Appendix or Colorectal Cancer With Peritoneal Metastases, The IMPACT Trial

Colorectal Cancer Liver Metastases (CRLM) (1)

NCTAcronymPhaseStatusTitle
NCT07570914P2not yet recruitingHepatic Arterial Infusion of Liposomal Irinotecan Plus Oxaliplatin and Capecitabine as Adjuvant Therapy for Colorectal Cancer Liver Metastases

Platinum-resistant Recurrent Ovarian Cancer (1)

NCTAcronymPhaseStatusTitle
NCT07591831P2not yet recruitingLiposomal Irinotecan Plus Enlonstobart for Platinum-Resistant Recurrent Ovarian Cancer

Rectal Cancer Patients (1)

NCTAcronymPhaseStatusTitle
NCT07521605P2not yet recruitingShort-Course Radiotherapy, Nal-IRI, Capecitabine, and Camrelizumab for Locally Advanced MSS Rectal Cancer

Liver Metastases From Colorectal Cancer (mCRC) (1)

NCTAcronymPhaseStatusTitle
NCT07441369P2enrolling by invitationAbemaciclib Combined With FOLFOX/FOLFIRI Regimen in Patients With Advanced Colorectal Liver Metastases Cancer

Soft Tissue Sarcoma (Excluding GIST) (1)

NCTAcronymPhaseStatusTitle
NCT07457775P2not yet recruitingLiposomal Irinotecan in Combination With Temozolomide and Bevacizumab in Patients With Advanced STS

Locally Advanced/Metastatic/Recurrent ESCC (1)

NCTAcronymPhaseStatusTitle
NCT07417735P3not yet recruitingSYS6010 Versus Chemotherapy in Locally Advanced or Metastatic/Recurrent Esophageal Squamous Cell Carcinoma

ESCC (1)

NCTAcronymPhaseStatusTitle
NCT07524374IIP2not yet recruitingSHR-1701 in Combination With Irinotecan Liposome (II) for Second-line Treatment of ESCC After Immunotherapy

Osteosarcoma (1)

NCTAcronymPhaseStatusTitle
NCT07479732P1/P2recruitingApatinib Combined With Liposomal Irinotecan for Refractory or Metastatic Osteosarcoma

Borderline Resectable Pancreatic Ductal Adenocarcinoma (1)

NCTAcronymPhaseStatusTitle
NCT06821997P2recruitingNALIRIFOX Before Surgery for the Treatment of Borderline Resectable Pancreatic Ductal Adenocarcinoma, Nectar Trial

Medulloblastoma (1)

NCTAcronymPhaseStatusTitle
NCT07346157PNOC044P1/P2not yet recruitingLiothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual Disease

Relapsed or Refractory Pediatric Malignant Solid Tumors (Including Neuroblastoma, Rhabdomyosarcoma, Ewing Sarcoma, Osteosarcoma) (1)

NCTAcronymPhaseStatusTitle
NCT07444918P2not yet recruitingLiposomal Irinotecan, Vincristine, Temozolomide, and Anlotinib for R/R Pediatric Solid Tumors

Gastric Cancer (GC) (1)

NCTAcronymPhaseStatusTitle
NCT07364422P1/P2not yet recruitingTo Evaluate the Safety and Tolerability of Study Drug as a Third-line and Beyond Therapy for Recurrent or Metastatic Gastric Cancer

Pancreatic Adenocarcinoma Metastatic (1)

NCTAcronymPhaseStatusTitle
NCT07314385P1not yet recruitingNH002-mediated Sonoporation With Chemotherapy in Advanced Pancreatic Cancer

Metastatic Colorectal Carcinoma (mCRC) (1)

NCTAcronymPhaseStatusTitle
NCT07150403P2not yet recruitingSecond-line Doublet Chemotherapy (FOLFOX or FOLFIRI) Plus Fruquintinib Versus Doublet Chemotherapy (FOLFOX or FOLFIRI) Plus Bevacizumab in Metastatic Colorectal Cancer

SCLC, Extensive Stage (1)

NCTAcronymPhaseStatusTitle
NCT07141771P1/P2not yet recruitingAn Umbrella Study of Recurrent, Extensive Stage Small Cell Lung Cancer Based on Molecular Typing

Advanced Gastric or Gastroesophageal Junction Adenocarcinoma (1)

NCTAcronymPhaseStatusTitle
NCT07284134P3recruitingJS107 vs Investigator's Choice as Second-line or Later Therapy for Advanced CLDN18.2-Positive Gastricor GEJ Adenocarcinoma.

First-line Treatment of Metastatic Pancreatic Cancer (1)

NCTAcronymPhaseStatusTitle
NCT07238283IIP3recruitingIrinotecan Hydrochloride Liposome Injection (II)in Combination With Oxaliplatin, 5-FU/LV Versus AG for First-line Treatment of Metastatic Pancreatic Cancer

Rectal Cancer, Adenocarcinoma (1)

NCTAcronymPhaseStatusTitle
NCT07474103N/ArecruitingSCRT-NALIRIXELOX+Sintilimab as TNT for High-Risk LARC

Malignant Ascites (1)

NCTAcronymPhaseStatusTitle
NCT07397819P1/P2recruitingIntraperitoneal Injection of Liposomal Irinotecan as Monotherapy or in Combination With Recombinant Mutant Human Tumor Necrosis Factor or Bevacizumab for the Treatment of Malignant Ascites Following Failure of Prior Standard Therapy

Metastatic Esophageal Adenocarcinoma (1)

NCTAcronymPhaseStatusTitle
NCT06846346GRACIEP2recruitingTesting Ivonescimab in Combination With Chemotherapy in Advanced or Metastatic Gastric/Gastroesophageal Adenocarcinoma

CIC-Rearranged Sarcoma (1)

NCTAcronymPhaseStatusTitle
NCT06820957P2/P3active not recruitingTesting a New Combination of Anti-cancer Drugs in Patients Newly Diagnosed With Ewing Sarcoma Who Have Cancer That Has Spread to Other Parts of the Body

Advanced Rectal Cancer (1)

NCTAcronymPhaseStatusTitle
NCT07281157P2recruitingLiposomal Irinotecan, Capecitabine and Enlonstobart With Short-Course Radiotherapy for Locally Advanced Rectal Cancer

Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma (1)

NCTAcronymPhaseStatusTitle
NCT06958328LAP100P3recruitingTesting Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

GEP-NET (1)

NCTAcronymPhaseStatusTitle
NCT05385861P1/P2enrolling by invitationNal-IRI (ONIVYDE® ) and Carboplatin in Patients With Advanced or Metastatic GEP-NET

Biliary Tract Cancer (BTC) (1)

NCTAcronymPhaseStatusTitle
NCT07099794IIP2not yet recruitingA Randomized, Two-cohort, Prospective Phase II Clinical Study of the Second-line Treatment of Advanced Biliary System Tumors With Liposomal Irinotecan (II) Combination Regimen

Advanced Small Intestine Cancer (1)

NCTAcronymPhaseStatusTitle
NCT07060014P1not yet recruitingNALIRIFOX (Nal-IRI Plus 5-FU/LV Plus Oxaliplatin) as First-Line Treatment for Patients With Advanced Small Intestine and Appendiceal Cancers

HER2 Positive (1)

NCTAcronymPhaseStatusTitle
NCT07059338HERBICP2not yet recruitingDual EGFR/HER2 Blockade Combined With Irinotecan for the Treatment of HER2-Positive Metastatic Colorectal Cancer

Small Bowel Adenocarcinoma (1)

NCTAcronymPhaseStatusTitle
NCT06835387P2recruitingStudy of NALIRIFOX in Advanced Unresectable Small Bowel Tumors

Gastroesophageal Adenocarcinoma (1)

NCTAcronymPhaseStatusTitle
NCT05733689P1recruitingResponse Adapted Neoadjuvant Therapy in Gastroesophageal Cancers (RANT-GC Trial)

Neuroendocrine Carcinomas (NEC) (1)

NCTAcronymPhaseStatusTitle
NCT07014540P4not yet recruitingA Irinotecan Liposome Trial of in Advanced Neuroendocrine Carcinoma

Childhood Fibrolamellar Carcinoma (1)

NCTAcronymPhaseStatusTitle
NCT06620302P1/P2recruitingTesting the Addition of an Anti-cancer Drug, DT2216, to the Usual Chemotherapy Treatment for Relapsed or Refractory Solid Tumors and Fibrolamellar Carcinoma

BRAF V600 Colorectal Cancer (1)

NCTAcronymPhaseStatusTitle
NCT07150247P2recruitingSafety and Efficacy of IB-FOLFIRI in BRAF V600E-Mutant Metastatic Colorectal Cancer

CRC (1)

NCTAcronymPhaseStatusTitle
NCT07204574P1/P2recruitingThe Phase 1b/IIa, Open-label, Dose Escalation and Dose Expansion to Evaluate Safety, Tolerability, and Preliminary Efficacy of the Combination of HCB101, Cetuximab/Bevacizumab, and FOLFOX/FOLFIRI in Advanced or Metastatic Colorectal Cancer

Recurrent Ovarian Cancer (1)

NCTAcronymPhaseStatusTitle
NCT06769425HS-10502P1recruitingHS-10502 Combination Treatment in Patients With Advanced Solid Tumors

Stage I Mixed Cell Type Kidney Wilms Tumor (1)

NCTAcronymPhaseStatusTitle
NCT06401330FHWTP3recruitingA Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)

Pancreatic Adenocarcinoma Advanced or Metastatic (1)

NCTAcronymPhaseStatusTitle
NCT06897644PANThEONP3recruitingGemcitabine Plus Nab-paclitaxel as Switch Maintenance Versus Continuation of Modified FOLFIRINOX as 1st Line Chemotherapy in Patients With Advanced Pancreatic Cancer.

Solid Cancer (1)

NCTAcronymPhaseStatusTitle
NCT06771622P1/P2active not recruitingSafety and Efficacy of HCB101 in Combination With Multiple Agents in Patients With Advanced Solid Tumors

Metastatic Gastro-esophageal Adenocarcinoma (1)

NCTAcronymPhaseStatusTitle
NCT06680622P2active not recruitingBemarituzumab in FGFR2b+ Patients With Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction, Who Failed at Least One Prior Line of Palliative Chemotherapy

SCLC (1)

NCTAcronymPhaseStatusTitle
NCT06820762IIP2not yet recruitingIrinotecan Liposome(II) Combined With Ivonescimab as Second-line Treatment for Small Cell Lung Cancer : A Prospective, Single-arm, Multicenter Clinical Study

Metastatic Sarcoma (1)

NCTAcronymPhaseStatusTitle
NCT04199026N/ArecruitingImplantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma

Advanced Esophageal Carcinoma (1)

NCTAcronymPhaseStatusTitle
NCT06745193P2not yet recruitingA Prospective, Randomized, Open, Phase II Clinical Study of Chidamide in Combination with Camrelizumab and Apatinib for Advanced Esophageal Cancer

Non-Muscle Invasive Bladder Urothelial Carcinoma (1)

NCTAcronymPhaseStatusTitle
NCT06766266P1recruitingIrinotecan Liposomes Combined with Epirubicin in Recurrent Non-muscle Invasive Bladder Urothelium Carcinoma After Anthracyclines Treatment

Rare Tumour (1)

NCTAcronymPhaseStatusTitle
NCT06692491SPRINGP2not yet recruitingStudy of Precision Treatment for Rare Tumours in China Guided by PDO and NGS

Hepatocellular Carcinoma (1)

NCTAcronymPhaseStatusTitle
NCT05669339P2recruitingAD HOC Trial: Artificial Intelligence-Based Drug Dosing In Hepatocellular Carcinoma

Solid Tumor Cancer (1)

NCTAcronymPhaseStatusTitle
NCT06710821P1not yet recruitingIrinotecan Liposomes Combined with Temozolomide and Vincristine in the Treatment of Pediatric Patients with Solid Tumors

Second-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma (1)

NCTAcronymPhaseStatusTitle
NCT06649292P3recruitingSHR-A1904 Compared With Investigator's Choice of Therapy in Claudin18.2 Positive Patitens With Second-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

Advanced Oesophageal Squamous Cell Carcinoma (1)

NCTAcronymPhaseStatusTitle
NCT06656091P3not yet recruitingA Study of Simmitinib Versus Chemotherapy for Participants With Advanced Oesophageal Squamous Cell Carcinoma

Colon Cancer Stage II (1)

NCTAcronymPhaseStatusTitle
NCT06490536P3recruitingThe Sagittarius Trial

Localized Advanced or Metastatic Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma (1)

NCTAcronymPhaseStatusTitle
NCT06577376P1/P2not yet recruitingA PhaseⅠ/Ⅱ Study of Simmitinib or Irinotecan Liposomes Combined With DP303c in Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma

High-risk Neuroblastoma (1)

NCTAcronymPhaseStatusTitle
NCT06528496N10P2recruitingN10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma

Pancreatic Cancer Metastatic to Liver (1)

NCTAcronymPhaseStatusTitle
NCT06531278P2recruitingAdebelimab Combined With Irinotecan Liposomal Injection, Oxaliplatin, Fluorouracil and Calcium Folinate Are Used in the First-line Treatment of Pancreatic Cancer Liver Metastasis Efficacy and Safety

Childhood Cancer (1)

NCTAcronymPhaseStatusTitle
NCT06208657P1/P2recruitingOptimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer

Soft Tissue Sarcoma (1)

NCTAcronymPhaseStatusTitle
NCT06514313P2recruitingClinical Trial of VIM With VIT in Children With Relapsed and Refractory Soft Tissue Sarcoma.

Neuroendocrine Tumors (1)

NCTAcronymPhaseStatusTitle
NCT06485739P4not yet recruitingIrinotecan Liposomes for the Treatment of Neuroendocrine Carcinoma

Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma (1)

NCTAcronymPhaseStatusTitle
NCT06238843G-HOPE-001P3active not recruitingA Multicenter, Phase 3 Study of IBI343 Monotherapy Versus Treatment of Investigator's Choice in Subjects With Previously Treated, Claudin (CLDN) 18.2-positive, HER2-negative, Gastric or Gastroesophageal Junction Adenocarcinoma (G-HOPE-001)

Locally Advanced or Metastatic GC and GCJ Adenocarcinoma (1)

NCTAcronymPhaseStatusTitle
NCT06351020P3active not recruitingLM-302 for the Treatment of Subjects With Claudin18.2-Positive Gastric and Gastroesophageal Junction Adenocarcinoma.

Advanced Pancreatic Cancer (Part 1) (1)

NCTAcronymPhaseStatusTitle
NCT06782685P1/P2recruitingLiposomal Irinotecan + Oxaliplatin + Bevacizumab Versus Liposomal Irinotecan + 5-FU/LV

Advanced Malignant Neoplasm (1)

NCTAcronymPhaseStatusTitle
NCT06394713P1/P2not yet recruitingA Study to Evaluate the Efficacy and Safety of QLF31907 Combination Therapy in Patients With Advanced Malignant Tumors

Colorectal Cancer Stage IV (1)

NCTAcronymPhaseStatusTitle
NCT06509126IMPROVE-2P3recruitingIntermittent or Continuous Panitumumab Plus FOLFIRI for Left Sided RAS/B-RAF Wild-type Metastatic Colorectal Cancer

Nasopharyngeal Cancer (1)

NCTAcronymPhaseStatusTitle
NCT06414577P2active not recruitingIrinotecan Liposomes in Combination With Nituzumab for the Treatment of Recurrent/Metastatic Nasopharyngeal Carcinoma After Failure of First-Line or Higher Immunotherapy

Gastroesophageal Cancer (1)

NCTAcronymPhaseStatusTitle
NCT06356311TroFuse-015P3active not recruitingA Study to Evaluate Sacituzumab Tirumotecan (MK-2870) in Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-2870-015)

Small Cell Lung Cancer Recurrent (1)

NCTAcronymPhaseStatusTitle
NCT06258642N/ArecruitingIrinotecan Liposome Combined With Anlotinib as Second-line Regimen for SCLC

Nanoliposomal Irinotecan (1)

NCTAcronymPhaseStatusTitle
NCT06405490P2recruitingNALIRI-XELOX+AK104 for First-line Treatment of Advanced PDAC

Unresectable/Metastatic Gastric Cancer (1)

NCTAcronymPhaseStatusTitle
NCT06365008P2recruitingSintilimab Plus FOLFIRI as Salvage Therapy for Patients With Advanced Gastric Cancer

Xiao Chai Hu Tang (1)

NCTAcronymPhaseStatusTitle
NCT06055179N/ArecruitingXCHT for Irinotecan-Induced Gut Toxicities (Randomized Controlled Trial)

RAS Mutation (1)

NCTAcronymPhaseStatusTitle
NCT06321081P2recruitingICE Study: Combination of Irinotecan Plus Cetuximab and Envafolimab as a Rechallenge Regimen in mCRC

Neoadjuvant Chemotherapy (1)

NCTAcronymPhaseStatusTitle
NCT06172036CAPT-02P2not yet recruitingIrinotecan Liposome for Resectable Pancreatic Cancer With or Without Addebelizumab

HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma (1)

NCTAcronymPhaseStatusTitle
NCT06123494P3recruitingSHR-A1811 for Subjects With Her2-positive Gastric Cancer and Gastroesophageal Junction Adenocarcinoma After Progression on or After First-line Anti-HER2 Therapy-containing Regimen

Previously AG Chemotherapy Treated Pancreatic Cancer (1)

NCTAcronymPhaseStatusTitle
NCT06166589P2not yet recruitingSecond-line Zimberelimab and SIRIOX Chemotherapy for Patient With Previously AG Chemotherapy Treated Pancreatic Cancer

Metastatic Biliary Tract Cancer (1)

NCTAcronymPhaseStatusTitle
NCT06282120N/AunknownEfficacy and Safety of Irinotecan Liposome Injection Combined With 5-FU/LV± Immunotherapy in First-line Gemsitabine + Immunoprogressive Patients With Metastatic Biliary Tract Cancer

Rhabdomyosarcoma, Child (1)

NCTAcronymPhaseStatusTitle
NCT05457829P2recruitingDoxorubicin Hydrochloride Liposome Combined With Irinotecan (AI Regimen) Versus VIT Regimen in the Treatment of Relapsed and Refractory Pediatric Rhabdomyosarcoma: a Prospective, Open-label, Randomized Controlled, Multicenter, Phase II Clinical Study

Triple Negative Breast Cancer (1)

NCTAcronymPhaseStatusTitle
NCT05255666TNBCP2withdrawnCombination Liposomal Irinotecan and Pembrolizumab For Triple-Negative Breast Cancer (TNBC) With Brain Metastases (BM)

Locally Advanced (Unresectable) or Metastatic Solid Tumors (1)

NCTAcronymPhaseStatusTitle
NCT05978492P1recruitingA Study of TXN10128 in Subjects With Solid Tumors

Locally Advanced Unresectable or Metastatic Solid Tumors Including Esophageal Cancer (1)

NCTAcronymPhaseStatusTitle
NCT05945823P2active not recruitingPhase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid Tumors

MSIhi or dMMR Advanced Unresectable or Metastatic Solid Tumors, Including Colorectal Cancers (1)

NCTAcronymPhaseStatusTitle
NCT05838768P1active not recruitingStudy of HRO761 Alone or in Combination in Cancer Patients With Specific DNA Alterations Called Microsatellite Instability or Mismatch Repair Deficiency.

Fruquintinib (1)

NCTAcronymPhaseStatusTitle
NCT06169202N/AunknownA Study of Fruquintinib in Combination With Irinotecan and Capecitabine for the Second-line Treatment of Patients

Metastatic Solid Tumor (1)

NCTAcronymPhaseStatusTitle
NCT05694715P1recruitingCombination Therapy in Cancers With Mutations in DNA Repair Genes

Stage II Colon Cancer (1)

NCTAcronymPhaseStatusTitle
NCT05062889ERASE-CRCP2suspendedExploiting Circulating Tumour DNA to Intensify the Postoperative Treatment Resected Colon Cancer Patients

Homologous Recombination Deficiency Alterations Metastatic Colorectal Cancer (1)

NCTAcronymPhaseStatusTitle
NCT05732129HRDP2unknownThe Efficacy and Safety of Fluzoparib Plus Irinotecan as Second-line Treatment in Patients With Homologous Recombination Deficiency (HRD) Metastatic Colorectal Cancer.

Esophageal Squamous Cell Carcinoma Abdominal Stage 0 (1)

NCTAcronymPhaseStatusTitle
NCT05737563EscapeP3unknownPD-1 Antibody Combined With mXELIRI Versus mXELIRI in the Second-line Setting for ESCC

Gastric Cancer Stage IV (1)

NCTAcronymPhaseStatusTitle
NCT05319639POFIP1/P2recruitingPhase I/II Study of the Combination of Irinotecan and POF (POFI) and Tislelizumab

Advanced Esophageal Adenocarcinoma (1)

NCTAcronymPhaseStatusTitle
NCT05677490P3recruitingmFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

Advanced Breast Carcinoma (1)

NCTAcronymPhaseStatusTitle
NCT05238831ACTEarly P1withdrawnSMMART Adaptive Clinical Treatment (ACT) Trial

Brain Tumor, Recurrent (1)

NCTAcronymPhaseStatusTitle
NCT04525014PIRATEP1terminatedRRx-001 Given With Irinotecan and Temozolomide for Pediatric Patients With Recurrent or Progressive Malignant Solid and Central Nervous System Tumors

Second Line Treatment of Gastric Cancer (1)

NCTAcronymPhaseStatusTitle
NCT05669807P2unknownCamrelizumab Combined With Irinotecan or Albumin Paclitaxel for Second-line Treatment of Advanced Gastric Cancer

Locally Advanced Rectal Carcinoma (1)

NCTAcronymPhaseStatusTitle
NCT05610163JANUSP2active not recruitingTesting the Addition of an Anti-Cancer Drug, Irinotecan, to the Standard Chemotherapy Treatment (FOLFOX) After Long-Course Radiation Therapy for Advanced-Stage Rectal Cancers to Improve the Rate of Complete Response and Long-Term Rates of Organ Preservation

Sarcoma, Ewing (1)

NCTAcronymPhaseStatusTitle
NCT05440786LY2835219P2active not recruitingCAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's Sarcoma

Wilms Tumor (1)

NCTAcronymPhaseStatusTitle
NCT05384821MetroWilmsP1/P2recruitingMetronomic Chemotherapy in Wilms Tumor (MetroWilms-1906)

Advanced or Metastatic Colorectal Cancer (1)

NCTAcronymPhaseStatusTitle
NCT05379595OrigAMI-1P1/P2recruitingA Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer

Advanced Malignant Tumors (1)

NCTAcronymPhaseStatusTitle
NCT05235542P1/P2completedA Phase Ib/II Study of AK104 and AK117 in Combination With or Without Chemotherapy in Advanced Malignant Tumors

Childhood CNS Tumor (1)

NCTAcronymPhaseStatusTitle
NCT03554707Early P1withdrawnSGT-53 in Children With Recurrent or Progressive CNS Malignancies

Cancer of Rectum (1)

NCTAcronymPhaseStatusTitle
NCT05358704CRAFTERP2suspendedPreoperative ChemoRadiation And FOLFOXIRI for Rectal Cancer (CRAFTER) for Rectal Cancer

Stage IV Esophagus Squamous Cell Carcinoma (1)

NCTAcronymPhaseStatusTitle
NCT05322499P2unknownPhase II Clinical Study of Camrelizumab Combined With Chemotherapy or Anlotinib in Advanced Esophageal Squamous Cell Cancer

Recurrent Medulloblastoma (1)

NCTAcronymPhaseStatusTitle
NCT04743661P2active not recruiting131I-Omburtamab, in Recurrent Medulloblastoma and Ependymoma

Rectal Cancer Stage III (1)

NCTAcronymPhaseStatusTitle
NCT05148767P4recruitingUGT1A1-Based Irinotecan Therapy for Locally Advanced Rectal Cancer

Recurrent Glioblastoma (1)

NCTAcronymPhaseStatusTitle
NCT05201326P1unknownIrinotecan And Bevacizumab Combined With Re-radiotherapy in Recurrent Glioblastoma

Esophageal Squamous Cell Carcinomas (1)

NCTAcronymPhaseStatusTitle
NCT05022654P2active not recruitingSI-B001 Combined With Irinotecan in the Treatment of Recurrent Metastatic Esophageal Squamous Cell Carcinoma.

Locally Advanced Pancreatic Ductal Adenocarcinoma (1)

NCTAcronymPhaseStatusTitle
NCT04821284P1/P2active not recruitingSonoporation and Chemotherapy for the Treatment of Pancreatic Cancer

Advanced Metastatic Colorectal Cancer (1)

NCTAcronymPhaseStatusTitle
NCT05160896P2unknownSALIRI Based Regimen as First-line Treatment for Advanced Metastatic Colorectal Cancer

Pancreatic Cancer Non-resectable (1)

NCTAcronymPhaseStatusTitle
NCT05047991P2unknownStudy of Irinotecan Liposome Injection-containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma

Gastroesophageal Junction Adenocarcinoma (1)

NCTAcronymPhaseStatusTitle
NCT04808791GEJP2completediTTo for Treatment Naive Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

Metastatic Lung Small Cell Carcinoma (1)

NCTAcronymPhaseStatusTitle
NCT04514497P1active not recruitingTesting the Addition of an Anti-cancer Drug, BAY 1895344, to Usual Chemotherapy for Advanced Stage Solid Tumors, With a Specific Focus on Patients With Small Cell Lung Cancer, Poorly Differentiated Neuroendocrine Cancer, and Pancreatic Cancer

Mismatch Repair-proficient (1)

NCTAcronymPhaseStatusTitle
NCT05160727P2unknownRadiotherapy Combined With Tislelizumab and Irinotecan in MSS/pMMR Recurrence and Metastatic Colorectal Cancer

Advanced Neuroendocrine Carcinoma (1)

NCTAcronymPhaseStatusTitle
NCT05015621P3unknownA Phase 3 Study to Evaluate Surufatinib Plus Toripalimab in the Treatment of Advanced Neuroendocrine Carcinoma

Advanced Lung Carcinoma (1)

NCTAcronymPhaseStatusTitle
NCT04924192P2terminatedA Clinical Study of TQB3616 Capsules Combined With Anlotinib Hydrochloride Capsules or Standard Chemotherapy Second-line and Above in the Treatment of Advanced Lung Cancer

High-risk Locally Advanced Colorectal Cancer (1)

NCTAcronymPhaseStatusTitle
NCT05018182P2unknownFOLFOXIRI for Neoadjuvant Treatment of High-risk Locally Advanced Colorectal Cancer

Metastatic Colorectal Adenocarcinoma (1)

NCTAcronymPhaseStatusTitle
NCT05312398P2active not recruitingCAPRI 2 GOIM Study: Investigate the Efficacy and Safety of a Bio-marker Driven Cetuximab-based Treatment Regimen

Gastro-Oesophageal Cancer (1)

NCTAcronymPhaseStatusTitle
NCT04879368INTEGRATEIIbP3completedRegoNivo vs Standard of Care Chemotherapy in AGOC

Advanced Breast Cancer (1)

NCTAcronymPhaseStatusTitle
NCT04728035P1completedStudy of Irinotecan Liposome Injection in Patients With Advanced Breast Cance

Liver and Intrahepatic Bile Duct Carcinoma (1)

NCTAcronymPhaseStatusTitle
NCT04251715P2active not recruitingmFOLFIRINOX Followed by Hepatic Arterial Infusion of Floxuridine and Dexamethasone With Systemic mFOLFIRI for Unresectable Liver-dominant Intrahepatic Cholangiocarcinoma

Refractory or Recurrent Neuroblastoma in Children (1)

NCTAcronymPhaseStatusTitle
NCT04842526P2unknownEfficacy and Safety of Anlotinib, Irinotecan and Temozolomide in the Treatment of Refractory or Recurrent Neuroblastoma in Children: an Open, Single Arm, Single Center, Phase II Clinical Study

Locally Advanced Cervical Carcinoma (1)

NCTAcronymPhaseStatusTitle
NCT04789941P2unknownHow To Evaluate The Efficiency And Safety Of Neoadjuvant Chemotherapy In Locally Advanced Cancer Cervix

Platinum-Resistant Fallopian Tube Carcinoma (1)

NCTAcronymPhaseStatusTitle
NCT04753216P2completedIrinotecan Liposome and Bevacizumab for the Treatment of Platinum Resistant, Recurrent, or Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Clinical Stage III Gastric Cancer AJCC v8 (1)

NCTAcronymPhaseStatusTitle
NCT03641313P2active not recruitingBerzosertib and Irinotecan in Treating Patients With Progressive, Metastatic, or Unresectable TP53 Mutant Gastric or Gastroesophageal Junction Cancer

Relapsed Solid Tumor (1)

NCTAcronymPhaseStatusTitle
NCT04238819LY2835219P1/P2completedA Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma

Metastatic Gastric Cancer (1)

NCTAcronymPhaseStatusTitle
NCT04358354P3unknownTriplet Combination of Cytotoxics as First-line Treatment for Metastatic Gastric Cancer

Anaplastic Kidney Wilms Tumor (1)

NCTAcronymPhaseStatusTitle
NCT04322318P2recruitingA Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

Pancreatic Adenosquamous Carcinoma (1)

NCTAcronymPhaseStatusTitle
NCT04340141P3active not recruitingTesting the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic Cancer

Locally Advanced Pancreatic Carcinoma(LAPC) (1)

NCTAcronymPhaseStatusTitle
NCT03861702P2completedLiposomal Irinotecan in Combination With Oxaliplatin, Leucovorin, and 5-fluorouracil for Patients With Locally Advanced Pancreatic Carcinoma:

Clinical Stage IV Gastric Cancer AJCC v8 (1)

NCTAcronymPhaseStatusTitle
NCT04329494P1recruitingPIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer

Carcinoma, Pancreatic Ductal (1)

NCTAcronymPhaseStatusTitle
NCT03403101P2unknownThe Combination Chemotherapy of SIRIOX as First- or Second-Line Chemotherapy for Pancreatic Cancer

P1b: Advanced Solid Tumors (1)

NCTAcronymPhaseStatusTitle
NCT04492033ABL001P1/P2terminatedA Study of CTX-009 (ABL001) in Combination With Irinotecan or Paclitaxel in Advanced or Metastatic Solid Tumor Patients

Refractory Cancer (1)

NCTAcronymPhaseStatusTitle
NCT04239092P1terminated9-ING-41 in Pediatric Patients With Refractory Malignancies.

Metastatic Small Intestinal Adenocarcinoma (1)

NCTAcronymPhaseStatusTitle
NCT04205968P2recruitingRamucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers

Unresectable Metastatic Colorectal Carcinoma (1)

NCTAcronymPhaseStatusTitle
NCT04508452P2unknownA Phase II Prospective Trial of mXELOXIRI Reintroduction for mCRC

Locally Advanced Unresectable Gastric Adenocarcinoma (1)

NCTAcronymPhaseStatusTitle
NCT03739801P1/P2withdrawnMM-398 and Ramucirumab in Treating Patients With Gastric Cancer or Gastroesophageal Junction Adenocarcinoma

BRAF V600E Negative (1)

NCTAcronymPhaseStatusTitle
NCT04117945P2active not recruitingRegorafenib, With Cetuximab or Panitumumab, for the Treatment of Unresectable, Locally Advanced, or Metastatic Colorectal Cancer

Glioblastoma, Recurrent (1)

NCTAcronymPhaseStatusTitle
NCT04267978P2recruitingStudy of Recombinant Human Endostatin Combined with Temozolomide and Irinotecan in Recurrent Gliomas

Cancer Colorectal (1)

NCTAcronymPhaseStatusTitle
NCT04189055CETIDYLP2unknownCetuximab as Salvage Therapy in Patients With Neo Wild-type RAS/RAF Metastatic Colorectal Cancer With Liver Metastases.

HER-2 Protein Overexpression (1)

NCTAcronymPhaseStatusTitle
NCT04215159BIOs-HerP2unknownTrastuzumab Biosimilar (Samfenet®) Plus Treatment of Physician's Choice (TPC) in Patients With HER2-positive Solid Tumor

Rectal Neoplasm Malignant Carcinoma (1)

NCTAcronymPhaseStatusTitle
NCT04227886N/AunknownStudy on Predictive Biomarkers of Neoadjuvant Chemoradiotherapy for Rectal Cancer

Gastric Carcinoma Stage IV (1)

NCTAcronymPhaseStatusTitle
NCT04442984IRIGAP2unknownFOLFOX6 Versus mFOLFIRINOX as First Line Chemotherapy in Metastatic Gastric Cancer or Esophagogastric Junction Adenocarcinoma (Type II-III)

Peritoneal Cancer (1)

NCTAcronymPhaseStatusTitle
NCT04088786P1completedPhase I Trial HIPEC With Nal-irinotecan

Advanced Bile Duct Carcinoma (1)

NCTAcronymPhaseStatusTitle
NCT04072445P2completedTrifluridine/Tipiracil and Irinotecan for the Treatment of Advanced Refractory Biliary Tract Cancer

High Risk Neuroblastoma (1)

NCTAcronymPhaseStatusTitle
NCT03794349P2active not recruitingIrinotecan Hydrochloride, Temozolomide, and Dinutuximab With or Without Eflornithine in Treating Patients With Relapsed or Refractory Neuroblastoma

Locally Advanced Digestive System Neuroendocrine Carcinoma (1)

NCTAcronymPhaseStatusTitle
NCT03736720P2terminatedLiposomal Irinotecan, Fluorouracil and Leucovorin in Treating Patients With Refractory Advanced High Grade Neuroendocrine Cancer of Gastrointestinal, Unknown, or Pancreatic Origin

Gastrointestinal Neuroendocrine Tumor (1)

NCTAcronymPhaseStatusTitle
NCT03963193P2unknownEtoposide/Cisplatin Compared With Irinotecan/Cisplatin for Advanced Gastrointestinal Neuroendocrine Tumor G3 Type

Cancer of Pancreas (1)

NCTAcronymPhaseStatusTitle
NCT03607643P1/P2unknownA Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies

Recurrent Colorectal Cancer (1)

NCTAcronymPhaseStatusTitle
NCT04499586P2unknownA Study of Radiotherapy Combined With Raltitrexed and Irinotecan in Metastatic or Locally Recurrent Colorectal Cancer

Head & Neck Cancer (1)

NCTAcronymPhaseStatusTitle
NCT03712397P2completedNanoliposomal Irinotecan in Head & Neck and Esophagus After Prior Platinum-based Chemotherapy or Chemoradiotherapy

Resectable Gastric and Gastroesophageal Junction Adenocarcinoma (1)

NCTAcronymPhaseStatusTitle
NCT03773367INTENSEP2active not recruitingIrinotecan-based Triplet (FOLFOXIRI) as Perioperative Treatment in Resectable Gastric and Gastroesophageal Junction Adenocarcinoma.

Advanced Esophageal Squamous Cell Cancer (1)

NCTAcronymPhaseStatusTitle
NCT03732508P2unknownSHR-1316 in Combination With Chemotherapy in Patients With Esophageal Squamous Cell Cancer

Metastatic Biliary Tract Carcinoma (1)

NCTAcronymPhaseStatusTitle
NCT03337087P1/P2unknownLiposomal Irinotecan, Fluorouracil, Leucovorin Calcium, and Rucaparib in Treating Patients With Metastatic Pancreatic, Colorectal, Gastroesophageal, or Biliary Cancer

Colorectal Neoplasms, Malignant (1)

NCTAcronymPhaseStatusTitle
NCT03608046AVETUXIRIP2unknownAvelumab Combined With Cetuximab and Irinotecan for Treatment Refractory Metastatic Colorectal Microsatellite Stable Cancer

Intrahepatic Cholangiocarcinoma (1)

NCTAcronymPhaseStatusTitle
NCT03771846P3unknownHAIC Versus Systemic Chemotherapy for Unresectable ICC

mCRC (1)

NCTAcronymPhaseStatusTitle
NCT03567629P2unknownEvaluate the Efficacy of Irinotecan Versus Oxaliplatin in the First-line Treatment of Refractory Metastatic Colorectal Cancer

Childhood Hepatocellular Carcinoma (1)

NCTAcronymPhaseStatusTitle
NCT03533582P3active not recruitingCisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery

Locally Advanced Pancreatic Cancer (1)

NCTAcronymPhaseStatusTitle
NCT03468335PREDICTP3completed2nd-line Therapy With Nal-IRI After Gem/Nab-pac in Advanced Pancreatic Cancer - Predictive Role of 1st-line Therapy

Locally Advanced or Metastatic Pancreatic Cancer (1)

NCTAcronymPhaseStatusTitle
NCT03443492PancreasP2completedSLOG vs mFOLFIRINOX as the First-line Treatment in Locally Advanced Uncresectable or Metastatic Pancreatic Cancer

Refractory or Recurrent Solid Tumors (1)

NCTAcronymPhaseStatusTitle
NCT03245450P1/P2completedStudy Evaluating the Safety and Efficacy of Eribulin Mesilate in Combination With Irinotecan Hydrochloride in Children With Refractory or Recurrent Solid Tumors

Overall Survival (1)

NCTAcronymPhaseStatusTitle
NCT03726021P2completedStudy of Irinotecan,Oxaliplatin, and S1 in Patients With Advanced Pancreatic Cancer

Second-line Treatment for Locally Advanced or Metastatic Pancreatic Cancer After Treatment Failure With Gemcitabine-based Therapy (1)

NCTAcronymPhaseStatusTitle
NCT05074589P3completedIrinotecan Liposome in Combination With 5-FU/LV Versus 5-FU/LV in Second-line Therapy for Gemcitabine-Refractory Pancreatic Cancer

Ewing's Tumor Metastatic (1)

NCTAcronymPhaseStatusTitle
NCT03416517P1/P2unknownAnlotinib and Irinotecan for Ewing Sarcoma

Solid Tumor, Unspecified, Adult (1)

NCTAcronymPhaseStatusTitle
NCT03318445P1completedRucaparib and Irinotecan in Cancers With Mutations in DNA Repair

Recurrent Lymphoma (1)

NCTAcronymPhaseStatusTitle
NCT03323034P1completedPevonedistat, Irinotecan, and Temozolomide in Treating Patients With Recurrent or Refractory Solid Tumors or Lymphoma

Diffuse Intrinsic Pontine Glioma (1)

NCTAcronymPhaseStatusTitle
NCT03086616DIPGP1completedCED With Irinotecan Liposome Injection Using Real Time Imaging in Children With Diffuse Intrinsic Pontine Glioma (DIPG) (PNOC 009)

GastroEsophageal Cancer (1)

NCTAcronymPhaseStatusTitle
NCT03279237P1completedA Pilot Study of FOLFIRINOX in Combination With Neoadjuvant Radiation for Gastric and GE Junction Cancers

Childhood Solid Neoplasm (1)

NCTAcronymPhaseStatusTitle
NCT02975882P1completedNanoparticle Albumin-Bound Rapamycin, Temozolomide, and Irinotecan Hydrochloride in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors

Colon Cancer Liver Metastasis (1)

NCTAcronymPhaseStatusTitle
NCT03175016DEBIRI-CRLMP2/P3unknownIrinotecan-Eluting Bead (DEBIRI) for Patients With Liver Metastases From Colorectal Cancer

High Grade Malignant Neuroendocrine Carcinoma (Diagnosis) (1)

NCTAcronymPhaseStatusTitle
NCT03136055P2completedPembrolizumab-based Therapy in Previously Treated High Grade Neuroendocrine Carcinomas

Malignant Solid Neoplasm (1)

NCTAcronymPhaseStatusTitle
NCT02631733P1completedLiposomal Irinotecan and Veliparib in Treating Patients With Solid Tumors

Metastatic Gastric Adenocarcinoma (1)

NCTAcronymPhaseStatusTitle
NCT03116555P2unknownApatinib Plus Irinotecan as Second-line Treatment in AGC or EGJA

Colon Cancer (High-risk Stage III: pT4N1 or pT1 to 4 N2) (1)

NCTAcronymPhaseStatusTitle
NCT02967289IROCASP3completedIRinotecan and Oxaliplatin for Colon Cancer in Adjuvant Setting

Colorectal Adenocarcinoma Metastatic to the Liver (1)

NCTAcronymPhaseStatusTitle
NCT03069950P2withdrawnStudy of Chemotherapy With or Without Hepatic Arterial Infusion for Patients With Unresectable Metastatic Colorectal Cancer to the Liver

ColoRectal Cancer (1)

NCTAcronymPhaseStatusTitle
NCT03053167P2unknownIrinotecan Plus Raltitrexed as Second-line Treatment in Advanced Colorectal Cancer Patients

Cancer, Solid Tumor (1)

NCTAcronymPhaseStatusTitle
NCT02937116P1completedFirst in Human Study of IBI308 in Chinese Subjects With Advanced Solid Tumors

BRAF V600E-mutant Metastatic Colorectal Cancer (1)

NCTAcronymPhaseStatusTitle
NCT02928224BEACON CRCP3completedStudy of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer

Malignant Solid Tumor (1)

NCTAcronymPhaseStatusTitle
NCT02801097PAYLOADP1terminatedRRx-001 in Combination With Irinotecan in Metastatic or Advanced Cancer (PAYLOAD)

Pediatric Cancer (1)

NCTAcronymPhaseStatusTitle
NCT02813135ESMARTP1/P2recruitingEuropean Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory Tumors

High-grade Glioma (1)

NCTAcronymPhaseStatusTitle
NCT02848794P1/P2unknownApatinib and Irinotecan in Treating Patients With Recurrent High-grade Glioma

Alveolar Rhabdomyosarcoma (1)

NCTAcronymPhaseStatusTitle
NCT02567435P3active not recruitingCombination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma

Ductal Adenocarcinoma of Pancreas (1)

NCTAcronymPhaseStatusTitle
NCT02626520P2terminatedPhase 2 Evaluation of Multi-modality Algorithm for Non-metastatic Adenocarcinoma of Pancreas or Ampulla

Pineoblastoma (1)

NCTAcronymPhaseStatusTitle
NCT02596828P2completedProspective Pilot Trial to Assess a Multimodal Molecular Targeted Therapy in Children, Adolescent and Young Adults With Relapsed or Refractory High-grade Pineoblastoma

Recurrent Anaplastic Astrocytoma (1)

NCTAcronymPhaseStatusTitle
NCT02192359P1active not recruitingCarboxylesterase-Expressing Allogeneic Neural Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas

Unresectable, Recurrent, Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma (1)

NCTAcronymPhaseStatusTitle
NCT02625623P3completedAvelumab in Third-Line Gastric Cancer (JAVELIN Gastric 300)

Unresectable Advanced Cancer (1)

NCTAcronymPhaseStatusTitle
NCT02640365DOUBLIRIP1completedA Dose Escalation Study of MM-398 Plus Irinotecan in Patients With Unresectable Advanced Cancer

Advanced Solid Tumours (1)

NCTAcronymPhaseStatusTitle
NCT02588105AToMP1completedStudy to Assess the Safety and Preliminary Efficacy of AZD0156 at Increasing Doses Alone or in Combination With Other Anti-cancer Treatment in Patients With Advanced Cancer

Relapsed Solid Tumors (1)

NCTAcronymPhaseStatusTitle
NCT02596503P1completedA Study of Eribulin in Combination With Oral Irinotecan for Adolescent and Young Adult Patients With Relapsed or Refractory Solid Tumors

Biliary Tract Neoplasms (1)

NCTAcronymPhaseStatusTitle
NCT02558959P2completedSecond-line Irinotecan and Capecitabine Versus Irinotecan for Gemcitabine and Cisplatin Refractory Biliary Tract Cancer

Stage IV Non-small Cell Lung Cancer (NSCLC) (1)

NCTAcronymPhaseStatusTitle
NCT02312622P2completedPhase 2 Etirinotecan Pegol in Refractory Brain Metastases & Advanced Lung Cancer / Metastatic Breast Cancer

Small Cell Carcinoma (1)

NCTAcronymPhaseStatusTitle
NCT02489903QUADRUPLE THREATP2completedRRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)

Stage IVA Colorectal Cancer (1)

NCTAcronymPhaseStatusTitle
NCT02573220P1withdrawnIrinotecan Hydrochloride With FOLFIRI and Cetuximab as First-Line Therapy in Treating Patients With RAS Wild-Type Colorectal Cancer

Biliary Tract Neoplasm (1)

NCTAcronymPhaseStatusTitle
NCT02527824P2unknownStudy of Oxaliplatin, Irinotecan, and S-1 in Biliary Tract Cancer

Childhood Solid Tumors (1)

NCTAcronymPhaseStatusTitle
NCT02392793P1completedTalazoparib Plus Irinotecan With or Without Temozolomide in Children With Refractory or Recurrent Solid Malignancies

Advanced Nonhematologic Malignancies (1)

NCTAcronymPhaseStatusTitle
NCT02327169P1completedA Study MLN2480 in Combination With MLN0128 or Alisertib, or Paclitaxel, or Cetuximab, or Irinotecan in Adult Participants With Advanced Nonhematologic Malignancies

Adenocarcinoma of Unknown Primary (1)

NCTAcronymPhaseStatusTitle
NCT02333188P1completedGenetic Analysis-Guided Dosing of FOLFIRABRAX in Treating Patients With Advanced Gastrointestinal Cancer

Inoperable Gastric Cancer (1)

NCTAcronymPhaseStatusTitle
NCT03067792P3completedFOLFIRI Versus Docetaxel and Cisplatin as a Second-line Chemotherapy After Failure of First-line Chemotherapy in Advanced Gastric Cancer

Esophageal Adenocarcinoma (1)

NCTAcronymPhaseStatusTitle
NCT02366819P4suspendedGenetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer

Resectable Prancreas Carcinoma (1)

NCTAcronymPhaseStatusTitle
NCT02172976P2/P3completedRandomized Multicenter Phase II/III Study With Adjuvant Gemcitabine Versus Neoadjuvant / Adjuvant FOLFIRINOX for Resectable Pancreas Carcinoma

Rectal Adenocarcinoma (1)

NCTAcronymPhaseStatusTitle
NCT02314182GRECCAR8P3completedGRECCAR 8: Primary Tumor Resection in Rectal Cancer With Unresectable Metastasis

Lung Neoplasms, Non-Small Cell Lung Cancer (1)

NCTAcronymPhaseStatusTitle
NCT02275806P2terminatedCisplatin/Irinotecan With Concurrent Radiation for Inoperable NSCLC

High Grade Glioma (1)

NCTAcronymPhaseStatusTitle
NCT02022644P1completedStudy of Convection-Enhanced, Image-Assisted Delivery of Liposomal-Irinotecan In Recurrent High Grade Glioma

Stage IIIB, IV, Recurrent, and Metastatic Breast Cancer (1)

NCTAcronymPhaseStatusTitle
NCT02030678P2unknownA Phase II Study of Irinotecan in 3 Line or More Therapy in Local Recurrence or Metastatic Breast Cancer

Solid Tumor Malignancy (1)

NCTAcronymPhaseStatusTitle
NCT05177276P1/P2withdrawnSelinexor Combination Ph 1 Study

Pancreatic Metastatic Cancer (1)

NCTAcronymPhaseStatusTitle
NCT02143219PAMELA70P2completedEfficacy and Tolerance Evaluation in FOLFIRINOX Dose Adjusted in Elderly Patients With a Metastatic Pancreatic Cancer

Medulloblastoma Recurrent (1)

NCTAcronymPhaseStatusTitle
NCT01356290MEMMATP2recruitingAntiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors

Digestive Cancer (1)

NCTAcronymPhaseStatusTitle
NCT02387138SIRINOXP1completedA Trial Assessing Several Schedules of Oral S-1 in Combination With a Fixed Dose of Oxaliplatin and Irinotecan

Pediatric Oncology (1)

NCTAcronymPhaseStatusTitle
NCT02085148P1completedA Phase I Dose Finding Study in Children With Solid Tumors Recurrent or Refractory to Standard Therapy

Resectable Pancreatic Cancer (1)

NCTAcronymPhaseStatusTitle
NCT01992705GCC 1324Early P1completedBorderline Pancreas Study: FOLFIRINOX +SBRT

Central Nervous System Embryonal Tumor With Rhabdoid Features (1)

NCTAcronymPhaseStatusTitle
NCT02095132P1/P2completedAdavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors

Recurrent Childhood Soft Tissue Sarcoma (1)

NCTAcronymPhaseStatusTitle
NCT02509234TrIPReSarcN/AunknownTrabectedin and Irinotecan for Refractory Pediatric Sarcomas

Advanced Gastrointestinal Cancer (1)

NCTAcronymPhaseStatusTitle
NCT02024607P1/P2completedA Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Advanced Gastrointestinal Cancer

Recurrent or Refractory Solid Tumors (1)

NCTAcronymPhaseStatusTitle
NCT02013336P1unknownPhase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors

First Line Metastatic Colorectal Cancer (1)

NCTAcronymPhaseStatusTitle
NCT01963182IriGenP2completedIndividualization of Dosage of Irinotecan in the FOLFIRI According to the Genetic Polymorphism of UGT1A1 in the First Line Treatment of Metastatic Colorectal Cancer

Pilomyxoid Astrocytoma (1)

NCTAcronymPhaseStatusTitle
NCT01837862P1/P2completedA Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas

Neoplasm Malignant (1)

NCTAcronymPhaseStatusTitle
NCT01930552P1completedA Phase I Study of Aflibercept Plus FOLFIRI (Irinotecan, 5-Fluorouracil, and Leucovorin) in Chinese Patients With Advanced Solid Malignancies

High-risk Medulloblastoma (1)

NCTAcronymPhaseStatusTitle
NCT02025881HR MB-5P1/P2terminatedStudy of Sequential High-dose Chemotherapy in Children With High Risk Medulloblastoma

Recurrent Small Cell Lung Carcinoma (1)

NCTAcronymPhaseStatusTitle
NCT01876446P2completedPegylated Irinotecan NKTR 102 in Treating Patients With Relapsed Small Cell Lung Cancer

Incurable Colorectal Cancer (1)

NCTAcronymPhaseStatusTitle
NCT02071069P2unknownEfficacy and Tolerance of Maintenance Therapy in Patients With Incurable Advanced Colorectal Cancer

Colorectal Cancer Liver Metastases (1)

NCTAcronymPhaseStatusTitle
NCT02086656COI-BP2completedPERIOPERATIVE TREATMENT WITH COI-B (CAPECITABINE, OXALIPLATIN, IRINOTECAN AND BEVACIZUMAB) OF HIGH RISK OR BORDERLINE RESECTABLE COLORECTAL CANCER LIVER METASTASES

Newly Diagnosed Ewing Sarcoma (1)

NCTAcronymPhaseStatusTitle
NCT01864109P2active not recruitingIrinotecan and Temozolomide in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Patients With Newly Diagnosed Ewing Sarcoma

Recurrent Non-Small Cell Lung Carcinoma (1)

NCTAcronymPhaseStatusTitle
NCT01935947P2terminatedAzacitidine and Entinostat Before Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer

Astrocytoma, Oligoastrocytoma, Mixed (1)

NCTAcronymPhaseStatusTitle
NCT01999270P1completedEvaluation of FDOPA-PET/MRI in Pediatric Patients With CNS Tumors

Colonic Neoplasms (1)

NCTAcronymPhaseStatusTitle
NCT01826396P2unknownStandard and High Dose Irinotecan Based on UGT1A1 Genotype for First-line Treatment of Locally Advanced Colon Cancer

BRAF NP_004324.2:p.V600X (1)

NCTAcronymPhaseStatusTitle
NCT01787500P1completedVemurafenib, Cetuximab, and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or That Cannot Be Removed by Surgery

Ganglioneuroblastoma (1)

NCTAcronymPhaseStatusTitle
NCT01767194P2completedIrinotecan Hydrochloride and Temozolomide With Temsirolimus or Dinutuximab in Treating Younger Patients With Refractory or Relapsed Neuroblastoma

Metastatic Non Small Cell Lung Cancer (1)

NCTAcronymPhaseStatusTitle
NCT01773109NKTR-102P2completedEtirinotecan Pegol (NKTR-102) in NSCLC

Central Nervous System Metastases (1)

NCTAcronymPhaseStatusTitle
NCT01939483N/AwithdrawnA Pilot Study of Irinotecan in Patients With Breast Cancer and CNS Metastases

Metastatic Colorectal Cancer Patients With KRAS Mutated Tumors (1)

NCTAcronymPhaseStatusTitle
NCT01715441NEXIRI2P2completedSorafenib in Combination With Irinotecan in Metastatic Colorectal Cancer Patients With KRAS Mutated Tumors

Anaplastic Astrocytomas (1)

NCTAcronymPhaseStatusTitle
NCT01663012P2completedPhase II NKTR-102 In Bevacizumab-Resistant High Grade Glioma

Small Cell Carcinoma of Lung (1)

NCTAcronymPhaseStatusTitle
NCT01635400P2unknownStudy of Relationship Between UGT1A1 Gene Polymorphism and Toxicity and Efficacy of Irinotecan in Small Cell Lung Cancer

Gastrointestinal Neoplasms (1)

NCTAcronymPhaseStatusTitle
NCT01693445P1completedS-1, Oxaliplatin, and Irinotecan for Advanced Gastrointestinal Cancer

Carcinoma of Esophagus (1)

NCTAcronymPhaseStatusTitle
NCT01608464P2terminatedPre-op Chemo-RT w/CDDP/5FU vs Chemo w/ Docetaxel/Irinotecan in PET Non Responder Resectable Esophagus Cancer

Brain Tumor (1)

NCTAcronymPhaseStatusTitle
NCT01535183P2unknownIrinotecan Combination Chemotherapy for Refractory or Relapsed Brain Tumor in Children and Adolescents

RHABDOMYOSARCOMA (1)

NCTAcronymPhaseStatusTitle
NCT01355445VIT-0910P2completedVincristine and Irinotecan With or Without Temozolomide in Children and Adults With Refractory/Relapsed Rhabdomyosarcoma

Rhabdomyosarcoma and Other Soft Tissue Sarcomas (1)

NCTAcronymPhaseStatusTitle
NCT01518413P1completedDose Escalation Study of Sorafenib and Irinotecan Combination Therapy in Pediatric Patients With Solid Tumors

Progression Free Survival of the Treatment (1)

NCTAcronymPhaseStatusTitle
NCT01480986P2completedIPO-NEC Trial:Study on the Efficacy and Safety Using Sequential IP Therapy and Oct Lar in the Treatment of Advanced GI NEC

Recurrent Colon Carcinoma (1)

NCTAcronymPhaseStatusTitle
NCT01383343P1completedSorafenib Tosylate, Bevacizumab, Irinotecan Hydrochloride, Leucovorin Calcium, and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer

Bone Cancer (1)

NCTAcronymPhaseStatusTitle
NCT01313884P2terminatedCyclophosphamide, Doxorubicin, Vincristine w/ Irinotecan and Temozolomide in Ewings Sarcoma

Adenocarcinoma of Pancreas (1)

NCTAcronymPhaseStatusTitle
NCT01359007P2terminatedFOLFIRINOX in Patients With Inoperable Pancreatic Cancer

Neoplasm Metastases (1)

NCTAcronymPhaseStatusTitle
NCT01336985P1terminatedSafety and Pharmacokinetics of Treating Liver Cancer With Drug-Eluting Beads

KRAS Mutant Metastatic Colorectal Cancer (1)

NCTAcronymPhaseStatusTitle
NCT01274624P1completedStudy of REOLYSIN® in Combination With FOLFIRI and Bevacizumab in FOLFIRI Naive Patients With KRAS Mutant Metastatic Colorectal Cancer

Acute Leukemia (1)

NCTAcronymPhaseStatusTitle
NCT01239485P1unknownStudy of IRNEA (Irinotecan, Etoposide, Cytarabine) for Refractory or Relapsed Acute Leukemia in Children and Adolescents

Central Nervous System Neoplasm (1)

NCTAcronymPhaseStatusTitle
NCT01217437P2completedTemozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors

Gastrointestinal Neoplasm (1)

NCTAcronymPhaseStatusTitle
NCT01129310IXOGoo1P2completedFirst Line Study of Irinotecan, Capecitabine and Oxaliplatin in Metastatic Gastric or Gastroesophageal Cancer.

Extensive-stage Small Cell Lung Cancer (1)

NCTAcronymPhaseStatusTitle
NCT02323737P2completedPhase II Study of Irinotecan and Cisplatin in Extensive-stage Small Cell Lung Cancer

Estrogen Receptor Negative (ER-Negative) Breast Cancer (1)

NCTAcronymPhaseStatusTitle
NCT01173497P2completedA Study Evaluating INIPARIB in Combination With Chemotherapy to Treat Triple Negative Breast Cancer Brain Metastasis

Recurrent Malignant Glioma (1)

NCTAcronymPhaseStatusTitle
NCT01144988AVIRMA01-09P2unknownAvastin / Irinotecan in Patients With Recurrent or Progressive Malignant Glioma

Ovarian Cancer (1)

NCTAcronymPhaseStatusTitle
NCT01091259P2completedIrinotecan and Bevacizumab for Recurrent Ovarian Cancer

Malignant Glioma of Brain (1)

NCTAcronymPhaseStatusTitle
NCT01017653P2terminatedPanitumumab and Irinotecan for Malignant Gliomas

Gastro-Intestinal Cancer (1)

NCTAcronymPhaseStatusTitle
NCT01046864FOLFIRIP1completedCombination of Brivanib With 5-Fluorouracil/Leucovorin (5FU/LV) and 5-Fluorouracil/Leucovorin/Irinotecan (FOLFIRI)

Brain Cancer (1)

NCTAcronymPhaseStatusTitle
NCT01014767P3terminatedIntercontinental Multidisciplinary Registry and Treatment Optimization Study for Choroid Plexus Tumors

Pediatric High Risk Gliomas (1)

NCTAcronymPhaseStatusTitle
NCT01574092P2completedIrinotecan in Combination With Cisplatin in Pediatric Patients With Unfavorable Prognosis Gliomas

PRETEXT I Hepatoblastoma (1)

NCTAcronymPhaseStatusTitle
NCT00980460P3active not recruitingRisk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer

Advanced Esophageal Squamous Carcinoma (1)

NCTAcronymPhaseStatusTitle
NCT01051765P2unknownIrinotecan Combined With Cisplatin as 1st Line Treatment for Esophageal Squamous Cell Cancer : a Single Center Prospective Clinical Trial

Newly Diagnosed High-Grade Gliomas (1)

NCTAcronymPhaseStatusTitle
NCT00890786Early P1completedA Study of Bevacizumab Therapy in Patients With Newly Diagnosed High-Grade Gliomas and Diffuse Intrinsic Pontine Gliomas

Unresectable Metastatic Colo-rectal Cancer (1)

NCTAcronymPhaseStatusTitle
NCT00816777PARAGONP1/P2terminatedChemoembolization, Irinotecan Bead, Second Line Chemotherapy Treatment of Unresectable Metastatic Colorectal Cancer

Advanced Non-Small Cell Lung Cancer (1)

NCTAcronymPhaseStatusTitle
NCT00874328IPP1/P2unknownA Study of TS-1 Plus Irinotecan and Cisplatin (IP) for Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)

Central Nervous System Tumors (1)

NCTAcronymPhaseStatusTitle
NCT00876993CNSP1completedStudy of Irinotecan and Bevacizumab With Temozolomide in Refractory/Relapsed Central Nervous System (CNS) Tumors

Hepatoma (1)

NCTAcronymPhaseStatusTitle
NCT00861783P1completedSafety of ON 01910.Na and Irinotecan or ON 01910.Na and Oxaliplatin in Patients With Hepatoma

Metastatic Colorectal Cancer (MCRC) (1)

NCTAcronymPhaseStatusTitle
NCT00594984P1/P2completedPhase I/II Combination With Irinotecan- Erbitux

Unresectable or Metastatic Colorectal Cancer (1)

NCTAcronymPhaseStatusTitle
NCT00668863P2completedStudy Of Sunitinib With FOLFIRI In Colorectal Cancer

Colorectal, Cancer (1)

NCTAcronymPhaseStatusTitle
NCT00569335SIRBP2completedPhase II Trial of Combination Therapy With S-1, Irinotecan, and Bevacizumab (SIRB) in Patients With Unresectable or Recurrent Colorectal Cancer

Colorecal Neoplasms (1)

NCTAcronymPhaseStatusTitle
NCT00506571TIROX2P2unknownPhase II Study of Irinotecan,Oxaliplatin Plus TS-1 in Untreated Metastatic Colorectal Cancer

Neoplasms, Colorectal (1)

NCTAcronymPhaseStatusTitle
NCT00540943P1completedStudy of Pazopanib, Irinotecan and Cetuximab in Combination to Treat 2nd Line Metastatic Colorectal Cancer

Small Intestine Adenocarcinoma (1)

NCTAcronymPhaseStatusTitle
NCT00433550P2completedIrinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel Cancer

Brain Neoplasms (1)

NCTAcronymPhaseStatusTitle
NCT00463203P2completedBevacizumab and Irinotecan for Patients With Primary Brain Tumors and Progression After Standard Therapy

Adult Glioblastoma (1)

NCTAcronymPhaseStatusTitle
NCT00433381P2completedBevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma

Non Small Cell Lung Cancer (1)

NCTAcronymPhaseStatusTitle
NCT00614965P2completedIrinotecan Plus Cisplatin vs Pemetrexed Plus Cisplatin as 2nd Line in NSCLC Stage IIIB/IV

High-Grade Gliomas (1)

NCTAcronymPhaseStatusTitle
NCT00393094P2terminatedBevacizumab and Irinotecan to Treat Brain Tumors

Childhood Cerebral Anaplastic Astrocytoma (1)

NCTAcronymPhaseStatusTitle
NCT00381797P2completedBevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma

Childhood Renal Cell Carcinoma (1)

NCTAcronymPhaseStatusTitle
NCT00335556P2completedCombination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors

Tumors (1)

NCTAcronymPhaseStatusTitle
NCT00298675P1completedPhase 1/1b Dose Escalation Study Evaluating BSI-201 as a Single Agent and in Combination With Irinotecan in Subjects With Advanced Solid Tumors

Astrocytoma (1)

NCTAcronymPhaseStatusTitle
NCT00360828P2terminatedPhase II Study of Irinotecan HCI for Recurrent Anaplastic Astrocytomas, Mixed Malignant Gliomas, and Oligodendrogliomas

Metastatic (1)

NCTAcronymPhaseStatusTitle
NCT00507091P1completedPhase I Irinotecan, 5-Fluorouracil and Leucovorin Combination

Recurrent Squamous Cell Carcinoma of the Hypopharynx (1)

NCTAcronymPhaseStatusTitle
NCT00103259P2completedBortezomib With or Without Irinotecan in Treating Patients With Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Childhood Burkitt Lymphoma (1)

NCTAcronymPhaseStatusTitle
NCT00101270P1completedOxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas

Non-Hodgkins Lymphoma (1)

NCTAcronymPhaseStatusTitle
NCT00718757P1completedIrinotecan, Vincristine, and Dexamethasone In Children With Relapsed And/Or Refractory Hematologic Malignancies

Lymphomas (1)

NCTAcronymPhaseStatusTitle
NCT00222443P1completedPilot Study Combining Temozolomide, Oncovin, Camptosar and Oral Antibiotic in Children and Adolescents With Recurrent Malignancy

Adenocarcinoma of Esophagus (1)

NCTAcronymPhaseStatusTitle
NCT00165490P2completedCombination Chemotherapy, Radiation Therapy and Surgery for Esophageal Cancer

Rectal Neoplasm (1)

NCTAcronymPhaseStatusTitle
NCT00506623P2unknownPreoperative Chemoradiotherapy With Capecitabine Plus Irinotecan in Rectal Cancer

Uterine Cervical Neoplasms (1)

NCTAcronymPhaseStatusTitle
NCT00136955P2completedIrinotecan Study For Cervical Cancer

Diarrhea (1)

NCTAcronymPhaseStatusTitle
NCT00093353N2003-01P1completedN2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma

Gastrointestinal Carcinoid Tumor (1)

NCTAcronymPhaseStatusTitle
NCT00416767P2completedCombination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors of the Duodenum or Pancreas That Cannot Be Removed By Surgery

Epidermal Growth Factor Receptor (EGFR) Expressing Metastatic Colorectal Cancer (1)

NCTAcronymPhaseStatusTitle
NCT00154102CRYSTALP3completedCetuximab Combined With Irinotecan in First-line Therapy for Metastatic Colorectal Cancer (CRYSTAL)

Rectal Mucinous Adenocarcinoma (1)

NCTAcronymPhaseStatusTitle
NCT00068692P3completedComparison of Adjuvant Chemotherapy Regimens in Treating Stage II/III Rectal Cancer

Neoplasms, Unknown Primary (1)

NCTAcronymPhaseStatusTitle
NCT00193596P3completedGemcitabine/Irinotecan/ZD1839 vs Paclitaxel/Carboplatin/Etoposide/ZD1839 in Carcinoma of Unknown Primary Site

Neoplasm (1)

NCTAcronymPhaseStatusTitle
NCT00143533P1completedPrevention of Diarrhea in Patients Taking IV Irinotecan for Relapsed or Difficult to Treat Pediatric Solid Tumors

Penile Cancer (1)

NCTAcronymPhaseStatusTitle
NCT00066391P2completedIrinotecan and Cisplatin in Treating Patients With Locally Advanced or Metastatic Penile Cancer

Colon Tumors (1)

NCTAcronymPhaseStatusTitle
NCT00180960P2terminatedTreatment of a Cancerous Disease of the Peritoneum With Complete Cytoreductive Surgery and Intraperitoneal Chemohyperthermia

Carcinoma, Hepatocellular (1)

NCTAcronymPhaseStatusTitle
NCT00635323P2completedSafety And Efficacy Of Irinotecan Plus Capecitabine As First-Line Treatment In Asian Subjects With Hepatocellular Carcinoma

Cervix Cancer (1)

NCTAcronymPhaseStatusTitle
NCT00251888P1completedCAmpto-CISplatine Plus Radiotherapy in Advanced Cervix Cancer : Search of Tolerated Maximum Dose of Campto

Rectal Carcinoma (1)

NCTAcronymPhaseStatusTitle
NCT00682786P2completedGenotype-directed Neoadjuvant Chemoradiation for Rectal Carcinoma

Small-Cell-Lung Cancer (1)

NCTAcronymPhaseStatusTitle
NCT00144989IPP3completedA Study Comparing Irinotecan and Cisplatin (IP) With Etoposide and Cisplatin (EP) Following EP/TRT for LD-SCLC

Non-Hodgkin's Lymphoma (1)

NCTAcronymPhaseStatusTitle
NCT00276003P2completedINST Phase II Trial of Gemcitabine and Irinotecan in Patients With Relapsed or Refractory Lymphoma.

Adult Solid Neoplasm (1)

NCTAcronymPhaseStatusTitle
NCT00045201P1active not recruitingErlotinib Hydrochloride and Irinotecan Hydrochloride in Treating Patients With Advanced Solid Tumors

Advanced Adult Primary Liver Cancer (1)

NCTAcronymPhaseStatusTitle
NCT00031681P1completed7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)

Alveolar Childhood Rhabdomyosarcoma (1)

NCTAcronymPhaseStatusTitle
NCT00025363P2completedComparison of Chemotherapy Regimens in Treating Children With Relapsed or Progressive Rhabdomyosarcoma

Malignant Glioma (1)

NCTAcronymPhaseStatusTitle
NCT00283556CPT-11P1/P2completedHigh Dose Camptothecin-11 (CPT-11) in Recurrent Unresectable Malignant Glioma

Brain and Nervous System (1)

NCTAcronymPhaseStatusTitle
NCT00251797P1completedA Phase I Trial Using Combination Irinotecan and Thalidomide for Recurrent CNS Tumors

Childhood Central Nervous System Germ Cell Tumor (1)

NCTAcronymPhaseStatusTitle
NCT00004078P2completedIrinotecan in Treating Children With Refractory Solid Tumors

AIDS-related Peripheral/Systemic Lymphoma (1)

NCTAcronymPhaseStatusTitle
NCT00003970P1completedGenetic Testing Plus Irinotecan in Treating Patients With Solid Tumors or Lymphoma

Gallbladder Cancer (1)

NCTAcronymPhaseStatusTitle
NCT00003276P2completedIrinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer

Drug/Agent Toxicity by Tissue/Organ (1)

NCTAcronymPhaseStatusTitle
NCT00002759P1completedIrinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or Lymphoma

Unspecified Adult Solid Tumor (1)

NCTAcronymPhaseStatusTitle
NCT00037804P1completedIrinotecan in Treating Patients With Refractory Solid Tumors and Liver Dysfunction

Adult Anaplastic Astrocytoma (1)

NCTAcronymPhaseStatusTitle
NCT02055196P1withdrawnGenetically Modified Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas

Irinotecan pivotal trial highlights (Phase 2/3/4)

Phase-2/3/4 studies with named acronyms — the registration-grade trials most cited in label discussions and Wikipedia.

AcronymNCTPhaseStatusIndicationEnrollmentPubMed
ARIEL-ENGICNCT07094893P4not yet recruitingColorectal Cancer280
ASCENTNCT01588990P4completedColorectal Neoplasms128PMID 32142532
CRCNCT00138060P4completedMetastatic Colorectal Cancer71PMID 11990381
HR-NBL2NCT04221035P3recruitingHigh-Risk Neuroblastoma800
OrigAMI-2NCT06662786P3recruitingColorectal Neoplasms1,000
IR RMSNCT07466316P3not yet recruitingRhabdomyosarcoma342
FHWTNCT06401330P3recruitingStage I Mixed Cell Type Kidney Wilms Tumor1,656
CAPRI-3 GOIMNCT07389265P3recruitingMetastatic Colorectal Cancer (mCRC)480
LAP100NCT06958328P3recruitingLocally Advanced Unresectable Pancreatic Ductal Adenocarcinoma356
PANThEONNCT06897644P3recruitingPancreatic Adenocarcinoma Advanced or Metastatic340PMID 41318310
CLDNNCT07518147P3recruitingGastric Cancer438
EFFIPECNCT04861558P3recruitingColorectal Cancer213
ESCCNCT06644781P3recruitingEsophageal Squamous Cell Carcinoma510
PREOPANC-3NCT04927780P3active not recruitingPancreatic Cancer378PMID 37550634
OrigAMI-3NCT06750094P3recruitingColorectal Neoplasms700
AtezoTRIBE2NCT06733038P3recruitingColorectal Cancer238
PANKU-BTC01NCT07582315P3not yet recruitingBiliary Tract Cancer538
IINCT07238283P3recruitingFirst-line Treatment of Metastatic Pancreatic Cancer662
NB-NK-2026NCT07375563P3recruitingNeuroblastoma (NB)5
OSCARNCT02885753P3recruitingColorectal Neoplasms348PMID 35027324
MK-3475NCT05239741P3active not recruitingColorectal Neoplasms100
IMPROVE-2NCT06509126P3recruitingColorectal Cancer Stage IV500
MK-2870NCT06459180P3active not recruitingCervical Cancer686
PTCA199-11NCT06250972P3recruitingPancreatic Adenocarcinoma210PMID 38050737
RASolute 302NCT06625320P3active not recruitingPancreatic Cancer500
G-HOPE-001NCT06238843P3active not recruitingUnresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma464
PHITTNCT03017326P3active not recruitingHepatoblastoma450
TroFuse-015NCT06356311P3active not recruitingGastroesophageal Cancer450
NEXT-REGIRINCT03829462P3active not recruitingMetastatic Colorectal Cancer (mCRC)377PMID 14612495
SOLARISNCT04094688P3active not recruitingColorectal Adenocarcinoma455
CheckMate 8HWNCT04008030P3active not recruitingMetastatic Colorectal Cancer839PMID 39602630
LIBImAbNCT04776655P3recruitingColorectal Cancer280
LAGOONNCT05153239P3completedRelapsed Small Cell Lung Cancer705
EscapeNCT05737563P3unknownEsophageal Squamous Cell Carcinoma Abdominal Stage 0380
innovaTV 301NCT04697628P3completedCervical Cancer502PMID 38959480
IROCASNCT02967289P3completedColon Cancer (High-risk Stage III: pT4N1 or pT1 to 4 N2)792PMID 30415988
INTEGRATEIIbNCT04879368P3completedGastro-Oesophageal Cancer462PMID 36814222
NAPOLI 3NCT04083235P3completedMetastatic Adenocarcinoma of the Pancreas770PMID 37708904
AIO-KRK-0114NCT02934529P3completedMetastatic Colorectal Cancer673PMID 39903881
STRATEGIC-1NCT01910610P3unknownColorectal Cancer Metastatic464PMID 26141683
NEOPANNCT02539537P3completedPancreatic Cancer171PMID 40378359
RESILIENTNCT03088813P3completedSmall Cell Lung Cancer491PMID 38648575
CinClareNCT02605265P3completedLocally Advanced Rectal Cancer356PMID 33119477
BGB-A317NCT03430843P3completedEsophageal Squamous Cell Carcinoma (ESCC)512PMID 35442766
BEACON CRCNCT02928224P3completedBRAF V600E-mutant Metastatic Colorectal Cancer702PMID 30892987
TRIPLETENCT03231722P3completedMetastatic Colorectal Cancer435PMID 36822922
PREDICTNCT03468335P3completedLocally Advanced Pancreatic Cancer151PMID 41087530
MK-3475NCT03933449P3completedEsophageal Carcinoma123PMID 34973513
MK-3475NCT02564263P3completedEsophageal Carcinoma628PMID 33026938
VITANCT03495921P3terminatedEwing Sarcoma32PMID 25917459
Trybeca-1NCT03665441P3completedPancreatic Adenocarcinoma512PMID 41187298
GB201NCT03522649P3unknownPreviously Treated Metastatic Colorectal Cancer668
BRAVANCT04943627P3withdrawnAdvanced Cancer0
CanStem303CNCT02753127P3completedColorectal Cancer1,253
TRIBE2NCT02339116P3unknownMetastatic Colorectal Cancer654PMID 28599628
AXEPTNCT01996306P3completedColorectal Neoplasms650PMID 29555258
GRECCAR8NCT02314182P3completedRectal Adenocarcinoma5PMID 25849254
FOLFIRINCT00433927P3unknownNeoplasm Metastasis568PMID 30293873
FOLF(HA)iriNCT01290783P3unknownMetastatic Colorectal Cancer390PMID 20333384
AFEQTNCT01670721P3completedColorectal Cancer Metastatic175
COMETSNCT01030042P3completedMetastatic Colorectal Cancer110
BEBYPNCT00720512P3terminatedColorectal Cancer184PMID 25600568
PROCEEDNCT01501669P3unknownMetastatic Breast Cancer222
ITACA-SNCT01640782P3completedAdenocarcinoma of the Stomach1,100PMID 24728035
VELOURNCT00561470P3completedColorectal Neoplasms1,226PMID 39207600
IPNCT00144989P3completedSmall-Cell-Lung Cancer281PMID 24309370
CRYSTALNCT00154102P3completedEpidermal Growth Factor Receptor (EGFR) Expressing Metastatic Colorectal Cancer1,221PMID 19339720
S0124NCT00045162P3completedLung Cancer671PMID 19349543
PACCENCT00115765P3completedColorectal Cancer1,053PMID 30679026
RNCT00143455P3completedSmall Cell Lung Carcinoma485
TRIBENCT00719797P3completedColorectal Cancer509PMID 35594613
MIROXNCT00268398P3completedColorectal Cancer284PMID 25403578
JANUSNCT05610163P2active not recruitingLocally Advanced Rectal Carcinoma783PMID 39116386
I-SPYNCT01042379P2recruitingBreast Neoplasms5,000PMID 21796368
ROMANCE - GOIMNCT07381764P2not yet recruitingMetastatic Colorectal Cancer (CRC)150
ISG-TULIPSNCT07328425P2recruitingDesmoplastic Small Round Cell Tumor20PMID 37158111
MEMMATNCT01356290P2recruitingMedulloblastoma Recurrent232PMID 36291912
NOVELTY-RNCT07183865P2recruitingLocally Recurrent Rectal Cancer44
TNBCNCT05255666P2withdrawnTriple Negative Breast Cancer0
OPTICALNCT07356973P2not yet recruitingGlioblastoma147
SPRINGNCT06692491P2not yet recruitingRare Tumour200
ERASE-CRCNCT05062889P2suspendedStage II Colon Cancer477
IINCT07099794P2not yet recruitingBiliary Tract Cancer (BTC)90
N10NCT06528496P2recruitingHigh-risk Neuroblastoma45
RAD-NALIRIFOXNCT07173387P2active not recruitingPancreatic Cancer42PMID 26615328
TRACERNCT06751394P2not yet recruitingRecurrent Rectal Cancer44
HERBICNCT07059338P2not yet recruitingHER2 Positive34
ShorTripNCT05253846P2active not recruitingLocally Advanced Rectal Cancer63
GRACIENCT06846346P2recruitingMetastatic Esophageal Adenocarcinoma88
IINCT07123441P2not yet recruitingColorectal Cancer300
ARKNCT07051785P2not yet recruitingColorectal Cancer (CRC)68
CANTORNCT06792695P2recruitingMetastatic Colorectal Cancer120
IINCT07524374P2not yet recruitingESCC33
QL1706NCT07229846P2not yet recruitingColorectal Cancer30
IINCT06827717P2recruitingEwing Sarcoma29
CRAFTERNCT05358704P2suspendedCancer of Rectum38
IINCT06820762P2not yet recruitingSCLC40PMID 36147357
LIAESNCT06749691P2recruitingSmall Cell Lung Cancer Extensive Stage30
NALPACNCT05472259P2recruitingMetastatic Pancreatic Ductal Adenocarcinoma134
IINCT06739928P2recruitingSmall Cell Lung Cancer Extensive Stage120
IINCT06766019P2active not recruitingPancreatic Cancer47
GM-CSFNCT04385277P2active not recruitingGanglioneuroblastoma, Nodular41
IINCT07047560P2recruitingColorectal Cancer (CRC)46
IINCT07044921P2recruitingColorectal Cancer Metastatic30
FRUITFULNCT07011576P2recruitingColon Cancer60
VICTORIANCT06714357P2recruitingColorectal Cancer Metastatic130
CAMPFIRENCT05999994P2recruitingNeoplasms105
NALIRI-VTNCT07092306P2not yet recruitingEwing's Sarcoma74
SCOTINCT05806931P2recruitingColon Cancer50
CAPT-02NCT06172036P2not yet recruitingNeoadjuvant Chemotherapy180
VICPROIRINCT06763029P2recruitingColorectal Cancer Metastatic36
IINCT06643793P2recruitingColorectal Neoplasms Malignant30
IVNCT06107413P2active not recruitingUnresectable Metastatic Colorectal Cancer280
LY2835219NCT05440786P2active not recruitingSarcoma, Ewing46
NAPOLI-2NCT04005339P2active not recruitingAdvanced Biliary Tract Cancer48
CA225200NCT00248287P2active not recruitingMetastatic Breast Cancer154
NALIRIBVRGNCT06801730P2recruitingGlioma38
INTENSENCT03773367P2active not recruitingResectable Gastric and Gastroesophageal Junction Adenocarcinoma60
NICRRBTCNCT06699459P2not yet recruitingBiliary Tract Carcinoma76
LyRICXNCT03764553P2active not recruitingEsophageal Cancer320
undeterminedNCT06387810P2recruitingBorderline Resectable Pancreatic Cancer45
NEO-IMPACTNCT06094140P2active not recruitingPancreatic Cancer20
BEACONNCT02308527P2completedNeuroblastoma225PMID 38190578
LIVERPEARLNCT04595266P2active not recruitingColorectal Cancer Metastatic48
PANIRINOXNCT02980510P2active not recruitingMetastatic Colorectal Cancer219PMID 36443816
HAICNCT06538623P2completedPancreatic Neoplasms40
NaliCapNCT04371224P2unknownPancreatic Cancer200
TORCH-RNCT05628038P2recruitingRecurrent Rectal Cancer93PMID 38053659
HOLIPANCNCT04617457P2unknownPancreatic Cancer150PMID 34794396
S1613NCT03365882P2completedColon Adenocarcinoma240PMID 39761503
PhenomenalNCT03328884P2completedBreast Cancer Metastatic55
POFINCT06197438P2unknownGastric Cancer36
FUNGEMAXNCT03693677P2completedMetastatic Pancreatic Cancer288
INTERACT-IINCT06003998P2unknownColorectal Cancer85PMID 38238055
SINAINCT05363007P2unknownMetastatic Pancreatic Cancer60
AVETRICNCT04513951P2completedMetastatic Colorectal Cancer62
NET02NCT03837977P2completedOncology58PMID 37287870
IRIGANCT04442984P2unknownGastric Carcinoma Stage IV326
NIVACORNCT04072198P2completedColorectal Cancer73PMID 32867715
TAS-102NCT04109924P2completedAdvanced Colorectal Carcinoma42PMID 39244627
CETIDYLNCT04189055P2unknownCancer Colorectal72PMID 18281264
ELEVATE CRCNCT05330429P2terminatedMetastatic Colorectal Cancer77
ERASE-TMZNCT05031975P2unknownColorectal Cancer35PMID 21859995
TRITICCNCT04059562P2completedCholangiocarcinoma28PMID 37217885
HRDNCT05732129P2unknownHomologous Recombination Deficiency Alterations Metastatic Colorectal Cancer29
AVETUXIRINCT03608046P2unknownColorectal Neoplasms, Malignant59PMID 40562041
AIO-KRK-0116NCT04034459P2unknownMetastatic Colorectal Cancer109
AtezoTRIBENCT03721653P2completedMetastatic Colorectal Cancer218PMID 38865678
FOOTPATHNCT03487016P2unknownMetastatic Pancreatic Cancer270
GEJNCT04808791P2completedGastroesophageal Junction Adenocarcinoma7
LY01610NCT04381910P2completedSmall Cell Lung Cancer66
AFEMANCT03279289P2completedMetastatic Colorectal Cancer170
BEYONDNCT03751176P2unknownColorectal Cancer Metastatic31
nITRoNCT03528785P2unknownPancreatic Adenocarcinoma67PMID 33403007
S1505NCT02562716P2completedPancreatic Adenocarcinoma147PMID 33475684
QUATTRO-IINCT04097444P2unknownMetastatic Colorectal Cancer112PMID 32703200
SCLCNCT04727853P2completedSmall Cell Lung Cancer (SCLC)66
TRICAPNCT04160416P2unknownUnresectable Metastatic Colorectal Cancer48
QUADRUPLE THREATNCT02489903P2completedSmall Cell Carcinoma139PMID 33569311
SULTANNCT03164655P2completedColorectal Cancer Metastatic20PMID 32000724
N2011-01NCT02035137P2completedNeuroblastoma114PMID 34270348
OPALONCT03142516P2completedColorectal Neoplasms20
CELIM2NCT01802645P2unknownColorectal Cancer91
PAMELA70NCT02143219P2completedPancreatic Metastatic Cancer72
HIGH-LIGHTNCT02842580P2terminatedColorectal Neoplasms21
CBLNCT03711240P2unknownColorectal Cancer40
ROCKETNCT02096354P2completedColorectal Neoplasms62PMID 36529613
RIST-rNB-2011NCT01467986P2completedNeuroblastoma Recurrent130PMID 38936379
DEEPERNCT02515734P2unknownColorectal Cancer360
BIOs-HerNCT04215159P2unknownHER-2 Protein Overexpression42
IriGenNCT01963182P2completedFirst Line Metastatic Colorectal Cancer47PMID 37932443
PancreasNCT03443492P2completedLocally Advanced or Metastatic Pancreatic Cancer130PMID 31765987
FOLFIRINOXNCT01928290P2completedStomach Neoplasms67PMID 32469386
IPNCT03168594P2terminatedNeuroendocrine Carcinoma66
S1201NCT01498289P2completedAdenocarcinoma of the Gastroesophageal Junction213
BTCNCT03110510P2withdrawnBiliary Tract Cancer0
PANTHERNCT01862003P2completedMetastatic Colorectal Cancer24PMID 36352028
CAPTEMNCT02414009P2completedMetastatic Colorectal Cancer82
BeTRINCT02497157P2completedMetastatic Colorectal Cancer45
BEV-ONCO2012NCT01858649P2completedMetastatic Colorectal Cancer60PMID 10673991
VIT-0910NCT01355445P2completedRHABDOMYOSARCOMA120PMID 34343032
MINOASNCT02624726P2unknownMetastatic Colorectal Cancer31PMID 31203498
BACCHUSNCT01650428P2completedRectal Cancer20PMID 26493588
GAMBITNCT01859728P2unknownBiliary Cancer48
FOLFIRI-ADNCT01639326P2unknownMetastatic Colorectal Cancer96
RS CAMPTONCT01220063P2completedMetastatic Colorectal Cancer48
CHARTANCT01321957P2completedMetastatic Colorectal Cancer250PMID 22897915
NIEGANCT03400592P2unknownStomach Neoplasms55
CRICKETNCT02296203P2unknownMetastatic Colorectal Cancer27PMID 36880426
FolfirinoxNCT03167112P2unknownPancreatic Cancer20PMID 23532000
IXOGoo1NCT01129310P2completedGastrointestinal Neoplasm47
IMC-1121BNCT01634555P2completedSolid Tumors29
LAPCNCT01397019P2completedPancreatic Cancer56
ML22774NCT01729481P2unknownMetastatic Pancreatic Adenocarcinoma150PMID 37794220
TDICCNCT01977235P2unknownSmall Cell Lung Carcinoma110PMID 22983686
AMALTHEANCT02129257P2completedMetastatic Colorectal Cancer73
PASSIONNCT02119026P2completedMetastatic Colorectal Cancer120PMID 7535799
COI-BNCT02086656P2completedColorectal Cancer Liver Metastases46
NKTR-102NCT01773109P2completedMetastatic Non Small Cell Lung Cancer40
QUATTRONCT02246049P2completedColorectal Neoplasms69
REGAINNCT02316496P2terminatedColorectal Cancer Metastatic2
ChimeNCT02216487P2unknownMetastatic Colorectal Cancer45
TPCANCT00394433P2completedEsophageal Cancer38
STEAMNCT01765582P2terminatedColorectal Neoplasms280PMID 30552157
BEVIACNCT01677884P2completedColorectal Neoplasms10
NEXIRI2NCT01715441P2completedMetastatic Colorectal Cancer Patients With KRAS Mutated Tumors173PMID 32737004
MAVERICCNCT01374425P2completedColorectal Cancer376
DEBIRITUXNCT01060423P2terminatedColorectal Cancer8
SIMNCT01479465P2terminatedColorectal Cancer266PMID 28246207
PEPCOLNCT01375816P2terminatedColorectal Cancer55
DINCT01380275P2unknownSarcoma35PMID 25164234
MK-0646-025NCT01609231P2terminatedRectal Neoplasms11
FLNCT01269216P2completedRectal Cancer136
SPECTRANCT00958386P2completedMetastatic Colorectal Cancer61
CRCNCT01367275P2terminatedColorectal Cancer8
AGCNCT01138904P2completedGastric Cancer80
PCANCT00911820P2completedEsophageal Cancer88
eSCOUTNCT01225744P2completedMetastatic Colorectal Cancer47
XRTNCT00597402P2completedGlioblastoma125
AVIRMA01-09NCT01144988P2unknownRecurrent Malignant Glioma35
CRCNCT01281761P2completedMetastatic Colorectal Cancer52
FOSCONCT00889343P2terminatedColorectal Neoplasms101
FOLFERANCT01205711P2completedColorectal Cancer111
GEJNCT00848783P2terminatedGastric Cancer8
AZD6244NCT01116271P2completedColorectal Cancer32
PIMABINCT00655499P2completedColorectal Cancer65PMID 23041588
AVAXIRINCT00875771P2completedMetastatic Colorectal Cancer80PMID 25925749
MK-0646NCT00614393P2completedMetastatic Colorectal Cancer558PMID 26405092
OMEGANCT00467142P2completedColorectal Cancer62PMID 24758527
GBMNCT00817284P2completedGlioblastoma Multiforme60
EGFRNCT00637091P2completedAdvanced Colorectal Cancer40PMID 21706149
RNCLCNCT00546130P2unknownSmall Cell Lung Cancer45PMID 14676791
TIRASMUSNCT00827684P2completedMetastatic Colorectal Cancer50
P-HDFL-DINCT00166881P2completedGastric Cancer29
FC-4NCT00845039P2terminatedColon Cancer4
ERBIFORTNCT00557102P2completedColorectal Cancer24
TIROX2NCT00506571P2unknownColorecal Neoplasms42
SCLCNCT00240097P2completedNon-Small Cell Lung Cancer30PMID 20934233
ERBIRIXNCT00506844P2unknownRectal Neoplasms40
ED-SCLCNCT00452634P2completedSmall Cell Lung Cancer62
S0306NCT00066612P2completedBladder Cancer45PMID 18501081
FOIBNCT01163396P2completedColorectal Cancer Metastatic57PMID 20702138
CEPAFIRINCT00210184P2completedGastric Cancer42PMID 21907007
SIRBNCT00569335P2completedColorectal, Cancer52
TIROX2NCT00512681P2completedStomach Neoplasms44
DCE-MRINCT00352521P2completedBrain and Central Nervous System Tumors20
CPT-11NCT00165464P2completedEsophageal Cancer54PMID 19139178
S0119NCT00030433P2completedLung Cancer85PMID 17545848
ABX-EGFNCT00111761P2completedColorectal Cancer43PMID 17531105
STEPPNCT00332163P2completedMetastatic Colorectal Cancer95PMID 22070868
BRAINNCT00345163P2completedGlioblastoma167PMID 19720927
GENCT00256269P2terminatedEsophageal Cancer4
CPT-11NCT00819728P2completedCarcinoma, Non-Small-Cell Lung35
CC6NCT02118064P2completedColorectal Cancer161

Terminated and withdrawn Irinotecan trials (176)

Studies that ended before completion. Reasons are filed in each trial's ClinicalTrials.gov entry.

All Irinotecan trials (1344)

Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.

NCT IDAcronymTitlePhaseStatusEnrollmentSponsorStarted
NCT06450041NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) TrialP2recruiting62New Approaches to Neuroblastoma Therapy ConsortiumDec 2024
NCT04581473Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CT041 Autologous CAR T-cell InjectionP1/P2active not recruiting192CARsgen Therapeutics Co., Ltd.Oct 2020
NCT06023641Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk DiseaseP2recruiting135St. Jude Children's Research HospitalMar 2024
NCT06208657Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent CancerP1/P2recruiting90Australian & New Zealand Children's Haematology/Oncology GroupJul 2024
NCT06541262CX-4945Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid TumorsP1/P2recruiting104Milton S. Hershey Medical CenterOct 2024
NCT07521605Short-Course Radiotherapy, Nal-IRI, Capecitabine, and Camrelizumab for Locally Advanced MSS Rectal CancerP2not yet recruiting44Guangdong Provincial People's HospitalMay 2026
NCT05863195Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP TrialP3recruiting408ECOG-ACRIN Cancer Research GroupOct 2023
NCT05610163JANUSTesting the Addition of an Anti-Cancer Drug, Irinotecan, to the Standard Chemotherapy Treatment (FOLFOX) After Long-Course Radiation Therapy for Advanced-Stage Rectal Cancers to Improve the Rate of Complete Response and Long-Term Rates of Organ PreservationP2active not recruiting783Alliance for Clinical Trials in OncologyDec 2022
NCT04221035HR-NBL2High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)P3recruiting800Gustave Roussy, Cancer Campus, Grand ParisNov 2019
NCT07444918Liposomal Irinotecan, Vincristine, Temozolomide, and Anlotinib for R/R Pediatric Solid TumorsP2not yet recruiting33Tianjin Medical University Cancer Institute and HospitalMar 2026
NCT07570914Hepatic Arterial Infusion of Liposomal Irinotecan Plus Oxaliplatin and Capecitabine as Adjuvant Therapy for Colorectal Cancer Liver MetastasesP2not yet recruiting28Tianjin Medical University Cancer Institute and HospitalMay 2026
NCT07281157Liposomal Irinotecan, Capecitabine and Enlonstobart With Short-Course Radiotherapy for Locally Advanced Rectal CancerP2recruiting30Tianjin Medical University Cancer Institute and HospitalNov 2025
NCT07585279A Clinical Study of Liposomal Irinotecan for Second-Line Therapy in Metastatic Colorectal CancerP2/P3not yet recruiting408Hebei Medical University Fourth HospitalMay 2026
NCT06662786OrigAMI-2A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal CancerP3recruiting1,000Janssen Research & Development, LLCOct 2024
NCT01042379I-SPYI-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast CancerP2recruiting5,000QuantumLeap Healthcare CollaborativeMar 2010
NCT06620302Testing the Addition of an Anti-cancer Drug, DT2216, to the Usual Chemotherapy Treatment for Relapsed or Refractory Solid Tumors and Fibrolamellar CarcinomaP1/P2recruiting81Children's Oncology GroupJun 2025
NCT05314998Adjuvant Trial in Patients With Resected PDAC Randomized to Allocation of Oxaliplatin- or Gemcitabine-based Chemotherapy by Standard Clinical Criteria or by a Transcriptomic Treatment Specific Stratification SignatureP3not yet recruiting394John NeoptolemosJan 2025
NCT07490301IVA Study to Assess Intravenous (IV) Telisotuzumab Adizutecan in Combination With Fluorouracil, Folinic Acid, and Oxaliplatin (FOLFOX) Compared to Standard of Care in Adult Participants With First-Line Metastatic Pancreatic Ductal AdenocarcinomaP2/P3recruiting900AbbVieApr 2026
NCT07466316IR RMSA Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)P3not yet recruiting342Children's Oncology GroupJun 2026
NCT07549321SHINEA Safety and Efficacy Study of hu14 in High-Risk Neuroblastoma PatientsP2/P3recruiting144Renaissance Pharma Ltd.Apr 2026
NCT07346157PNOC044Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual DiseaseP1/P2not yet recruiting69Sabine Mueller, MD, PhDJul 2026
NCT07381764ROMANCE - GOIMROMANCE: "Irinotecan Plus Cetuximab Rechallenge Versus Trifluridine/Tipiracil Plus Bevacizumab in Molecularly Selected Metastatic Colorectal Cancer"P2not yet recruiting150Gruppo Oncologico Italia MeridionaleMar 2026
NCT07271355Pressurized Intraperitoneal Aerosolized Chemotherapy With Mitomycin for the Treatment of Unresectable Appendix or Colorectal Cancer With Peritoneal Metastases, The IMPACT TrialP3not yet recruiting129City of Hope Medical CenterJul 2026
NCT02813135ESMARTEuropean Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory TumorsP1/P2recruiting472Gustave Roussy, Cancer Campus, Grand ParisAug 2016
NCT06401330FHWTA Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)P3recruiting1,656Children's Oncology GroupApr 2025
NCT06998940Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS MutationsP3recruiting94SWOG Cancer Research NetworkMay 2026
NCT07328919Efficacy and Safety of TT-00420 (Tinengotinib) Tablets Versus Chemotherapy in Patients With Advanced Intrahepatic Cholangiocarcinoma Harboring FGFR2 Fusions/Rearrangements or MutationsP3not yet recruiting138TransThera Sciences (Nanjing), Inc.Jan 2026
NCT07141771An Umbrella Study of Recurrent, Extensive Stage Small Cell Lung Cancer Based on Molecular TypingP1/P2not yet recruiting100Cancer Institute and Hospital, Chinese Academy of Medical SciencesDec 2025
NCT07334301BEACON2A Multi-Arm, Platform Trial For Relapsed NeuroblastomaP1/P2recruiting160University of BirminghamNov 2024
NCT04340141Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic CancerP3active not recruiting358Alliance for Clinical Trials in OncologyOct 2020
NCT07194044METTSEOMetastatic Ewing's Trial Testing Schedule Enhancement to Improve OutcomesP1recruiting15H. Lee Moffitt Cancer Center and Research InstituteFeb 2026
NCT07389265CAPRI-3 GOIMContinuation of Cetuximab Beyond First-Line Progression in Metastatic Colorectal CancerP3recruiting480University of Campania Luigi VanvitelliOct 2025
NCT05379595OrigAMI-1A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal CancerP1/P2recruiting225Janssen Research & Development, LLCJul 2022
NCT06958328LAP100Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic CancerP3recruiting356NRG OncologyAug 2025
NCT07328425ISG-TULIPSClinical Study in Adult and Young Adult Patients With Advanced Desmoplastic Small Round Cell Tumor (DSRCT) ISG-TULIPSP2recruiting20Italian Sarcoma GroupNov 2025
NCT07096362Utility of ctDNA in Early Switch of First-line mFOLFIRINOX in Metastatic Pancreatic Ductal AdenocarcinomaP2recruiting50University of MiamiSep 2025
NCT04625907FaR-RMSFaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcomaP1/P2recruiting1,672University of BirminghamSep 2020
NCT01871766Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified ChemotherapyP2active not recruiting115St. Jude Children's Research HospitalDec 2013
NCT07591831Liposomal Irinotecan Plus Enlonstobart for Platinum-Resistant Recurrent Ovarian CancerP2not yet recruiting30Tianjin Medical University Cancer Institute and HospitalMay 2026
NCT06963502A Phase Ib Study of HS-10370 in Addition to Other Anti-cancer Therapies in Patients With Advanced Solid TumorsP1not yet recruiting762Jiangsu Hansoh Pharmaceutical Co., Ltd.May 2025
NCT01356290MEMMATAntiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS TumorsP2recruiting232Medical University of ViennaApr 2014
NCT07094893ARIEL-ENGICAnti-EGFR Agents in Patients With Right-sided Advanced Colorectal Cancer With Wild-type RAS and AREG/EREG High StatusP4not yet recruiting280Gruppo Oncologico del Nord-OvestApr 2026
NCT06928584Hypofractionated Radiotherapy Plus Immunotherapy Versus Conventional Radiotherapy in Locally Recurrent Rectal CancerP2recruiting221Fudan UniversityMar 2025
NCT07183865NOVELTY-RHypofractionated Radiotherapy Combined With NALIRIF, PD-1 Antibody in Locally Recurrent Rectal Cancer(NOVELTY-R)P2recruiting44Fudan UniversityMar 2025
NCT06607185A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid TumorsP1active not recruiting750Eli Lilly and CompanyOct 2024
NCT05255666TNBCCombination Liposomal Irinotecan and Pembrolizumab For Triple-Negative Breast Cancer (TNBC) With Brain Metastases (BM)P2withdrawn0Washington University School of MedicineJul 2023
NCT03977233Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic CancerP2recruiting45UNC Lineberger Comprehensive Cancer CenterJun 2019
NCT06897644PANThEONGemcitabine Plus Nab-paclitaxel as Switch Maintenance Versus Continuation of Modified FOLFIRINOX as 1st Line Chemotherapy in Patients With Advanced Pancreatic Cancer.P3recruiting340Gruppo Oncologico del Nord-OvestMar 2025
NCT07518147CLDNA Study Comparing BL-M05D1 With the Investigator's Choice of Treatment Regimen in Patients With Claudin (CLDN)18.2-Positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma (GC/GEJC) Who Have Received Prior First-Line TreatmentP3recruiting438Sichuan Baili Pharmaceutical Co., Ltd.May 2026
NCT07356973OPTICALIrinotecan-ChemoSeed in Surgically Resectable GlioblastomaP2not yet recruiting147CRISM Therapeutics LTDMar 2026
NCT07417735SYS6010 Versus Chemotherapy in Locally Advanced or Metastatic/Recurrent Esophageal Squamous Cell CarcinomaP3not yet recruiting436CSPC Megalith Biopharmaceutical Co.,Ltd.Mar 2026
NCT06692491SPRINGStudy of Precision Treatment for Rare Tumours in China Guided by PDO and NGSP2not yet recruiting200Peking University Shenzhen HospitalJan 2025
NCT06172296Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk NeuroblastomaP3recruiting478National Cancer Institute (NCI)Apr 2024
NCT05062889ERASE-CRCExploiting Circulating Tumour DNA to Intensify the Postoperative Treatment Resected Colon Cancer PatientsP2suspended477Gruppo Oncologico del Nord-OvestMay 2023
NCT04861558EFFIPECEfficacy of Hyperthermic Intraperitoneal ChemotherapyP3recruiting213Uppsala UniversityMay 2021
NCT06381154Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advanced or Metastatic Pancreatic CancerP2recruiting25Mayo ClinicDec 2024
NCT07076212Evaluating NALIRIFOX vs Modified Gemcitabine, Nab-Paclitaxel and Cisplatin in Patients With Locally Advanced and Metastatic Pancreatic AdenocarcinomaP2recruiting52Medical University of South CarolinaApr 2026
NCT06644781ESCCA Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)P3recruiting510Daiichi SankyoMar 2025
NCT04587128Early-Line Anti-EGFR Therapy to Facilitate Retreatment for Select Patients With mCRCP2active not recruiting34University of Wisconsin, MadisonOct 2020
NCT07325214Chemotherapy With or Without IMD10 (Focused Ultrasound) in the Treatment of Borderline Resectable or Locally Advanced Pancreatic CancerN/Anot yet recruiting136IMGT Co., Ltd.Apr 2026
NCT07409272A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic CancerP3recruiting614Astellas Pharma Global Development, Inc.Feb 2026
NCT07099794IIA Randomized, Two-cohort, Prospective Phase II Clinical Study of the Second-line Treatment of Advanced Biliary System Tumors With Liposomal Irinotecan (II) Combination RegimenP2not yet recruiting90Cancer Institute and Hospital, Chinese Academy of Medical SciencesAug 2025
NCT05800587Dose Attenuated Chemotherapy in Compromised Patients With Lung CancerP2recruiting280Fox Chase Cancer CenterFeb 2023
NCT04927780PREOPANC-3Perioperative or Adjuvant mFOLFIRINOX for Resectable Pancreatic CancerP3active not recruiting378Erasmus Medical CenterSep 2021
NCT06547203Cetuximab, Irinotecan, Toripalimab in RAS/BRAF Wild-type Ultraselected Right-sided Colorectal Cancer StudyP2recruiting34Sun Yat-sen UniversityJul 2024
NCT06528496N10N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With NeuroblastomaP2recruiting45Memorial Sloan Kettering Cancer CenterJul 2024
NCT07463573QLC5508 vs. Chemotherapy in Pretreated Advanced or Metastatic Esophageal Squamous Cell CarcinomaP3recruiting466Qilu Pharmaceutical Co., Ltd.Apr 2026
NCT07397819Intraperitoneal Injection of Liposomal Irinotecan as Monotherapy or in Combination With Recombinant Mutant Human Tumor Necrosis Factor or Bevacizumab for the Treatment of Malignant Ascites Following Failure of Prior Standard TherapyP1/P2recruiting48Dong sheng ZhangNov 2025
NCT03715933Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including SarcomasP1recruiting411Inhibrx Biosciences, IncOct 2018
NCT06995872Phase I Trial of rhIL-15 Plus Dinutuximab Plus Irinotecan/Temozolomide for Children and Young Adults With Relapsed/Refractory NeuroblastomaP1recruiting40National Cancer Institute (NCI)Oct 2025
NCT07559760New Second-Line Combo Therapy for MSS Metastatic Colorectal CancerP2recruiting30The First Hospital of Jilin UniversityNov 2025
NCT06750094OrigAMI-3A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received ChemotherapyP3recruiting700Janssen Research & Development, LLCDec 2024
NCT05319730MK-3475A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)P1/P2recruiting230Merck Sharp & Dohme LLCMay 2023
NCT06733038AtezoTRIBE2FOLFOXIRI Plus Bevacizumab With or Without Atezolizumab as 1st Line Treatment of pMMR and IS IC-High Metastatic Colorectal Cancer Patients.P3recruiting238Gruppo Oncologico del Nord-OvestNov 2024
NCT06571461Liposomal Irinotecan in Combination With Oxaliplatin and S-1 Versus Gemcitabine Combined With Capecitabine as Postoperative Adjuvant Therapy for Pancreatic CancerP3not yet recruiting408CSPC Ouyi Pharmaceutical Co., Ltd.Sep 2024
NCT06586515MOONRAY-01MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid TumorsP1recruiting630Eli Lilly and CompanySep 2024
NCT03794349Irinotecan Hydrochloride, Temozolomide, and Dinutuximab With or Without Eflornithine in Treating Patients With Relapsed or Refractory NeuroblastomaP2active not recruiting94Children's Oncology GroupJul 2019
NCT07364422To Evaluate the Safety and Tolerability of Study Drug as a Third-line and Beyond Therapy for Recurrent or Metastatic Gastric CancerP1/P2not yet recruiting49Onconic Therapeutics Inc.Feb 2026
NCT07395063A Clinical Study on the Treatment of Metastatic Colorectal Cancer at the Second-line or Beyond.P2not yet recruiting68The Fourth Affiliated Hospital of Zhejiang University School of MedicineFeb 2026
NCT07085338A Phase II Study With a Safety Run-In of the Addition of N-803 to a Chemoimmunotherapy Backbone for the Treatment of Patients With Relapsed or Refractory NeuroblastomaP2recruiting54St. Jude Children's Research HospitalNov 2025
NCT07155200Small Cell Lung Cancer Irinotecan and CDC2-like Kinase Inhibition Trial (SLICK Trial)P1/P2recruiting42Washington University School of MedicineDec 2025
NCT06951503AK112 and Chemotherapy in First-line Metastatic Colorectal CancerP3recruiting560AkesoMay 2025
NCT06771622Safety and Efficacy of HCB101 in Combination With Multiple Agents in Patients With Advanced Solid TumorsP1/P2active not recruiting500FBD Biologics LimitedMar 2025
NCT07595913A Study of ZG006 for Injection Versus Investigator-Selected Chemotherapy in Participants With Advanced Neuroendocrine CarcinomaP3not yet recruiting240Suzhou Zelgen Biopharmaceuticals Co.,LtdJul 2026
NCT07606599A Study of BL-M07D1 Versus Physician's Choice of Chemotherapy in Patients With HER2-expressing Locally Advanced or Metastatic Biliary Tract Cancer After Platinum-containing Chemotherapy FailureP3not yet recruiting398Sichuan Baili Pharmaceutical Co., Ltd.May 2026
NCT07582315PANKU-BTC01A Study Comparing BL-B01D1 With Treatment of Physician's Choice in Patients With Locally Advanced or Metastatic Biliary Tract Cancer After Failure of Platinum-based Chemotherapy and PD-1/PD-L1 Monoclonal Antibody Therapy(PANKU-BTC01)P3not yet recruiting538Sichuan Baili Pharmaceutical Co., Ltd.May 2026
NCT07487896A Study of YL201 Versus Investigator's Choice of Chemotherapy in Participants With Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma After Failure of First-Line TherapyP3not yet recruiting440MediLink Therapeutics (Suzhou) Co., Ltd.Apr 2026
NCT07391566LPM6690176 in Combination With Chemotherapy and Bevacizumab in Metastatic Colorectal Cancer Patients With RAS MutationP1/P2not yet recruiting99Luye Pharma Group Ltd.Mar 2026
NCT07318831Phase II Study of Chidamide-Dinutuximab Beta-Irinotecan-Temozolomide for Refractory/Relapsed Neuroblastoma in ChildrenP2recruiting27Tianjin Medical University Cancer Institute and HospitalJan 2026
NCT07238283IIIrinotecan Hydrochloride Liposome Injection (II)in Combination With Oxaliplatin, 5-FU/LV Versus AG for First-line Treatment of Metastatic Pancreatic CancerP3recruiting662Jiangsu HengRui Medicine Co., Ltd.Dec 2025
NCT07474103SCRT-NALIRIXELOX+Sintilimab as TNT for High-Risk LARCN/Arecruiting49Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyNov 2025
NCT07173387RAD-NALIRIFOXStereotactic Body Radiotherapy and NALIRIFOX for Locally Advanced Pancreatic CancerP2active not recruiting42Shandong Cancer Hospital and InstituteOct 2025
NCT06941857NC410 and FOLFIRINOX in Combination With Nivolumab With or Without Ipilimumab in Patients With Untreated Metastatic Pancreatic CancerP2recruiting20Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsSep 2025
NCT04199026Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent SarcomaN/Arecruiting20M.D. Anderson Cancer CenterFeb 2025
NCT06751394TRACERPreoperative Chemoradiotherapy and Toripalimab in Locally Recurrent Rectal CancerP2not yet recruiting44Sixth Affiliated Hospital, Sun Yat-sen UniversityJan 2025
NCT06006273A Phase Ib Trial of Eribulin in Combination With Irinotecan and Temozolamide in Children With Relapsed or Refractory Solid TumorsP1recruiting48M.D. Anderson Cancer CenterAug 2023
NCT05382559A Study of ASP3082 in Adults With Advanced Solid TumorsP1recruiting681Astellas Pharma IncJun 2022
NCT07258147Safety and Efficacy of Radiotherapy Combined With Immunochemotherapy in Pre-treated SCLC Patients With Liver MetastasesP2not yet recruiting30Sichuan UniversityOct 2026
NCT07059338HERBICDual EGFR/HER2 Blockade Combined With Irinotecan for the Treatment of HER2-Positive Metastatic Colorectal CancerP2not yet recruiting34Sun Yat-sen UniversityJul 2025
NCT07235202PDACA Study of MR001 Combined With Chemotherapy in Patients With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) After First-line TherapyP1/P2recruiting45Shenzhen Majory Biotechnology Co., Ltd.Dec 2025
NCT06652412CGA Guided Ultrafractionated RT and Systemic Treatment in Elderly or Frail Patients with Inoperable Localized CRCP2not yet recruiting124Fudan UniversityNov 2024
NCT07375563NB-NK-2026Chemoimmunotherapy Combined With Autologous NK Cell Therapy for Pediatric Patients With Refractory and Relapsed High-Risk Neuroblastoma and GanglioneuroblastomaP3recruiting5Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyNov 2025
NCT05677490mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric AdenocarcinomaP3recruiting382Alliance for Clinical Trials in OncologyJan 2023
NCT07150403Second-line Doublet Chemotherapy (FOLFOX or FOLFIRI) Plus Fruquintinib Versus Doublet Chemotherapy (FOLFOX or FOLFIRI) Plus Bevacizumab in Metastatic Colorectal CancerP2not yet recruiting74Federation Francophone de Cancerologie DigestiveDec 2025
NCT06128837Study of LY01610 in Patients With Recurrent Small Cell Lung CancerP3recruiting686Luye Pharma Group Ltd.Mar 2024
NCT05412082SMART TNTSMART TNT for the Conservative Management of Locally Advanced Rectal CancerP1recruiting25University of MiamiOct 2022
NCT05384821MetroWilmsMetronomic Chemotherapy in Wilms Tumor (MetroWilms-1906)P1/P2recruiting28Centre Oscar LambretSep 2022
NCT05253846ShorTripShort-course Radiotherapy Followed by Consolidation Chemotherapy. 2021-001206-29P2active not recruiting63Gruppo Oncologico del Nord-OvestJan 2022
NCT07284134JS107 vs Investigator's Choice as Second-line or Later Therapy for Advanced CLDN18.2-Positive Gastricor GEJ Adenocarcinoma.P3recruiting560Shanghai Junshi Bioscience Co., Ltd.Dec 2025
NCT07214298Pegcetacoplan in Combination With Modified FOLFIRINOX for the Treatment of Metastatic Pancreatic Ductal AdenocarcinomaP1/P2recruiting35Roswell Park Cancer InstituteFeb 2026
NCT07134205The Study of JMT101 Combined With Irinotecan as a ≥3rd-Line Treatment in Metastatic Colorectal CancerP3not yet recruiting252Shanghai JMT-Bio Inc.Oct 2025
NCT06846346GRACIETesting Ivonescimab in Combination With Chemotherapy in Advanced or Metastatic Gastric/Gastroesophageal AdenocarcinomaP2recruiting88UNICANCERNov 2025
NCT02885753OSCARSystemic Oxaliplatin or Intra-arterial Chemotherapy Combined With LV5FU2 +/- Irinotecan and an Target Therapy in First Line Treatment of Metastatic Colorectal Cancer Restricted to the LiverP3recruiting348Federation Francophone de Cancerologie DigestiveDec 2016
NCT05239741MK-3475Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Chinese Participants With Stage IV Colorectal Cancer (MK-3475-C66)P3active not recruiting100Merck Sharp & Dohme LLCApr 2022
NCT06467786Study on the Therapeutic Effect of Irinotecan Liposomes in Small Cell Lung CancerP4recruiting24Tang-Du HospitalMar 2024
NCT07123441IIA Study on the Efficacy and Safety of Irinotecan Liposome (II), 5-FU/LV in Combination With Bevacizumab for the Treatment of Advanced Colorectal CancerP2not yet recruiting300Sanjun CaiSep 2025
NCT07004712Efficacy and Biomarkers of the Second-line Treatment of Adebelizumab Combined With Irinotecan Liposome in Advanced Small Cell Lung CancerP2not yet recruiting46Peking University Cancer Hospital & InstituteJun 2025
NCT06490536The Sagittarius TrialP3recruiting700IFOM ETS - The AIRC Institute of Molecular OncologyOct 2024
NCT06485739Irinotecan Liposomes for the Treatment of Neuroendocrine CarcinomaP4not yet recruiting20First Affiliated Hospital Xi'an Jiaotong UniversityJul 2024
NCT06835387Study of NALIRIFOX in Advanced Unresectable Small Bowel TumorsP2recruiting36Tiago Biachi de CastriaJun 2025
NCT07543744A Comparative Study of Pharmacokinetics, Safety, and Immunogenicity of RPH-030 and Vectibix® in Patients With Metastatic Colorectal Cancer With Wild-type RAS as First-line Therapy in Combination With FOLFIRIP1recruiting180R-PharmApr 2025
NCT05004116A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor CancerP1/P2recruiting77Memorial Sloan Kettering Cancer CenterAug 2021
NCT05382442A Study of AK112 With or Without AK117 in Metastatic Colorectal CancerP2active not recruiting254AkesoJun 2022
NCT07309185Adebrelimab Combined With Famitinib and Irinotecan in Advanced Gastric Cancer After Failure of First-Line TherapyP2recruiting66Shandong Tumor HospitalJul 2024
NCT06361316Irinotecan Liposome Combined With Oxaliplatin and Tegafur as Adjuvant Therapy for Pancreatic CancerN/Arecruiting53Kuirong JiangApr 2024
NCT05854498Liposomal Irinotecan With TAS102 and Bevacizumab for Patients With Metastatic Colorectal CancerP2recruiting50University of Wisconsin, MadisonOct 2023
NCT07051785ARKFruquintinib vs Bevacizumab Combined With Irinotecan Liposome and Capecitabine as Second-Line Therapy for Advanced Metastatic Colorectal CancerP2not yet recruiting68Liu HuangJul 2025
NCT06210971Neoadjuvant Chemoradiation With Nal-IRI and Capecitabine Guided by UGT1A1 Status in Patients With Rectal CancerP2recruiting60Hebei Medical University Fourth HospitalFeb 2024
NCT07150247Safety and Efficacy of IB-FOLFIRI in BRAF V600E-Mutant Metastatic Colorectal CancerP2recruiting20Sun Yat-sen UniversityJun 2025
NCT06496048Lurbinectedin or in Combination with Irinotecan Versus Topotecan in Patients with Relapsed SCLCP3recruiting180Luye Pharma Group Ltd.Sep 2024
NCT06509126IMPROVE-2Intermittent or Continuous Panitumumab Plus FOLFIRI for Left Sided RAS/B-RAF Wild-type Metastatic Colorectal CancerP3recruiting500National Cancer Institute, NaplesJun 2024
NCT04543916Venetoclax and Irinotecan in Relapsed/Refractory SCLCP1/P2withdrawn0Virginia Commonwealth UniversityJun 2021
NCT06459180MK-2870A Study to Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of Physician's Choice as Second-line Treatment for Participants With Recurrent or Metastatic Cervical Cancer (MK-2870-020/TroFuse-020/Gog-3101/ENGOT-cx20)P3active not recruiting686Merck Sharp & Dohme LLCJul 2024
NCT06967155A Study of Irinotecan With Dabrafenib Plus Trametinib and Anti-EGFR in the Second Line of Therapy in People With Metastatic Colorectal CancerP2active not recruiting23Blokhin's Russian Cancer Research CenterMar 2025
NCT06792695CANTORA Study of Novel Study Interventions and Combinations in Participants With Colorectal CancerP2recruiting120AstraZenecaMar 2025
NCT06974110Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid TumorsP1recruiting132MOMA TherapeuticsJul 2025
NCT05365581A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic CancerP1recruiting398Astellas Pharma Global Development, Inc.Jun 2022
NCT06250972PTCA199-11Radiotherapy to Patients With CA19-9-elevated Advanced Pancreatic CancerP3recruiting210Fudan UniversityMay 2024
NCT06954246A Study of MHB088C Injection Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung CancerP3recruiting450Qilu Pharmaceutical Co., Ltd.Jun 2025
NCT06648525Adebrelimab Combined with Irinotecan Liposomes, 5-FU, CF ± Lenvatinib As First-line Treatment for Advanced ICCP2not yet recruiting68Harbin Medical UniversityOct 2024
NCT07062536mFOLFOX/mFOLFIRI vs. mFOLFOX in Advanced or Recurrent Biliary Tract Cancer Second-lineP2not yet recruiting130Seoul National University Bundang HospitalJun 2026
NCT06680622Bemarituzumab in FGFR2b+ Patients With Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction, Who Failed at Least One Prior Line of Palliative ChemotherapyP2active not recruiting126Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus NordwestMar 2025
NCT07524374IISHR-1701 in Combination With Irinotecan Liposome (II) for Second-line Treatment of ESCC After ImmunotherapyP2not yet recruiting33Zhigang LiMar 2026
NCT06649292SHR-A1904 Compared With Investigator's Choice of Therapy in Claudin18.2 Positive Patitens With Second-line Advanced or Metastatic Gastric or Gastroesophageal Junction AdenocarcinomaP3recruiting524Shanghai Hengrui Pharmaceutical Co., Ltd.Nov 2024
NCT07229846QL1706A Single-arm, Single-center, Phase II Clinical Study of Aipalolitovorelizumab (QL1706) Combined With Bevacizumab and Standard Chemotherapy as First-line Treatment for MSS/pMMR Metastatic Colorectal Cancer With BRAF V600E MutationP2not yet recruiting30Yanqiao ZhangFeb 2026
NCT06827717IIPhase II Study of Irinotecan Liposome (II) Combined With Temozolomide and Fluzoparib in Recurrent or Metastatic Ewing SarcomaP2recruiting29Sun Yat-sen UniversityApr 2025
NCT07474727A Phase II Study of AMT-676 Combination Therapies in Advanced Colorectal CancerP2not yet recruiting180Multitude Therapeutics Inc.Apr 2026
NCT06491134Liposomal Irinotecan With Cisplatin and Concurrent Radiotherapy in Locally Advanced Esophageal Squamous Cell CarcinomaP1not yet recruiting12Hebei Medical University Fourth HospitalJun 2024
NCT07415031A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib StudiesP2recruiting170Mirati Therapeutics Inc.May 2026
NCT06745193A Prospective, Randomized, Open, Phase II Clinical Study of Chidamide in Combination with Camrelizumab and Apatinib for Advanced Esophageal CancerP2not yet recruiting63Peking UniversityFeb 2025
NCT07457775Liposomal Irinotecan in Combination With Temozolomide and Bevacizumab in Patients With Advanced STSP2not yet recruiting24Second Affiliated Hospital, School of Medicine, Zhejiang UniversityMar 2026
NCT07024615A Study of ASP2138 Given Before Surgery, Then Chemotherapy After Surgery, in People With Pancreatic Ductal CancerP1recruiting25Astellas Pharma Global Development, Inc.Oct 2025
NCT05694715Combination Therapy in Cancers With Mutations in DNA Repair GenesP1recruiting24University of California, San FranciscoMay 2023
NCT07070479Combination Therapy for PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma: A Bayesian Adaptive Phase II TrialP2recruiting208Ming-Yuan ChenJun 2025
NCT05358704CRAFTERPreoperative ChemoRadiation And FOLFOXIRI for Rectal Cancer (CRAFTER) for Rectal CancerP2suspended38Rutgers, The State University of New JerseyMay 2022
NCT04920032Study of ctDNA Guided Change in Tx for Refractory Minimal Residual Disease in Colon AdenocarcinomasP1recruiting22University of California, IrvineAug 2021
NCT04329494PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric CancerP1recruiting49City of Hope Medical CenterAug 2020
NCT07479732Apatinib Combined With Liposomal Irinotecan for Refractory or Metastatic OsteosarcomaP1/P2recruiting56Peking University People's HospitalMar 2026
NCT07314385NH002-mediated Sonoporation With Chemotherapy in Advanced Pancreatic CancerP1not yet recruiting24National Taiwan University HospitalJan 2026
NCT06820957Testing a New Combination of Anti-cancer Drugs in Patients Newly Diagnosed With Ewing Sarcoma Who Have Cancer That Has Spread to Other Parts of the BodyP2/P3active not recruiting437Children's Oncology GroupNov 2025
NCT07014540A Irinotecan Liposome Trial of in Advanced Neuroendocrine CarcinomaP4not yet recruiting45Beijing GoBroad HospitalJun 2025
NCT06820762IIIrinotecan Liposome(II) Combined With Ivonescimab as Second-line Treatment for Small Cell Lung Cancer : A Prospective, Single-arm, Multicenter Clinical StudyP2not yet recruiting40The Second Affiliated Hospital of Dalian Medical UniversityFeb 2025
NCT06749691LIAESLiposomal Irinotecan and Apatinib in ES-SCLCP2recruiting30Second Affiliated Hospital, School of Medicine, Zhejiang UniversityDec 2024
NCT06625320RASolute 302Phase 3 Study of Daraxonrasib (RMC-6236) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)P3active not recruiting500Revolution Medicines, Inc.Oct 2024
NCT06513455Irinotecan Liposome,Albumin Paclitaxel and Gemcitabine First-line Treatment for Pancreatic CancerP1/P2not yet recruiting132Harbin Medical UniversitySep 2024
NCT06578052Irinotecan Liposome in Combination With CapecitabineN/Arecruiting20Junjie HangAug 2024
NCT06238843G-HOPE-001A Multicenter, Phase 3 Study of IBI343 Monotherapy Versus Treatment of Investigator's Choice in Subjects With Previously Treated, Claudin (CLDN) 18.2-positive, HER2-negative, Gastric or Gastroesophageal Junction Adenocarcinoma (G-HOPE-001)P3active not recruiting464Innovent Biologics (Suzhou) Co. Ltd.Jun 2024
NCT06013618Clinical Analysis of Naxitamab (hu3F8) in the Treatment of Pediatric High Risk or Refractory/ Relapsed NeuroblastomaP2recruiting120Sun Yat-Sen University Cancer CenterJun 2023
NCT04211675STINGNK Cells Infusions With Irinotecan, Temozolomide, and DinutuximabP1/P2recruiting31Nationwide Children's HospitalSep 2022
NCT05472259NALPACA Study Evaluating the Efficacy of 5-FU + NALIRI and 5-FU + NALIRINOX for PDAC (NALPAC)P2recruiting134Belgian Group of Digestive OncologyMay 2022
NCT04657068A Study of ART0380 for the Treatment of Advanced or Metastatic Solid TumorsP1/P2recruiting442Artios Pharma LtdJan 2021
NCT03017326PHITTPaediatric Hepatic International Tumour TrialP3active not recruiting450University of BirminghamAug 2017
NCT06739928IIIrinotecan Liposome (II) or Etoposide Combined With Adebrelimab and Carboplatin in the Treatment of ES-SCLCP2recruiting120Guangzhou Institute of Respiratory DiseaseJan 2025
NCT06194734A Study of KC1036 Versus Investigator's Choice of Chemotherapy in Patients With Advanced Esophageal CancerP3recruiting490Beijing Konruns Pharmaceutical Co., Ltd.Feb 2024
NCT04607421A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal CancerP3active not recruiting841PfizerDec 2020
NCT07027748Feasibility Study of Prolonged Administration of Naxitamab, Irinotecan, and Temozolomide for Patients With Relapsed or Refractory NeuroblastomaP1recruiting18Steven DuBois, MDJun 2025
NCT06259058Stereotactic Body Radiation Therapy Followed by NALIRIFOX vs NALIRIFOX for Borderline Resectable Pancreatic CancerP1/P2not yet recruiting96Tianjin Medical University Cancer Institute and HospitalApr 2024
NCT06501664Liposomal Irinotecan and 5-FU as Second-line Therapy for Patients With ESCCP3not yet recruiting360Rui-hua Xu, MD, PhDAug 2024
NCT06894797Preoperative Chemoradiotherapy Combined With Consolidation or Induction NALIRIFOX in Rectal Cancer.N/Arecruiting68Peking University Cancer Hospital & InstituteApr 2025
NCT06540326Clinical Study of Second-line Treatment in Advanced Colorectal Cancer With Chemotherapy With Bevacizumab or CetuximabP2recruiting100Second Affiliated Hospital, School of Medicine, Zhejiang UniversityNov 2024
NCT06657690Irinotecan Liposome Combined with S-1 in PD-1/L1 Inhibitor Refractory Recurrent or Metastatic NPCP2recruiting56Sun Yat-sen UniversityNov 2024
NCT00077285Irinotecan and Carboplatin as Upfront Window Therapy in Treating Patients With Newly Diagnosed Intermediate-Risk or High-Risk RhabdomyosarcomaP2active not recruiting65Memorial Sloan Kettering Cancer CenterOct 2003
NCT06499610Clinical Study of Irinotecan Liposome Combination Therapy for Advanced Gastric CancerP4not yet recruiting44First Affiliated Hospital Xi'an Jiaotong UniversityJul 2024
NCT06766019IIAdebrelimab Combined With Irinotecan Liposomal (II), Oxaliplatin, and 5-FU/LV Conversion Therapy for Locally Advanced Pancreatic CancerP2active not recruiting47The First Affiliated Hospital with Nanjing Medical UniversityOct 2024
NCT06365008Sintilimab Plus FOLFIRI as Salvage Therapy for Patients With Advanced Gastric CancerP2recruiting40Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityApr 2024
NCT06219941AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2P2recruiting224AstraZenecaDec 2023
NCT05722327MRTX849Phase I Trial of Adagrasib (MRTX849) in Combination With Cetuximab and Irinotecan in Patients With Colorectal CancerP1active not recruiting24M.D. Anderson Cancer CenterDec 2023
NCT04743661131I-Omburtamab, in Recurrent Medulloblastoma and EpendymomaP2active not recruiting62Pediatric Brain Tumor ConsortiumApr 2022
NCT04478292A Multi-institutional Study for Treatment of Children With Newly Diagnosed Hepatoblastoma Using a Modified PHITT StrategyP3recruiting330Shanghai Children's Medical CenterMar 2021
NCT04385277GM-CSFTreatment With Dinutuximab, Sargramostim (GM-CSF), and Isotretinoin in Combination With Irinotecan and Temozolomide After Intensive Therapy for People With High-Risk Neuroblastoma (NBL)P2active not recruiting41Children's Oncology GroupDec 2020
NCT06478043A Study to Investigate the Efficacy and Safety of Ivonescimab Combined With Irinotecan Liposome as Second-line Regimen for ES-SCLCP2not yet recruiting54Zhejiang Cancer HospitalSep 2024
NCT05424692PTCDrug Sensitivity Detection of Micro Tumor (PTC) to Guide Postoperative Adjuvant Treatment Strategy of Colorectal CancerN/Arecruiting200Peking Union Medical College HospitalSep 2021
NCT05838768Study of HRO761 Alone or in Combination in Cancer Patients With Specific DNA Alterations Called Microsatellite Instability or Mismatch Repair Deficiency.P1active not recruiting123Novartis PharmaceuticalsJun 2023
NCT06577376A PhaseⅠ/Ⅱ Study of Simmitinib or Irinotecan Liposomes Combined With DP303c in Gastric Adenocarcinoma or Gastroesophageal Junction AdenocarcinomaP1/P2not yet recruiting252Shanghai Runshi Pharmaceutical Technology Co., LtdAug 2024
NCT07047560IILiposomal Irinotecan (II) Fractionated Dosing Combined With 5-FU/LV (FOLFIRInali-3) and Bevacizumab in Second-line Treatment of Advanced Colorectal Cancer: A Single-arm, Phase II Clinical StudyP2recruiting46Tianjin Medical University Cancer Institute and HospitalSep 2024
NCT04205968Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel CancersP2recruiting94SWOG Cancer Research NetworkJun 2020
NCT07044921IIClinical Study of Irinotecan Liposome (II)-Based Combination Treatment for Irinotecan-resistant Colorectal Cancer.P2recruiting30Chinese PLA General HospitalSep 2024
NCT07363408Ivonescimab and ADG126, Alone, and in Combination With Leucovorin and Fluorouracil or FOLFIRI Regimen for the Treatment of Microsatellite Stable Advanced/Metastatic Colorectal CancerP1not yet recruiting30City of Hope Medical CenterJul 2026
NCT04322318A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWTP2recruiting256Children's Oncology GroupOct 2020
NCT07376499Prospective, Single-arm, Phase II Clinical Study of Irinotecan Hydrochloride Liposome Injection Combined With Platinum and Immune Checkpoint Inhibitors Combined With Anlotinib for the Maintenance of Extensive Small Cell Lung Cancer After First-line InductionP2not yet recruiting31China Medical University, ChinaJan 2026
NCT07011576FRUITFULA Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)P2recruiting60SCRI Development Innovations, LLCSep 2025
NCT07085273Irinotecan Liposome II + 5-FU/LV + Oxaliplatin + Karelizumab in Neoadjuvant Treatment of Gastric CancerP2not yet recruiting33The First Affiliated Hospital of Zhengzhou UniversityAug 2025
NCT07104604Study on the Efficacy and Safety of Neoadjuvant Radiotherapy Combined With Toripalimab, Liposomal Irinotecan, and Capecitabine in the Treatment of pMMR Locally Advanced Rectal Adenocarcinoma With Low Rectal InvolvementP1recruiting59Affiliated Cancer Hospital of Shantou University Medical CollegeAug 2025
NCT05733689Response Adapted Neoadjuvant Therapy in Gastroesophageal Cancers (RANT-GC Trial)P1recruiting20University of California, IrvineJun 2025
NCT06951841Prospective, Single-arm, Phase II Clinical Study of Irinotecan Hydrochloride Liposome Injection Combined With Platinum and Immune Checkpoint Inhibitors Combined With Anlotinib for the Maintenance of Extensive Small Cell Lung Cancer After First-line InductionP4not yet recruiting31China Medical University, ChinaApr 2025
NCT06462105Liposomal Irinotecan Combination Regimen for First-line Treatment of Small Cell Lung CancerN/Anot yet recruiting60Zhou ChengzhiJul 2024
NCT06123494SHR-A1811 for Subjects With Her2-positive Gastric Cancer and Gastroesophageal Junction Adenocarcinoma After Progression on or After First-line Anti-HER2 Therapy-containing RegimenP3recruiting360Jiangsu HengRui Medicine Co., Ltd.Jan 2024
NCT06714357VICTORIAValproIc Acid to Potentiate Anti-EGFR Treatment Efficacy and Prevent/Revert Resistance in Colorectal CancerP2recruiting130National Cancer Institute, NaplesMar 2025
NCT05391126GENOCAREGENOCARE: A Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual CareN/Arecruiting178Reema A. PatelSep 2022
NCT04361708I-FLOATSafety of Combining Irinotecan With 5-FU, Leucovorin/Folinic Acid, Oxaliplatin, and Docetaxel ChemotherapiesP1recruiting54University of ChicagoMay 2020
NCT05999994CAMPFIREA Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With CancerP2recruiting105Eli Lilly and CompanyJan 2020
NCT01864109Irinotecan and Temozolomide in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Patients With Newly Diagnosed Ewing SarcomaP2active not recruiting83Memorial Sloan Kettering Cancer CenterMay 2013
NCT00492999Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combined With Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the LiverP2active not recruiting64Memorial Sloan Kettering Cancer CenterMay 2007
NCT06356311TroFuse-015A Study to Evaluate Sacituzumab Tirumotecan (MK-2870) in Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-2870-015)P3active not recruiting450Merck Sharp & Dohme LLCMay 2024
NCT07092306NALIRI-VTA Randomized Controlled Study Comparing the Safety and Efficacy of Irinotecan Hydrochloride Liposome Injection Combined With Temozolomide and Vincristine (NALIRI-VT) Versus Irinotecan Combined With Temozolomide and Vincristine (VIT) in Patients With Advanced Ewing's SarcomaP2not yet recruiting74Tang XiaodongAug 2025
NCT05806931SCOTISequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal CancerP2recruiting50Rutgers, The State University of New JerseyMay 2023
NCT07441369Abemaciclib Combined With FOLFOX/FOLFIRI Regimen in Patients With Advanced Colorectal Liver Metastases CancerP2enrolling by invitation16Fudan UniversityMay 2026
NCT05669339AD HOC Trial: Artificial Intelligence-Based Drug Dosing In Hepatocellular CarcinomaP2recruiting12University of FloridaDec 2024
NCT06405139Nanoliposomal Irinotecan, Oxaliplatin Plus Capecitabine As Conversion Therapy of Locally Advanced Colorectal CancerP2recruiting36Cancer Institute and Hospital, Chinese Academy of Medical SciencesMay 2024
NCT06370754FD-IMPACTNewly Emerging Immunotherapy for Pancreatic Cancer TreatmentP1/P2not yet recruiting117Fudan UniversityApr 2024
NCT06375473MA-PC-RWS-011Treatment of Irinotecan Hydrochloride Liposome Injection II in China: a Real World Study of Pancreatic Cancer Patientsrecruiting3,000Peking Union Medical College HospitalApr 2024
NCT05381038Optimizing and Personalising Azacitidine Combination Therapy for Treating Solid Tumours QPOP and CURATE.AIP1/P2recruiting10National University Hospital, SingaporeFeb 2023
NCT06332950IISafety and Efficacy of Adebrelimab Plus Irinotecan Liposome (II) With or Without Famitinib in ES-SCLC Pre-treated With ImmunotherapyP1/P2not yet recruiting80Baohui HanApr 2024
NCT06210360Perioperative Treatment in High-risk Resectable Pancreatic Cancer With NALIRIFOXP2not yet recruiting134Changhai HospitalFeb 2024
NCT06782685Liposomal Irinotecan + Oxaliplatin + Bevacizumab Versus Liposomal Irinotecan + 5-FU/LVP1/P2recruiting138Dai, GuanghaiJun 2024
NCT04725994Study to Assess the Safety, Tolerability, and Efficacy of IDX-1197 in Combination With XELOX or Irinotecan in Patients With Advanced Gastric CancerP1/P2active not recruiting87Idience Co., Ltd.Jun 2021
NCT00980460Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver CancerP3active not recruiting236National Cancer Institute (NCI)Sep 2009
NCT02595931M6620 and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by SurgeryP1active not recruiting66National Cancer Institute (NCI)Jul 2016
NCT04514497Testing the Addition of an Anti-cancer Drug, BAY 1895344, to Usual Chemotherapy for Advanced Stage Solid Tumors, With a Specific Focus on Patients With Small Cell Lung Cancer, Poorly Differentiated Neuroendocrine Cancer, and Pancreatic CancerP1active not recruiting29National Cancer Institute (NCI)Oct 2021
NCT05688215Zimberelimab and Quemliclustat in Combination With Chemotherapy for the Treatment of Patients With Borderline Resectable and Locally Advanced Pancreatic AdenocarcinomaP1/P2recruiting56Jonsson Comprehensive Cancer CenterMar 2023
NCT06821997NALIRIFOX Before Surgery for the Treatment of Borderline Resectable Pancreatic Ductal Adenocarcinoma, Nectar TrialP2recruiting20Roswell Park Cancer InstituteMar 2026
NCT06184698Liposomal Irinotecan and Leucovorin/5-fluorouracil Plus Bevacizumab in Metastatic Colorectal CancerP2recruiting173Hebei Medical University Fourth HospitalJan 2024
NCT05062317ctDNA-Directed Post-Hepatectomy Chemotherapy for Patients With Resectable Colorectal Liver MetastasesP2recruiting120M.D. Anderson Cancer CenterApr 2022
NCT05945823Phase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid TumorsP2active not recruiting53Taiho Oncology, Inc.Jul 2023
NCT04796012VITASVITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid TumorsP1/P2recruiting23University of Texas Southwestern Medical CenterApr 2023
NCT046893475FU/LV, Irinotecan, Temozolomide and Bevacizumab for MGMT Silenced, Microsatellite Stable Metastatic Colorectal Cancer.P1/P2recruiting27Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoJan 2021
NCT06656091A Study of Simmitinib Versus Chemotherapy for Participants With Advanced Oesophageal Squamous Cell CarcinomaP3not yet recruiting450Shanghai Runshi Pharmaceutical Technology Co., LtdOct 2024
NCT03641313Berzosertib and Irinotecan in Treating Patients With Progressive, Metastatic, or Unresectable TP53 Mutant Gastric or Gastroesophageal Junction CancerP2active not recruiting17National Cancer Institute (NCI)Nov 2020
NCT06172036CAPT-02Irinotecan Liposome for Resectable Pancreatic Cancer With or Without AddebelizumabP2not yet recruiting180Zhejiang UniversityJan 2024
NCT04539808NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic CancerP2active not recruiting42OHSU Knight Cancer InstituteMay 2021
NCT06166589Second-line Zimberelimab and SIRIOX Chemotherapy for Patient With Previously AG Chemotherapy Treated Pancreatic CancerP2not yet recruiting19Shanghai Zhongshan HospitalJan 2024
NCT07060014NALIRIFOX (Nal-IRI Plus 5-FU/LV Plus Oxaliplatin) as First-Line Treatment for Patients With Advanced Small Intestine and Appendiceal CancersP1not yet recruiting22The Methodist Hospital Research InstituteJul 2025
NCT06763029VICPROIRIIrinotecan Liposomes Combined with Cetuximab + Vermofenib in First-line Failure of Advanced Colorectal CancerP2recruiting36Fudan UniversityFeb 2025
NCT06710821Irinotecan Liposomes Combined with Temozolomide and Vincristine in the Treatment of Pediatric Patients with Solid TumorsP1not yet recruiting40Yizhuo ZhangDec 2024
NCT06700603Second-line Irinotecan Liposome Combination Regimen for Irinotecan-treated Pancreatic CancerP2not yet recruiting48Rui-hua Xu, MD, PhDNov 2024
NCT06643793IIEvaluation of Irinotecan Liposome (II) Combined With 5-FU, LV, and Bevacizumab for mCRCP2recruiting30Affiliated Hospital of Nantong UniversityNov 2024
NCT06531278Adebelimab Combined With Irinotecan Liposomal Injection, Oxaliplatin, Fluorouracil and Calcium Folinate Are Used in the First-line Treatment of Pancreatic Cancer Liver Metastasis Efficacy and SafetyP2recruiting40Jiang LongJul 2024
NCT06463548Irinotecan Hydrochloride Liposome Combined With Capecitabine and Lenvatinib in Patients With Biliary Tract CarcinomaN/Anot yet recruiting30Yunpeng LiuJul 2024
NCT06341296Phase II Study of Irinotecan Liposomes in First-line Treatment of Metastatic Colorectal CancerP2recruiting86West China HospitalJun 2024
NCT06258642Irinotecan Liposome Combined With Anlotinib as Second-line Regimen for SCLCN/Arecruiting39Fudan UniversityApr 2024
NCT06107413IVStudy to Assess Adverse Events and Change in Disease Activity in Previously Treated Adult Participants Receiving Intravenous (IV) ABBV-400 With Unresectable Metastatic Colorectal Cancer in Combination With IV Fluorouracil, Folinic Acid, and BevacizumabP2active not recruiting280AbbVieNov 2023
NCT05400603Aflac-NBL-2002Allogeneic Expanded Gamma Delta T Cells With GD2 Chemoimmunotherapy in Relapsed /Refractory Neuroblastoma or Refractory/ Relapsed OsteosarcomaP1recruiting24Emory UniversityNov 2023
NCT05440786LY2835219CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's SarcomaP2active not recruiting46Eli Lilly and CompanySep 2022
NCT05727163FOLFOX Via HAI Plus Intravenous Irinotecan With or Without Bevacizumab Versus Systemic FOLFOXIRI With or Without Bevacizumab in Initially Unresectable RAS-mutated CRLM PatientsP2recruiting194Sun Yat-sen UniversityJul 2022
NCT06532344An Open-label, Uncontrolled Study of ONO-7913 and ONO-4538 in Combination With Modified FOLFIRINOX Therapy, the Standard of Care, as First-line Treatment in Patients With Metastatic Pancreatic CancerP1active not recruiting32Ono Pharmaceutical Co., Ltd.Jul 2021
NCT04233866Comparing Two Treatment Combinations, Gemcitabine and Nab-Paclitaxel With 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan for Older Patients With Pancreatic Cancer That Has SpreadP2active not recruiting176ECOG-ACRIN Cancer Research GroupAug 2020
NCT04443543An Adaptive-design Prospective Cohort Study of Watch and Wait Strategy in Patients With Locally Advanced Rectal CancerP2not yet recruiting222Fudan UniversityJun 2020
NCT04005339NAPOLI-2NAPOLI-2: Fluorouracil, Leucovorin, and Nanoliposomal Irinotecan in Biliary CancerP2active not recruiting48Georgetown UniversityJul 2019
NCT03483038A Study of the Safety and Activity of Liposomal Irinotecan in Combination With the 5-FU and Oxaliplatin in the Preoperative Treatment of Pancreatic AdenocarcinomaP2active not recruiting45University of FloridaDec 2018
NCT03533582Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After SurgeryP3active not recruiting537Children's Oncology GroupMay 2018
NCT00248287CA225200PhII ICb With/Without Erbitux in MBC PtsP2active not recruiting154US Oncology ResearchJul 2005
NCT06405490NALIRI-XELOX+AK104 for First-line Treatment of Advanced PDACP2recruiting30Cancer Institute and Hospital, Chinese Academy of Medical SciencesApr 2024
NCT05962502Cetuximab Plus Irinotecan in Patients With NeoRAS Wild-type Metastatic Colorectal Cancer In Third-line TherapyP2recruiting54Sun Yat-sen UniversityAug 2023
NCT06417476Short-course Radiotherapy or Long-course Chemoradiation Followed by mFOLFOXIRI Consolidation Chemotherapy for Organ Preservation in Low Rectal CancerP2active not recruiting66Pei-Rong DingDec 2022
NCT05148767UGT1A1-Based Irinotecan Therapy for Locally Advanced Rectal CancerP4recruiting606Zhejiang Cancer HospitalJan 2022
NCT04415853Study of Larotinib in Unresectable Advanced or Recurrent Esophageal CancerP3recruiting416Sunshine Lake Pharma Co., Ltd.Jan 2021
NCT06340204Weekly Irinotecan Liposomes in Recurrent or Refractory Ewing SarcomaP1recruiting44Peking University People's HospitalMar 2024
NCT06801730NALIRIBVRGIrinotecan Liposomes Combined With Bevacizumab in the Treatment of Recurrent GliomaP2recruiting38Zhifeng Tian,MDJan 2025
NCT06351020LM-302 for the Treatment of Subjects With Claudin18.2-Positive Gastric and Gastroesophageal Junction Adenocarcinoma.P3active not recruiting387LaNova Medicines Zhejiang Co., Ltd.Jun 2024
NCT06394713A Study to Evaluate the Efficacy and Safety of QLF31907 Combination Therapy in Patients With Advanced Malignant TumorsP1/P2not yet recruiting60Qilu Pharmaceutical Co., Ltd.Jun 2024
NCT06011772EGF-Depleting Therapy CIMAvax-EGF in Combination With Standard Therapy for RAS- and BRAF Wild-Type Metastatic Colorectal CancerEarly P1active not recruiting2Roswell Park Cancer InstituteDec 2023
NCT06514313Clinical Trial of VIM With VIT in Children With Relapsed and Refractory Soft Tissue Sarcoma.P2recruiting110Yizhuo ZhangJul 2024
NCT06055179XCHT for Irinotecan-Induced Gut Toxicities (Randomized Controlled Trial)N/Arecruiting98Guangzhou University of Traditional Chinese MedicineMar 2024
NCT06438822Cadonilimab Combined With Liposomal Irinotecan Plus Leucovorin and Fluorouracil for Advanced CholangiocarcinomaP2recruiting51West China HospitalAug 2024
NCT05427383KN026 in Combination With Chemotherapy in HER2 Positive Gastric Cancer Subjects Who Have Failed First-line TherapyP2/P3recruiting286Shanghai JMT-Bio Inc.Apr 2022
NCT03773367INTENSEIrinotecan-based Triplet (FOLFOXIRI) as Perioperative Treatment in Resectable Gastric and Gastroesophageal Junction Adenocarcinoma.P2active not recruiting60Lund University HospitalDec 2018
NCT06697366Liposomal Irinotecan Combined with Sintilimab for Second-line Treatment of Progressive Gastric CancerP2not yet recruiting27Ruijin HospitalNov 2024
NCT06699459NICRRBTCIrinotecan Liposomes +5-FU/LV Versus Capecitabine in Patients of Recurrence After Resection of Resectable BTCP2not yet recruiting76Sir Run Run Shaw HospitalNov 2024
NCT02567435Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk RhabdomyosarcomaP3active not recruiting325National Cancer Institute (NCI)Jun 2016
NCT05843188Study of Hydroxychloroquine With FOLFIRI and Bevacizumab in DTP-high Metastatic Colorectal CancerP2active not recruiting155University Health Network, TorontoAug 2023
NCT05462236MNK Inhibitor AUM001 in Combination With Either Pembrolizumab or Irinotecan to Treat Metastatic Colorectal CancerP2recruiting120AUM Biosciences Pte LtdApr 2023
NCT06346392AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2P3active not recruiting592AstraZenecaMar 2024
NCT06192680Liposomal Irinotecan and Capecitabine Plus Bevacizumab as Second-line Therapy in Metastatic Colorectal CancerP2not yet recruiting63Harbin Medical UniversityApr 2024
NCT06202001Irinotecan, TAS-102 Plus Bevacizumab as a Second-Line Therapy in mCRC PatientsP1/P2recruiting70Cancer Institute and Hospital, Chinese Academy of Medical SciencesOct 2022
NCT03829462NEXT-REGIRIAssessing a Regorafenib-irinotecan Combination Versus Regorafenib Alone in Metastatic Colorectal Cancer PatientsP3active not recruiting377Institut du Cancer de Montpellier - Val d'AurelleMar 2019
NCT02192359Carboxylesterase-Expressing Allogeneic Neural Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade GliomasP1active not recruiting18City of Hope Medical CenterApr 2016
NCT04342910Study to Evaluate the Efficacy and Safety of Camrelizumab and Apatinib in Patients With GC/GEJCP3recruiting550Jiangsu HengRui Medicine Co., Ltd.Sep 2020
NCT06769425HS-10502HS-10502 Combination Treatment in Patients With Advanced Solid TumorsP1recruiting157Jiangsu Hansoh Pharmaceutical Co., Ltd.May 2025
NCT01189643Irinotecan, Temozolomide and Bevacizumab in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Newly Diagnosed Patients With Desmoplastic Small Round Cell TumorEarly P1active not recruiting15Memorial Sloan Kettering Cancer CenterAug 2010
NCT00045201Erlotinib Hydrochloride and Irinotecan Hydrochloride in Treating Patients With Advanced Solid TumorsP1active not recruiting60National Cancer Institute (NCI)Jun 2002
NCT05312398CAPRI 2 GOIM Study: Investigate the Efficacy and Safety of a Bio-marker Driven Cetuximab-based Treatment RegimenP2active not recruiting219University of Campania Luigi VanvitelliJul 2021
NCT06321081ICE Study: Combination of Irinotecan Plus Cetuximab and Envafolimab as a Rechallenge Regimen in mCRCP2recruiting60Beijing HospitalMar 2024
NCT05846867A Phase Ib/II Clinical Study on AK112 Combined or Not Combined With AK119 in pMMR/MSS Colorectal CancerP1/P2active not recruiting170AkesoMay 2023
NCT06341309Exploratory Study of Irinotecan Liposomes in Maintenance Therapy of Metastatic Colorectal CancerP1/P2not yet recruiting20West China HospitalAug 2024
NCT06443307Real-world Study to Evaluate the Efficacy and Safety of Liposome Irinotecanrecruiting933Peking UniversityJul 2024
NCT06403709Irinotecan, TAS-102 Plus Bevacizumab as a Third-Line or Beyond Therapy in mCRC PatientsP2active not recruiting35Cancer Institute and Hospital, Chinese Academy of Medical SciencesAug 2022
NCT04034173Optimal Anti-EGFR Treatment of mCRC Patients With Low-Frequency RAS MutationP2not yet recruiting120Ludwig-Maximilians - University of MunichAug 2019
NCT05457829Doxorubicin Hydrochloride Liposome Combined With Irinotecan (AI Regimen) Versus VIT Regimen in the Treatment of Relapsed and Refractory Pediatric Rhabdomyosarcoma: a Prospective, Open-label, Randomized Controlled, Multicenter, Phase II Clinical StudyP2recruiting88Sun Yat-sen UniversityDec 2023
NCT06434090Liposomal Irinotecan Plus Bevacizumab in Irinotecan-refractory Metastatic Colorectal CancerP1/P2not yet recruiting74Sun Yat-sen UniversityJun 2024
NCT04753879Multi-agent Low Dose Chemotherapy GAX-CI Followed by Olaparib and Pembro in Metastatic Pancreatic Ductal Cancer.P2active not recruiting38Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsSep 2021
NCT04094688SOLARISVitamin D3 With Chemotherapy and Bevacizumab in Treating Patients With Advanced or Metastatic Colorectal CancerP3active not recruiting455Alliance for Clinical Trials in OncologyOct 2019
NCT03764553LyRICXLiposomal iRInotecan, Carboplatin or oXaliplatin for Esophagogastric CancerP2active not recruiting320Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)May 2019
NCT07056777Evaluation of the Preliminary Efficacy and Safety of DR30206 in Combination With Standard Therapy in Patients With Gastrointestinal CancerP1/P2recruiting186Zhejiang Doer Biologics Co., Ltd.Mar 2025
NCT06387810undeterminedIrinotecan Liposome II in Combination With 5-FU/LV and Oxaliplatin in Perioperative Treatment of Borderline Resectable Pancreatic CancerP2recruiting45Peking Union Medical College HospitalApr 2024
NCT05978492A Study of TXN10128 in Subjects With Solid TumorsP1recruiting96Txinno Bioscience Inc.Jul 2023
NCT06094140NEO-IMPACTNEO-adjuvant Chemo-immunotherapy in Pancreatic CancerP2active not recruiting20Australasian Gastro-Intestinal Trials GroupMay 2022
NCT03872947A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid TumorsP1active not recruiting138Toray Industries, IncApr 2019
NCT036788839-ING-41 in Patients With Advanced CancersP2active not recruiting350Actuate Therapeutics Inc.Jan 2019
NCT03493048Cetuximab Plus FOLFOXIRI vs Cetuximab Plus FOLFOX For CRCLMP2active not recruiting146Sun Yat-sen UniversityApr 2018
NCT03189706Study of Chemoimmunotherapy for High-Risk NeuroblastomaEarly P1active not recruiting48Memorial Sloan Kettering Cancer CenterJun 2017
NCT04008030CheckMate 8HWA Study of Nivolumab, Nivolumab Plus Ipilimumab, or Investigator's Choice Chemotherapy for the Treatment of Participants With Deficient Mismatch Repair (dMMR)/Microsatellite Instability High (MSI-H) Metastatic Colorectal Cancer (mCRC)P3active not recruiting839Bristol-Myers SquibbAug 2019
NCT02366819Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach CancerP4suspended36University of ChicagoDec 2014
NCT07542002Liposomal Irinotecan, 5-fluorouracil/Calcium Folinate, Oxaliplatin, and Adebrelimab in Combination With Radiotherapy for Resectable or Borderline Resectable Pancreatic Cancer With Risk Factors:A Prospective Exploratory StudyP2recruiting37Ningbo Medical Center Lihuili HospitalMar 2025
NCT06304974A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma(PANKU-Esophagus01)P3active not recruiting497Sichuan Baili Pharmaceutical Co., Ltd.Mar 2024
NCT05238831ACTSMMART Adaptive Clinical Treatment (ACT) TrialEarly P1withdrawn0OHSU Knight Cancer InstituteJan 2023
NCT04390399Combination Immunotherapy Plus Standard-of-Care Chemotherapy Versus Standard-of-Care Chemotherapy for the Treatment of Locally Advanced or Metastatic Pancreatic CancerP2active not recruiting328ImmunityBio, Inc.Jul 2020
NCT05083481A Study of ASP1570 Taken by Itself, or ASP1570 Taken Together With Either Pembrolizumab, Standard Therapies, or Both, in Adults With Solid TumorsP1/P2terminated226Astellas Pharma Global Development, Inc.Oct 2021
NCT05235542A Phase Ib/II Study of AK104 and AK117 in Combination With or Without Chemotherapy in Advanced Malignant TumorsP1/P2completed128AkesoMar 2022
NCT04776655LIBImAbStudy in mCRC Patients RAS/BRAF wt Tissue and RAS Mutated LIquid BIopsy to Compare FOLFIRI Plus CetuxiMAb or BevacizumaBP3recruiting280Azienda USL Reggio Emilia - IRCCSApr 2021
NCT06225622Dose Escalation and Expansion Clinical Trial of Irinotecan Liposome Combined With Oxaliplatin and 5-FU/LV Plus Bevacizumab as First-line Treatment of Metastatic Colorectal CancerP1unknown78Shanghai Zhongshan HospitalMar 2024
NCT02919787Nordic Pancreatic Cancer Trial (NorPACT) - 1P2/P3active not recruiting140Oslo University HospitalSep 2016
NCT04481204New and Emerging Therapies for the Treatment of Resectable, Borderline Resectable, or Locally Advanced Pancreatic Cancer, PIONEER-Panc StudyP2withdrawn0M.D. Anderson Cancer CenterApr 2023
NCT05153239LAGOONClinical Trial of Lurbinectedin as Single-agent or in Combination With Irinotecan Versus Topotecan or Irinotecan in Patients With Relapsed Small-cell Lung Cancer (LAGOON)P3completed705PharmaMarJul 2022
NCT03279237A Pilot Study of FOLFIRINOX in Combination With Neoadjuvant Radiation for Gastric and GE Junction CancersP1completed25Massachusetts General HospitalOct 2017
NCT06437678Phase II Study of Liposomal Irinotecan for Advanced Refractory Gastric CancerP2unknown50Zhejiang Cancer HospitalMay 2024
NCT05731518ES-SCLCSC0245 and Irinotecan in Treating Patients With Relapsed Extensive-Stage Small Cell Lung Cancer (ES-SCLC)P1/P2unknown67Biocity Biopharmaceutics Co., Ltd.Feb 2023
NCT05818982To Evaluate the Efficacy and Safety of Afatinib for Advanced ALTRK-negative ESCCP2unknown72Peking UniversityFeb 2023
NCT04821284Sonoporation and Chemotherapy for the Treatment of Pancreatic CancerP1/P2active not recruiting120Flemming ForsbergDec 2021
NCT02308527BEACONActivity Study of Bevacizumab With Temozolomide ± Irinotecan for Neuroblastoma in ChildrenP2completed225University of BirminghamJul 2013
NCT05737563EscapePD-1 Antibody Combined With mXELIRI Versus mXELIRI in the Second-line Setting for ESCCP3unknown380Sun Yat-sen UniversityFeb 2023
NCT05027386Apatinib Mesylate Combined With IT Regimen for the Treatment of Recurrent or Refractory Pediatric Neuroblastoma: A Single-arm, Phase I/II,Multi-center, Clinical Study.P1/P2recruiting125Sun Yat-sen UniversityAug 2021
NCT04595266LIVERPEARLChemoembolization (Lifepearls-Irinotecan) in Patients With Colorectal Cancer and Metastatic DiseaseP2active not recruiting48Grupo Espanol Multidisciplinario del Cancer DigestivoJun 2021
NCT02980510PANIRINOXComparison FOLFIRINOX Panitumumab vs mFOLFOX6 Panitumumab in RAS/B-RAF Wild-type Metastatic Colorectal Cancer PatientsP2active not recruiting219UNICANCERDec 2016
NCT06486545Liposomal Irinotecan Combination Regimen for Second-line Treatment of Advanced Gastric CancerN/Anot yet recruiting18Hunan Cancer HospitalAug 2024
NCT06512428A Study of Simmitinib Plus Irinotecan in Advanced Esophageal Squamous Cell CarcinomaP2recruiting138Shanghai Runshi Pharmaceutical Technology Co., LtdMar 2024
NCT06139211A Phase Ib/II Study Of JS015 Combination Therapy in Advanced Solid TumorsP1/P2recruiting186Shanghai Junshi Bioscience Co., Ltd.Jan 2024
NCT04697628innovaTV 301Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical CancerP3completed502Seagen, a wholly owned subsidiary of PfizerFeb 2021
NCT06282120Efficacy and Safety of Irinotecan Liposome Injection Combined With 5-FU/LV± Immunotherapy in First-line Gemsitabine + Immunoprogressive Patients With Metastatic Biliary Tract Cancerunknown30Tianjin Medical University Cancer Institute and HospitalJan 2024
NCT04393584RusGCG-01FOLFIRINOX vs FLOT Chemotherapy for Resectable Gastric or Esophagogastric Junction AdenocarcinomaP2/P3unknown538Blokhin's Russian Cancer Research CenterJan 2019
NCT05385861Nal-IRI (ONIVYDE® ) and Carboplatin in Patients With Advanced or Metastatic GEP-NETP1/P2enrolling by invitation52National Health Research Institutes, TaiwanAug 2025
NCT07204574The Phase 1b/IIa, Open-label, Dose Escalation and Dose Expansion to Evaluate Safety, Tolerability, and Preliminary Efficacy of the Combination of HCB101, Cetuximab/Bevacizumab, and FOLFOX/FOLFIRI in Advanced or Metastatic Colorectal CancerP1/P2recruiting40Chang Gung Memorial HospitalMay 2025
NCT06538623HAICOxaliplatin Combined With Irinotecan Liposome Injection II Through Hepatic Artery Infusion (HAIC) Followed by 5-FU/LV (HAIC) or Tegorgor Oral Combination Therapy for Hepatic Metastasis of Pancreatic CancerP2completed40Ruijin HospitalAug 2024
NCT06430827Clinical Study of Irinotecan Hydrochloride Liposome Combined With Capecitabine for Second-line Treatment in Patients With Advanced or Metastatic Biliary Tract CarcinomaP2unknown20Ba YiJun 2024
NCT06475326Adebrelimab in Combination With NALIRIFOX in Locally Advanced Pancreatic CancerP2recruiting87Fudan UniversityJun 2024
NCT06467565NALIRIFOX as Induction Therapy in LAPCP2recruiting20The First Affiliated Hospital with Nanjing Medical UniversityDec 2023
NCT05859750A Study of AK104 With Chemotherapy as First-line Treatment in Patients With Advanced Pancreatic CancerP2recruiting78AkesoMay 2023
NCT05319639POFIPhase I/II Study of the Combination of Irinotecan and POF (POFI) and TislelizumabP1/P2recruiting51Fujian Cancer HospitalFeb 2023
NCT05750290CKD-702 Plus Irinotecan in Gastric CancerP2unknown40National Cancer Center, KoreaDec 2022
NCT05229003Irinotecan Plus Anlotinib or Further in Combination With Penpulimab for Second-line Treatment of mCRCP2recruiting44Fudan UniversityMar 2022
NCT06760117UGT1A1 Genotype-drien Phase I Study of Irinotecan in VIT Regimen for the Treatment of Pediatric R/R Solid TumorsP1recruiting39Sun Yat-sen UniversityJan 2022
NCT05022654SI-B001 Combined With Irinotecan in the Treatment of Recurrent Metastatic Esophageal Squamous Cell Carcinoma.P2active not recruiting22Sichuan Baili Pharmaceutical Co., Ltd.Dec 2021
NCT04447092Pembrolizumab Plus Chemotherapy in 1st Line Treatment of Pancreatic CancerP2unknown77Seoul National University HospitalJul 2020
NCT04371224NaliCapNaliCap (Irinotecan Liposome (Nal-IRI)/Capecitabine) vs. NAPOLI (Nal-IRI/5-FU/LV) ) in Advanced Pancreatic CancerP2unknown200Seoul National University HospitalJun 2020
NCT04267978Study of Recombinant Human Endostatin Combined with Temozolomide and Irinotecan in Recurrent GliomasP2recruiting109Beijing Sanbo Brain HospitalFeb 2020
NCT03290937Utomilumab, Cetuximab, and Irinotecan Hydrochloride in Treating Patients With Metastatic Colorectal CancerP1completed34M.D. Anderson Cancer CenterDec 2017
NCT06766266Irinotecan Liposomes Combined with Epirubicin in Recurrent Non-muscle Invasive Bladder Urothelium Carcinoma After Anthracyclines TreatmentP1recruiting18First Affiliated Hospital of Chongqing Medical UniversityJan 2025
NCT06345300NALIRIFOX in Combination With Camrelizumab for BRPC: a Prospective, Exploratory StudyP2unknown40Cancer Institute and Hospital, Chinese Academy of Medical SciencesMar 2024
NCT01858168Phase I Study of Olaparib and Temozolomide for Ewings Sarcoma or RhabdoomyosarcomaP1completed49Massachusetts General HospitalJul 2013
NCT05342636MK-3475A Study of Combination Therapies With or Without Pembrolizumab (MK-3475) and/or Chemotherapy in Participants With Advanced Esophageal Cancer (MK-3475-06A)P1/P2completed90Merck Sharp & Dohme LLCJul 2022
NCT06509906M9466 in Combination With Topoisomerase 1 Inhibitors-based Regimens in Advanced Solid Tumors and Colorectal Cancer (DDRiver 511)P1terminated3EMD Serono Research & Development Institute, Inc.Oct 2024
NCT05628038TORCH-RThe Combination of Hypofractionated Radiotherapy and Immunotherapy in Locally Recurrent Rectal CancerP2recruiting93Fudan UniversityNov 2022
NCT05278351Tislelizumab Plus Cetuximab and Irinotecan vs Third-line Standard-of-care in Refractory mCRCP2unknown87Shanghai Zhongshan HospitalJul 2022
NCT05643677Fruquintinib Plus Irinotecan in the Treatment of Advanced Gastric CancerP2unknown47Fujian Medical UniversityDec 2022
NCT05669807Camrelizumab Combined With Irinotecan or Albumin Paclitaxel for Second-line Treatment of Advanced Gastric CancerP2unknown184Zhejiang Cancer HospitalDec 2022
NCT04251715mFOLFIRINOX Followed by Hepatic Arterial Infusion of Floxuridine and Dexamethasone With Systemic mFOLFIRI for Unresectable Liver-dominant Intrahepatic CholangiocarcinomaP2active not recruiting5OHSU Knight Cancer InstituteApr 2021
NCT03368963TAS102 in Combination With NAL-IRI in Advanced GI CancersP1/P2active not recruiting64Emory UniversityJan 2018
NCT03366155Hepatic Artery Infusion Pump Chemotherapy With Floxuridine and Dexamethasone in Combination With Systemic Chemotherapy for Patients With Colorectal Cancer Metastatic to the LiverP2completed24National Cancer Institute (NCI)Jun 2019
NCT06300489Genotype-driven Weekly Irinotecan Liposomes in Combination With Capecitabine-based Neoadjuvant Chemoradiation for Locally Advanced Rectal CancerP1unknown30Zhejiang Cancer HospitalMar 2024
NCT03709680Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid TumorsP2active not recruiting128PfizerMay 2019
NCT05595889Surufatinib Combined With Irinotecan as a Second-line Treatment for Small Cell Lung CancerP2unknown40Fujian Cancer HospitalDec 2022
NCT04617457HOLIPANCChemotherapy and Surgical Resection in Patients With Hepatic Oligometastatic Adenocarcinoma of the PancreasP2unknown150University of CologneOct 2021
NCT06225999Phase 2 Study of Irinotecan Liposome Injection, Oxaliplatin, 5-fluorouracil/Levoleucovorin in Japanese Participants Not Previously Treated for Metastatic Adenocarcinoma of the PancreasP2completed41Institut de Recherches Internationales ServierApr 2024
NCT03866525OH2 Oncolytic Viral Therapy in Solid TumorsP1/P2recruiting300Binhui Biopharmaceutical Co., Ltd.Apr 2019
NCT04238819LY2835219A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including NeuroblastomaP1/P2completed47Eli Lilly and CompanyNov 2020
NCT03337087Liposomal Irinotecan, Fluorouracil, Leucovorin Calcium, and Rucaparib in Treating Patients With Metastatic Pancreatic, Colorectal, Gastroesophageal, or Biliary CancerP1/P2unknown18Academic and Community Cancer Research UnitedNov 2018
NCT02967289IROCASIRinotecan and Oxaliplatin for Colon Cancer in Adjuvant SettingP3completed792UNICANCERMar 2017
NCT042390929-ING-41 in Pediatric Patients With Refractory Malignancies.P1terminated40Actuate Therapeutics Inc.Jun 2020
NCT03365882S1613S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by SurgeryP2completed240SWOG Cancer Research NetworkNov 2017
NCT02611024Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid TumorsP1/P2completed316PharmaMarMay 2016
NCT06169202A Study of Fruquintinib in Combination With Irinotecan and Capecitabine for the Second-line Treatment of Patientsunknown50China Medical University, ChinaJun 2023
NCT04714190A Study of RC48-ADC in Local Advanced or Metastatic Gastric Cancer With the HER2-OverexpressionP3unknown351RemeGen Co., Ltd.Mar 2021
NCT05546853LAP-NET1Study Investigating the Association of NP137 With mFOLFIRINOX in Locally Advanced Pancreatic Ductal AdenocarcinomaP1completed43University Hospital, GrenobleMar 2023
NCT05620862Phase I Dose Escalation and Pharmacokinetics Clinical Trial of Mitoxantrone Hydrochloride Liposome in Children With Relapsed and Refractory Lymphoma and Solid TumorsP1active not recruiting68Sun Yat-sen UniversityOct 2022
NCT05015621A Phase 3 Study to Evaluate Surufatinib Plus Toripalimab in the Treatment of Advanced Neuroendocrine CarcinomaP3unknown194Hutchison Medipharma LimitedSep 2021
NCT04934618A Phase II Study of Carelizumab Combined With Irinotecan and Apatinib of Second-line Treatment for Advanced Gastric CancerP2unknown85Nanfang Hospital, Southern Medical UniversityMay 2020
NCT04141995FOLFIRINOX With Digoxin in Patients With Resectable Pancreatic CancerP2terminated11University of NebraskaFeb 2021
NCT04879368INTEGRATEIIbRegoNivo vs Standard of Care Chemotherapy in AGOCP3completed462Australasian Gastro-Intestinal Trials GroupMay 2021
NCT04535401Testing the Addition of an Anticancer Drug, BAY 1895344, to the Usual Chemotherapy With FOLFIRI in Advanced or Metastatic Cancers of the Stomach and IntestinesP1unknown10National Cancer Institute (NCI)Aug 2021
NCT04067115U01CA236220SARC037: A Phase I/II Study to Evaluate the Safety of Trabectedin in Combination With Irinotecan in Ewing Sarcoma PatientsP1/P2completed37Sarcoma Alliance for Research through CollaborationJan 2021
NCT05383352SIRACUSAA Study to Compare Onivyde Manufactured at Two Different Production Sites in Adult Participants With Advanced Cancer in the PancreasP1completed177IpsenMay 2022
NCT05322499Phase II Clinical Study of Camrelizumab Combined With Chemotherapy or Anlotinib in Advanced Esophageal Squamous Cell CancerP2unknown80Zhejiang Cancer HospitalApr 2022
NCT05799443Efficacy and Safety of SBRT Followed by Tislelizumab Plus Cetuximab and Irinotecan in Patients With Previously Treated RAS Wild-type Advanced Refractory Colorectal CancerP2unknown23Fujian Cancer HospitalApr 2023
NCT03328884PhenomenalEvaluation of the Efficacy and Safety of Nal-IRI for Progressing Brain Metastases in Breast Cancer PatientsP2completed55MedSIRMay 2017
NCT06197438POFIPhase II Study of the Combination of Irinotecan and POF (POFI) and Tislelizumab in Advanced Gastric CancerP2unknown36Fujian Cancer HospitalJan 2024
NCT04117945Regorafenib, With Cetuximab or Panitumumab, for the Treatment of Unresectable, Locally Advanced, or Metastatic Colorectal CancerP2active not recruiting22Academic and Community Cancer Research UnitedMar 2020
NCT06414577Irinotecan Liposomes in Combination With Nituzumab for the Treatment of Recurrent/Metastatic Nasopharyngeal Carcinoma After Failure of First-Line or Higher ImmunotherapyP2active not recruiting38XIANG YANQUNMay 2024
NCT05839470Cadonilimab Plus FOLFOXIRI and Bevacizumab as First Line Therapy for Metastatic MSS Colorectal CancerP2unknown20Fujian Cancer HospitalNov 2023
NCT04083235NAPOLI 3A Study to Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously Treated for Metastatic Pancreatic Cancer, Compared to Nab-paclitaxel+Gemcitabine TreatmentP3completed770IpsenFeb 2020
NCT04095221A Study of the Drugs Prexasertib, Irinotecan, and Temozolomide in People With Desmoplastic Small Round Cell Tumor and RhabdomyosarcomaP1/P2completed21Memorial Sloan Kettering Cancer CenterSep 2019
NCT05379790Concomitant Intraperitoneal and Systemic Chemotherapy in Patients With Extensive Peritoneal Carcinomatosis of Gastric OriginP1completed20Erasmus Medical CenterMay 2022
NCT06538207An Open-label, Uncontrolled Study of ONO-4578 and ONO-4538 in Combination With Standard-of-care Modified FOLFIRINOX (mFFX) or Gemcitabine Plus Nab-paclitaxel (GnP) Therapy as First-line Treatment in Patients With Metastatic Pancreatic CancerP1completed46Ono Pharmaceutical Co., Ltd.Jan 2021
NCT02934529AIO-KRK-0114Metastatic Colorectal Cancer (RAS-wildtype) After Response to First-line Treatment With FOLFIR Plus CetuximabP3completed673Ludwig-Maximilians - University of MunichMar 2015
NCT03693677FUNGEMAXFirst Line Metastatic Pancreatic Cancer : 5FU/LV+Nal-IRI, Gemcitabine+Nab-paclitaxel or a Sequential Regimen of 2 Months 5FU/LV+Nal-IRIP2completed288Federation Francophone de Cancerologie DigestiveNov 2018
NCT04492033ABL001A Study of CTX-009 (ABL001) in Combination With Irinotecan or Paclitaxel in Advanced or Metastatic Solid Tumor PatientsP1/P2terminated41Handok Inc.Jun 2020
NCT06003998INTERACT-IIIntraperitoneal Irinotecan With Concomitant FOLFOX and BevacizumabP2unknown85Catharina Ziekenhuis EindhovenDec 2022
NCT06089330A Study of JMT101 in Patients With Metastatic Colorectal CancerP2unknown102Shanghai JMT-Bio Inc.Jan 2024
NCT05363007SINAISpleen Irradiation With Nanoliposomal Irinotecan Plus 5-FU and Leucovorin in Metastatic Pancreatic AdenocarcinomaP2unknown60National Taiwan University HospitalMay 2022
NCT04668976A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or CholangiocarcinomaP2unknown100Benaroya Research InstituteNov 2020
NCT04358354Triplet Combination of Cytotoxics as First-line Treatment for Metastatic Gastric CancerP3unknown388Sixth Affiliated Hospital, Sun Yat-sen UniversityOct 2020
NCT04513951AVETRICAVELUMAB and CETUXIMAB and mFOLFOXIRI as Initial Therapy for Unresectable Metastatic Colorectal Cancer PatientsP2completed62Gruppo Oncologico del Nord-OvestApr 2020
NCT02975882Nanoparticle Albumin-Bound Rapamycin, Temozolomide, and Irinotecan Hydrochloride in Treating Pediatric Patients With Recurrent or Refractory Solid TumorsP1completed33Children's Oncology GroupAug 2017
NCT01910610STRATEGIC-1Multi-Line Therapy Trial in Unresectable Metastatic Colorectal CancerP3unknown464GERCOR - Multidisciplinary Oncology Cooperative GroupOct 2013
NCT02087475Perioperative FOLFIRI VS Adjuvant FOLFIRI in Resectable Advanced CRC Failed to OxaliplatinP3unknown360Sixth Affiliated Hospital, Sun Yat-sen UniversityJan 2011
NCT04757779A Single-arm, Phase Ⅱ Clinical Trial of Anlotinib Hydrochloride Combined With Irinotecan or Docetaxel for Second Line Treatment of Nonsensitive Relapsed Small-cell Lung CancerP2unknown40First People's Hospital of HangzhouDec 2019
NCT04752696Onvansertib in Combination With Nanoliposomal Irinotecan, Leucovorin, and Fluorouracil for Second-Line Treatment of Participants With Metastatic Pancreatic Ductal AdenocarcinomaP2completed41Cardiff OncologyMay 2021
NCT05201326Irinotecan And Bevacizumab Combined With Re-radiotherapy in Recurrent GlioblastomaP1unknown20Ruijin HospitalDec 2021
NCT05453825A Study of Navicixizumab Monotherapy or in Combination in Patients With Select Advanced Solid TumorsP2unknown180OncXerna Theraputics, Inc.Aug 2022
NCT05047991Study of Irinotecan Liposome Injection-containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic AdenocarcinomaP2unknown153CSPC Ouyi Pharmaceutical Co., Ltd.Oct 2021
NCT03837977NET02Second-line Therapy for Patients With Progressive Poorly Differentiated Extra-pulmonary Neuroendocrine CarcinomaP2completed58The Christie NHS Foundation TrustNov 2018
NCT05049863Chemotherapy in Patients With Relapsed Small Cell Lung Cancer in Combination With Allopurinol and MycoPhenolate (CLAMP Trial)P1terminated17Washington University School of MedicineFeb 2023
NCT03785873Phase Ib/II Trial of Nal-Irinotecan and Nivolumab as Second-Line Treatment in Patients With Advanced Biliary Tract CancerP1/P2completed34University of Michigan Rogel Cancer CenterMay 2019
NCT04442984IRIGAFOLFOX6 Versus mFOLFIRINOX as First Line Chemotherapy in Metastatic Gastric Cancer or Esophagogastric Junction Adenocarcinoma (Type II-III)P2unknown326Blokhin's Russian Cancer Research CenterNov 2019
NCT05160727Radiotherapy Combined With Tislelizumab and Irinotecan in MSS/pMMR Recurrence and Metastatic Colorectal CancerP2unknown44Zhejiang Cancer HospitalOct 2021
NCT04072198NIVACORNivolumab Plus FOLFOXIRI/Bevacizumab in First Line Chemotherapy of Advanced Colorectal Cancer RASm/BRAFm PatientsP2completed73Gruppo Oncologico Italiano di Ricerca ClinicaSep 2019
NCT03323034Pevonedistat, Irinotecan, and Temozolomide in Treating Patients With Recurrent or Refractory Solid Tumors or LymphomaP1completed30Children's Oncology GroupJan 2018
NCT03861702Liposomal Irinotecan in Combination With Oxaliplatin, Leucovorin, and 5-fluorouracil for Patients With Locally Advanced Pancreatic Carcinoma:P2completed28Nelson YeeSep 2020
NCT03699319CPI-613 in Combination With Modified FOLFIRINOX in Locally Advanced Pancreatic CancerP1/P2completed49David Bajor, MDDec 2018
NCT02419495KPT-330Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced MalignanciesP1terminated221M.D. Anderson Cancer CenterJun 2015
NCT04109924TAS-102TAS-102, Irinotecan, and Bevacizumab for the Treatment of Pre-treated Metastatic or Unresectable Colorectal Cancer, the TABAsCO StudyP2completed42Roswell Park Cancer InstituteDec 2019
NCT05678257A Study of NUC-3373 in Combination With Other Agents in Patients With Colorectal CancerP2terminated180NuCana plcApr 2023
NCT03736720Liposomal Irinotecan, Fluorouracil and Leucovorin in Treating Patients With Refractory Advanced High Grade Neuroendocrine Cancer of Gastrointestinal, Unknown, or Pancreatic OriginP2terminated11Roswell Park Cancer InstituteJun 2019
NCT02138617Genotype-Directed Study Of Irinotecan Dosing In FOLFIRI + BevacizumabTreated Metastatic Colorectal CancerP2completed100UNC Lineberger Comprehensive Cancer CenterMay 2014
NCT04189055CETIDYLCetuximab as Salvage Therapy in Patients With Neo Wild-type RAS/RAF Metastatic Colorectal Cancer With Liver Metastases.P2unknown72Hôpital Franco-Britannique-Fondation Cognacq-JayJan 2020
NCT04525014PIRATERRx-001 Given With Irinotecan and Temozolomide for Pediatric Patients With Recurrent or Progressive Malignant Solid and Central Nervous System TumorsP1terminated2EpicentRx, Inc.Jan 2023
NCT03403101The Combination Chemotherapy of SIRIOX as First- or Second-Line Chemotherapy for Pancreatic CancerP2unknown65Fudan UniversityJul 2020
NCT04929652Surufatinib Combine With Immunotherapy and Chemotherapy for Second-line Treatment in Advanced Colorectal CancerP1/P2unknown48Jiangsu Cancer Institute & HospitalJun 2021
NCT04796948A Study of Irinotecan Liposome in Advanced Pancreatic CancerP1completed41Jiangsu HengRui Medicine Co., Ltd.Apr 2021
NCT03693807A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or CholangiocarcinomaP2completed35Memorial Sloan Kettering Cancer CenterOct 2018
NCT05330429ELEVATE CRCStudy of Magrolimab Given Together With FOLFIRI/Bevacizumab (BEV) in Participants With Previously Treated Advanced Inoperable Metastatic Colorectal Cancer (mCRC)P2terminated77Gilead SciencesJul 2022
NCT04728035Study of Irinotecan Liposome Injection in Patients With Advanced Breast CanceP1completed119CSPC Ouyi Pharmaceutical Co., Ltd.May 2021
NCT04641871Sym021 in Combination With Either Sym022 or Sym023 or Sym023 and Irinotecan in Patients With Recurrent Advanced Selected Solid Tumor MalignanciesP1completed78Symphogen A/SOct 2020
NCT05031975ERASE-TMZTemozolomide and Irinotecan in Patients With MGMT Silenced Colorectal Cancer After Adjuvant ChemotherapyP2unknown35Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoMay 2022
NCT03970252Nivolumab in Combination With Chemotherapy Pre-Surgery in Treating Patients With Borderline Resectable Pancreatic CancerEarly P1completed28Jonsson Comprehensive Cancer CenterJul 2019
NCT01837862A Phase I Study of Mebendazole for the Treatment of Pediatric GliomasP1/P2completed36Julie KrystalOct 2013
NCT02705300Side Effects to FOLFOXIRI + Tocotrienol/Placebo as First Line Treatment of Metastatic Colorectal CancerP2completed70Vejle HospitalMay 2016
NCT02720068MK-4280Study of Favezelimab (MK-4280) as Monotherapy and in Combination With Pembrolizumab (MK-3475) With or Without Chemotherapy or Lenvatinib (MK-7902) AND Favezelimab/Pembrolizumab (MK-4280A) as Monotherapy in Adults With Advanced Solid Tumors (MK-4280-001)P1completed481Merck Sharp & Dohme LLCMay 2016
NCT02085148A Phase I Dose Finding Study in Children With Solid Tumors Recurrent or Refractory to Standard TherapyP1completed62BayerApr 2014
NCT05435313Fruquintinib Combined With Tislelizumab and HAIC in Patients With Advanced Colorectal Liver Metastases Cancer Who Failed Standard TherapyP2unknown39Fudan UniversityJul 2022
NCT05461794Study To Investigate the Efficacy and Safety of Sitravatinib in Combination With Tislelizumab in Participants With Esophageal Squamous Cell CarcinomaP2terminated96BeiGeneOct 2022
NCT02047474Combination Chemotherapy Before and After Surgery in Treating Patients With Localized Pancreatic CancerP2completed46Yale UniversityMar 2014
NCT04059562TRITICCTrifluridine/Tipiracil in Combination With Irinotecan as a Second Line Therapy in Patients With CholangiocarcinomaP2completed28Heinrich-Heine University, DuesseldorfOct 2021
NCT05732129HRDThe Efficacy and Safety of Fluzoparib Plus Irinotecan as Second-line Treatment in Patients With Homologous Recombination Deficiency (HRD) Metastatic Colorectal Cancer.P2unknown29Fudan UniversityMar 2023
NCT04842526Efficacy and Safety of Anlotinib, Irinotecan and Temozolomide in the Treatment of Refractory or Recurrent Neuroblastoma in Children: an Open, Single Arm, Single Center, Phase II Clinical StudyP2unknown27Tianjin Medical University Cancer Institute and HospitalApr 2021
NCT03608046AVETUXIRIAvelumab Combined With Cetuximab and Irinotecan for Treatment Refractory Metastatic Colorectal Microsatellite Stable CancerP2unknown59Cliniques universitaires Saint-Luc- Université Catholique de LouvainOct 2018
NCT04034459AIO-KRK-0116FOLFOXIRI Plus Cetuximab vs. FOLFOXIRI Plus Bevacizumab 1st-line in BRAF-mutated mCRCP2unknown109Ludwig-Maximilians - University of MunichNov 2016
NCT02013336Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid TumorsP1unknown30South Plains Oncology ConsortiumDec 2013
NCT03567629Evaluate the Efficacy of Irinotecan Versus Oxaliplatin in the First-line Treatment of Refractory Metastatic Colorectal CancerP2unknown130Peking UniversityMay 2018
NCT04988191Toripalimab Plus Bevacizumab and Chemotherapy as Neoadjuvant Therapy in Advanced MSI-H or dMMR Colorectal CancerP1/P2unknown44Peking UniversityDec 2020
NCT03263429Novel PET/CT Imaging Biomarkers of CB-839 in Combination With Panitumumab and Irinotecan in Patients With Metastatic and Refractory RAS Wildtype Colorectal CancerP1/P2completed29Vanderbilt-Ingram Cancer CenterAug 2017
NCT05868317Induction Chemotherapy Followed by Short Course Radiotherapy in Rectal CancerP2unknown70Salah Azaïz Cancer InstituteNov 2020
NCT01959139S1313S1313, PEGPH20 in Treating Patients With Newly Diagnosed Metastatic Pancreatic CancerP1/P2completed126SWOG Cancer Research NetworkJan 2014
NCT03810742Nanoliposomal Irinotecan (Nal-IRI, ONIVYDE®) in Combination With TAS-102 (LONSURF®) in Refractory Solid TumorsP1completed44PharmaEngineMar 2019
NCT05217069FOLFIRI + Cetuximab + Avelumab RAS Wild-type CRCP2completed57Ludwig-Maximilians - University of MunichSep 2019
NCT05546411A Trial of NIS793 With FOLFIRINOX in Pancreatic CancerP2terminated8Kimberly Perez, MDJan 2023
NCT04915807RWDReal-world Data (RWD) of Ramucirumab Plus Paclitaxelunknown222Hallym University Medical CenterJun 2021
NCT05824455JS109A Clinical Study of IMP4297 Capsule (JS109) Combined With Irinotecan in the Treatment of Advanced Malignant Solid TumorsP1/P2terminated4Shanghai Jun Pai Ying Shi Therapeutics Co., Ltd.Mar 2023
NCT02539537NEOPANA Randomized Phase III Trial Comparing Folfirinox to Gemcitabine in Locally Advanced Pancreatic CarcinomaP3completed171UNICANCEROct 2015
NCT03721653AtezoTRIBEFOLFOXIRI + Bev + Atezo vs FOLFOXIRI + Bev as First-line Treatment of Unresectable Metastatic Colorectal Cancer PatientsP2completed218Gruppo Oncologico del Nord-OvestNov 2018
NCT04486651HX008 Plus Irinotecan Versus Placebo Plus Irinotecan as Second-line Treatment in Advanced Gastric CancerP3unknown560Taizhou Hanzhong biomedical co. LTDSep 2020
NCT04985201Combined Simvastatin and Irinotecan in Treating ES-SCLC Patients Relapsed From 1st ChemotherapyP2unknown40Shanghai Pulmonary Hospital, Shanghai, ChinaNov 2021
NCT03487016FOOTPATHFirst-line Therapy in Metastatic PDACP2unknown270Ludwig-Maximilians - University of MunichFeb 2019
NCT03088813RESILIENTStudy of Irinotecan Liposome Injection (ONIVYDE®) in Patients With Small Cell Lung CancerP3completed491IpsenApr 2018
NCT05148195A Phase II Study of Envofolimab and BD0801 With/Without Chemotherapy in Patients With Advanced Solid TumorsP2terminated86Jiangsu Simcere Pharmaceutical Co., Ltd.Dec 2021
NCT04808791GEJiTTo for Treatment Naive Advanced Gastric or Gastroesophageal Junction (GEJ) AdenocarcinomaP2completed7AHS Cancer Control AlbertaOct 2021
NCT03374254MK-3475Safety and Efficacy of Pembrolizumab (MK-3475) Plus Binimetinib Alone or Pembrolizumab Plus Chemotherapy With or Without Binimetinib in Metastatic Colorectal Cancer (mCRC) Participants (MK-3475-651/KEYNOTE-651)P1completed116Merck Sharp & Dohme LLCFeb 2018
NCT05417386FOLFIRINOX + NIS793 in Pancreatic CancerP1terminated4Colin D. Weekes, M.D., PhDAug 2022
NCT05160896SALIRI Based Regimen as First-line Treatment for Advanced Metastatic Colorectal CancerP2unknown90Second Affiliated Hospital, School of Medicine, Zhejiang UniversityNov 2021
NCT05027100Tislelizumab Combined With Anlotinib and 2-cycles Irinotecan as Second Line Treatment of SCLCN/Aunknown33Haibo ZhangSep 2021
NCT04453930A Study of Sequential Therapy of Camrelizumab Combined With Chemotherapy(Irinotecan Plus Platinum)and With Apatinib in Participants With Untreated Advanced Small Cell Lung Cancer(SCLC)P2unknown60Peking Union Medical College HospitalJun 2020
NCT04324476A Study of Bevacizumab Plus XELOX/XELIRI for First-line Treatment in Unresectable Advanced Colorectal CancerP2unknown50Jiangsu Cancer Institute & HospitalSep 2019
NCT02605265CinClareTrial of Capecitabine With or Without Irinotecan Driven by UGT1A1P3completed356Fudan UniversityOct 2015
NCT02095132Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid TumorsP1/P2completed76National Cancer Institute (NCI)Mar 2014
NCT03184870A Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Participants With Advanced Solid TumorsP1/P2completed332Bristol-Myers SquibbAug 2017
NCT04912258Preoperative Irinotecan Drug-eluting Beads for Patients With Unresectable Colorectal Liver MetastasisP3unknown80Fudan UniversityAug 2021
NCT04508452A Phase II Prospective Trial of mXELOXIRI Reintroduction for mCRCP2unknown91First Affiliated Hospital of Zhejiang UniversityMay 2020
NCT03336216A Study of Cabiralizumab Given With Nivolumab With and Without Chemotherapy in Patients With Advanced Pancreatic CancerP2completed205Bristol-Myers SquibbDec 2017
NCT04569916Radiotherapy Combined With Irinotecan and Apatinib Followed by PD-1 Antibody and Apatinib for Advanced Solid TumorsP2unknown30The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolSep 2020
NCT02022644Study of Convection-Enhanced, Image-Assisted Delivery of Liposomal-Irinotecan In Recurrent High Grade GliomaP1completed18University of California, San FranciscoOct 2014
NCT02631733Liposomal Irinotecan and Veliparib in Treating Patients With Solid TumorsP1completed18National Cancer Institute (NCI)May 2017
NCT03879798DS-3201b and Irinotecan for Patients With Recurrent Small Cell Lung CancerP1/P2terminated22Memorial Sloan Kettering Cancer CenterMar 2019
NCT03141034Ramucirumab Plus Irinotecan for Previously Treated Advanced Gastric or Gastro-esophageal Junction AdenocarcinomaP2completed40Washington University School of MedicineNov 2017
NCT03739801MM-398 and Ramucirumab in Treating Patients With Gastric Cancer or Gastroesophageal Junction AdenocarcinomaP1/P2withdrawn0University of Southern CaliforniaApr 2020
NCT01835041CPI-613 and Combination Chemotherapy in Treating Patients With Metastatic Pancreatic CancerP1completed21Wake Forest University Health SciencesApr 2013
NCT04381910LY01610Irinotecan Hydrochloride Liposome Injection (LY01610) For Small Cell Lung CancerP2completed66Luye Pharma Group Ltd.Sep 2020
NCT03726021Study of Irinotecan,Oxaliplatin, and S1 in Patients With Advanced Pancreatic CancerP2completed47Qingdao Central HospitalJan 2018
NCT03126071Raltitrexed-based Chemotherapy Plus Bevacizumab in Retreated Patients With Advanced Colorectal CancerP2unknown100Jiangsu Cancer Institute & HospitalFeb 2017
NCT03279289AFEMAStudy to Assess the Efficacy and Safety of Treatment With FOLFIRI-aflibercept Compared to Initial Treatment With FOLFIRI-aflibercept (for 6 Cycles) Followed by Maintenance With 5FU-aflibercept, in an Elderly Population With mCRC After Failure of an Oxaliplatin-based RegimenP2completed170Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)Oct 2017
NCT05251038Study of Sotorasib Combined With Chemotherapy for Second Line Treatment of Pancreas CancerP1/P2withdrawn0Devalingam MahalingamSep 2022
NCT05009953Study of Irinotecan Liposome Injection in Patients With Advanced Biliary Tract CancerP2terminated17CSPC Ouyi Pharmaceutical Co., Ltd.Sep 2021
NCT04770623Docetaxel and Irinotecan in Gastric CancerP2completed32Menoufia UniversityMar 2021
NCT03678428FUDR/Oxaliplatin HAI Plus Irinotecan vs. FOLFOXIRI Chemotherapy in Treating Initially Unresectable CRCLMP3terminated92Sun Yat-sen UniversityDec 2021
NCT04411537The Combination of Immunotherapy and Neoadjuvant Chemoradiotherapy in MSS Locally Advanced Rectal CancerP2unknown50Fudan UniversityJul 2020
NCT04411524The Combination of Immunotherapy and Neoadjuvant Chemoradiotherapy in MSI-H Locally Advanced Rectal CancerP2unknown50Fudan UniversityJul 2020
NCT03712397Nanoliposomal Irinotecan in Head & Neck and Esophagus After Prior Platinum-based Chemotherapy or ChemoradiotherapyP2completed59National Health Research Institutes, TaiwanDec 2018
NCT00354835Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed RhabdomyosarcomaP3completed481Children's Oncology GroupDec 2006
NCT03493061A Study of Systemic Chemotherapy With CPT-11 Plus HAI (FUDR+L-OHP) in Patients With Initially Unresectable CRCLMP2completed60Sun Yat-sen UniversityFeb 2018
NCT03430843BGB-A317A Study of Tislelizumab (BGB-A317) Versus Chemotherapy as Second Line Treatment in Participants With Advanced Esophageal Squamous Cell CarcinomaP3completed512BeiGeneJan 2018
NCT04358341Pegliposomal Doxorubicin and 5-fluorouracil as Second Line Therapy for Metastatic Gastric CancerP2unknown136Sixth Affiliated Hospital, Sun Yat-sen UniversityJun 2020
NCT04394598A Study of Chinese Herbal Compound Dendrobium Huoshanense Granules in NCRT for Patients With Locally Advanced Rectal CancerP2unknown210Fudan UniversityMar 2020
NCT03387904Study of Anlotinib Plus Irinotecan in Patients With Esophageal Squamous Cell CarcinomaP2unknown120The First Affiliated Hospital of Zhengzhou UniversityJan 2019
NCT04833036c-CetuIRI Versus Ersecond-line Irinotecan s-IRI-CetuIRIP2unknown120Fudan UniversityOct 2019
NCT03751176BEYONDSecond-line FOLFIRI + Panitumumab in Subjects With Wild Type RAS Metastatic ColorectalP2unknown31Grupo Espanol Multidisciplinario del Cancer DigestivoNov 2018
NCT02928224BEACON CRCStudy of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients With BRAF V600E-mutant Metastatic Colorectal CancerP3completed702PfizerOct 2016
NCT03528785nITRoA Study of Nal-IRI With 5-FU, Levofolinic Acid and Oxaliplatin in Patients With Resectable Pancreatic CancerP2unknown67Centro Ricerche Cliniche di VeronaMar 2018
NCT03369041Study of the Practice of Debiri in Franceunknown70Federation Francophone de Cancerologie DigestiveFeb 2016
NCT04924192A Clinical Study of TQB3616 Capsules Combined With Anlotinib Hydrochloride Capsules or Standard Chemotherapy Second-line and Above in the Treatment of Advanced Lung CancerP2terminated21Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Aug 2021
NCT03535727A Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic CancerP1/P2completed48Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsJun 2018
NCT01926197Phase 3 Study of FOLFIRINOX (mFFX) +/- SBRT in Locally Advanced Pancreatic CancerP3completed27Stanford UniversityAug 2013
NCT01767194Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Dinutuximab in Treating Younger Patients With Refractory or Relapsed NeuroblastomaP2completed73National Cancer Institute (NCI)Feb 2013
NCT02562716S1505S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by SurgeryP2completed147SWOG Cancer Research NetworkJan 2016
NCT04560166Naxitamab and GM-CSF in Combination With IT in Patients With High-Risk NeuroblastomaP2terminated2Y-mAbs TherapeuticsNov 2021
NCT04097444QUATTRO-IICAPOXIRI+Bevacizumab vs. FOLFOXIRI+Bevacizumab for mCRCP2unknown112Chugai PharmaceuticalOct 2019
NCT05042934Lurbinectedin With or Without Irinotecan in Treating Patients With Relapsed or High Risk Metastatic Ewing SarcomaP1/P2withdrawn0M.D. Anderson Cancer CenterSep 2021
NCT05018182FOLFOXIRI for Neoadjuvant Treatment of High-risk Locally Advanced Colorectal CancerP2unknown69West China HospitalAug 2021
NCT03771846HAIC Versus Systemic Chemotherapy for Unresectable ICCP3unknown188Shi MingAug 2018
NCT02588105AToMStudy to Assess the Safety and Preliminary Efficacy of AZD0156 at Increasing Doses Alone or in Combination With Other Anti-cancer Treatment in Patients With Advanced CancerP1completed84AstraZenecaNov 2015
NCT04074343TAS-102 and Irinotecan in 2L+ Gastric and Gastroesophageal AdenocarcinomaP1completed20University of California, IrvineAug 2019
NCT03883919Liposomal Irinotecan Plus 5-FU / LV Combined With Paricalcitol in Patients With Advanced Pancreatic Cancer Progressed on Gemcitabine-based TherapyP1completed20Washington University School of MedicineJul 2019
NCT04446091MACA Clinical Study of Exploring Camrelizumab in the Treatment of Colorectal Mucinous Adenocarcinoma(MAC)P1/P2unknown40Zhejiang Cancer HospitalJul 2020
NCT03231722TRIPLETEFirst Line mFOLFOXIRI + PANITUMUMAB vs mFOLFOX + PANITUMUMAB IN RAS AND BRAF WT METASTATIC COLORECTAL CANCER PATIENTSP3completed435Gruppo Oncologico del Nord-OvestSep 2017
NCT05039944SI-B001 as a Single Agent or in Combination With Chemotherapy in the Treatment of Digestive System MalignanciesP2terminated7Sichuan Baili Pharmaceutical Co., Ltd.Nov 2021
NCT03554707SGT-53 in Children With Recurrent or Progressive CNS MalignanciesEarly P1withdrawn0SynerGene Therapeutics, Inc.Jun 2022
NCT03668418xenoZXenotransplantation of Primary Cancer Samples in Zebrafish Embryosunknown120University of PisaJun 2018
NCT03468335PREDICT2nd-line Therapy With Nal-IRI After Gem/Nab-pac in Advanced Pancreatic Cancer - Predictive Role of 1st-line TherapyP3completed151AIO-Studien-gGmbHMar 2018
NCT05178745Resection Observatorycompleted140SanofiSep 2016
NCT04173325Feasibility and Safety Study of Nivolumab With Irinotecan for Small Cell Lung CancerP1terminated10Augusta UniversityJan 2020
NCT03722108REGIRIRegorafenib Combined With Irinotecan as Second-line in Patients With Metastatic Gastro-oesophageal AdenocarcinomasP1/P2terminated89UNICANCERFeb 2019
NCT03206151CMAB009 Combined With FOLFIRI First-line Treatment in Patients With RAS/BRAF Wild-type, Metastatic Colorectal CancerP3completed520Taizhou Mabtech Pharmaceutical Co.,LtdDec 2017
NCT05025033Chemotherapy Combined With Apatinib and PD-1 AntibodyP2completed30Tianjin Medical University Cancer Institute and HospitalMay 2019
NCT04727853SCLCStudy of Irinotecan Liposome Injection as Second-line Regimen in Patients With Small Cell Lung Cancer (SCLC)P2completed66CSPC Ouyi Pharmaceutical Co., Ltd.Mar 2021
NCT04088786Phase I Trial HIPEC With Nal-irinotecanP1completed18Stony Brook UniversityOct 2019
NCT03329183High-dose FOLFIRI in Advanced Colorectal Cancer Patients With Wild-type UGT1A1*6 and *28P2unknown90Shanghai Changzheng HospitalMar 2019
NCT03933449MK-3475Study of Pembrolizumab (MK-3475) Versus Investigator's Choice of Chemotherapy for Participants With Advanced Esophageal/Esophagogastric Junction Carcinoma That Progressed After First-Line Therapy (MK-3475-181/KEYNOTE-181)-China Extension StudyP3completed123Merck Sharp & Dohme LLCDec 2016
NCT02564263MK-3475Study of Pembrolizumab (MK-3475) Versus Investigator's Choice Standard Therapy for Participants With Advanced Esophageal/ Esophagogastric Junction Carcinoma That Progressed After First-Line Therapy (MK-3475-181/KEYNOTE-181)P3completed628Merck Sharp & Dohme LLCDec 2015
NCT05074589Irinotecan Liposome in Combination With 5-FU/LV Versus 5-FU/LV in Second-line Therapy for Gemcitabine-Refractory Pancreatic CancerP3completed298Jiangsu HengRui Medicine Co., Ltd.Jan 2018
NCT04247984A Comparison of mXELIRI Regimen and FOLFIRI Combined Bevacizumab Regimen as First-line Chemotherapy Regimen for Metastatic Colorectal CancerP2completed264Chinese Academy of Medical SciencesMay 2018
NCT03495921VITAA Trial For Participants With Ewing's Sarcoma Treated With Vigil in Combination With Irinotecan and TemozolomideP3terminated32Gradalis, Inc.Aug 2018
NCT01787500Vemurafenib, Cetuximab, and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or That Cannot Be Removed by SurgeryP1completed47M.D. Anderson Cancer CenterFeb 2013
NCT03665441Trybeca-1Study of Eryaspase in Combination With Chemotherapy Versus Chemotherapy Alone as 2nd-Line Treatment in PACP3completed512ERYtech PharmaSep 2018
NCT03454620A Study to Assess Safety, Efficacy, Immunogenicity, PK of GC1118 With Combination ChemotherapyP1/P2completed53Green Cross CorporationApr 2018
NCT04160416TRICAPmXELOXIRI Combined With Molecular Targeted Drug in mCRCP2unknown48First Affiliated Hospital of Zhejiang UniversityJul 2019
NCT04790448Efficacy of VIC Regimen in BRAF Mutant Metastatic Colorectal CancerP1/P2completed37Sun Yat-sen UniversityJul 2020
NCT04227886Study on Predictive Biomarkers of Neoadjuvant Chemoradiotherapy for Rectal Cancerunknown250Fudan UniversityDec 2019
NCT04101929Apatinib, Irinotecan and S-1 (ApaIRIS) in Treating Patients With Metastatic Pancreatic Cancer After AG RegimenP2unknown126Fudan UniversityOct 2019
NCT03316326S-1, Irinotecan, and Oxaliplatin in Locally-Advanced Pancreatic CancerP2unknown35National Taiwan University HospitalNov 2017
NCT03797625Endostar Combined With IP Second-line Treatment of Advanced Esophageal Squamous Cell CarcinomasP2completed52Fudan UniversityMay 2017
NCT03562390Irinotecan for Advanced and Metastatic Breast CancerP2unknown124Liaoning Cancer Hospital & InstituteApr 2017
NCT04789941How To Evaluate The Efficiency And Safety Of Neoadjuvant Chemotherapy In Locally Advanced Cancer CervixP2unknown50Assiut UniversityApr 2021
NCT04088604LY01610Irinotecan Hydrochloride Liposome Injection (LY01610) For Advanced Solid TumorsP1completed38Luye Pharma Group Ltd.Feb 2019
NCT02489903QUADRUPLE THREATRRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)P2completed139EpicentRx, Inc.Jun 2015
NCT03522649GB201A Phase III Clinical Study of Napabucasin (GB201) Plus FOLFIRI in Adult Patients With Metastatic Colorectal CancerP3unknown6681Globe Health Institute LLCApr 2018
NCT03164655SULTANImproving SUrgery of Liver Metastases: a Trial of the Arterial Chemotherapy NetworkP2completed20UNICANCERJul 2018
NCT01897454Gemcitabine Hydrochloride, and Radiation Therapy in Patients With Borderline Resectable Pancreatic CancerP2terminated23Albert Einstein College of MedicineJan 2012
NCT03136055Pembrolizumab-based Therapy in Previously Treated High Grade Neuroendocrine CarcinomasP2completed36University of California, San FranciscoJun 2017
NCT04753216Irinotecan Liposome and Bevacizumab for the Treatment of Platinum Resistant, Recurrent, or Refractory Ovarian, Fallopian Tube, or Primary Peritoneal CancerP2completed3Northwestern UniversityMar 2021
NCT04943627BRAVABalstilimab Versus Investigator Choice Chemotherapy in Patients With Recurrent Cervical Cancer (BRAVA)P3withdrawn0Agenus Inc.Aug 2021
NCT02890355FOLFIRI or Modified FOLFIRI and Veliparib as Second Line Therapy in Treating Patients With Metastatic Pancreatic CancerP2completed123National Cancer Institute (NCI)Oct 2016
NCT03119064329BrUOG 329 Onivyde & Metronomic Temozolomide in Recurrent GlioblastomaP1/P2terminated12Brown UniversityNov 2017
NCT03086616DIPGCED With Irinotecan Liposome Injection Using Real Time Imaging in Children With Diffuse Intrinsic Pontine Glioma (DIPG) (PNOC 009)P1completed6Sabine Mueller, MD, PhDOct 2017
NCT03500874Adjuvant Systemic Chemotherapy With or Without HAI-FUDR in Patients With Resected CRLMP3terminated92Sun Yat-sen UniversityMay 2018
NCT01079780Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing ChemotherapyP2completed136Eastern Cooperative Oncology GroupJan 2011
NCT04072445Trifluridine/Tipiracil and Irinotecan for the Treatment of Advanced Refractory Biliary Tract CancerP2completed28Mayo ClinicOct 2019
NCT02171325Study of Different Doses of Irinotecan and Cisplatin for First-line Extensive-stage Small-cell Lung Cancer TreatmentP2unknown54Guangdong Association of Clinical TrialsJun 2014
NCT02021422A Pilot, Prospective, Non-randomized Evaluation of the Safety of Anakinra Plus Standard ChemotherapyP1completed13Baylor Research InstituteDec 2013
NCT01217437Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal TumorsP2completed108National Cancer Institute (NCI)Nov 2010
NCT02620865BATS With in Combination With Low Dose IL-1 and GM-CSF for Advanced Pancreatic CancerP1/P2completed2Barbara Ann Karmanos Cancer InstituteDec 2015
NCT03963193Etoposide/Cisplatin Compared With Irinotecan/Cisplatin for Advanced Gastrointestinal Neuroendocrine Tumor G3 TypeP2unknown112Henan Cancer HospitalJun 2019
NCT03613753Irinotecan Plus Lobaplatin Versus Irinotecan in the Second-line Treatment of Small Cell Lung CancerP2unknown72ShengFa SuJun 2018
NCT04299880Rollover Study to Provide Continued Access to Napabucasin for Patients Enrolled in Boston Biomedical-sponsored ProtocolsP1completed7Sumitomo Pharma America, Inc.Feb 2020
NCT03245450Study Evaluating the Safety and Efficacy of Eribulin Mesilate in Combination With Irinotecan Hydrochloride in Children With Refractory or Recurrent Solid TumorsP1/P2completed40Eisai Inc.Mar 2018
NCT02753127CanStem303CA Study of Napabucasin (BBI-608) in Combination With FOLFIRI in Adult Patients With Previously Treated Metastatic Colorectal CancerP3completed1,253Sumitomo Pharma America, Inc.Jun 2016
NCT02596828Prospective Pilot Trial to Assess a Multimodal Molecular Targeted Therapy in Children, Adolescent and Young Adults With Relapsed or Refractory High-grade PineoblastomaP2completed4University of RegensburgApr 2016
NCT03251417Apatinib and Irinotecan Combination Treatment in Unresectable or Metastatic Esophageal Squamous Cell CarcinomaP2terminated11Peking UniversitySep 2017
NCT04482257Bioequivalence Study of Irinotecan Liposome Injection in Chinese Advanced Pancreatic Cancer.P1unknown48CSPC Ouyi Pharmaceutical Co., Ltd.Jul 2020
NCT03603756SHR-1210 in Combination With Apatinib and Chemotherapy in Patients With Advanced Esophageal Squamous Cell CancerP2unknown45Chinese Academy of Medical SciencesJul 2018
NCT03318445Rucaparib and Irinotecan in Cancers With Mutations in DNA RepairP1completed22Pamela MunsterJan 2018
NCT02339116TRIBE2Folfoxiri Plus Bev Followed by Reintroduction of Folfoxiri Plus Bev at Progression Versus Folfox Plus Bev Followed by Folfiri Plus Bev in mCRCP3unknown654Gruppo Oncologico del Nord-OvestFeb 2015
NCT02035137N2011-01131I-MIBG Alone VS. 131I-MIBG With Vincristine and Irinotecan VS131I-MIBG With VorinostatP2completed114New Approaches to Neuroblastoma Therapy ConsortiumJul 2014
NCT02044120ESP1/SARC025 Global Collaboration: A Phase I Study of a Combination of the PARP Inhibitor, Niraparib and Temozolomide and/or Irinotecan Patients With Previously Treated, Incurable Ewing SarcomaP1completed34Sarcoma Alliance for Research through CollaborationMay 2014
NCT01442935Chemotherapies Associated With Targeted Therapies on the Resection Rate of Hepatic MetastasesP2completed256UNICANCERFeb 2011
NCT03142516OPALOFOLFIRI + Panitumumab First-line Treatment in Elderly Patients With Unresectable Metastatic Colorectal Cancer, RAS/BRAF Wild-type and Good Performance StatusP2completed20Grupo Espanol Multidisciplinario del Cancer DigestivoOct 2017
NCT03778593FOLFIRINOX for 2nd-line Treatment of BTCP2completed34Dong-A University HospitalMar 2019
NCT04337879A Study of AL2846 Capsule Combined With Standard Chemotherapy Regimen in Subjects With Advanced Colorectal CancerP1/P2unknown56Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Jul 2020
NCT03416517Anlotinib and Irinotecan for Ewing SarcomaP1/P2unknown47Peking University People's HospitalJan 2018
NCT03053167Irinotecan Plus Raltitrexed as Second-line Treatment in Advanced Colorectal Cancer PatientsP2unknown100China Medical University, ChinaDec 2016
NCT03792269Intraperitoneal and System Chemotherapy Versus XELOX as First-line Chemotherapy for mCRCP2unknown100The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolJan 2016
NCT02030678A Phase II Study of Irinotecan in 3 Line or More Therapy in Local Recurrence or Metastatic Breast CancerP2unknown124Liaoning Cancer Hospital & InstituteSep 2014
NCT01802645CELIM2Cetuximab/FOLFIRI With or Without Oxaliplatin and FOLFOXIRI With or Without Bevacizumab in Neoadjuvant Treatment of Non-resectable Colorectal Liver MetastasesP2unknown91Technische Universität DresdenMar 2013
NCT02511132A Two-part Phase IIb Trial of Vigil (Bi-shRNAfurin and GMCSF Augmented Autologous Tumor Cell Immunotherapy) in Ewing's SarcomaP2completed22Gradalis, Inc.Feb 2016
NCT03607643A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI MalignanciesP1/P2unknown160Leaf Vertical Inc.Jan 2019
NCT04499586A Study of Radiotherapy Combined With Raltitrexed and Irinotecan in Metastatic or Locally Recurrent Colorectal CancerP2unknown30Fudan UniversityJan 2019
NCT01930864Metformin Plus Irinotecan for Refractory Colorectal CancerP2unknown41Barretos Cancer HospitalSep 2015
NCT02143219PAMELA70Efficacy and Tolerance Evaluation in FOLFIRINOX Dose Adjusted in Elderly Patients With a Metastatic Pancreatic CancerP2completed72Institut Cancerologie de l'OuestJul 2014
NCT03545711Safety and Efficacy of Anlotinib in Combination With Irinotecan in Patients With Pretreated Advanced Colorectal CancerP1/P2unknown42Chinese Academy of Medical SciencesMay 2018
NCT02164916S1406 Phase II Study of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF Mutant Metastatic Colorectal CancerP2completed106SWOG Cancer Research NetworkNov 2014
NCT03732508SHR-1316 in Combination With Chemotherapy in Patients With Esophageal Squamous Cell CancerP2unknown30Jiangsu HengRui Medicine Co., Ltd.Nov 2018
NCT02842580HIGH-LIGHTDe-escalation Chemotherapies Versus Escalation in Non Pre-treated Unresectable Patients With Metastatic Colorectal CancerP2terminated21Federation Francophone de Cancerologie DigestiveSep 2016
NCT03711240CBLThe Efficacy of Bevacizumab Combined With m-FOLFOXIRI in Borderline Resectable Colorectal Liver MetastasesP2unknown40National Cheng-Kung University HospitalJan 2019
NCT02025881HR MB-5Study of Sequential High-dose Chemotherapy in Children With High Risk MedulloblastomaP1/P2terminated29Gustave Roussy, Cancer Campus, Grand ParisSep 2013
NCT02096354ROCKETA Phase 2 Randomized, Open-Label Study of RRx-001 vs Regorafenib in Subjects With Metastatic Colorectal CancerP2completed62EpicentRx, Inc.May 2014
NCT03139331PAZIT Study for Children and Young Adults With Relapsed or Refractory SarcomaP1completed16University of California, San FranciscoJun 2017
NCT03116555Apatinib Plus Irinotecan as Second-line Treatment in AGC or EGJAP2unknown37China Medical University, ChinaApr 2017
NCT02937116First in Human Study of IBI308 in Chinese Subjects With Advanced Solid TumorsP1completed233Innovent Biologics (Suzhou) Co. Ltd.Oct 2016
NCT01467986RIST-rNB-2011Multimodal Molecular Targeted Therapy to Treat Relapsed or Refractory High-risk NeuroblastomaP2completed130University of RegensburgAug 2013
NCT03651219Mesylate Apatinib Combined With Irinotecan in Treatment of Recurrent Small Cell Lung CancerP3unknown90Beijing Chest HospitalSep 2018
NCT03464968mFOLFOX vs. mFOLFIRI in Advanced or Recurrent Biliary Tract Cancer Refractory to First LineP2completed120Seoul National University Bundang HospitalJul 2015
NCT03222089Phase II Trial of FOLFOXIGIL Versus FOLFOXIRI as First-line Therapy in Patients With mCRCP2withdrawn0Fujian Cancer HospitalJul 2017
NCT02515734DEEPERA Study of FOLFOXIRI Plus Cetuximab vs. FOLFOXIRI Plus BevacizumabP2unknown360Japan Clinical Cancer Research OrganizationAug 2015
NCT02231723A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Pancreatic CancerP1completed139Sumitomo Pharma America, Inc.Aug 2014
NCT00952003Oxaliplatin/Irinotecan/Bevacizumab Followed by Docetaxel/Bevacizumab in Inoperable Locally Advanced or Metastatic Gastric Cancer PatientsP2completed40Arbeitsgemeinschaft medikamentoese TumortherapieJul 2009
NCT02172976Randomized Multicenter Phase II/III Study With Adjuvant Gemcitabine Versus Neoadjuvant / Adjuvant FOLFIRINOX for Resectable Pancreas CarcinomaP2/P3completed40Krankenhaus NordwestNov 2014
NCT02368860OXIRIOXIRI [Oxaliplatin (O), Xeloda (X) and Irinotecan (I)] in Pancreatic AdenocarcinomaP1completed33National Cancer Centre, SingaporeSep 2013
NCT02720601Irinotecan and Capecitabine as Second-line Treatment for Advanced/Metastatic Biliary Tract CancersP2withdrawn0New Mexico Cancer Research AllianceNov 2015
NCT03098030Dinutuximab and Irinotecan Versus Irinotecan to Treat Subjects With Relapsed or Refractory Small Cell Lung CancerP2/P3completed483United TherapeuticsJun 2017
NCT02906059Study of Irinotecan and AZD1775, a Selective Wee 1 Inhibitor, in RAS or BRAF Mutated, Second-line Metastatic Colorectal CancerP1completed7NYU Langone HealthSep 2016
NCT02157792M6620 First in Human StudyP1completed200EMD Serono Research & Development Institute, Inc.Dec 2012
NCT03702985Radiation-protection Effect of Amifostine in Locally Advanced Rectal CancerP2unknown160Fudan UniversityMay 2018
NCT02747537Treating Relapsed/Recurrent/Refractory Pediatric Solid Tumors With Sorafenib in Combination With IrinotecanP2withdrawn0Washington University School of MedicineJun 2016
NCT02324543GTXStudy of Gemcitabine/Taxotere/Xeloda (GTX) in Combination With Cisplatin and Irinotecan in Subjects With Metastatic Pancreatic CancerP1/P2completed47Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsFeb 2015
NCT01876446Pegylated Irinotecan NKTR 102 in Treating Patients With Relapsed Small Cell Lung CancerP2completed38Roswell Park Cancer InstituteAug 2013
NCT01528046Metformin in Children With Relapsed or Refractory Solid TumorsP1completed26H. Lee Moffitt Cancer Center and Research InstituteSep 2012
NCT03823079Comparison of Interleukin-11 and rhTPO for Recurrent Colorectal Cancer Patients With ThrombocytopeniaP2unknown50Fudan UniversityFeb 2019
NCT02244632Modufolin (Arfolitixorin) in Combination With 5-Fluorouracil Alone or Together With Oxaliplatin or Irinotecan in Colorectal CancerP1/P2completed105Isofol Medical ABSep 2014
NCT02596503A Study of Eribulin in Combination With Oral Irinotecan for Adolescent and Young Adult Patients With Relapsed or Refractory Solid TumorsP1completed2University of Colorado, DenverOct 2015
NCT00576654Veliparib and Irinotecan Hydrochloride in Treating Patients With Cancer That Is Metastatic or Cannot Be Removed by SurgeryP1completed73National Cancer Institute (NCI)Mar 2008
NCT03175016DEBIRI-CRLMIrinotecan-Eluting Bead (DEBIRI) for Patients With Liver Metastases From Colorectal CancerP2/P3unknown200Tianjin Medical University Cancer Institute and HospitalJun 2017
NCT02688023Neoadjuvant Triplet Chemotherapy Regimen in Patients With Resectable Colorectal CancerP2unknown50Chinese Academy of Medical SciencesMar 2014
NCT03061058Individualized Intraperitoneal and System Chemotherapy Versus System Chemotherapy as First-line Chemotherapy for AGCP3unknown240The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolApr 2013
NCT01271582Investigation of Association Between UGT1A1 Polymorphisms and Irinotecan Toxicity in Korean PatientsP4unknown1,500Asan Medical CenterJan 2009
NCT04215159BIOs-HerTrastuzumab Biosimilar (Samfenet®) Plus Treatment of Physician's Choice (TPC) in Patients With HER2-positive Solid TumorP2unknown42Jin-Hee AhnDec 2019
NCT03045770mFOLFOX Versus mFOLFIRI Versus FOLFPTX as First-line Treatment in AGC or EGJAN/Aunknown150Fujian Cancer HospitalFeb 2017
NCT03368859A Study of ABT-165 Plus FOLFIRI vs Bevacizumab Plus FOLFIRI in Subjects With Metastatic Colorectal Cancer Previously Treated With Fluoropyrimidine, Oxaliplatin and BevacizumabP2terminated70AbbVieMar 2018
NCT02801097PAYLOADRRx-001 in Combination With Irinotecan in Metastatic or Advanced Cancer (PAYLOAD)P1terminated28EpicentRx, Inc.Aug 2016
NCT01963182IriGenIndividualization of Dosage of Irinotecan in the FOLFIRI According to the Genetic Polymorphism of UGT1A1 in the First Line Treatment of Metastatic Colorectal CancerP2completed47Centre Jean PerrinOct 2013
NCT03443492PancreasSLOG vs mFOLFIRINOX as the First-line Treatment in Locally Advanced Uncresectable or Metastatic Pancreatic CancerP2completed130National Health Research Institutes, TaiwanMar 2018
NCT02024607A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Advanced Gastrointestinal CancerP1/P2completed495Sumitomo Pharma America, Inc.Jan 2014
NCT01485744LDE225 With Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan for Untreated Advanced Pancreatic CancerP1completed39Massachusetts General HospitalDec 2011
NCT02625623Avelumab in Third-Line Gastric Cancer (JAVELIN Gastric 300)P3completed371EMD Serono Research & Development Institute, Inc.Dec 2015
NCT01928290FOLFIRINOXCombination Chemotherapy in Treating Patients With Advanced Stomach, Gastroesophageal, or Esophageal CancerP2completed67Washington University School of MedicineNov 2013
NCT02049593PARP Inhibitor BMN-673 and Temozolomide or Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic Solid TumorsP1completed44Jonsson Comprehensive Cancer CenterJun 2014
NCT03116152Study of IBI308 With Advanced/Metastatic Esophageal Squamous Cell Carcinoma After Failure of First-line TreatmentP2completed190Innovent Biologics (Suzhou) Co. Ltd.May 2017
NCT02292758Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With RAS Wild-Type Locally Advanced or Metastatic Colorectal Cancer That Cannot Be Removed by SurgeryP2completed36Academic and Community Cancer Research UnitedDec 2014
NCT03168594IPStudy to Compare Irinotecan Combined With Cisplatin (IP) Versus Etoposide Combined With Cisplatin (EP) in Advanced and Metastatic Gastrointestinal Pancreatic and Esophageal Neuroendocrine CarcinomaP2terminated66Peking UniversityApr 2017
NCT01498289S1201S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction CancerP2completed213SWOG Cancer Research NetworkFeb 2012
NCT03110510BTCFOLFIRI as Salvage Treatment in Metastatic Biliary Tract Cancer (BTC) Patients Who Were Failed After Gemcitabine Containing Chemotherapy: A Phase II Single Arm Prospective StudyP2withdrawn0Samsung Medical CenterSep 2019
NCT02392793Talazoparib Plus Irinotecan With or Without Temozolomide in Children With Refractory or Recurrent Solid MalignanciesP1completed43St. Jude Children's Research HospitalMar 2015
NCT01896856Phase I/II Study of SGI-110 With Irinotecan Versus Regorafenib or TAS-102 in Metastatic Colorectal CancerP1/P2completed118Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOct 2013
NCT01862003PANTHERPhase I/II Trial of Antagonism of HER in GI CancerP2completed24University College, LondonMay 2014
NCT02312622Phase 2 Etirinotecan Pegol in Refractory Brain Metastases & Advanced Lung Cancer / Metastatic Breast CancerP2completed27Joel NealAug 2015
NCT01643499Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal MalignanciesP1completed79University of ChicagoMar 2012
NCT02414009CAPTEMStudy to Compare CAPTEM vs FOLFIRI as Second Line Treatment in Advanced, Colorectal Cancer PatientsP2completed82Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoSep 2014
NCT01941316Study of Carfilzomib With Irinotecan in Irinotecan-Sensitive Malignancies and Small Cell Lung Cancer PatientsP1/P2completed78Cancer Research and Biostatistics Clinical Trials ConsortiumNov 2013
NCT02497157BeTRIBevacizumab + Triplet Treatment for Untreated With Chemotherapy Metastatic Colorectal CancerP2completed45Translational Research Center for Medical Innovation, Kobe, Hyogo, JapanMay 2015
NCT00354744High-Dose Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Metastatic Rhabdomyosarcoma or EctomesenchymomaP3completed109Children's Oncology GroupJul 2006
NCT01867892A Phase II Study of Locally Advanced Pancreatic CancerP2unknown86National Health Research Institutes, TaiwanJun 2013
NCT01858649BEV-ONCO2012Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Bevacizumab With FOLFOX or FOLFIRI.P2completed60Cliniques universitaires Saint-Luc- Université Catholique de LouvainMay 2013
NCT01355445VIT-0910Vincristine and Irinotecan With or Without Temozolomide in Children and Adults With Refractory/Relapsed RhabdomyosarcomaP2completed120Centre Oscar LambretJan 2012
NCT03069950Study of Chemotherapy With or Without Hepatic Arterial Infusion for Patients With Unresectable Metastatic Colorectal Cancer to the LiverP2withdrawn0Memorial Sloan Kettering Cancer CenterFeb 2017
NCT03099382Study of SHR-1210 Versus Investigator's Choice of Chemotherapy for Participants With Advanced Esophageal CancerP3completed457Jiangsu HengRui Medicine Co., Ltd.May 2017
NCT01803282Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Chemotherapy in Participants With Advanced Solid TumorsP1completed236Gilead SciencesMar 2013
NCT02677116A Study of Olaratumab Alone and in Combination With Standard Chemotherapies in Children With CancerP1completed68Eli Lilly and CompanyAug 2016
NCT02896907Ascorbic Acid and Combination Chemotherapy in Treating Patients With Locally Advanced or Recurrent Pancreatic Cancer That Cannot Be Removed by SurgeryEarly P1completed8Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOct 2016
NCT02624726MINOASTrial in Metastatic Colorectal Cancer With FOLFIRI Plus Aflibercept as First Line TreatmentP2unknown31Hellenic Oncology Research GroupJan 2016
NCT01867697Nordic 8 - A Phase II TrialP2completed173Per PfeifferMay 2012
NCT03503604A Study of Anti-VEGF Monoclonal Antibody hPV19 in Patients With Solid TumorsP1unknown18SuZhou Stainwei Biotech Inc.May 2018
NCT01560949Preoperative Folfirinox, Radiation Therapy for Resectable Adenocarcinoma of the PancreasP2completed34M.D. Anderson Cancer CenterJun 2012
NCT01650428BACCHUSBevacizumab And Combination Chemotherapy in Rectal Cancer Until SurgeryP2completed20University College, LondonApr 2013
NCT03380689SIRB2Phase I Study of Biweekly SIRB Regimen for Metastatic Colorectal CancerP1withdrawn0Fujian Cancer HospitalJan 2018
NCT02645864Apatinib and Irinotecan Combination Treatment in Esophageal Squamous Cell CarcinomaP1completed12Peking UniversityJan 2016
NCT02348450Irinotecan Plus Cisplatin Compared With Etoposide Plus Cisplatin for Extensive Stage Small-cell Lung CancerP4unknown308Guangdong Association of Clinical TrialsFeb 2015
NCT01859728GAMBITGAMBIT Trial: Cisplatin Plus Irinotecan in the Treatment of Gallbladder or Biliary Tract CancerP2unknown48Hospital de Cancer de Barretos - Fundacao Pio XIIJan 2013
NCT03030937Clinical Trial to Compare Apatinib Plus Irinotecan Versus Single Irinotecan as Second-line Treatment in AGC or EGJAP2unknown74Fujian Cancer HospitalFeb 2017
NCT01274624Study of REOLYSIN® in Combination With FOLFIRI and Bevacizumab in FOLFIRI Naive Patients With KRAS Mutant Metastatic Colorectal CancerP1completed36Oncolytics BiotechDec 2010
NCT01114555Bevacizumab, Irinotecan and Temozolomide for Relapsed or Refractory NeuroblastomaP2completed34Memorial Sloan Kettering Cancer CenterApr 2010
NCT03295084Safety, Tolerability and Pharmacokinetics of Oral Tablet of Irinotecan in Adult Patients With Solid TumorsP1completed39Dorte NielsenJul 2015
NCT02387138SIRINOXA Trial Assessing Several Schedules of Oral S-1 in Combination With a Fixed Dose of Oxaliplatin and IrinotecanP1completed24Institut du Cancer de Montpellier - Val d'AurelleApr 2014
NCT01639326FOLFIRI-ADStudy to Evaluate the Efficacy and Safety of FOLFIRI-AD in Patients With Metastatic Colorectal Cancer UGT1A Genotype 1P2unknown96Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauJul 2012
NCT01992705GCC 1324Borderline Pancreas Study: FOLFIRINOX +SBRTEarly P1completed8University of Maryland, BaltimoreMar 2014
NCT02620423Study of Pembrolizumab With REOLYSIN® and Chemotherapy in Patients With Advanced Pancreatic AdenocarcinomaP1completed11Oncolytics BiotechDec 2015
NCT01939483A Pilot Study of Irinotecan in Patients With Breast Cancer and CNS MetastasesN/Awithdrawn0University of California, IrvineDec 2012
NCT01220063RS CAMPTORSHF in Colorectal CancerP2completed48Institut Cancerologie de l'OuestOct 2007
NCT01660711A Pilot Study of Pre- and Post-surgery Chemotherapy With mFOLFIRINOX in Localized, Resectable Pancreatic AdenocarcinomaP2completed22Endeavor HealthJul 2012
NCT01321957CHARTAEfficacy of FOLFOX+Bevacizumab in Combination With Irinotecan in the Treatment of Metastatic Colorectal CancerP2completed250Martin-Luther-Universität Halle-WittenbergMay 2011
NCT01814501Panitumumab and Chemotherapy in Patients With Advanced Colorectal Cancer After Prior Therapy With BevacizumabP2completed16John HaysFeb 2013
NCT02485834FDG-PET Directed Treatment in Improving Response in Patients With Locally Advanced Stomach or Gastroesophageal Junction CancerP2terminated5Alliance for Clinical Trials in OncologyNov 2015
NCT02848794Apatinib and Irinotecan in Treating Patients With Recurrent High-grade GliomaP1/P2unknown40The First People's Hospital of LianyungangJul 2016
NCT01601535Study of MLN8237 in Combination With Irinotecan and TemozolomideP1/P2completed54New Approaches to Neuroblastoma Therapy ConsortiumMay 2012
NCT02327169A Study MLN2480 in Combination With MLN0128 or Alisertib, or Paclitaxel, or Cetuximab, or Irinotecan in Adult Participants With Advanced Nonhematologic MalignanciesP1completed81Millennium Pharmaceuticals, Inc.Jan 2015
NCT03400592NIEGAStudy of Nimotuzumab and Irinotecan as Second Line With Recurrent or Metastatic Gastric AdenocarcinomaP2unknown55Peking UniversityJun 2015
NCT01996306AXEPTA Phase III Study of 2nd-line XELIRI ± Bevacizumab vs. FOLFIRI ± Bevacizumab in mCRCP3completed650Epidemiological and Clinical Research Information NetworkDec 2013
NCT00730158A Phase II Multicenter, Randomized, Placebo Controlled, Double Blinded Clinical Study of KD018 as a Modulator of Irinotecan Chemotherapy in Patients With Metastatic Colorectal CancerP2completed33Edward Chu, MDDec 2008
NCT02296203CRICKETCetuximab Rechallenge in Irinotecan-pretreated mCRC, KRAS, NRAS and BRAF Wild-type Treated in 1st Line With Anti-EGFR Therapy (CRICKET).P2unknown27Gruppo Oncologico del Nord-OvestOct 2014
NCT01821612Chemotherapy and Radiation Therapy Before Surgery Followed by Gemcitabine in Treating Patients with Pancreatic CancerEarly P1completed23Alliance for Clinical Trials in OncologyMay 2013
NCT05086848A Study of Irinotecan Hydrochloride Liposome in Combination With 5-FU/LV in Advanced Solid TumorsP1completed15Jiangsu HengRui Medicine Co., Ltd.May 2016
NCT03167112FolfirinoxA Study of Administering FOLFIRINOX Before Surgery For Potentially Curable Pancreatic CancerP2unknown20Petr KavanJul 2017
NCT01129310IXOGoo1First Line Study of Irinotecan, Capecitabine and Oxaliplatin in Metastatic Gastric or Gastroesophageal Cancer.P2completed47AHS Cancer Control AlbertaJul 2010
NCT02782182Perioperative FOLFIRINOX for Patients With Resectable Pancreatic Adenocarcinoma: A Pilot StudyP1terminated1University of ChicagoJun 2016
NCT02046538Phase II Study of Zaltrap and Chemotherapy for Advanced Resectable Colorectal CancerP2withdrawn0Weill Medical College of Cornell UniversityFeb 2014
NCT01634555IMC-1121BA Study to Assess the Pharmacokinetics of Ramucirumab (IMC-1121B) in Combination With FOLFIRIP2completed29Eli Lilly and CompanyOct 2012
NCT01397019LAPCChemotherapy for Patients With Locally Advanced Pancreatic Cancer (LAPC) With Additional Chemo-radiotherapy (CRT) for Patients With Borderline Resectable TumoursP2completed56Per PfeifferApr 2011
NCT02314182GRECCAR8GRECCAR 8: Primary Tumor Resection in Rectal Cancer With Unresectable MetastasisP3completed5Hospices Civils de LyonNov 2014
NCT01760252Neoadjuvant CAPOXIRI Chemotherapy in the Treatment of Pancreatic Adenocarcinoma ProtocolP2terminated17Beth Israel Medical CenterDec 2011
NCT01813253Phase 3 Study of Nimotuzumab and Irinotecan as Second Line With Advanced or Recurrect Gastric and Gastroesophageal Junction CancerP3terminated400Kuhnil Pharmaceutical Co., Ltd.May 2013
NCT02331251Study of Pembrolizumab Plus Chemotherapy in Patients With Advanced Cancer (PembroPlus)P1/P2terminated81Western Regional Medical CenterDec 2014
NCT00952029Combination Chemotherapy and Bevacizumab With or Without Bevacizumab Maintenance Therapy in Treating Patients With Metastatic Colorectal CancerP2/P3completed492Federation Francophone de Cancerologie DigestiveMar 2010
NCT02558868Second-Line Oxaliplatin and Irinotecan Versus Irinotecan Alone for Gemcitabine and S-1 Refractory Pancreatic CancerP2completed80Zhejiang UniversitySep 2015
NCT02558959Second-line Irinotecan and Capecitabine Versus Irinotecan for Gemcitabine and Cisplatin Refractory Biliary Tract CancerP2completed64Zhejiang UniversitySep 2015
NCT02333188Genetic Analysis-Guided Dosing of FOLFIRABRAX in Treating Patients With Advanced Gastrointestinal CancerP1completed50University of ChicagoDec 2014
NCT01729481ML22774Gemcitabine Plus Erlotinib in RASH-positive Patients With Metastatic Pancreatic CancerP2unknown150Ludwig-Maximilians - University of MunichJul 2012
NCT01442649Efficacy of Chemotherapy, Associated to Either Cetuximab or Bevacizumab, in KRAS Wild-type Metastatic Colorectal Cancer Patients With Progressive Disease After Receiving First-line Treatment With BevacizumabP2completed133UNICANCERDec 2010
NCT00890786A Study of Bevacizumab Therapy in Patients With Newly Diagnosed High-Grade Gliomas and Diffuse Intrinsic Pontine GliomasEarly P1completed27Children's Hospital Medical Center, CincinnatiMay 2009
NCT02256800Escalated Dose of Irinotecan in mCRCN/Acompleted213Jaw-Yuan Wang, MD, PhDAug 2014
NCT01847495Evaluation of Low-dose Irinotecan and Cyberknife® SBRT to Treat Colorectal Cancer With Limited Liver MetastasisN/Awithdrawn0Wake Forest University Health SciencesOct 2013
NCT02423954NivoPlusStudy of Nivolumab Plus Chemotherapy in Patients With Advanced Cancer (NivoPlus)P1/P2terminated33Western Regional Medical CenterApr 2015
NCT02527824Study of Oxaliplatin, Irinotecan, and S-1 in Biliary Tract CancerP2unknown31Hallym University Medical CenterMar 2015
NCT01977235TDICCTwo Different Dosages of Irinotecan Combined With Cisplatin Scheme in Extensive Disease-Small Cell Lung CancerP2unknown110Third Military Medical UniversitySep 2013
NCT00137852Cisplatin, CPT-11 and Celecoxib With Radiation Therapy and Surgery for Operable Esophageal CancerP2completed35Dana-Farber Cancer InstituteJan 2002
NCT02275806Cisplatin/Irinotecan With Concurrent Radiation for Inoperable NSCLCP2terminated4Leo W. Jenkins Cancer CenterOct 2014
NCT02129257AMALTHEAClinical Trial of Combination Chemotherapy With Aflibercept in Patients With Advanced Colorectal CancerP2completed73Hellenic Cooperative Oncology GroupMay 2014
NCT02626520Phase 2 Evaluation of Multi-modality Algorithm for Non-metastatic Adenocarcinoma of Pancreas or AmpullaP2terminated11Essentia HealthMay 2016
NCT02508077FOLFIRI and Panitumumab in Treating Patients With RAS and BRAF Wild-Type Metastatic Colorectal CancerP2terminated1City of Hope Medical CenterFeb 2016
NCT02119026PASSIONEfficacy And Safety Of Xeliri + Avastin Followed By Xelox + Avastin Or Reverse Sequence In Metastatic Colorectal CancerP2completed120Prof. Dr. Werner ScheithauerFeb 2011
NCT03009058MODULATEStudy of IMM 101 in Combination With Standard of Care in Patients With Metastatic or Unresectable CancerP1/P2terminated2Immodulon Therapeutics LtdMay 2017
NCT05086822A Study of Irinotecan Hydrochloride Liposome in Advanced Solid TumorsP1completed32Jiangsu HengRui Medicine Co., Ltd.Sep 2014
NCT02110953Irinotecan-Eluting Beads in Treating Patients With Refractory Metastatic Colon or Rectal Cancer That Has Spread to the LiverP1terminated2Fox Chase Cancer CenterJan 2016
NCT02509234TrIPReSarcTrabectedin and Irinotecan for Refractory Pediatric Sarcomasunknown30Technical University of MunichFeb 2014
NCT02319187Irinotecan Plus S1 Versus S1 in Patients With Previously Treated Advanced Esophageal Cancer: ESWN 01 TrialP3unknown240Chinese Academy of Medical SciencesDec 2014
NCT01566942FOLFIRI or mFOLFOX6 in Adjuvant Chemotherapy in Advanced Colorectal CancerP3unknown200Sun Yat-sen UniversityJun 2012
NCT01139138PIESafety Study of the Combination of Panitumumab, Irinotecan and Everolimus in the Treatment of Advanced Colorectal CancerP1/P2completed49The Queen Elizabeth HospitalJun 2010
NCT01183494FOLFIRIA Genotype-guided Study of Irinotecan Administered in Combination With 5-fluorouracil/Leucovorin (FOLFIRI) and Bevacizumab in Advanced Colorectal Cancer PatientsP1completed17University of ChicagoDec 2009
NCT01653470Study to Evaluate Safety & Tolerability of BMS-906024 in Combination With Chemotherapy & to Define DLTs & MTD of BMS-906024 in Combination With One of the Following Chemotherapy Regimens; Weekly Paclitaxel, 5FU+Irinotecan or Carboplatin+Paclitaxel in Subjects With Advanced / Metastatic Solid TumorsP1completed141Bristol-Myers SquibbOct 2012
NCT02527785Study of Oxaliplatin, Irinotecan, and S-1 in Gastric CancerP2completed44Hallym University Medical CenterFeb 2015
NCT01935947Azacitidine and Entinostat Before Chemotherapy in Treating Patients With Advanced Non-small Cell Lung CancerP2terminated17National Cancer Institute (NCI)May 2013
NCT02086656COI-BPERIOPERATIVE TREATMENT WITH COI-B (CAPECITABINE, OXALIPLATIN, IRINOTECAN AND BEVACIZUMAB) OF HIGH RISK OR BORDERLINE RESECTABLE COLORECTAL CANCER LIVER METASTASESP2completed46Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoJun 2013
NCT01773109NKTR-102Etirinotecan Pegol (NKTR-102) in NSCLCP2completed40Abramson Cancer Center at Penn MedicineJan 2013
NCT01506167ACORNAn Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Colorectal Cancer (ACORN)completed719Hoffmann-La RocheJul 2012
NCT02246049QUATTROA Multicenter, Clinical Study of FOLFOXIRI With Bevacizumab As First-line Therapy in Patients With mCRCP2completed69EPS CorporationMay 2014
NCT01383343Sorafenib Tosylate, Bevacizumab, Irinotecan Hydrochloride, Leucovorin Calcium, and Fluorouracil in Treating Patients With Metastatic Colorectal CancerP1completed17National Cancer Institute (NCI)Aug 2011
NCT02641873A Study of BBI608 Administrated With FOLFIRI + Bevacizumab in Adult Patients With Metastatic Colorectal CancerP1completed4Sumitomo Pharma Co., Ltd.Dec 2015
NCT02316496REGAINRechallenge of Cetuximab Combined With Irinotecan as Third-line Chemotherapy in Patients With Metastatic Colorectal Cancer - Phase II StudyP2terminated2GERCOR - Multidisciplinary Oncology Cooperative GroupSep 2015
NCT02376452Phase II Study of 2-weekly RAILIRI Versus FOLFIRI as Second-line Treatment in Advanced Colorectal Cancer PatientsP2unknown100Fudan UniversitySep 2014
NCT03146377Study of Xeloxiri Regimen for Patients With Refractory Metastatic Colorectal CancerP2completed32The University of Hong KongApr 2014
NCT01558869Xeloxiri as First-line Treatment in Patients With Advanced Unresectable Pancreatic AdenocarcinomaP2completed37The University of Hong KongApr 2012
NCT01535183Irinotecan Combination Chemotherapy for Refractory or Relapsed Brain Tumor in Children and AdolescentsP2unknown40Seoul National University HospitalJan 2012
NCT01249638Cap+Bev vs Cap+Iri+Bev 1st-line Therapy in mCRCP3unknown516Ludwig-Maximilians - University of MunichDec 2010
NCT00972881EXCITECapecitabine, Irinotecan Hydrochloride, Cetuximab, and Radiation Therapy in Treating Patients Undergoing Surgery for Locally Advanced Rectal CancerP1/P2completed82University College, LondonApr 2009
NCT00433927FOLFIRI5-FU, Folinic Acid and Irinotecan (FOLFIRI) Plus Cetuximab Versus FOLFIRI Plus Bevacizumab in First Line Treatment Colorectal Cancer (CRC)P3unknown568PD Dr. med. Volker HeinemannJan 2007
NCT00081289Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy in Treating Patients Who Are Undergoing Surgical Resection for Locally Advanced Rectal CancerP2completed146Radiation Therapy Oncology GroupMar 2004
NCT02640365DOUBLIRIA Dose Escalation Study of MM-398 Plus Irinotecan in Patients With Unresectable Advanced CancerP1completed10GERCOR - Multidisciplinary Oncology Cooperative GroupNov 2015
NCT02358863mEGAMolecularly Tailored Therapy for Patients With Metastatic Cancer of the Esophagus and StomachN/Aterminated13Georgetown UniversityFeb 2015
NCT02216487ChimeTrial of FOLF(HA)Iri With Cetuximab in mCRCP2unknown45Western General Hospital, AustraliaJun 2014
NCT00068692Comparison of Adjuvant Chemotherapy Regimens in Treating Stage II/III Rectal CancerP3completed225National Cancer Institute (NCI)Oct 2003
NCT02935764FOLFIRI Versus Irinotecan as Second-line Treatment in Metastatic Colorectal Cancer PatientsP3unknown164Fudan UniversityOct 2016
NCT00394433TPCADocetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric CancerP2completed38Dana-Farber Cancer InstituteSep 2006
NCT03067792FOLFIRI Versus Docetaxel and Cisplatin as a Second-line Chemotherapy After Failure of First-line Chemotherapy in Advanced Gastric CancerP3completed52Yonsei UniversityDec 2014
NCT01923337Irinotecan and Alisertib in Treating Patients With Advanced Solid Tumors or Colorectal CancerP1completed17University of California, DavisAug 2013
NCT01859858Effect of Curcumin on Dose Limiting Toxicity and Pharmacokinetics of Irinotecan in Patients With Solid TumorsP1completed23UNC Lineberger Comprehensive Cancer CenterJun 2013
NCT01588990ASCENTA Translational Study of Bevacizumab in Participants With Metastatic Colorectal CancerP4completed128Hoffmann-La RocheJun 2012
NCT01593228Treatment Extension Study for Patients Who Have Previously Participated and Have Benefited From Iniparib in a Clinical TrialP3completed37SanofiMay 2012
NCT01413022FOLFIRINOX Plus PF-04136309 in Patients With Borderline Resectable and Locally Advanced Pancreatic AdenocarcinomaP1completed44Washington University School of MedicineApr 2012
NCT00400114Sutent Following Chemotherapy, Radiation and Surgery For Resectable Esophageal CancerP2completed36University Health Network, TorontoSep 2006
NCT02573220Irinotecan Hydrochloride With FOLFIRI and Cetuximab as First-Line Therapy in Treating Patients With RAS Wild-Type Colorectal CancerP1withdrawn0University of ChicagoJun 2015
NCT00708773Genotype-Directed Dose-Escalation Study of Irinotecan in Patients With Advanced Solid TumorsP1completed68University of ChicagoFeb 2006
NCT02071069Efficacy and Tolerance of Maintenance Therapy in Patients With Incurable Advanced Colorectal CancerP2unknown54Tianshu LiuJul 2013
NCT01055314Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic RhabdomyosarcomaP2completed175National Cancer Institute (NCI)Jan 2010
NCT01183780A Study in Second Line Metastatic Colorectal CancerP3completed1,072Eli Lilly and CompanyDec 2010
NCT01822613ESCCStudy of Safety & Efficacy of the Combination of LJM716 & BYL719 in Patients With Previously Treated Esophageal Squamous Cell Carcinoma (ESCC)P1completed48Novartis PharmaceuticalsJul 2013
NCT01999270Evaluation of FDOPA-PET/MRI in Pediatric Patients With CNS TumorsP1completed6Washington University School of MedicineApr 2013
NCT00433550Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel CancerP2completed33Alliance for Clinical Trials in OncologyMay 2007
NCT00731276Irinotecan in Treating Asian Patients With Solid TumorsP1completed18National Cancer Centre, SingaporeApr 2008
NCT00524186Sunitinib, Irinotecan, Fluorouracil, and Leucovorin In Treating Patients With Advanced Stomach Cancer or Gastroesophageal CancerP1terminated23Roswell Park Cancer InstituteMay 2007
NCT01523431CPT-11Individual Dosage Selection of Irinotecan (CPT-11) Based on UGT1A1 Genotype in Metastatic Colorectal Cancer PatientsP2/P3completed583The Affiliated Hospital of the Chinese Academy of Military Medical SciencesMar 2012
NCT01925274A Study Of PF-05212384 Plus Irinotecan Vs Cetuximab Plus Irinotecan In Patients With KRAS And NRAS Wild Type Metastatic Colorectal CancerP2terminated19PfizerNov 2013
NCT02345460Preoperative Folfirinox for Resectable Pancreatic Adenocarcinoma - A Phase II StudyP2terminated1Case Comprehensive Cancer CenterSep 2015
NCT01765582STEAMSequential and Concurrent FOLFOXIRI/Bevacizumab Regimens Versus FOLFOX/Bevacizumab in First-Line Metastatic Colorectal CancerP2terminated280Hoffmann-La RocheJan 2013
NCT01677884BEVIACIntra-arterial Hepatic Bevacizumab and Systemic ChemotherapyP2completed10Gustave Roussy, Cancer Campus, Grand ParisNov 2012
NCT01296763Trial of ICM With or Without AZD2281 (Olaparib) in Patients With Advanced Pancreatic CancerP1completed18Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsJan 2011
NCT02283359Selinexor in Combination With Irinotecan in Adenocarcinoma of Stomach and Distal EsophagusP1terminated3H. Lee Moffitt Cancer Center and Research InstituteDec 2014
NCT01520389Safety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary TreatmentP1completed112Merrimack PharmaceuticalsJan 2012
NCT02395068Pharmacokinetics Study of Nimotuzumab in Patients With Solid TumorsP1unknown40Biotech Pharmaceutical Co., Ltd.Nov 2012
NCT01675128ISIS 183750 With Irinotecan for Advanced Solid Tumors or Colorectal CancerP1/P2completed24National Cancer Institute (NCI)Aug 2012
NCT01290783FOLF(HA)iriTrial of FOLF(HA)Iri Versus FOLFIRI in mCRCP3unknown390Alchemia OncologyDec 2011
NCT01347866Clinical Study Of PI3K/mTOR Inhibitors In Combination With An Oral MEK Inhibitor Or Irinotecan In Patients With Advanced CancerP1terminated105PfizerOct 2011
NCT01858662Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Treatment Combining Cetuximab With FOLFOX or FOLFIRI in RAS and B-RAF WT TumorsP2terminated4Cliniques universitaires Saint-Luc- Université Catholique de LouvainJan 2014
NCT01394939Recombinant Vaccinia Virus Administered Intravenously in Patients With Metastatic, Refractory Colorectal CarcinomaP1/P2completed52Jennerex BiotherapeuticsJan 2012
NCT01304602A Trial of Irinotecan and BKM120 in Previously Treated Advanced Colorectal CancerP1completed20University of Kansas Medical CenterFeb 2011
NCT00381797Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade GliomaP2completed97National Cancer Institute (NCI)Aug 2006
NCT00857246Pre-operation Chemo and Antibody Therapy Followed by Surgical Resection and Adjuvant Chemoradiation for Gastric CancerP2completed30NYU Langone HealthJul 2005
NCT00183872Study of Irinotecan and Docetaxel in Patients With Metastatic or Unresectable Gastric or Gastroesophageal Junction AdenocarcinomaP2completed40University of Southern CaliforniaApr 2005
NCT02575508Pan FGFR Kinase Inhibitor BGJ398 and Combination Chemotherapy in Treating Patients With Untreated Metastatic Pancreatic CancerP1/P2withdrawn0Roswell Park Cancer Institute
NCT05177276Selinexor Combination Ph 1 StudyP1/P2withdrawn0Martin GutierrezSep 2014
NCT01715441NEXIRI2Sorafenib in Combination With Irinotecan in Metastatic Colorectal Cancer Patients With KRAS Mutated TumorsP2completed173Institut du Cancer de Montpellier - Val d'AurelleSep 2012
NCT01608464Pre-op Chemo-RT w/CDDP/5FU vs Chemo w/ Docetaxel/Irinotecan in PET Non Responder Resectable Esophagus CancerP2terminated170King Faisal Specialist Hospital & Research CenterMay 2012
NCT00876993CNSStudy of Irinotecan and Bevacizumab With Temozolomide in Refractory/Relapsed Central Nervous System (CNS) TumorsP1completed26Johns Hopkins All Children's HospitalSep 2008
NCT02453464A Phase Ib Study of Humanized Anti-VEGF Monoclonal Antibody (Sevacizumab) Injection Plus FOLFIRI in Chinese Patients With Metastatic Colorectal CancerP1unknown36Jiangsu Simcere Pharmaceutical Co., Ltd.Aug 2015
NCT01882868A Study of Aflibercept in Combination With FOLFIRI in Patients With Second-Line Metastatic Colorectal Cancer in JapanP2completed62SanofiJul 2013
NCT00980239HAI Irinotecan + IV Bevacizumab, Bevacizumab & Oxaliplatin or Bevacizumab & Cetuximab in Advanced Cancers Metastatic to LiverP1completed115M.D. Anderson Cancer CenterSep 2009
NCT00836277Phase II Study of Irinotecan and PanitumumabP2completed24Weijing Sun, MD, FACPMay 2009
NCT02060955Randomized Phase 2 Study to Investigate Efficacy of ALECSAT in Patients With GBM Measured Compared to Avastin/IrinotecanP2terminated25CytoVac A/SFeb 2014
NCT01374425MAVERICCStudy of Bevacizumab + mFOLFOX6 Versus Bevacizumab + FOLFIRI With Biomarker Stratification in Participants With Previously Untreated Metastatic Colorectal Cancer (mCRC)P2completed376Genentech, Inc.Aug 2011
NCT01550055CRC009Study of CMAB009 to Treat KRAS Wild Type Metastatic Colorectal CancerP2/P3completed512Shanghai Zhangjiang Biotechnology Limited CompanyMay 2009
NCT01670721AFEQTColorectal Cancer MetastaticP3completed175SanofiAug 2012
NCT01030042COMETSTrial Comparing Two Two Sequences of Therapy in Colorectal Metastatic PatientsP3completed110Gruppo Italiano per lo studio dei Carcinomi dell'Apparato DigerenteSep 2009
NCT00354679Irinotecan, Cisplatin, Bevacizumab, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Esophageal CancerP2completed34Memorial Sloan Kettering Cancer CenterApr 2006
NCT01091259Irinotecan and Bevacizumab for Recurrent Ovarian CancerP2completed29NYU Langone HealthMar 2010
NCT01060423DEBIRITUXTACE With Irinotecan Drug-eluting Beads and Intravenous (IV) Cetuximab in Refractory Colorectal CancerP2terminated8Hans-Joachim Schmoll, MDFeb 2010
NCT02662959Irinotecan as 3rd Line Therapy in Gastric CancerP2unknown93Fudan UniversityApr 2015
NCT01008475POSEIDONEMD 525797 in Combination With Cetuximab and Irinotecan in K-ras Wild Type Metastatic Colorectal CancerP1/P2completed232Merck KGaA, Darmstadt, GermanyOct 2009
NCT00871169Combination of Irinotecan, Oxaliplatin and Cetuximab for Locally Advanced or Metastatic Pancreatic CancerP2completed61New Mexico Cancer Research AllianceOct 2008
NCT00098787Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal CancerP2completed247Eastern Cooperative Oncology GroupSep 2005
NCT01574092Irinotecan in Combination With Cisplatin in Pediatric Patients With Unfavorable Prognosis GliomasP2completed39Hospital Sant Joan de DeuNov 2009
NCT00620269Induction Chemotherapy Followed by CCRT According to EGFR Mutation Status in NSCLC IIIP2unknown212National Cancer Center, KoreaFeb 2008
NCT01663012Phase II NKTR-102 In Bevacizumab-Resistant High Grade GliomaP2completed20Lawrence RechtJul 2012
NCT01550510Research Study of IV Vitamin C in Combination With Irinotecan vs Irinotecan Alone for Advanced Colorectal CAP1/P2terminated4Thomas Jefferson UniversityDec 2011
NCT01479465SIMEfficacy and Safety of Simtuzumab (SIM) With FOLFIRI as Second Line Treatment in Colorectal AdenocarcinomaP2terminated266Gilead SciencesDec 2011
NCT00737438Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ AdenocarcinomaP2completed22Memorial Sloan Kettering Cancer CenterAug 2008
NCT00522665Phase I/Randomized Phase II Study of Second Line Therapy With Irinotecan + Cetuximab +/- RAD001 for Colorectal CancerP1/P2completed41Hoosier Cancer Research NetworkAug 2007
NCT01075048ARQ 197 in Combination With Chemotherapy in Patients With Metastatic Colorectal CancerP1/P2completed131Daiichi SankyoJan 2010
NCT00535353AZD2281 and Irinotecan in Treating Patients With Locally Advanced or Metastatic Colorectal CancerP1completed26NCIC Clinical Trials GroupJan 2008
NCT01518413Dose Escalation Study of Sorafenib and Irinotecan Combination Therapy in Pediatric Patients With Solid TumorsP1completed17HMeanyDec 2011
NCT00940316Dual Epidermal Growth Factor Receptor Inhibition With Erlotinib and Panitumumab With or Without Chemotherapy for Advanced Colorectal CancerP2completed28Northwestern UniversityJan 2010
NCT01930552A Phase I Study of Aflibercept Plus FOLFIRI (Irinotecan, 5-Fluorouracil, and Leucovorin) in Chinese Patients With Advanced Solid MalignanciesP1completed20SanofiSep 2013
NCT01826396Standard and High Dose Irinotecan Based on UGT1A1 Genotype for First-line Treatment of Locally Advanced Colon CancerP2unknown100Colorectal Cancer Institute of the Heilongjiang Academy of Medical SciencesApr 2013
NCT01631539Chemoembolisation With CPT11 Loaded DC Bead With Cetuximab and 5FU/LV in First Line in Patients With KRAS Wildtype mCRCN/Awithdrawn0Universitaire Ziekenhuizen KU LeuvenSep 2012
NCT01505608Randomized Efficacy Study of TPI 287 to Treat Primary Refractory or Early Relapsed NeuroblastomaP1/P2terminated14Giselle ShollerDec 2011
NCT01375816PEPCOLLiposome-encapsulated Irinotecan Hydrochloride PEP02 or Irinotecan Hydrochloride, Leucovorin Calcium, and Fluorouracil as Second-Line Therapy in Treating Patients With Metastatic Colorectal CancerP2terminated55GERCOR - Multidisciplinary Oncology Cooperative GroupMay 2011
NCT01320683Combination Chemotherapy and Bevacizumab Before Surgery and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal CancerP2terminated1City of Hope Medical CenterMar 2011
NCT01086345Radiosurgery Plus Bevacizumab in GlioblastomaEarly P1terminated9Case Comprehensive Cancer CenterFeb 2010
NCT00856375NKTR-102 Versus Irinotecan in Patients With Second-Line, Irinotecan-Naïve, KRAS Mutant, Colorectal CancerP2completed83Nektar TherapeuticsDec 2008
NCT01380275DITrial of Docetaxel and Irinotecan (DI) for Recurrent or Refractory Bone and Soft Tissue Sarcomas.P2unknown35National Cancer Center, KoreaApr 2008
NCT01609231MK-0646-025A Trial of Dalotuzumab in Combination With Irinotecan Versus Cetuximab and Irinotecan for Participants With Metastatic Rectal Cancers (mRC) (MK-0646-025)P2terminated11Merck Sharp & Dohme LLCJul 2012
NCT01652482Safety and Efficacy Study of MEHD7945A + FOLFIRI Versus Cetuximab + FOLFIRI as Second Line Therapy in Participants With KRAS Wild-Type Metastatic Colorectal Cancer (mCRC)P2completed135Genentech, Inc.Oct 2012
NCT00165490Combination Chemotherapy, Radiation Therapy and Surgery for Esophageal CancerP2completed19Dana-Farber Cancer InstituteAug 2004
NCT00316862Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By SurgeryP2completed82Alliance for Clinical Trials in OncologyFeb 2006
NCT00967330A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With GlioblastomaP2completed182Hoffmann-La RocheJun 2010
NCT01269216FLA Study of Neoadjuvant Chemoradiotherapy With 5-FU/Leucovorin (FL) vs. TS-1/Irinotecan in Patients With Locally Advanced Rectal CancerP2completed136Yonsei UniversityOct 2008
NCT00948935Study of Gemcitabine, Irinotecan and Panitumumab in Patients With Advanced and Metastatic Biliary Tract AdenocarcinomaP2completed35Abramson Cancer Center at Penn MedicineApr 2009
NCT01693445S-1, Oxaliplatin, and Irinotecan for Advanced Gastrointestinal CancerP1completed22Hallym University Medical CenterJun 2012
NCT01313884Cyclophosphamide, Doxorubicin, Vincristine w/ Irinotecan and Temozolomide in Ewings SarcomaP2terminated3Stanford UniversityMay 2011
NCT00958386SPECTRASafety and Efficacy Study of Panitumumab+Irinotecan in Patients Wild-Type (WT) KRAS Metastatic Colorectal Cancer Refractory to Irinotecan Based Chemotherapy (SPECTRA)P2completed61Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)Aug 2009
NCT01635400Study of Relationship Between UGT1A1 Gene Polymorphism and Toxicity and Efficacy of Irinotecan in Small Cell Lung CancerP2unknown50Zhejiang Cancer HospitalJun 2012
NCT01451632A Safety Study of MM-121 With Cetuximab and Irinotecan in Patients With Advanced CancersP1completed48Merrimack PharmaceuticalsOct 2011
NCT01046864FOLFIRICombination of Brivanib With 5-Fluorouracil/Leucovorin (5FU/LV) and 5-Fluorouracil/Leucovorin/Irinotecan (FOLFIRI)P1completed49Bristol-Myers SquibbFeb 2010
NCT01654081A Protocol of Irinotecan for Carcinoma of the LungP2withdrawn0Susanne ArnoldOct 2013
NCT01444521Genotype-drive Study of Irinotecan-Cisplatin Combination for Advanced Gastric CancerP2completed50Chinese Academy of Medical SciencesApr 2011
NCT01280643Combination Chemotherapy and Cetuximab or Bevacizumab in Treating Patients With Metastatic Colorectal CancerN/Aterminated3Fox Chase Cancer CenterMar 2010
NCT00991952Irinotecan Hydrochloride With or Without Alvocidib in Treating Patients With Advanced Stomach or Gastroesophageal Junction Cancer That Cannot Be Removed By SurgeryP2completed19National Cancer Institute (NCI)Sep 2009
NCT01226719FOLFOXIRI Plus Panitumumab Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases OnlyP2completed15SCRI Development Innovations, LLCDec 2010
NCT00720512BEBYPSecond-Line Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer Who Have Received First-Line Chemotherapy and BevacizumabP3terminated184Gruppo Oncologico del Nord-OvestJun 2008
NCT01533740Circulating Regulatory Lymphocytes and Outcome of Metastatic Colorectal Cancer Patientscompleted31University of Rome Tor VergataMar 2012
NCT01501669PROCEEDIrinotecan/Capecitabine Versus Capecitabine in Patients Treated With A/T for HER2 Negative Metastatic Breast CancerP3unknown222National Cancer Center, KoreaJun 2011
NCT00940303OPAL Study: A Study of Avastin (Bevacizumab) in Combination With FOLFOXIRI in Patients With Previously Untreated Metastatic Colorectal CancerP2completed97Hoffmann-La RocheJun 2009
NCT00671801Irinotecan Plus Lenalidomide in Adult Patients With Recurrent Glioblastoma Multiforme: Phase IP1terminated24M.D. Anderson Cancer CenterApr 2008
NCT00465907Study of Weekly Paclitaxel, Carboplatin and Irinotecan to Treat Lung CancerP2terminated7Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsMay 2003
NCT02055196Genetically Modified Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade GliomasP1withdrawn0City of Hope Medical Center
NCT01941173Short-Infusion Ziv-aflibercept in Treating Patients With Metastatic Colorectal Cancer Receiving Combination ChemotherapyN/Awithdrawn0City of Hope Medical CenterJan 2014
NCT01205022Radiolabeled Monoclonal Antibody Therapy, Combination Chemotherapy, and Bevacizumab in Treating Patients With Metastatic Colorectal CancerP1completed3City of Hope Medical CenterApr 2011
NCT01042028ICEA Randomised Trial With Irinotecan, Cetuximab and Everolimus (ICE)Compared to Capecitabine and Oxaliplatin (CapOx) for Patients With Gemcitabin Resistant Pancreatic CancerP1/P2terminated39Per PfeifferJan 2010
NCT01014767Intercontinental Multidisciplinary Registry and Treatment Optimization Study for Choroid Plexus TumorsP3terminated27Tufts Medical CenterNov 2009
NCT00617539Irinotecan and Temozolomide in Treating Patients With Breast Cancer Who Have Received Previous Treatment for Brain MetastasesP2completed30University of California, San FranciscoFeb 2005
NCT01494363Phase II Study of FOLFOXIRI in Patients With Locally Advanced or Metastatic Biliary Tract CancerP2unknown53Soon Chun Hyang UniversityOct 2011
NCT01480986IPO-NEC Trial:Study on the Efficacy and Safety Using Sequential IP Therapy and Oct Lar in the Treatment of Advanced GI NECP2completed40Peking UniversitySep 2011
NCT01239485Study of IRNEA (Irinotecan, Etoposide, Cytarabine) for Refractory or Relapsed Acute Leukemia in Children and AdolescentsP1unknown18Seoul National University HospitalNov 2010
NCT05278728Phase IIa Study of Nimotuzumab to Treat Colorectal CancerP1/P2completed31Biotech Pharmaceutical Co., Ltd.Jul 2009
NCT00921167A Study to Evaluate the Efficacy of Bevacizumab Plus Irinotecan in Recurrent GliomasP2completed32Clinical Research Center for Solid Tumor, KoreaJun 2009
NCT00541125G-CSF in Preventing Neutropenia During First-Line Treatment With Chemotherapy and Bevacizumab in Patients With Metastatic Colorectal CancerP2completed20Federation Francophone de Cancerologie DigestiveNov 2007
NCT00311584Irinotecan and Temozolomide in Treating Young Patients With Recurrent NeuroblastomaP2completed59Children's Oncology GroupApr 2006
NCT01367275CRCIrinotecan Plus Brivanib in Metastatic Colorectal Cancer (CRC) Enriched for Elevated Levels of Plasma FGFP2terminated8M.D. Anderson Cancer CenterAug 2011
NCT00996346Phase I/II Study of Irinotecan and Temsirolimus in Patients With Refractory SarcomasP1terminated17New Mexico Cancer Research AllianceOct 2009
NCT00099125Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma MultiformeP2completed170Radiation Therapy Oncology GroupNov 2004
NCT00061932Bortezomib With or Without Irinotecan in Treating Patients With Cancer of the Gastroesophageal Junction or StomachP2completed41National Cancer Institute (NCI)Apr 2003
NCT00059761Chemotherapy Combined With Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung CancerP1completed36Radiation Therapy Oncology GroupMar 2003
NCT01359007FOLFIRINOX in Patients With Inoperable Pancreatic CancerP2terminated5University of OklahomaMay 2011
NCT00778102A Study of Avastin (Bevacizumab) in Combination With mFOLFOX-6 or FOLFOXIRI in Patients With Metastatic Colorectal Cancer.P2completed80Hoffmann-La RocheOct 2008
NCT01138904AGCFOLFOX Followed by FOLFIRI or Reverse Sequence Treatment in Advanced Gastric Cancer (AGC)P2completed80Dong-A University HospitalSep 2009
NCT00911820PCACisplatin, Irinotecan and Bevacizumab (PCA) Versus Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric CancerP2completed88Dana-Farber Cancer InstituteJul 2009
NCT01173497A Study Evaluating INIPARIB in Combination With Chemotherapy to Treat Triple Negative Breast Cancer Brain MetastasisP2completed44SanofiJul 2010
NCT00762255A Phase I Trial of Vorinostat in Combination With Bevacizumab & Irinotecan in Recurrent GlioblastomaP1completed19H. Lee Moffitt Cancer Center and Research InstituteSep 2008
NCT00891930Study to Evaluate Mechanisms of Acquired Resistance to PanitumumabP2completed74NantBioScience, Inc.May 2009
NCT01322152Study of Irinotecan Plus Capecitabine to Treat Advanced Colorectal CancerP2completed52Fudan UniversityMar 2011
NCT01009073A Study Evaluating ABT-263 With Erlotinib, ABT-263 With Irinotecan, and ABT-263 Monotherapy in Cancer SubjectsP1completed51AbbVie (prior sponsor, Abbott)Oct 2009
NCT00537121Vorinostat, Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Upper Gastrointestinal CancerP1completed23Roswell Park Cancer InstituteNov 2006
NCT01225744eSCOUTErbitux Study of CPT11, Oxaliplatin, UFToral Targeted TherapyP2completed47The Christie NHS Foundation TrustApr 2009
NCT00693719Irinotecan and Etoposide in Treating Patients With Recurrent, Locally Advanced, or Metastatic Breast CancerP2completed31University of ArizonaAug 2007
NCT00597402XRTAvastin in Combination With Radiation (XRT) & Temozolomide, Followed by Avastin, Temozolomide and Irinotecan for Glioblastoma (GBM) and GliosarcomasP2completed125Duke UniversityJul 2007
NCT01016860OSI-906 and Irinotecan in Patients With Advanced CancerP1terminated16University of Colorado, DenverDec 2009
NCT00967616Study of CS-7017 in Combination With FOLFIRI in Subjects With Metastatic Colorectal Cancer Who Failed First-Line TherapyP2completed100Daiichi SankyoSep 2009
NCT00418938SPIRITT - Second-Line Panitumumab Irinotecan Treatment TrialP2completed266AmgenNov 2006
NCT01607554Irinotecan for Previously Treated, Advanced, Non-Small Cell Lung CancerP1/P2terminated2New Mexico Cancer Research AllianceApr 2012
NCT01144988AVIRMA01-09Avastin / Irinotecan in Patients With Recurrent or Progressive Malignant GliomaP2unknown35Medical University InnsbruckMar 2010
NCT00060567Dose-Finding Study of E7070 in Combination With IrinotecanP1completed88Eisai Inc.Mar 2003
NCT00993044VIT-BA Study of Vincristine, Escalating Doses of Irinotecan, Temozolomide and Bevacizumab (Vit-b) in Pediatric and Adolescent Patients With Recurrent or Refractory Solid Tumors of Non-hematopoietic OriginP1completed13Children's Hospital Los AngelesSep 2009
NCT01282697RAPIRIClinical Trial of Rapamycin and Irinotecan in Pediatric Patients With Refractory Solid TumorsP1completed42University Hospital, Strasbourg, FranceApr 2011
NCT01285102Chemoembolization Using Irinotecan in Treating Patients With Liver Metastases From Metastatic Colon or Rectal CancerP1terminated4Fox Chase Cancer CenterOct 2010
NCT00979017Avastin/Temozolomide/Irinotecan for Unresectable/Multifocal Glioblastoma MultiformeP2completed41Katy PetersNov 2009
NCT01640782ITACA-SIntergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the StomachP3completed1,100Mario Negri Institute for Pharmacological ResearchFeb 2005
NCT00303992Trastuzumab and Irinotecan in Treating Patients With HER2/Neu Positive Metastatic Breast CancerP2completed9University of California, San FranciscoMay 2004
NCT00072527Cisplatin and Irinotecan Followed by Carboplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung CancerP2completed78Alliance for Clinical Trials in OncologyNov 2003
NCT01474187Genotype-driven Phase I Study of Irinotecan Administered in Neoadjuvant Chemoradiotherapy in Patients With Stage II/III Rectal CancerP1unknown60Fudan UniversityNov 2011
NCT01281761CRCSimvastatin + Cetuximab/Irinotecan in K-ras Mutant Colorectal Cancer (CRC)P2completed52Samsung Medical CenterNov 2010
NCT00975897Study of Tumor Tissue Testing in Selecting Treatment for Patients With Metastatic or Locally Advanced Colorectal CancerP2/P3completed3,240Medical Research CouncilJul 2009
NCT00889343FOSCOStudy to Evaluate the Effects of Sorafenib if Combined With Chemotherapy (FOLFOX6 or FOLFIRI) in the Second-Line Treatment of Colorectal CancerP2terminated101AIO-Studien-gGmbHMar 2009
NCT00811993A Study of R1507 in Combination With Multiple Standard Chemotherapy Treatments in Patients With Advanced Solid TumorsP1terminated104Hoffmann-La RocheFeb 2009
NCT00874328IPA Study of TS-1 Plus Irinotecan and Cisplatin (IP) for Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)P1/P2unknown74National Cancer Center, KoreaOct 2008
NCT00594984Phase I/II Combination With Irinotecan- ErbituxP1/P2completed38Bristol-Myers SquibbMay 2008
NCT00717990Irinotecan, Capecitabine and Avastin for Metastatic Colorectal Cancer as Salvage TreatmentP2terminated15University Hospital of CreteApr 2008
NCT00654160Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal CancerP1completed7Mayo ClinicJun 2008
NCT00786669VITACA Pilot Study of the Addition of Bevacizumab to VOIT Regimen for Relapsed/Refractory Pediatric Solid TumorsP1completed13Children's Hospital Medical Center, CincinnatiOct 2008
NCT00499369Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line TherapyP3terminated72National Cancer Institute (NCI)Jun 2007
NCT01131078A Study of Avastin (Bevacizumab) in Combination Chemotherapy in Patients With Metastatic Cancer of the Colon or RectumP2completed306Hoffmann-La RocheJun 2005
NCT00079274Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon CancerP3completed3,397National Cancer Institute (NCI)Feb 2004
NCT00838578Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal CancerP1/P2terminated65Kyowa Kirin Co., Ltd.Mar 2009
NCT01205711FOLFERAIrinotecan Hydrochloride, Fluorouracil, and Leucovorin Calcium With or Without Zibotentan in Treating Patients With Metastatic Colorectal CancerP2completed111Cardiff UniversityApr 2010
NCT00695292Irinotecan, Carboplatin, and Sunitinib in First Line Extensive-Stage Small Cell Lung CancerP2completed37SCRI Development Innovations, LLCJun 2008
NCT00986843Clinical Trial to Evaluate Safety and Tolerability of OratecanTM in Patients With Advanced Solid Malignancies (Oratecan-102)P1completed14Hanmi Pharmaceutical Company LimitedJun 2008
NCT00848783GEJIrinotecan/Cisplatin, Potentially Curative Surgery With or Without Floxuridine, Followed by Capecitabine for Stomach and Gastro-esophageal Junction (GEJ) CancersP2terminated8NYU Langone HealthMay 2008
NCT01473303Combination Chemotherapy With or Without Ganitumab in Treating Patients With Previously Untreated Metastatic Pancreatic CancerP1/P2withdrawn0Alliance for Clinical Trials in OncologyAug 2012
NCT01051765Irinotecan Combined With Cisplatin as 1st Line Treatment for Esophageal Squamous Cell Cancer : a Single Center Prospective Clinical TrialP2unknown60Peking UniversityAug 2009
NCT00755118Lohp, 5-Fu/Lv and Bevacizumab, Alternative With Cpt-11, 5-Fu/Lv and Cetuximab In Metastatic CrcP2terminated24University Hospital of CreteOct 2008
NCT00436072ZD6474ZD6474, Cetuximab, and Irinotecan in Patients With Metastatic Colorectal CancerP1completed46Dana-Farber Cancer InstituteFeb 2007
NCT00547547High-Selenium Brassica Juncea, Irinotecan, and Capecitabine in Treating Patients With Advanced CancerP1completed22City of Hope Medical CenterApr 2006
NCT00057837Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Extensive-Stage Small Cell Lung CancerP2completed140Eastern Cooperative Oncology GroupJul 2004
NCT01116271AZD6244Study of Selumetinib (AZD6244)(ARRY-142886) in Combination With Irinotecan in Previously Treated Patients With ColorecP2completed32AstraZenecaApr 2010
NCT00644696Study of Irinotecan and Bortezomib in Children With Recurrent/Refractory NeuroblastomaP1completed18University of Michigan Rogel Cancer CenterApr 2008
NCT02323737Phase II Study of Irinotecan and Cisplatin in Extensive-stage Small Cell Lung CancerP2completed62Chinese Academy of Medical SciencesJul 2010
NCT00655499PIMABIPanitumumab and Irinotecan as Third-Line Therapy in Treating Patients With Metastatic Colorectal CancerP2completed65GERCOR - Multidisciplinary Oncology Cooperative GroupJun 2008
NCT00577109A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Previously Untreated Metastatic Colorectal Cancer.P2withdrawn0Hoffmann-La RocheDec 2007
NCT01308632Metronomic Temozolamide in Patients With Recurrent GlioblastomaP2/P3unknown30Grupo Español de Investigación en NeurooncologíaNov 2007
NCT00561470VELOURAflibercept Versus Placebo in Combination With Irinotecan and 5-FU in the Treatment of Patients With Metastatic Colorectal Cancer After Failure of an Oxaliplatin Based RegimenP3completed1,226SanofiNov 2007
NCT00551421Pertuzumab and Cetuximab in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal CancerP1/P2completed17National Cancer Institute (NCI)Oct 2007
NCT00941655Prospective Randomized Trial Comparing Gastrectomy, Metastasectomy Plus Systemic Therapy Versus Systemic Therapy Alone: GYMSSA TrialP3completed15National Cancer Institute (NCI)Jul 2009
NCT01084330Phase II Trial of AUY922 vs. Comparators in Advanced Gastric CancerP2completed68Novartis PharmaceuticalsApr 2010
NCT01004159Cetuximab Plus Irinotecan in Colorectal Cancer Patients Who Progressed After Failure With Cetuximab Plus IrinotecanP2terminated20Roswell Park Cancer InstituteSep 2009
NCT00875771AVAXIRIIrinotecan, Capecitabine and Bevacizumab in Metastatic Colorectal Cancer PatientsP2completed80Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)Apr 2009
NCT00509353N2004-06N2004-06: Irinotecan and Vincristine With 131I-MIBG Therapy for Resistant/Relapsed High-Risk NeuroblastomaP1completed26New Approaches to Neuroblastoma Therapy ConsortiumJan 2007
NCT00109850S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal CancerP2terminated22SWOG Cancer Research NetworkMay 2005
NCT00615056A Study Combining FOLFOX or FOLFIRI With AG-013736 or Bevacizumab (Avastin) in Patients With Metastatic Colorectal Cancer After Failure Of One First Line RegimenP2completed171PfizerMar 2008
NCT01286818FOLFIRIA Study of Irinotecan, Levofolinate, and 5-Fluorouracil (FOLFIRI) Plus Ramucirumab (IMC-1121B)P1completed6Eli Lilly and CompanyFeb 2011
NCT00671372A Study of Dulanermin Administered in Combination With Camptosar®/Erbitux® Chemotherapy or FOLFIRI (With or Without Bevacizumab) in Subjects With Previously Treated Metastatic Colorectal CancerP1completed42Genentech, Inc.Jul 2006
NCT00614393MK-0646Study of Dalotuzumab (MK-0646) in Combination With Cetuximab and Irinotecan in Metastatic Colorectal Cancer (MK-0646-004)P2completed558Merck Sharp & Dohme LLCDec 2007
NCT01293942IXO+A in mCRC With Liver-only MetastasesP2withdrawn0Ottawa Hospital Research InstituteMar 2011
NCT00989469NEXIRISorafenib With Irinotecan in Metastatic Colorectal Cancer (mCRC) and K-RAS MutationP1/P2completed64Institut du Cancer de Montpellier - Val d'AurelleFeb 2009
NCT01167725Standard Therapy With or Without Surgery and Mitomycin C in Treating Patients With Advanced Limited Peritoneal Dissemination of Colon CancerP3terminated340Alliance for Clinical Trials in OncologyAug 2010
NCT00766220Yttrium Microspheres With Cetuximab Plus Irinotecan for Patients With Advanced Colorectal Cancer Mets to LiverP2withdrawn0M.D. Anderson Cancer CenterOct 2009
NCT00931840A Study of EZN-2208 Administered With or Without Cetuximab in Patients With Metastatic Colorectal CarcinomaP2unknown220Enzon Pharmaceuticals, Inc.Jun 2009
NCT00509860Irinotecan (Camptosar) in Patients With Advanced SarcomasP2completed38M.D. Anderson Cancer CenterMar 2003
NCT00969033CS-1008 Used With Irinotecan Versus Irinotecan Alone in Subjects With Metastatic Colorectal Carcinoma Who Failed First-line Treatment With OxaliplatinP2terminated8Daiichi SankyoJul 2009
NCT00642746Erlotinib and Chemotherapy for 2nd Line Treatment (Tx) of Metastatic Colorectal Cancer (mCRC)P2terminated16OHSU Knight Cancer InstituteMar 2008
NCT00562419CT-322 in Treating Patients With Recurrent Glioblastoma Multiforme and Combination Therapy With IrinotecanP2unknown72Adnexus, A Bristol-Myers Squibb R&D CompanyOct 2007
NCT00404495Combination of Irinotecan and Temozolomide in Children With Brain Tumors.P2completed83PfizerApr 2007
NCT00467142OMEGABevacizumab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by SurgeryP2completed62Institut BergoniéJan 2007
NCT00532714Phase II Study of Irinotecan/Capecitabine in Patients With Antracycline/Taxane Pretreated MBCP2completed36National Cancer Center, KoreaAug 2006
NCT00134069Sorafenib, Cetuximab, and Irinotecan in Treating Patients With Advanced or Metastatic Colorectal CancerP1completed48National Cancer Institute (NCI)Jun 2005
NCT00817284GBMBevacizumab and Irinotecan or Bevacizumab and Temozolomide With Concomitant Radiotherapy for Primary Glioblastoma Multiforme (GBM)P2completed60Ulrik LassenNov 2008
NCT00588900Irinotecan and Cediranib in Treating Patients With Metastatic Colorectal Cancer That Did Not Respond to Previous Oxaliplatin, Fluoropyrimidine, and BevacizumabP2terminated5Alliance for Clinical Trials in OncologyMar 2008
NCT00103259Bortezomib With or Without Irinotecan in Treating Patients With Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckP2completed71National Cancer Institute (NCI)Jul 2005
NCT00556413Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal CancerP2completed42Institut du Cancer de Montpellier - Val d'AurelleSep 2005
NCT01017653Panitumumab and Irinotecan for Malignant GliomasP2terminated16Annick DesjardinsFeb 2010
NCT00851045Ph II Trial of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Second-line Treatment of Metastatic Colorectal CancerP2completed17Bristol-Myers SquibbOct 2009
NCT00132158ZD1839 and Oral Irinotecan in Treating Young Patients With Refractory Solid TumorsP1completed19St. Jude Children's Research HospitalSep 2005
NCT00217711Oxaliplatin, Irinotecan, and Capecitabine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Cannot Be Removed By SurgeryP1/P2completed23Swiss Cancer InstituteMay 2005
NCT00637091EGFREfficacy Analysis of Cetuximab Plus Irinotecan in Patients With Wild-type KRAS Without Regard to Epidermal Growth Factor Receptor (EGFR) ExpressionsP2completed40Asan Medical CenterMar 2008
NCT00546130RNCLCFeasibility Study of CDDP + CPT-11 + PSK for Extensive-Stage Disease (ED) Small Cell Lung CancerP2unknown45University of ToyamaNov 2007
NCT00144989IPA Study Comparing Irinotecan and Cisplatin (IP) With Etoposide and Cisplatin (EP) Following EP/TRT for LD-SCLCP3completed281Haruhiko FukudaSep 2002
NCT00792363Irinotecan and Panitumumab as 3rd Line Treatment for mCRC Without KRAS MutationsP2completed32Vejle HospitalNov 2008
NCT01136031TI-2ndAGCPaclitaxel and Irinotecan in Advanced Gastric CancerP1/P2completed42Seoul National University HospitalJan 2008
NCT00423696Bevacizumab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By SurgeryP2completed145UNICANCERMar 2006
NCT00861783Safety of ON 01910.Na and Irinotecan or ON 01910.Na and Oxaliplatin in Patients With HepatomaP1completed16Traws Pharma, Inc.Jun 2008
NCT00861328Safety Study of ON 01910.Na in Combination With Irinotecan or OxaliplatinP1completed18Traws Pharma, Inc.Feb 2008
NCT00483834A Phase II Study of Bevacizumab, Irinotecan and Capecitabine in Patients With Previously Untreated Metastatic Colorectal CancerP2completed50University Health Network, TorontoDec 2006
NCT00118235Cisplatin, Irinotecan, and Bevacizumab, in Treating Patients With Small Cell Lung CancerP2completed72National Cancer Institute (NCI)Dec 2004
NCT00827684TIRASMUSTemsirolimus and Irinotecan for Treatment Resistant Patients With Metastatic Colorectal Cancer and KRAS MutationsP2completed50Vejle HospitalMar 2009
NCT00639327Second Line Chemotherapy for S-1 Refractory Advanced Gastric CancerP2/P3completed300Japan Clinical Cancer Research OrganizationMar 2008
NCT00463203Bevacizumab and Irinotecan for Patients With Primary Brain Tumors and Progression After Standard TherapyP2completed54Rigshospitalet, DenmarkMar 2007
NCT00364143Safety Study of IHL-305 (Irinotecan Liposome Injection) to Treat Advanced Solid TumorsP1completed40Yakult Honsha Co., LTDSep 2006
NCT00336856Irinotecan and Cetuximab for Colorectal Cancer as Second Line TherapyP2completed35University of PittsburghJun 2006
NCT00502567A Study to Assess Safety, Tolerability and PK of AZD2171 and Chemotherapy on Patients With Solid TumorsP1completed104AstraZenecaJan 2005
NCT00143533Prevention of Diarrhea in Patients Taking IV Irinotecan for Relapsed or Difficult to Treat Pediatric Solid TumorsP1completed20St. Jude Children's Research HospitalSep 2003
NCT00062374Irinotecan and Cisplatin in Treating Patients Who Are Undergoing Surgery For Locally Advanced Cancer of the Stomach or Gastroesophageal JunctionP2completed55National Cancer Institute (NCI)Jun 2003
NCT00166881P-HDFL-DIWeekly Docetaxel/Irinotecan for Non-resectable Gastric Cancers After Cisplatin Plus 5-FU/LeucovorinP2completed29National Taiwan University HospitalJun 2000
NCT00954512Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Participants With Advanced Solid Tumors (P04722, MK-7454-004)P1/P2terminated15Merck Sharp & Dohme LLCSep 2009
NCT00298675Phase 1/1b Dose Escalation Study Evaluating BSI-201 as a Single Agent and in Combination With Irinotecan in Subjects With Advanced Solid TumorsP1completed59SanofiMar 2006
NCT00296062Dose Dense Therapy and Bevacizumab in Solid Tumors and Colorectal CancerP1terminated12Case Comprehensive Cancer CenterMar 2006
NCT00160875Pre-operative Chemo (CPT11, Cisplatin), Radiotherapy, Plus Surgery for Resectable Esophageal CancerP2/P3completed54University Health Network, TorontoApr 2009
NCT00816777PARAGONChemoembolization, Irinotecan Bead, Second Line Chemotherapy Treatment of Unresectable Metastatic Colorectal CancerP1/P2terminated4Generic Devices Consulting, Inc.Dec 2008
NCT00354978Study of FOLFIRI Plus Bevacizumab in Colorectal Cancer PatientsP2completed49M.D. Anderson Cancer CenterJan 2005
NCT00154102CRYSTALCetuximab Combined With Irinotecan in First-line Therapy for Metastatic Colorectal Cancer (CRYSTAL)P3completed1,221Merck KGaA, Darmstadt, GermanyMay 2004
NCT01336985Safety and Pharmacokinetics of Treating Liver Cancer With Drug-Eluting BeadsP1terminated5National Institutes of Health Clinical Center (CC)Mar 2011
NCT00845039FC-4A Study of Irinotecan and Cetuximab With or Without IMC-A12 for Treatment of Participants With Colon or Rectum Cancer Who Got Worse After Their First Treatment With Oxaliplatin and BevacizumabP2terminated4Eli Lilly and CompanyMay 2009
NCT00433381Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or GliosarcomaP2completed123National Cancer Institute (NCI)Mar 2007
NCT00473616Phase I Single Ascending Dose/Multiple Ascending Dose in Patients Treated With AZD7762 and IrinotecanP1terminated60AstraZenecaMay 2007
NCT00138216Temozolomide, Vincristine, and Irinotecan in Treating Young Patients With Refractory Solid TumorsP1completed42Children's Oncology GroupOct 2005
NCT00303771Combination Chemotherapy as First-Line Therapy in Treating Older Patients With Metastatic Colorectal Cancer That Cannot Be Removed By SurgeryP3completed282Federation Francophone de Cancerologie DigestiveJun 2003
NCT00813072Study of PEP02, Irinotecan or Docetaxel in Gastric or Gastroesophageal Junction AdenocarcinomaP2completed135PharmaEngineNov 2007
NCT00557102ERBIFORTCetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver and/or LungP2completed24National Cancer Institute, FranceSep 2007
NCT00689624Irinotecan/Oxaliplatin/5-Fluorouracil/Leucovorin/Cetuximab As First Line Treatment In Colorectal CancerP2completed30University Hospital of CreteJul 2007
NCT00642577A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Chinese Patients With Metastatic Colorectal Cancer.P3completed214Hoffmann-La RocheJul 2007
NCT00079118Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast CancerP2completed70Alliance for Clinical Trials in OncologyApr 2004
NCT00960063A Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Pediatric Participants With Advanced Solid Tumors (P05883, MK-7454-006)P1terminated4Merck Sharp & Dohme LLCNov 2009
NCT00925015MK-0646Phase I Study of Dalotuzumab (MK-0646) in Combination With Cetuximab and Irinotecan in Participants With Colorectal Cancer (MK-0646-016)P1completed20Merck Sharp & Dohme LLCJun 2009
NCT00979563Oratecan-101Clinical Trial to Evaluate Safety and Tolerability of OratecanTM in Patients With Advanced Solid MalignanciesP1completed15Hanmi Pharmaceutical Company LimitedJul 2008
NCT00360828Phase II Study of Irinotecan HCI for Recurrent Anaplastic Astrocytomas, Mixed Malignant Gliomas, and OligodendrogliomasP2terminated10H. Lee Moffitt Cancer Center and Research InstituteFeb 2006
NCT01224652Efficacy Study of Paclitaxel Versus Irinotecan in Patients With Recurrent or Metastatic Gastric Cancer Who Progress Following First-line TherapyP3unknown518Korean Cancer Study Group
NCT00668863Study Of Sunitinib With FOLFIRI In Colorectal CancerP2completed71PfizerMay 2008
NCT00611728Ph I SU011248 + Irinotecan in Treatment of Pts w MGP1completed25Duke UniversityMar 2008
NCT00497497A Study of PRO95780 in Combination With Cetuximab and Irinotecan Chemotherapy or the FOLFIRI Regimen With Bevacizumab in Patients With Previously Treated Metastatic Colorectal Cancer (APM4187g)P1completed20Genentech, Inc.Oct 2007
NCT00397904Cetuximab, Cisplatin, and Irinotecan in Treating Patients With Metastatic Esophageal Cancer, Gastroesophageal Junction Cancer, or Gastric Cancer That Did Not Respond to Previous Irinotecan and CisplatinP2completed16Memorial Sloan Kettering Cancer CenterOct 2006
NCT00192712Irinotecan, Gemcitabine and Radiation Therapy for Pancreatic CancerP2/P3completed20Rambam Health Care CampusNov 2002
NCT00361244SU011248 in Combination With Irinotecan and Cetuximab as a Second Line Regimen for Stage IV Colorectal CancerP1/P2terminated6Massachusetts General HospitalJul 2006
NCT00682786Genotype-directed Neoadjuvant Chemoradiation for Rectal CarcinomaP2completed135Washington University School of MedicineOct 2002
NCT00177853Celecoxib, Irinotecan and Concurrent Radiotherapy in Preoperative Pancreatic CancerP1terminated23University of PittsburghDec 2006
NCT00469898Irinotecan and Carboplatin as First-Line Therapy in Treating Patients With Extensive-Stage Small Cell Lung CancerP2completed50Vanderbilt-Ingram Cancer CenterDec 2003
NCT01141244Temsirolimus, Irinotecan Hydrochloride, and Temozolomide in Treating Younger Patients With Relapsed or Refractory Solid TumorsP1completed72National Cancer Institute (NCI)Jun 2010
NCT00984438BCNUSurgery With Implantable Biodegradable Carmustine (BCNU) Wafer Followed by Chemo for Patients With Recurrent Glioblastoma MultiformeP1/P2withdrawn0University of CincinnatiJun 2009
NCT00563316Effect of Panitumumab on the Pharmacokinetics of IrinotecanP1completed28AmgenMar 2008
NCT00506571TIROX2Phase II Study of Irinotecan,Oxaliplatin Plus TS-1 in Untreated Metastatic Colorectal CancerP2unknown42National Cancer Center, KoreaJul 2007
NCT00314353Study of Bevacizumab Combined With Capecitabine and Either Oxaliplatin or Irinotecan as First Course of Treatment for Patients With Colorectal Cancer That Has Spread Beyond the ColonP2terminated7NSABP Foundation IncMar 2006
NCT00240097SCLCStudy of Sequential Topoisomerase, Irinotecan/Oxaliplatin - Etoposide /Carboplatin in Extensive Small Cell Lung Cancer (SCLC)P2completed30University of Alabama at BirminghamJun 2005
NCT00112658Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Pancreatic CancerP2/P3completed342UNICANCERNov 2004
NCT00077233FOLFIRI or FOLFOX With or Without Cetuximab in Patients With Metastatic Adenocarcinoma of the Colon or RectumP3terminated238Alliance for Clinical Trials in OncologyDec 2003
NCT00506844ERBIRIXPreoperative Chemoradiotherapy With Cetuximab in Rectal CancerP2unknown40National Cancer Center, KoreaMay 2006
NCT00452634ED-SCLCIrinotecan/Cisplatin Plus Simvastatin in Extensive Disease-Small Cell Lung Cancer (ED-SCLC)P2completed62National Cancer Center, KoreaApr 2006
NCT00066612S0306S0306, Irinotecan in Treating Patients With Recurrent or Refractory Advanced Transitional Cell Cancer of the Urothelium Previously Treated With ChemotherapyP2completed45SWOG Cancer Research NetworkJul 2003
NCT00540943Study of Pazopanib, Irinotecan and Cetuximab in Combination to Treat 2nd Line Metastatic Colorectal CancerP1completed25GlaxoSmithKlineJul 2007
NCT01163396FOIBFirst-line FOLFOXIRI In Combination With Bevacizumab For Metastatic Colorectal CancerP2completed57Gruppo Oncologico del Nord-OvestJul 2007
NCT00276744Individualized Drug Treatment for Treating Patients With Pancreatic CancerP2terminated249Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOct 2005
NCT00210184CEPAFIRIEvaluation of Efficacy and Safety of FOLFIRI Association Treatment in Patients 70 Years of Age and Older With Gastric CancerP2completed42Institut BergoniéJul 2004
NCT00832689Irinotecan, Gemcitabine, Chemotherapy for Biliary Tract CancerP2completed39Yonsei UniversityJun 2008
NCT00569335SIRBPhase II Trial of Combination Therapy With S-1, Irinotecan, and Bevacizumab (SIRB) in Patients With Unresectable or Recurrent Colorectal CancerP2completed52Taiho Pharmaceutical Co., Ltd.Oct 2007
NCT00569790Phase II Trial of Combination Therapy With Irinotecan, S-1, and Bevacizumab (IRIS/Bev) in Patients With Unresectable or Recurrent Colorectal CancerP2completed53Taiho Pharmaceutical Co., Ltd.Oct 2007
NCT00457691Study Of FOLFIRI Chemotherapy With Or Without Sunitinib In Patients With Metastatic Colorectal CancerP3completed768PfizerJun 2007
NCT00614965Irinotecan Plus Cisplatin vs Pemetrexed Plus Cisplatin as 2nd Line in NSCLC Stage IIIB/IVP2completed124Hellenic Oncology Research GroupNov 2006
NCT00393094Bevacizumab and Irinotecan to Treat Brain TumorsP2terminated31National Cancer Institute (NCI)Sep 2006
NCT00449163Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colorectal CancerP2terminated25University of MiamiMar 2006
NCT00186979Study of ZD1839 Combined With Irinotecan and Vincristine in Pediatric Patients With Refractory Solid TumorsP1completed34St. Jude Children's Research HospitalMay 2003
NCT00003484Radiolabeled Monoclonal Antibody Therapy After Radiation Therapy in Treating Patients With Primary Brain TumorsP1completed21Darell D. Bigner, MD, PhDSep 1997
NCT00936832Sunitinib Malate and Combination Chemotherapy as Front-Line Therapy in Treating Patients With Metastatic Rectal Cancer That Cannot Be Removed by SurgeryP2withdrawn0Federation Francophone de Cancerologie DigestiveApr 2009
NCT00681876Phase II Study of Avastin + Erbitux + Irinotecan as 2nd Line Treatment of Colorectal CancerP2terminated16Hellenic Oncology Research GroupApr 2008
NCT00469443Randomized Phase III Study of Folfiri+Avastin Versus Xeliri+Avastin as 1st Line Treatment of CRCP3completed330Hellenic Oncology Research GroupDec 2006
NCT01070290A Study of ARQ 197 Versus Investigator's Choice of Second-Line Chemotherapy in Patients With Locally Advanced or Metastatic Gastric Cancer Who Have Progressive Neoplastic Disease Following Treatment With One Prior Chemotherapy RegimenP2withdrawn0ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
NCT00545545Safety/Efficacy Study of Imprime PGG With Cetuximab in Patients With Recurrent/Progressive Colorectal CarcinomaP1/P2completed32HiberCell, Inc.Oct 2007
NCT00506207TIROXA Phase I Study of S-1 Plus Irinotecan and Oxaliplatin in Advanced Gastrointestinal MalignancyP1unknown23National Cancer Center, KoreaSep 2006
NCT00601692Irinotecan, Radiation Therapy, and Docetaxel With or Without Cisplatin in Treating Patients With Locally Advanced Esophageal CancerP1completed27Memorial Sloan Kettering Cancer CenterApr 2003
NCT00590031Phase II Trial of Preoperative Combined Modality Therapy for Esophageal Carcinoma: Cisplatin-Irinotecan Followed by Radiation Therapy With Concurrent Cisplatin and Irinotecan.P2completed61Memorial Sloan Kettering Cancer CenterNov 2002
NCT00045162S0124S0124: Cisplatin Combined With Irinotecan or Etoposide For Extensive-Stage Small Cell Lung CancerP3completed671SWOG Cancer Research NetworkNov 2002
NCT00005791Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid TumorsP1completed0Memorial Sloan Kettering Cancer CenterOct 1999
NCT00004051Irinotecan in Treating Patients With Advanced Solid TumorsP1completed40Memorial Sloan Kettering Cancer CenterAug 1998
NCT00268359Bevacizumab and Irinotecan in Treating Patients With Recurrent or Refractory GliomasP2completed68Duke UniversityMay 2005
NCT00062322Neoadjuvant Chemoradiotherapy Followed By Surgery in Treating Patients With Limited-Stage Small Cell Lung CancerP1completed0Fox Chase Cancer CenterFeb 2003
NCT00033657Radiation Therapy and Chemotherapy Before and After Surgery in Treating Patients With Esophageal CancerP2completed97Eastern Cooperative Oncology GroupAug 2002
NCT00016952Irinotecan or Fluorouracil Plus Leucovorin in Treating Patients With Previously Treated Metastatic Colorectal CancerP2completed19Alliance for Clinical Trials in OncologyApr 2001
NCT00003955Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Metastatic Rhabdomyosarcoma or SarcomaP2completed77Children's Oncology GroupSep 1999
NCT00478634A Phase 1 Study Investigating the Combination of RAD001, Cetuximab and Irinotecan as Second-line Therapy After FOLFOX (or XELOX) Plus Bevacizumab in Patients With Metastatic Colorectal CancerP1completed19Novartis PharmaceuticalsMay 2007
NCT00143403Comparing Irinotecan and 5 FU/FA To 5-FU/FA After Resection Of Liver Metastases For Colorectal CancerP3completed321PfizerDec 2001
NCT00042939Irinotecan and Docetaxel With or Without Cetuximab in Treating Patients With Metastatic Pancreatic CancerP2completed94Eastern Cooperative Oncology GroupDec 2003
NCT00967655Capecitabine, Panitumumab, and Radiation Therapy With or Without Irinotecan Hydrochloride in Treating Patients Undergoing Surgery for Localized Rectal CancerP2unknown54Loma Linda Oncology Medical Group, Inc.Jul 2009
NCT00808899Neuroblastoma Protocol 2008: Therapy for Children With Advanced Stage High Risk NeuroblastomaP2terminated4St. Jude Children's Research HospitalDec 2008
NCT00512681TIROX2A Phase II Study of Irinotecan, Oxaliplatin, Plus TS-1 in Untreated Metastatic Gastric CancerP2completed44National Cancer Center, KoreaJul 2007
NCT00352521DCE-MRIDynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) With Bevacizumab and Irinotecan for Malignant GliomaP2completed20Duke UniversityApr 2006
NCT00271011A Study of Mitomycin C, Irinotecan, and CetuximabP2terminated13University of Michigan Rogel Cancer CenterDec 2005
NCT00089102Gemcitabine and Irinotecan in Treating Patients With Locally Advanced Unresectable or Metastatic Kidney CancerP2terminated9Medical University of South CarolinaSep 2003
NCT00276692Irinotecan in Treating Patients With Newly Diagnosed Ewing's SarcomaP2completed35Children's Cancer and Leukaemia GroupAug 2003
NCT00353015Irinotecan and Cisplatin for High Grade Neuroendocrine Carcinoma of the Gastrointestinal TractP2completed21M.D. Anderson Cancer CenterMar 2003
NCT00027612Irinotecan Plus Radiation Therapy Followed By Chemotherapy in Treating Patients With Glioblastoma MultiformeP1/P2completed58Alliance for Clinical Trials in OncologyJul 2002
NCT00183846Study of Irinotecan Administered as a Continuous Infusion and Radiation Therapy for Upper Gastrointestinal CancersP1completed22University of Southern CaliforniaDec 2000
NCT00616005Ph. II Treatment of Adults w Primary Malignant Glioma w Irinotecan + TemozolomideP2completed41Duke UniversityNov 2005
NCT00193596Gemcitabine/Irinotecan/ZD1839 vs Paclitaxel/Carboplatin/Etoposide/ZD1839 in Carcinoma of Unknown Primary SiteP3completed198SCRI Development Innovations, LLCSep 2003
NCT00054288Irinotecan and Gemcitabine in Treating Patients With Refractory Advanced Solid TumorsP1completed0Roswell Park Cancer InstituteAug 2001
NCT00004103Combination Chemotherapy Followed by Surgery in Treating Patients With Stomach CancerP2completed0NYU Langone HealthJul 1998
NCT00551213A Study to Determine the Activity of Robatumumab (SCH 717454, MK-7454) in Participants With Relapsed or Recurrent Colorectal Cancer (P04721, MK-7454-003)P2completed67Merck Sharp & Dohme LLCNov 2007
NCT00437268A Study of Irinotecan Plus Cetuximab With or Without Enzastaurin in Participants With Colorectal CancerP2completed26Eli Lilly and CompanyMar 2007
NCT00115765PACCEPACCE: Panitumumab Advanced Colorectal Cancer Evaluation StudyP3completed1,053AmgenJun 2005
NCT00040807Irinotecan and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Head and Neck CancerP2completed0Eastern Cooperative Oncology GroupNov 2002
NCT00165464CPT-11Taxotere, Cisplatin and Irinotecan (CPT-11) for Esophagogastric CancerP2completed54Dana-Farber Cancer InstituteAug 2001
NCT00012220Gemcitabine Alone or in Combination With Other Chemotherapy Drugs in Treating Patients With Metastatic Cancer of the PancreasP2completed259Alliance for Clinical Trials in OncologyJan 2001
NCT00183859Clinical and Pharmacokinetic Trial of Intra-Abdominal IrinotecanP1completed42University of Southern CaliforniaSep 1999
NCT00642603A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal CancerP2terminated41Hoffmann-La RocheMay 2008
NCT00066781Gemcitabine and Irinotecan in Treating Patients With Cancer of Unknown PrimaryP2completed31Alliance for Clinical Trials in OncologyFeb 2004
NCT00275041Irinotecan and Cetuximab in Treating Patients With Metastatic Breast CancerP2completed21Alliance for Clinical Trials in OncologyFeb 2006
NCT01311050A Trial of Capecitabine (Xeloda), Oxaliplatin and Irinotecan in Combination With Bevacizumab in 1st Line Treatment of Metastatic Colorectal Cancerunknown46King Faisal Specialist Hospital & Research CenterJan 2009
NCT00308529Irinotecan, Carboplatin, Bevacizumab, and Radiation Therapy in the Treatment of Limited Stage Small Cell Lung CancerP2completed55SCRI Development Innovations, LLCMar 2006
NCT00294931Irinotecan, Carboplatin, Bevacizumab in the Treatment of Patients With Extensive Stage Small Cell Lung CancerP2completed50SCRI Development Innovations, LLCFeb 2006
NCT00718757Irinotecan, Vincristine, and Dexamethasone In Children With Relapsed And/Or Refractory Hematologic MalignanciesP1completed4St. Jude Children's Research HospitalJan 2005
NCT00249977Phase I Study of Capecitabine in Combination With Cisplatin and IrinotecanP1completed21University of New MexicoApr 2003
NCT00387660Irinotecan and Carboplatin in Treating Patients With Metastatic or Recurrent Small Cell Lung CancerP2completed80University of California, DavisOct 2001
NCT00003134Irinotecan in Treating Patients With Recurrent GliomaP2completed64Alliance for Clinical Trials in OncologyJan 1998
NCT00628810Combination Chemotherapy and Bevacizumab in Treating Patients With Metastatic Colorectal CancerP2completed86Federation Francophone de Cancerologie DigestiveJan 2007
NCT00463073Cetuximab, Bevacizumab and Irinotecan for Patients With Malignant GlioblastomasP2completed32Rigshospitalet, DenmarkAug 2006
NCT00507143Study of Genetic Polymorphisms of Drug Transporters and Orphan Nuclear Receptors on Treatment Effects of IrinotecanN/Aunknown100National Cancer Center, KoreaAug 2006
NCT00361842Multicenter Study Of CPX-1 (Irinotecan HCl: Floxuridine) Liposome Injection In Patients With Advanced Colorectal CancerP2completed65Jazz PharmaceuticalsJul 2006
NCT00138060CRCToxicity/Benefit Ratio Optimization of Chemotherapy in Colorectal Cancer (CRC) Patients by Determination of Individual Genotypic DeterminantsP4completed71Institut de Recherche Clinique sur les Cancers et le SangJun 2005
NCT00506623Preoperative Chemoradiotherapy With Capecitabine Plus Irinotecan in Rectal CancerP2unknown48National Cancer Center, KoreaJul 2004
NCT00084617Phase II Study of Oxaliplatin, Irinotecan, and Capecitabine in Advanced Gastric/Gastroesophageal Junction CarcinomaP2completed39National Cancer Institute (NCI)Mar 2004
NCT00209664Phase II Study of Oral S-1 Plus Irinotecan in Patients With Advanced Gastric CancerP2suspended40Hokkaido Gastrointestinal Cancer Study GroupJan 2004
NCT00143455RStudy Of Irinotecan Hydrochloride (Campto(R)) And Cisplatin Versus Etoposide And Cisplatin In Small Cell Lung CancerP3completed485PfizerJun 2002
NCT00283556CPT-11High Dose Camptothecin-11 (CPT-11) in Recurrent Unresectable Malignant GliomaP1/P2completed30Kentuckiana Cancer InstituteAug 2001
NCT00755534Irinotecan/Cetuximab Followed by XELOX/Cetuximab vs the Reverse Sequence in Metastatic CRCP2terminated68Hellenic Oncology Research GroupNov 2008
NCT00100828Irinotecan in Treating Patients With Metastatic or Inoperable Thyroid CancerP2terminated6Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsNov 2004
NCT00132054Amrubicin and Irinotecan in Treating Patients With Recurrent or Relapsed Extensive Stage Small Cell Lung CancerP1completed30Japan Multinational Trial OrganizationMay 2004
NCT00104793Irinotecan and Carboplatin in Treating Patients With Newly Diagnosed Extensive-Stage Small Cell Lung CancerP2completed55Japan Multinational Trial OrganizationJun 2003
NCT00030433S0119S0119: Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung CancerP2completed85SWOG Cancer Research NetworkJan 2002
NCT00089128Gemcitabine and Irinotecan in Treating Patients With Locally Advanced or Metastatic Bladder CancerP2terminated16Medical University of South CarolinaNov 2001
NCT00101686Trial Of Irinotecan In Combination With Three Methods Of Administration Of Fluoropyrimidine.P3completed547PfizerFeb 2003
NCT00111761ABX-EGFEvaluating Panitumumab (ABX-EGF) in Patients With Metastatic Colorectal CancerP2completed43AmgenJul 2002
NCT00012389Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal CancerP3completed0SanofiDec 2000
NCT00004095Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid TumorsP1completed38Northwestern UniversityAug 1999
NCT00332163STEPPSkin Toxicity Treatment in Metastatic Colorectal Cancer (mCRC) Patients Receiving Panitumumab + Irinotecan-based TherapyP2completed95AmgenApr 2006
NCT00447967Combination of CPT-11 and LoHP vs Combination of 5-FU, Leucovorin and LoHP as 1st Line Treatment in Gastric PatientsP2completed110Hellenic Oncology Research GroupJul 2004
NCT00215501Capecitabine or 5-Fluorouracil in Combination With Irinotecan and Cisplatin in Patients With Solid Tumor MalignanciesP1completed54Dana-Farber Cancer InstituteNov 2001
NCT00719797TRIBECombination Chemotherapy and Bevacizumab as First-Line Therapy in Treating Patients With Metastatic Colorectal CancerP3completed509Gruppo Oncologico del Nord-OvestJul 2008
NCT00797485Bevacizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Metastatic Colorectal Cancer That Cannot Be Removed By SurgeryP3unknown672Southern Italy Cooperative Oncology GroupJul 2008
NCT00381862Phase II Trial of Aprepitant & Palonosetron for CINV Prevention w FOLFOXP2completed54OHSU Knight Cancer InstituteJun 2006
NCT00343668S-1 and Irinotecan Combination Chemotherapy for Advanced Gastric CancerP2unknown44Korean Cancer Study GroupSep 2005
NCT00612638Ph. I Temozolomide + O6-BG + Irinotecan in Treatment of Pts w Recurrent / Progressive Cerebral Anaplastic GliomasP1completed96Duke UniversityJan 2005
NCT00182806Irinotecan and Gemcitabine in Treating Patients With Recurrent or Progressive Stage III or Stage IV Non-Small Cell Lung CancerP2completed38Roswell Park Cancer InstituteSep 2004
NCT00639769Irinotecan and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck CancerP2completed41Vanderbilt-Ingram Cancer CenterFeb 2002
NCT00290719Gefitinib, Cisplatin, Irinotecan, and Radiation Therapy Before Surgery in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By SurgeryP1terminated6University of California, San FranciscoNov 2005
NCT00507091Phase I Irinotecan, 5-Fluorouracil and Leucovorin CombinationP1completed24Genzyme, a Sanofi CompanyAug 2005
NCT00216086Capecitabine + Irinotecan Followed by Combined Modality Capecitabine and Radiation in Locally Advanced Rectal CancerP2terminated22Gabi Chiorean, MDMay 2005
NCT00191984A Study of the Combination of Pemetrexed and Irinotecan Every Two Weeks in Metastatic Colorectal CancerP2completed46Eli Lilly and CompanyJun 2004
NCT00136955Irinotecan Study For Cervical CancerP2completed41PfizerJun 2004
NCT00193375Irinotecan, Carboplatin and Radiation Therapy Followed by Bevacizumab in Limited Stage Small Cell Lung CancerP2completed60SCRI Development Innovations, LLCAug 2003
NCT02582970A Study of Bevacizumab (Avastin) in Combination With Chemotherapy in Participants With Metastatic Cancer of the Colon or RectumP4completed40Hoffmann-La RocheMay 2005
NCT00110357Study of Erbitux™ (Cetuximab) in Pediatric Patients With Refractory Solid TumorsP1completed48Eli Lilly and CompanyAug 2005
NCT00183807A Study of Irinotecan, Cisplatin and Celebrex in Patients With Metastatic or Unresectable Esophageal CancerP2terminated6University of Southern CaliforniaOct 2003
NCT00230399Combination Chemotherapy Treatments in Patients With Metastatic Colorectal CancerP2completed15University of Michigan Rogel Cancer CenterJun 2003
NCT00396487Tailored Treatment in Metastatic Colorectal CancerP3terminated1Vejle HospitalNov 2006
NCT00080951Irinotecan, Fluorouracil, Leucovorin, and Oxaliplatin as First-Line Therapy in Treating Patients With Metastatic Colorectal CancerP2completed14Alliance for Clinical Trials in OncologyMar 2004
NCT00039468Thalidomide and Irinotecan in Treating Patients With Glioblastoma Multiforme Who Have Undergone Radiation TherapyP2completed26Dartmouth-Hitchcock Medical CenterMar 2002
NCT00005972Combination Chemotherapy in Treating Patients With Recurrent or Refractory Small Cell Lung CancerP2completed73Alliance for Clinical Trials in OncologyMay 2000
NCT00449020Carboplatin, Irinotecan, and Radiation Therapy Followed By Docetaxel in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung CancerP2completed32University of MiamiJan 2004
NCT00248482Imatinib Mesylate After Irinotecan and Cisplatin in Treating Patients With Extensive-Stage Small Cell Lung CancerP2completed6Barbara Ann Karmanos Cancer InstituteFeb 2002
NCT00222443Pilot Study Combining Temozolomide, Oncovin, Camptosar and Oral Antibiotic in Children and Adolescents With Recurrent MalignancyP1completed40University of OklahomaSep 2004
NCT00112892Irinotecan and Selenium in Treating Patients With Advanced Solid TumorsP1completed36Roswell Park Cancer InstituteAug 2004
NCT00193349Gleevec Combined With Camptosar Plus Paraplatin in Previously Untreated Extensive Stage Small Cell Lung CancerP2completed60SCRI Development Innovations, LLCSep 2002
NCT00006025Temozolomide Plus Irinotecan in Treating Patients With Recurrent Malignant GliomaP1completed0Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsJan 2001
NCT00323011FOLFIRI + Bevacizumab With or Without Dalteparin in First Line Treatment of Advanced Colorectal CancerP2terminated5University of Southern CaliforniaMay 2006
NCT00286130Safety and Efficacy of Folfox6 + Cetuximab Versus Folfiri +Cetuximab in Patients With Metastatic Colorectal CancerP2completed150Central European Cooperative Oncology GroupJul 2005
NCT00675194Efficacy of Irinotecan and Capecitabine Versus(vs) Cisplatin and Capecitabine in Patients With Esophago-Gastric CancerP2completed120Johannes Gutenberg University MainzOct 2003
NCT00063141Study of Irinotecan and Cetuximab Versus Irinotecan as Second-Line Treatment in Patients With Metastatic, EGFR-Positive Colorectal CancerP3completed1,302Eli Lilly and CompanyApr 2003
NCT00345163BRAINA Study to Evaluate Bevacizumab Alone or in Combination With Irinotecan for Treatment of Glioblastoma Multiforme (BRAIN)P2completed167Genentech, Inc.Jul 2006
NCT00005979Combination Chemotherapy With or Without Irinotecan in Treating Patients With Stage III Colon CancerP3completed0UNICANCERJul 1998
NCT00539877Phase I Study of Interperitoneal Chenotherapy in Patients With Gastric Adenocarainoma With Peritoneal SeedingP1completed17Samsung Medical CenterOct 2004
NCT00258232Celecoxib, Capecitabine, and Irinotecan in Treating Patients With Recurrent or Metastatic Colorectal CancerP2completed0Barbara Ann Karmanos Cancer InstituteJan 2002
NCT00509964Second-Line Irinotecan vs. ILF for AGCP2unknown50Gachon University Gil Medical CenterMay 2007
NCT00215982Study of Capecitabine With Irinotecan and Oxaliplatin (Eloxatin) in Advanced Colorectal CancerP2completed24H. Lee Moffitt Cancer Center and Research InstituteDec 2004
NCT00416767Combination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors of the Duodenum or Pancreas That Cannot Be Removed By SurgeryP2completed20Federation Francophone de Cancerologie DigestiveMay 2004
NCT00077298Bevacizumab and Cetuximab With or Without Irinotecan in Treating Patients With Irinotecan-Refractory Metastatic Colorectal CancerP2completed70National Cancer Institute (NCI)Dec 2003
NCT00506168Study of Irinotecan & Capecitabine in Metastatic Colorectal CancerP2terminated37National Cancer Center, KoreaNov 2001
NCT00616785Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by SurgeryP2unknown41Yonsei UniversityJun 2007
NCT00513266Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer With Liver Metastases or Lung Metastases That Are Potentially Removable by SurgeryP2unknown35Centre Hospitalier Universitaire VaudoisJun 2007
NCT00135135Therapy for Children With NeuroblastomaP2completed23St. Jude Children's Research HospitalAug 2005
NCT00072852Irinotecan in Patients With Advanced Metastatic Breast Cancer Who Have Experienced Failure of an Anthracycline, a Taxane, and CapecitabineP2completed134PfizerNov 2003
NCT00215995Cisplatin and Irinotecan Chemotherapy, Followed by ZD 1839 (Iressa) in Patients With Esophageal or Gastric CarcinomasP2completed21H. Lee Moffitt Cancer Center and Research InstituteJul 2003
NCT00544011Bevacizumab and Combination Chemotherapy in Treating Patients With Metastatic Colorectal CancerP2unknown47Hopital Jean MinjozApr 2007
NCT00320320Irinotecan Discontinuation and Reintroduction for Advanced Colorectal CancerP2terminated72Gachon University Gil Medical CenterApr 2005
NCT00066274Comparison of Combination Chemotherapy Regimens in Treating Patients With Metastatic Colorectal CancerP2completed0UNICANCERJul 2002
NCT00319800Second-Line Irinotecan or Gefitinib in Docetaxel Pretreated NSCLCP2unknown50Gachon University Gil Medical CenterFeb 2006
NCT00106262Study of Velcade and Irinotecan in Advanced Cervical, Vulvar, or Vaginal CancerP2terminated38Women and Infants Hospital of Rhode IslandMar 2005
NCT00320294ILF With/Without Cisplatin for Advanced Gastric CancerP2unknown86Gachon University Gil Medical CenterFeb 2005
NCT00401128Gemcitabine and Irinotecan in Treating Patients With Metastatic Kidney CancerP2completed9The Cleveland ClinicMay 2004
NCT00256269GEOxaliplatin and Irinotecan in Recurrent or Metastatic Esophageal and Gastroesophageal (GE) Junction CarcinomaP2terminated4University of California, IrvineJun 2005
NCT00316433Oxaliplatin/CPT-11 for Extensive Stage Small Cell Lung CancerP2terminated24Swedish Medical CenterFeb 2005
NCT00142350A Study of 5-FUci Versus CPT-11 Plus CDDP Versus S-1 Alone in Advanced Gastric CancerP3completed690Japan Clinical Oncology GroupNov 2000
NCT00389870Irinotecan With or Without Panitumumab or Cyclosporine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to FluorouracilP3completed1,198University of LeedsDec 2006
NCT00312000Sequential Versus Combination Chemotherapy in Advanced Colorectal CarcinomaP3completed820Dutch Colorectal Cancer GroupJan 2003
NCT00168896SCLCA Study for Small Cell Lung Cancer (SCLC) in Extensive Disease StageP2/P3unknown286Charite University, Berlin, GermanyOct 2001
NCT00254137Cap/Iri Plus Cetuximab Compared to Cap/ox Plus Cetuximab in Patients With Metastatic Colorectal Cancer.P2completed92Ludwig-Maximilians - University of MunichSep 2004
NCT00389584Irinotecan and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases From Solid TumorsP1/P2completed30University of California, DavisDec 2002
NCT00544063Capecitabine, Irinotecan, and Oxaliplatin in Treating Patients With Metastatic CancerP1unknown33Institut du Cancer de Montpellier - Val d'AurelleOct 2006
NCT00003351Irinotecan in Treating Patients With Refractory Metastatic Breast CancerP2completed104Alliance for Clinical Trials in OncologyAug 1998
NCT00106054Neoadjuvant Colorectal Cancer With Unresectable Liver MetastasesP2terminated2PfizerJan 2006
NCT00083148Irinotecan and Capecitabine in Treating Women With Advanced Breast CancerP1completed12Roswell Park Cancer InstituteNov 2002
NCT00006786Combination Chemotherapy Plus Bevacizumab in Treating Patients With Advanced Colorectal CancerP2completed0Eastern Cooperative Oncology GroupNov 2000
NCT00008424Irinotecan in Treating Children With Refractory or Advanced Solid Tumors Who Are Receiving AnticonvulsantsP1completed7Children's Oncology GroupOct 2000
NCT00022308Chemotherapy and Radiation Therapy in Treating Patients With Non-Small Cell Lung CancerP1completed0Fox Chase Cancer CenterJan 1999
NCT00062842Study of Irinotecan on a Weekly Schedule in ChildrenP1completed23Baylor College of MedicineSep 1998
NCT00392470Radiation Therapy, Irinotecan, and Cetuximab in Treating Patients Who Are Undergoing Surgery for Stage III or Stage IV Rectal CancerP1unknown20Centre Hospitalier Universitaire VaudoisAug 2006
NCT00087282Irinotecan and Flavopiridol in Treating Patients With Advanced Liver CancerP2completed0Memorial Sloan Kettering Cancer CenterJun 2004
NCT00003368Irinotecan in Treating Patients With Solid Tumors or Lymphoma Who Have Abnormal Liver or Kidney Function or Who Have Received Radiation Therapy to the PelvisP1completed0National Cancer Institute (NCI)Jun 1998
NCT00335556Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney TumorsP2completed291Children's Oncology GroupJun 2006
NCT00303745Irinotecan With or Without Capecitabine as Second-Line Therapy in Treating Older Patients With Progressive, Metastatic Colorectal Cancer That Cannot Be Removed By SurgeryP2unknown78Federation Francophone de Cancerologie DigestiveJun 2006
NCT00139711Three Combinations Of Docetaxel And Irinotecan For Recurrent Or Metastatic Non Small Cell Lung CancerP2completed138PfizerMar 2003
NCT00026195Irinotecan in Treating Aging Patients With Solid TumorsP1completed140Alliance for Clinical Trials in OncologySep 2001
NCT00251797A Phase I Trial Using Combination Irinotecan and Thalidomide for Recurrent CNS TumorsP1completed10University of New MexicoMar 2000
NCT00213486Weekly Cisplatin/Irinotecan and Radiotherapy in Patients With Locally Advanced Esophageal Cancer: Phase II TrialP2completed43University Hospital, RouenJan 2003
NCT00004923Docetaxel and Irinotecan in Treating Patients With Advanced Solid TumorsP1/P2completed47Yale UniversityApr 1999
NCT00318903Irinotecan and Taxotere With Radiotherapy as Preoperative Treatment in Resectable Esophageal CancerP2completed25University of Alabama at BirminghamJan 2002
NCT00012363S0101 Gemcitabine and Irinotecan in Treating Patients With Metastatic or Recurrent Cancer of the EsophagusP2completed61SWOG Cancer Research NetworkApr 2001
NCT00005951Irinotecan Plus Temozolomide in Treating Patients With Recurrent Primary Malignant GliomaP1completed0Duke UniversityAug 2000
NCT00003900Irinotecan With Docetaxel in Treating Patients With Recurrent or Metastatic Non-small Cell Lung CancerP2completed48Alliance for Clinical Trials in OncologyOct 1999
NCT00126256Trial Comparing Two Strategies of Chemotherapy for Metastatic Colorectal CancerP3completed570Gustave Roussy, Cancer Campus, Grand ParisFeb 2002
NCT00004924Paclitaxel and Irinotecan in Treating Patients With Advanced Non-small Cell Lung CancerP2completed28Yale UniversityMar 1999
NCT00233623Irinotecan, 5-Fluorouracil and Leucovorin With or Without Iressa in the Treatment of Metastatic Colorectal CancerP2withdrawn190AstraZenecaJul 2004
NCT00004139Gemcitabine Plus Docetaxel or Irinotecan in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerP2completed80Alliance for Clinical Trials in OncologySep 1999
NCT00003616Irinotecan in Treating Patients With Progressive or Recurrent Malignant GliomaP1/P2completed0Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOct 1998
NCT00408551Chemotherapy and Internal Radiation in Treating Patients With Colorectal Cancer That Has Spread to the LiverP2unknown20Goshen Health SystemNov 2005
NCT00990912A Study to Document Long-Term Safety and Continued Benefit of Irinotecan and Carboplatin or Irinotecan in Subjects With Refractory Solid Tumors (Rollover Study -001, -002)P1/P2completed20Bristol-Myers SquibbJan 2004
NCT00251888CAmpto-CISplatine Plus Radiotherapy in Advanced Cervix Cancer : Search of Tolerated Maximum Dose of CamptoP1completed15ARCAGY/ GINECO GROUPNov 2002
NCT00220064A Phase II Trial Evaluating Irinotecan Plus 5FU/LV in Patients With Relapsed/Refractory Upper GI TumoursP2completed65Royal Marsden NHS Foundation TrustJul 2000
NCT00559741Cetuximab and Combination Chemotherapy in Treating Patients With Advanced or Metastatic Colorectal CancerP2completed80Institut Cancerologie de l'OuestOct 2005
NCT00264134Docetaxel, Irinotecan, and Carboplatin in Extensive Stage Non-Small Cell Lung CancerP1/P2terminated40Kentuckiana Cancer InstituteJun 2003
NCT00030563Surgery With or Without Radiofrequency Ablation Followed by Irinotecan in Treating Patients With Colorectal Cancer That is Metastatic to the LiverP2completed0University of WashingtonMay 2001
NCT00004005Irinotecan Followed By Fluorouracil and Leucovorin in Treating Patients With Stage III or Stage IV Colorectal Carcinoma (Cancer), Other Refractory Carcinoma, or Metastatic Adenoma (Cancer) of Unknown Primary OriginP2completed12St. Jude Children's Research HospitalSep 1998
NCT00006095Combination Chemotherapy in Treating Children With Solid Tumors That Have Not Responded to Previous TherapyP1completed20Children's Oncology GroupJul 2000
NCT00276003INST Phase II Trial of Gemcitabine and Irinotecan in Patients With Relapsed or Refractory Lymphoma.P2completed22University of New MexicoAug 2002
NCT00020761Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus or StomachP2completed51Jonsson Comprehensive Cancer CenterApr 2000
NCT00033306BMS-247550 in Treating Patients With Metastatic Colorectal CancerP2terminated2University of Alabama at BirminghamFeb 2002
NCT00005076Cetuximab and Irinotecan in Treating Patients With Advanced Colorectal CancerP2completed110University of Alabama at BirminghamOct 1999
NCT00048139A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal CancerP2completed52Hoffmann-La RocheOct 2001
NCT0011923617-AAG and Irinotecan in Treating Patients With Locally Advanced or Metastatic Solid TumorsP1completed48National Cancer Institute (NCI)May 2005
NCT00635323Safety And Efficacy Of Irinotecan Plus Capecitabine As First-Line Treatment In Asian Subjects With Hepatocellular CarcinomaP2completed73PfizerNov 2002
NCT00006465Combination Chemotherapy in Treating Patients With Advanced Solid TumorsP1completed22Case Comprehensive Cancer CenterDec 2000
NCT00084721Irinotecan and Celecoxib in Treating Patients With Unresectable or Metastatic Colorectal CancerP1completed2Roswell Park Cancer InstituteMar 2005
NCT00101270Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or LymphomasP1completed24National Cancer Institute (NCI)Mar 2005
NCT00559676Study of Biomarkers in Patients Undergoing Chemotherapy for Metastatic Colorectal CancerP4completed200Centre Hospital Regional Universitaire de LimogesMar 2005
NCT00048126A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal CancerP2completed57Hoffmann-La RocheJul 2001
NCT00020501Chemotherapy With or Without Isolated Hepatic Perfusion With Melphalan in Treating Patients With Colorectal Cancer That Has Spread to the LiverP3completed0National Institutes of Health Clinical Center (CC)Mar 2001
NCT00016861Irinotecan in Treating Children With Refractory or Progressive Solid TumorsP1completed0Texas Children's Cancer CenterSep 1998
NCT00003748Irinotecan in Treating Patients With Esophageal or Stomach CancerP2completed40Jonsson Comprehensive Cancer CenterAug 1998
NCT00063960Hepatic Arterial Infusion With Floxuridine and Systemic Irinotecan After Surgery in Treating Patients With Hepatic (Liver) Metastases From Colorectal CancerP2completed94Alliance for Clinical Trials in OncologyAug 2003
NCT00073866Combination Chemotherapy and Celecoxib in Treating Patients With Advanced Non-Small Cell Lung CancerP1/P2completed0Northwestern UniversityJun 2003
NCT00022698Capecitabine and Irinotecan in Treating Patients With Locally Advanced, Recurrent, or Metastatic Colorectal CancerP2completed67Hoffmann-La RocheMay 2001
NCT00209625CPT-11Phase I / II Study of Irinotecan (CPT-11) Combined With l-Leucovorin (l-LV) and 5-FU in Patients With Advanced Colorectal CancerP1/P2completed23Hokkaido Gastrointestinal Cancer Study GroupApr 2000
NCT00020748Epirubicin Plus Irinotecan in Treating Patients With Advanced CancerP1completed0Georgetown UniversityAug 2000
NCT00003594Combination Chemotherapy in Treating Patients With Advanced Colorectal CancerP3completed1,691Alliance for Clinical Trials in OncologyOct 1998
NCT00134095S-1 and Irinotecan in Treating Patients Who Are Undergoing Surgery for Locally Advanced Stomach CancerP2unknown70Fukushima Medical University HospitalSep 2004
NCT00003711Combination Chemotherapy in Treating Patients With Metastatic Solid TumorsP1completed0San Antonio Cancer InstituteSep 1997
NCT00025285Combination Chemotherapy Plus Thalidomide in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerP2completed46Wake Forest University Health SciencesNov 2001
NCT00070434S0304 Induct Chemo Then Chemo-RT in Pts w/Locally Advanced Adenocarcinoma of the RectumP2withdrawn0SWOG Cancer Research NetworkAug 2004
NCT00004235Docetaxel and Irinotecan in Treating Patients With Advanced Cancer of the Esophagus or StomachP2completed47Alliance for Clinical Trials in OncologyJan 2000
NCT00053833S0025 Irinotecan in Treating Patients With Refractory Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube CancerP2terminated2SWOG Cancer Research NetworkApr 2003
NCT00003137Irinotecan in Treating Patients With Advanced Cancer of the StomachP2completed70Alliance for Clinical Trials in OncologyDec 1997
NCT00003245Irinotecan in Treating Patients With Recurrent or Refractory Non-Hodgkin's LymphomaP2completed50M.D. Anderson Cancer CenterFeb 1998
NCT00091312Fluorouracil and Irinotecan With or Without Leucovorin Compared With Observation in Treating Patients Who Have Undergone Surgery for Stage II Colon CancerP3unknown1,976Federation Francophone de Cancerologie DigestiveJun 2004
NCT00093353N2003-01N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant NeuroblastomaP1completed30New Approaches to Neuroblastoma Therapy ConsortiumMay 2004
NCT00079352Flavopiridol, Gemcitabine, and Irinotecan in Treating Patients With Unresectable or Metastatic Solid TumorsP1completed24National Cancer Institute (NCI)Apr 2004
NCT00084604Irinotecan, Cisplatin, and Bevacizumab in Treating Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction AdenocarcinomaP2completed47National Cancer Institute (NCI)Apr 2004
NCT00176774Irinotecan, 5-Fluorouracil, and Leucovorin in Colorectal CarcinomaP2completed24University of Michigan Rogel Cancer CenterFeb 2001
NCT00005638Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal CancerP1completed0Memorial Sloan Kettering Cancer CenterOct 1999
NCT00003753Floxuridine, Dexamethasone, and Irinotecan After Surgery in Treating Patients With Liver Metastases From Colorectal CancerP2completed0Memorial Sloan Kettering Cancer CenterSep 1998
NCT00003301Irinotecan in Treating Patients With Recurrent Malignant GliomaP1/P2completed0New Approaches to Brain Tumor Therapy ConsortiumJul 1998
NCT00003111Combination Chemotherapy Followed by Surgery in Treating Patients With Stage IIIA Non-small Cell Lung CancerP2completed10Yale UniversityApr 1997
NCT00220649Safety Study of Combination Chemotherapy in Patients With Metastatic Solid Tumors or Adenocarcinoma of the PancreasP1completed25St. Luke's-Roosevelt Hospital CenterMar 2004
NCT00084877Irinotecan and 3-AP in Treating Patients With Metastatic or Unresectable Solid TumorsP1completed36National Cancer Institute (NCI)Mar 2004
NCT00006000SU5416SU5416, Irinotecan, and Cisplatin in Treating Patients With Advanced Solid TumorsP1completed0Ohio State University Comprehensive Cancer CenterAug 2000
NCT00057473A Phase II Study of Carboplatin Plus Irinotecan Versus Irinotecan in Children With Refractory Solid TumorsP2completed0Bristol-Myers SquibbFeb 2003
NCT00020917Cetuximab Plus Combination Chemotherapy in Treating Patients With Stage IV Colorectal CancerP2completed0Memorial Sloan Kettering Cancer CenterFeb 2001
NCT00030862Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the EsophagusP2completed0Memorial Sloan Kettering Cancer CenterOct 2001
NCT00024284Carboplatin and Irinotecan in Treating Children With Refractory Solid TumorsP1completed0Bristol-Myers SquibbJun 2001
NCT00030797Combination Chemotherapy in Treating Patients With Advanced or Metastatic Colorectal CancerP2completed75Swiss Cancer InstituteFeb 2001
NCT00008060Combination Chemotherapy in Treating Patients With Unresectable Metastatic Colorectal CancerP3completed0Medical Research CouncilMay 2000
NCT00074321Irinotecan, Oxaliplatin, and Capecitabine in Treating Patients With Unresectable Solid TumorsP1completed84National Cancer Institute (NCI)Nov 2003
NCT00005626Phase II Trial With Correlative Laboratory Studies of Single Agent Irinotecan (Camptosar CPT-11)P2completed10H. Lee Moffitt Cancer Center and Research InstituteFeb 1998
NCT00075738Fluorouracil, Irinotecan, Leucovorin, and Cisplatin as First-Line Therapy in Treating Patients With Metastatic Esophageal CancerP2unknown0GERCOR - Multidisciplinary Oncology Cooperative GroupOct 2003
NCT00025168Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Unresectable Pancreatic CancerP2completed20Wake Forest University Health SciencesNov 2001
NCT00066391Irinotecan and Cisplatin in Treating Patients With Locally Advanced or Metastatic Penile CancerP2completed0European Organisation for Research and Treatment of Cancer - EORTCJun 2003
NCT00180960Treatment of a Cancerous Disease of the Peritoneum With Complete Cytoreductive Surgery and Intraperitoneal ChemohyperthermiaP2terminated100Gustave Roussy, Cancer Campus, Grand ParisJun 2003
NCT00005068Combination Chemotherapy In Treating Patients With Metastatic or Unresectable Solid TumorsP1completed0Mayo ClinicJan 2000
NCT00064181Combination Chemotherapy With or Without Celecoxib in Treating Patients With Metastatic Colorectal CancerP3completed86European Organisation for Research and Treatment of Cancer - EORTCMay 2003
NCT00062127Irinotecan and Thalidomide in Treating Patients With Advanced Solid TumorsP1completed35National Cancer Institute (NCI)Apr 2003
NCT00052494Combination Chemotherapy and Imatinib Mesylate in Treating Patients With Extensive-Stage Small Cell Lung CancerP1completed9University Health Network, TorontoApr 2003
NCT00287976Irinotecan in Treating Young Patients With Refractory or Recurrent HepatoblastomaP2unknown30Children's Cancer and Leukaemia GroupApr 2003
NCT00209638Phase I/II Study of Oral S-1 Plus Irinotecan in Patients With Advanced Gastric CancerP1/P2completed24Hokkaido Gastrointestinal Cancer Study GroupMay 2000
NCT00004068Irinotecan Followed by Radiation Therapy and Temozolomide in Treating Children With Newly Diagnosed Brain TumorP2completed53St. Jude Children's Research HospitalMar 1999
NCT00053144Irinotecan and Cytarabine in Treating Patients With Refractory or Recurrent Acute Myeloid Leukemia or Chronic Myelogenous LeukemiaP1completed0Roswell Park Cancer InstituteNov 1999
NCT00003867Irinotecan and Capecitabine in Treating Patients With Solid TumorsP1completed30Montefiore Medical CenterMar 1999
NCT00220168Phase II Trial Evaluating Irinotecan and Capecitabine Relapsed/Refractory Upper GI TumoursP4completed33Royal Marsden NHS Foundation TrustJan 2003
NCT00037180For Prevention of Diarrhea in Patients Diagnosed With Metastatic Colorectal Cancer Treated With ChemotherapyP2terminated212PfizerApr 2002
NCT00024141Irinotecan Followed by Fluorouracil in Treating Patients With Advanced Solid TumorsP1completed0Roswell Park Cancer InstituteMay 2001
NCT00819728CPT-11Trial of Weekly Taxotere and Irinotecan (CPT-11) in Patients With Advanced Non-small Cell Lung CancerP2completed35SanofiJun 2000
NCT00144378Irinotecan Versus Only Best Supportive Care for Gastric CancerP3completed44Charite University, Berlin, GermanyOct 2002
NCT00052585Gefitinib and Combination Chemotherapy in Treating Patients With Advanced or Recurrent Colorectal CancerP2terminated50National Cancer Institute (NCI)Oct 2002
NCT00004870Olimersen and Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal CancerP1/P2completed0The University of Texas Health Science Center at San AntonioJun 2000
NCT00023868Combination Chemotherapy With or Without Chemoembolization in Treating Patients With Colorectal Cancer Metastatic to the Liver (6655)P3terminated0American College of Radiology Imaging NetworkNov 2001
NCT00047242UCN-01 and Irinotecan in Treating Patients With Advanced Solid TumorsP1completed30Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsAug 2002
NCT00046917Combination Chemotherapy in Treating Patients With Advanced Solid TumorsP1completed13National Cancer Institute (NCI)Jul 2002
NCT00268398MIROXCombination Chemotherapy in Treating Patients With Colorectal Cancer and Resectable MetastasesP3completed284GERCOR - Multidisciplinary Oncology Cooperative GroupJul 2002
NCT00045604Imatinib Mesylate and Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung CancerP1completed0Memorial Sloan Kettering Cancer CenterJul 2002
NCT00003463Carmustine Wafers Plus Irinotecan in Treating Patients With Recurrent Supratentorial High Grade GliomasP1completed0Duke UniversityJul 1998
NCT00040391A Trial of an Investigational Drug for the Prevention of Diarrhea Associated With Irinotecan/5FU/Leucovorin Chemotherapy in Previously Untreated Metastatic Colorectal CancerP2terminated0Celgene CorporationJun 2002
NCT00075595Fluorouracil, Leucovorin, and Irinotecan in Treating Patients With Recurrent or Refractory Metastatic Unresectable Colorectal CancerP2unknown0GERCOR - Multidisciplinary Oncology Cooperative GroupJun 2002
NCT00004922Irinotecan in Treating Patients With Advanced Neuroendocrine TumorsP2completed0Memorial Sloan Kettering Cancer CenterJun 1999
NCT00042874Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid TumorsP1completed77National Cancer Institute (NCI)May 2002
NCT00037804Irinotecan in Treating Patients With Refractory Solid Tumors and Liver DysfunctionP1completed0Pfizer
NCT00006103Combination Chemotherapy in Treating Patients With Colorectal CancerP3completed400Alliance for Clinical Trials in OncologyJul 2000
NCT00003427Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal CancerP1completed36Memorial Sloan Kettering Cancer CenterApr 1998
NCT00002939Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent CancerP1completed21University of ChicagoNov 1996
NCT00034502A Trial of ALIMTA (Pemetrexed) Plus Irinotecan in Patients Who Have Been Previously Treated For Metastatic Colorectal Cancer.P1/P2completed0Eli Lilly and Company
NCT00039208Combination Chemotherapy in Treating Patients With Colorectal CancerP2completed0European Organisation for Research and Treatment of Cancer - EORTCFeb 2002
NCT000316817-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)P1completed41National Cancer Institute (NCI)Dec 2001
NCT00027833Vaccine Therapy and Chemotherapy With or Without Tetanus Toxoid Compared With Chemotherapy Alone in Treating Patients With Metastatic Colorectal CancerP2unknown0Herbert Irving Comprehensive Cancer CenterDec 2001
NCT00025363Comparison of Chemotherapy Regimens in Treating Children With Relapsed or Progressive RhabdomyosarcomaP2completed150National Cancer Institute (NCI)Nov 2001
NCT00026364ZD 1839 Plus Combination Chemotherapy in Treating Patients With Locally Advanced, Locally Recurrent, or Metastatic Colorectal CancerP1completed22National Cancer Institute (NCI)Nov 2001
NCT00006037Chemotherapy Plus IM-862 in Treating Patients With Metastatic Colorectal CancerP2terminated18University of Southern CaliforniaNov 1999
NCT00003345Cisplatin Plus Irinotecan in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal CancerP2completed35Memorial Sloan Kettering Cancer CenterOct 1997
NCT00544778Combination Chemotherapy and Dexrazoxane Followed by Surgery and Radiation Therapy in Treating Patients With Advanced Soft Tissue Sarcoma or Recurrent Bone SarcomaP2terminated7City of Hope Medical CenterAug 2001
NCT00003742Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid TumorsP1completed0Memorial Sloan Kettering Cancer CenterOct 1998
NCT00003225Amifostine Plus Irinotecan in Treating Patients With Metastatic Colorectal CancerP1/P2completed23Jonsson Comprehensive Cancer CenterJul 1997
NCT00021073Combination Chemotherapy in Treating Patients With Advanced CancerP1completed90National Cancer Institute (NCI)May 2001
NCT00003710Irinotecan Plus Mitomycin in Treating Patients With Advanced Solid TumorsP1completed12The University of Texas Health Science Center at San AntonioAug 1998
NCT00144053A Phase Ⅲ Randomized Study of Mitomycin/Vindesine/Cisplatin Versus Irinotecan/Carboplatin Versus Paclitaxel/Carboplatin With Concurrent Thoracic Radiotherapy for Unresectable Stage Ⅲ Non-Small-Cell Lung CancerP3completed450West Japan Thoracic Oncology GroupApr 2001
NCT00003055Cisplatin and Irinotecan in Treating Patients With Locally Advanced or Metastatic Esophageal or Gastric CancerP2completed0Memorial Sloan Kettering Cancer CenterJun 1997
NCT02118064CC6Phase II Study to Evaluate G17DT in Combination With Irinotecan in Patients With Colorectal CarcinomaP2completed161Cancer Advances Inc.Mar 2001
NCT00003544Irinotecan in Treating Patients With Metastatic Colorectal CancerP2completed0Memorial Sloan Kettering Cancer CenterJun 1998
NCT00003276Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct CancerP2completed40Alliance for Clinical Trials in OncologyMar 1998
NCT00020488Combination Chemotherapy in Treating Patients Who Have Advanced Solid TumorsP1completed0National Cancer Institute (NCI)Feb 2001
NCT00006366Radiation Therapy Plus Chemotherapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the RectumP2completed0Radiation Therapy Oncology GroupFeb 2001
NCT00003843Irinotecan in Treating Patients With Colorectal Cancerterminated28California Cancer ConsortiumOct 1998
NCT00026273Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients Following Surgery for Stage III Colorectal CancerP3completed0PfizerJan 2001
NCT00003109Irinotecan Plus Raltitrexed in Treating Patients With Refractory Solid TumorsP1completed39Fox Chase Cancer CenterDec 1997
NCT00002933Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal CancerP2completed21Case Comprehensive Cancer CenterSep 1996
NCT00021281Combination Chemotherapy With or Without SU5416 in Treating Patients With Metastatic Colorectal CancerP3unknown0Jonsson Comprehensive Cancer CenterDec 2000
NCT00002988Irinotecan Plus Carmustine in Treating Patients With Recurrent Primary Malignant GliomaP1completed36Duke UniversityApr 1997
NCT00001495CPT-11A Phase I Study of Irinotecan (CPT-11) Administered as a Prolonged Infusion in Adult Patients With Solid TumorsP1completed40National Cancer Institute (NCI)Nov 1995
NCT00006485Flavopiridol and Irinotecan in Treating Patients With Advanced Solid TumorsP1completed0Memorial Sloan Kettering Cancer CenterSep 2000
NCT00004182Irinotecan in Treating Patients With Metastatic or Recurrent Breast CancerP2completed0Northwestern UniversityOct 1999
NCT00005818SU5416 and Irinotecan in Treating Patients With Advanced Colorectal CancerP1/P2completed68National Cancer Institute (NCI)Mar 2000
NCT00005607Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Cancer of the Stomach or EsophagusP2unknown0Robert H. Lurie Cancer CenterFeb 2000
NCT00003344Radiation Therapy Plus Irinotecan in Treating Patients With Colon CancerP1/P2completed49Medical University of South CarolinaAug 1998
NCT00006269Octreotide in the Prevention of Diarrhea in Patients Receiving Irinotecan for Metastatic Colon CancerP3terminated89NovartisDec 1999
NCT00004919Irinotecan and Cisplatin With or Without Amifostine in Treating Children With Solid Tumors That Have Not Responded to Previous TherapyP1completed30National Cancer Institute (NCI)Dec 1999
NCT00005036Irinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal CancerP3completed560National Cancer Institute (NCI)Nov 1999
NCT00004078Irinotecan in Treating Children With Refractory Solid TumorsP2completed181Children's Oncology GroupOct 1999
NCT00003995Monoclonal Antibody Plus Chemotherapy in Treating Patients With Advanced Colorectal Cancer That Overexpresses HER2P2completed32National Cancer Institute (NCI)Sep 1999
NCT00004885Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients With Metastatic Colorectal CancerP3completed430European Organisation for Research and Treatment of Cancer - EORTCJul 1999
NCT00003835Combination Chemotherapy in Treating Patients With Stage III Colon CancerP3completed1,260National Cancer Institute (NCI)May 1999
NCT00010036Carboplatin Plus Irinotecan in Treating Patients With Glioblastoma MultiformeP2completed0NYU Langone HealthMay 1999
NCT00006115Combination Chemotherapy in Treating Patients With Metastatic Colorectal CancerP2unknown0GERCOR - Multidisciplinary Oncology Cooperative GroupApr 1999
NCT00003970Genetic Testing Plus Irinotecan in Treating Patients With Solid Tumors or LymphomaP1completed60National Cancer Institute (NCI)Jan 1999
NCT00003260Combination Chemotherapy in Treating Patients With Recurrent Metastatic Colorectal CancerP3unknown109GERCOR - Multidisciplinary Oncology Cooperative GroupJan 1998
NCT00003719Irinotecan in Treating Patients With Stage IV or Recurrent Soft Tissue SarcomaP2unknown27Herbert Irving Comprehensive Cancer CenterJul 1997
NCT00002902Irinotecan Plus ICI D1694 in Treating Patients With Advanced Solid TumorsP1completed0Abramson Cancer Center at Penn MedicineApr 1997
NCT00002759Irinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or LymphomaP1completed3National Cancer Institute (NCI)Jun 1996

Irinotecan clinical trials: frequently asked questions

How many Irinotecan clinical trials are there?
1344 Irinotecan clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 178 are actively recruiting participants. 638 are marked completed.
Are Irinotecan clinical trials recruiting in 2026?
Yes — 178 Irinotecan trials are actively recruiting in 2026, with 2591 U.S. sites across 51 states. See the recruiting trials and the per-state site list further down this page.
What conditions is Irinotecan being studied for?
Irinotecan is being studied for Colorectal Cancer, Metastatic Colorectal Cancer, Gastric Cancer, Pancreatic Cancer, Esophageal Cancer and 1223 more. The trials are grouped by indication on this page.
What phase is Irinotecan in?
Irinotecan clinical trials span 15 Phase 4, 172 Phase 3, 684 Phase 2, 266 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
Who sponsors Irinotecan clinical trials?
The lead sponsor across the most Irinotecan trials is National Cancer Institute (NCI), with 491 additional lead sponsors listed in the data. Each trial row links to the full study detail page including sponsor information.

Sources and methodology

Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming Irinotecanas an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.

Last refreshed .

Related pages on Hipa.ai: